CN1578785A - 预防和治疗脑膜炎球菌性疾病的新型免疫原性组合物 - Google Patents
预防和治疗脑膜炎球菌性疾病的新型免疫原性组合物 Download PDFInfo
- Publication number
- CN1578785A CN1578785A CNA028233301A CN02823330A CN1578785A CN 1578785 A CN1578785 A CN 1578785A CN A028233301 A CNA028233301 A CN A028233301A CN 02823330 A CN02823330 A CN 02823330A CN 1578785 A CN1578785 A CN 1578785A
- Authority
- CN
- China
- Prior art keywords
- composition
- seq
- protein
- antigen
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 490
- 230000002163 immunogen Effects 0.000 title claims abstract description 93
- 208000037941 meningococcal disease Diseases 0.000 title description 16
- 230000002265 prevention Effects 0.000 title description 9
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 331
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 239
- 241000588653 Neisseria Species 0.000 claims abstract description 49
- 150000007523 nucleic acids Chemical group 0.000 claims abstract description 26
- 208000015181 infectious disease Diseases 0.000 claims abstract description 17
- 230000001580 bacterial effect Effects 0.000 claims description 477
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 449
- 239000002773 nucleotide Substances 0.000 claims description 245
- 235000018102 proteins Nutrition 0.000 claims description 229
- 125000003729 nucleotide group Chemical group 0.000 claims description 223
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 161
- 241000588650 Neisseria meningitidis Species 0.000 claims description 155
- 239000000427 antigen Substances 0.000 claims description 151
- 108091007433 antigens Proteins 0.000 claims description 149
- 102000036639 antigens Human genes 0.000 claims description 149
- 235000001014 amino acid Nutrition 0.000 claims description 138
- 238000000034 method Methods 0.000 claims description 133
- 229920001184 polypeptide Polymers 0.000 claims description 133
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 132
- 238000002360 preparation method Methods 0.000 claims description 117
- 230000005847 immunogenicity Effects 0.000 claims description 108
- 102000040430 polynucleotide Human genes 0.000 claims description 107
- 108091033319 polynucleotide Proteins 0.000 claims description 107
- 239000002157 polynucleotide Substances 0.000 claims description 107
- 210000004027 cell Anatomy 0.000 claims description 103
- 150000001413 amino acids Chemical class 0.000 claims description 92
- 108700026244 Open Reading Frames Proteins 0.000 claims description 83
- 230000014509 gene expression Effects 0.000 claims description 62
- 239000002671 adjuvant Substances 0.000 claims description 46
- 239000013612 plasmid Substances 0.000 claims description 46
- 108090001030 Lipoproteins Proteins 0.000 claims description 42
- 102000004895 Lipoproteins Human genes 0.000 claims description 42
- 239000012634 fragment Substances 0.000 claims description 38
- 241000894006 Bacteria Species 0.000 claims description 33
- 239000003153 chemical reaction reagent Substances 0.000 claims description 32
- 238000006243 chemical reaction Methods 0.000 claims description 27
- -1 thinner Substances 0.000 claims description 27
- 241000124008 Mammalia Species 0.000 claims description 26
- 241000588652 Neisseria gonorrhoeae Species 0.000 claims description 26
- 239000000126 substance Substances 0.000 claims description 25
- 238000001890 transfection Methods 0.000 claims description 24
- 230000000855 fungicidal effect Effects 0.000 claims description 19
- 230000004044 response Effects 0.000 claims description 17
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 16
- 239000000872 buffer Substances 0.000 claims description 16
- 201000010099 disease Diseases 0.000 claims description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 16
- 150000004676 glycans Chemical class 0.000 claims description 16
- 229920001282 polysaccharide Polymers 0.000 claims description 16
- 239000005017 polysaccharide Substances 0.000 claims description 16
- 238000000926 separation method Methods 0.000 claims description 15
- 238000001819 mass spectrum Methods 0.000 claims description 14
- 241001465754 Metazoa Species 0.000 claims description 13
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims description 13
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims description 13
- 230000036039 immunity Effects 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 13
- 238000009396 hybridization Methods 0.000 claims description 12
- 238000000746 purification Methods 0.000 claims description 10
- 230000001404 mediated effect Effects 0.000 claims description 8
- 108700022034 Opsonin Proteins Proteins 0.000 claims description 7
- 239000003937 drug carrier Substances 0.000 claims description 7
- 230000001900 immune effect Effects 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 230000028993 immune response Effects 0.000 claims description 6
- 210000004408 hybridoma Anatomy 0.000 claims description 5
- 238000001727 in vivo Methods 0.000 claims description 5
- 230000002458 infectious effect Effects 0.000 claims description 5
- 206010027202 Meningitis bacterial Diseases 0.000 claims description 4
- 201000009904 bacterial meningitis Diseases 0.000 claims description 4
- 230000001717 pathogenic effect Effects 0.000 claims description 4
- 238000010254 subcutaneous injection Methods 0.000 claims description 4
- 239000007929 subcutaneous injection Substances 0.000 claims description 4
- 241001478240 Coccus Species 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 238000003780 insertion Methods 0.000 claims description 3
- 230000037431 insertion Effects 0.000 claims description 3
- 230000006798 recombination Effects 0.000 claims description 3
- 238000005215 recombination Methods 0.000 claims description 3
- 229920002401 polyacrylamide Polymers 0.000 claims 10
- 238000002105 Southern blotting Methods 0.000 claims 9
- 210000004877 mucosa Anatomy 0.000 claims 5
- 102000008133 Iron-Binding Proteins Human genes 0.000 claims 4
- 108010035210 Iron-Binding Proteins Proteins 0.000 claims 4
- 241001515965 unidentified phage Species 0.000 claims 4
- 239000012535 impurity Substances 0.000 claims 2
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims 1
- 238000003499 nucleic acid array Methods 0.000 claims 1
- 239000002853 nucleic acid probe Substances 0.000 claims 1
- 241000588677 Neisseria meningitidis serogroup B Species 0.000 abstract description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 263
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 259
- 230000035800 maturation Effects 0.000 description 255
- 108020004414 DNA Proteins 0.000 description 69
- 210000002966 serum Anatomy 0.000 description 66
- 229940024606 amino acid Drugs 0.000 description 64
- 102220023258 rs387907548 Human genes 0.000 description 56
- 102220369447 c.1352G>A Human genes 0.000 description 55
- 150000001875 compounds Chemical class 0.000 description 45
- 241000700605 Viruses Species 0.000 description 37
- 150000002632 lipids Chemical group 0.000 description 36
- 102220004457 rs11567847 Human genes 0.000 description 36
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 33
- 108010076504 Protein Sorting Signals Proteins 0.000 description 30
- 241000699666 Mus <mouse, genus> Species 0.000 description 29
- 230000008859 change Effects 0.000 description 27
- 238000003752 polymerase chain reaction Methods 0.000 description 27
- 239000013598 vector Substances 0.000 description 27
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 24
- 230000004927 fusion Effects 0.000 description 22
- 241000701161 unidentified adenovirus Species 0.000 description 22
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 21
- DRHZYJAUECRAJM-DWSYSWFDSA-N (2s,3s,4s,5r,6r)-6-[[(3s,4s,4ar,6ar,6bs,8r,8ar,12as,14ar,14br)-8a-[(2s,3r,4s,5r,6r)-3-[(2s,3r,4s,5r,6s)-5-[(2s,3r,4s,5r)-4-[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-5-[(3s,5s, Chemical compound O([C@H]1[C@H](O)[C@H](O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2[C@@]1(C=O)C)O)C(=O)O[C@@H]1O[C@H](C)[C@@H]([C@@H]([C@H]1O[C@H]1[C@@H]([C@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@](O)(CO)CO3)O)[C@H](O)CO2)O)[C@H](C)O1)O)O)OC(=O)C[C@@H](O)C[C@H](OC(=O)C[C@@H](O)C[C@@H]([C@@H](C)CC)O[C@H]1[C@@H]([C@@H](O)[C@H](CO)O1)O)[C@@H](C)CC)C(O)=O)[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O DRHZYJAUECRAJM-DWSYSWFDSA-N 0.000 description 19
- 230000003321 amplification Effects 0.000 description 19
- 102220369445 c.668T>C Human genes 0.000 description 19
- 239000000284 extract Substances 0.000 description 19
- 238000003199 nucleic acid amplification method Methods 0.000 description 19
- 229960005486 vaccine Drugs 0.000 description 18
- 239000000523 sample Substances 0.000 description 17
- 239000011780 sodium chloride Substances 0.000 description 17
- 241001430294 unidentified retrovirus Species 0.000 description 17
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 16
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 16
- 239000003599 detergent Substances 0.000 description 16
- 230000000968 intestinal effect Effects 0.000 description 16
- 230000001954 sterilising effect Effects 0.000 description 16
- 238000005406 washing Methods 0.000 description 16
- 238000005516 engineering process Methods 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 238000004458 analytical method Methods 0.000 description 14
- 102000039446 nucleic acids Human genes 0.000 description 14
- 108020004707 nucleic acids Proteins 0.000 description 14
- 238000004659 sterilization and disinfection Methods 0.000 description 14
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 13
- 238000012408 PCR amplification Methods 0.000 description 13
- 241000588724 Escherichia coli Species 0.000 description 12
- 101710116435 Outer membrane protein Proteins 0.000 description 12
- 239000004202 carbamide Substances 0.000 description 12
- 230000029087 digestion Effects 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- 102220023257 rs387907546 Human genes 0.000 description 12
- 108091035707 Consensus sequence Proteins 0.000 description 11
- 229920004890 Triton X-100 Polymers 0.000 description 11
- 239000013592 cell lysate Substances 0.000 description 11
- 235000013372 meat Nutrition 0.000 description 11
- 230000008521 reorganization Effects 0.000 description 11
- 238000011160 research Methods 0.000 description 11
- 238000012216 screening Methods 0.000 description 11
- 235000014347 soups Nutrition 0.000 description 11
- 238000006557 surface reaction Methods 0.000 description 11
- 206010008631 Cholera Diseases 0.000 description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 230000002950 deficient Effects 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 210000004379 membrane Anatomy 0.000 description 10
- 239000012528 membrane Substances 0.000 description 10
- 230000002441 reversible effect Effects 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 239000003053 toxin Substances 0.000 description 10
- 231100000765 toxin Toxicity 0.000 description 10
- 108700012359 toxins Proteins 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 235000014676 Phragmites communis Nutrition 0.000 description 9
- 239000013599 cloning vector Substances 0.000 description 9
- 238000013016 damping Methods 0.000 description 9
- 238000010586 diagram Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000012530 fluid Substances 0.000 description 9
- 239000000499 gel Substances 0.000 description 9
- 230000001939 inductive effect Effects 0.000 description 9
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 8
- 230000000295 complement effect Effects 0.000 description 8
- 238000010790 dilution Methods 0.000 description 8
- 239000012895 dilution Substances 0.000 description 8
- 230000008034 disappearance Effects 0.000 description 8
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 8
- 241000606768 Haemophilus influenzae Species 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 210000003000 inclusion body Anatomy 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 239000002953 phosphate buffered saline Substances 0.000 description 7
- 239000007921 spray Substances 0.000 description 7
- 238000012546 transfer Methods 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 6
- 208000034762 Meningococcal Infections Diseases 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 108020004511 Recombinant DNA Proteins 0.000 description 6
- 238000012300 Sequence Analysis Methods 0.000 description 6
- 239000000654 additive Substances 0.000 description 6
- 230000000996 additive effect Effects 0.000 description 6
- 102220369446 c.1274G>A Human genes 0.000 description 6
- 230000001419 dependent effect Effects 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 230000001976 improved effect Effects 0.000 description 6
- 239000008101 lactose Substances 0.000 description 6
- 231100000350 mutagenesis Toxicity 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 238000012163 sequencing technique Methods 0.000 description 6
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 6
- 241000702421 Dependoparvovirus Species 0.000 description 5
- 201000009906 Meningitis Diseases 0.000 description 5
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 5
- 108091081024 Start codon Proteins 0.000 description 5
- 241000193998 Streptococcus pneumoniae Species 0.000 description 5
- SRBFZHDQGSBBOR-QMKXCQHVSA-N alpha-L-arabinopyranose Chemical compound O[C@H]1CO[C@@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-QMKXCQHVSA-N 0.000 description 5
- 230000000890 antigenic effect Effects 0.000 description 5
- 239000007853 buffer solution Substances 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 238000007405 data analysis Methods 0.000 description 5
- 238000012217 deletion Methods 0.000 description 5
- 230000037430 deletion Effects 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 238000000502 dialysis Methods 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 238000002649 immunization Methods 0.000 description 5
- 238000011081 inoculation Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000002703 mutagenesis Methods 0.000 description 5
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 5
- 238000002741 site-directed mutagenesis Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 4
- 239000002033 PVDF binder Substances 0.000 description 4
- 229920001213 Polysorbate 20 Polymers 0.000 description 4
- 108020005038 Terminator Codon Proteins 0.000 description 4
- 230000000692 anti-sense effect Effects 0.000 description 4
- 125000002091 cationic group Chemical group 0.000 description 4
- 239000013611 chromosomal DNA Substances 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 238000004043 dyeing Methods 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000009257 reactivity Effects 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 238000012882 sequential analysis Methods 0.000 description 4
- ZNJHFNUEQDVFCJ-UHFFFAOYSA-M sodium;2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid;hydroxide Chemical compound [OH-].[Na+].OCCN1CCN(CCS(O)(=O)=O)CC1 ZNJHFNUEQDVFCJ-UHFFFAOYSA-M 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 241001529453 unidentified herpesvirus Species 0.000 description 4
- 102000014914 Carrier Proteins Human genes 0.000 description 3
- 108010078791 Carrier Proteins Proteins 0.000 description 3
- 108060003951 Immunoglobulin Proteins 0.000 description 3
- 206010027249 Meningitis meningococcal Diseases 0.000 description 3
- 201000010924 Meningococcal meningitis Diseases 0.000 description 3
- 108091061960 Naked DNA Proteins 0.000 description 3
- 239000013504 Triton X-100 Substances 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000008827 biological function Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 230000007717 exclusion Effects 0.000 description 3
- 108020001507 fusion proteins Proteins 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 102000018358 immunoglobulin Human genes 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 238000004255 ion exchange chromatography Methods 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- XUWPJKDMEZSVTP-LTYMHZPRSA-N kalafungina Chemical compound O=C1C2=C(O)C=CC=C2C(=O)C2=C1[C@@H](C)O[C@H]1[C@@H]2OC(=O)C1 XUWPJKDMEZSVTP-LTYMHZPRSA-N 0.000 description 3
- 239000002502 liposome Substances 0.000 description 3
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000017854 proteolysis Effects 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000004885 tandem mass spectrometry Methods 0.000 description 3
- 210000002845 virion Anatomy 0.000 description 3
- 238000009736 wetting Methods 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 description 2
- HKJKONMZMPUGHJ-UHFFFAOYSA-N 4-amino-5-hydroxy-3-[(4-nitrophenyl)diazenyl]-6-phenyldiazenylnaphthalene-2,7-disulfonic acid Chemical compound OS(=O)(=O)C1=CC2=CC(S(O)(=O)=O)=C(N=NC=3C=CC=CC=3)C(O)=C2C(N)=C1N=NC1=CC=C([N+]([O-])=O)C=C1 HKJKONMZMPUGHJ-UHFFFAOYSA-N 0.000 description 2
- WRDABNWSWOHGMS-UHFFFAOYSA-N AEBSF hydrochloride Chemical compound Cl.NCCC1=CC=C(S(F)(=O)=O)C=C1 WRDABNWSWOHGMS-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 102000009016 Cholera Toxin Human genes 0.000 description 2
- 108010049048 Cholera Toxin Proteins 0.000 description 2
- 241000759568 Corixa Species 0.000 description 2
- 238000001712 DNA sequencing Methods 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 210000000712 G cell Anatomy 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 2
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 101710183187 Major outer membrane lipoprotein Proteins 0.000 description 2
- 206010058858 Meningococcal bacteraemia Diseases 0.000 description 2
- 241001597008 Nomeidae Species 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 241000193996 Streptococcus pyogenes Species 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 108700019146 Transgenes Proteins 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 241000700618 Vaccinia virus Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 230000003302 anti-idiotype Effects 0.000 description 2
- 239000000074 antisense oligonucleotide Substances 0.000 description 2
- 238000012230 antisense oligonucleotides Methods 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000009668 clonal growth Effects 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 230000009260 cross reactivity Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 238000000326 densiometry Methods 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 108700004026 gag Genes Proteins 0.000 description 2
- 101150098622 gag gene Proteins 0.000 description 2
- 238000001415 gene therapy Methods 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229930186900 holotoxin Natural products 0.000 description 2
- 239000003547 immunosorbent Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 208000022089 meningococcemia Diseases 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- BSOQXXWZTUDTEL-ZUYCGGNHSA-N muramyl dipeptide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-ZUYCGGNHSA-N 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 238000012510 peptide mapping method Methods 0.000 description 2
- 235000013550 pizza Nutrition 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 235000019419 proteases Nutrition 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 235000004252 protein component Nutrition 0.000 description 2
- 238000001742 protein purification Methods 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
- 241000701447 unidentified baculovirus Species 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 229940125575 vaccine candidate Drugs 0.000 description 2
- WDQLRUYAYXDIFW-RWKIJVEZSA-N (2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-4-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 WDQLRUYAYXDIFW-RWKIJVEZSA-N 0.000 description 1
- YHQZWWDVLJPRIF-JLHRHDQISA-N (4R)-4-[[(2S,3R)-2-[acetyl-[(3R,4R,5S,6R)-3-amino-4-[(1R)-1-carboxyethoxy]-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-3-hydroxybutanoyl]amino]-5-amino-5-oxopentanoic acid Chemical compound C(C)(=O)N([C@@H]([C@H](O)C)C(=O)N[C@H](CCC(=O)O)C(N)=O)C1[C@H](N)[C@@H](O[C@@H](C(=O)O)C)[C@H](O)[C@H](O1)CO YHQZWWDVLJPRIF-JLHRHDQISA-N 0.000 description 1
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 1
- VLEIUWBSEKKKFX-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O VLEIUWBSEKKKFX-UHFFFAOYSA-N 0.000 description 1
- KMEMIMRPZGDOMG-UHFFFAOYSA-N 2-cyanoethoxyphosphonamidous acid Chemical compound NP(O)OCCC#N KMEMIMRPZGDOMG-UHFFFAOYSA-N 0.000 description 1
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 241000272478 Aquila Species 0.000 description 1
- 238000011725 BALB/c mouse Methods 0.000 description 1
- 101001044037 Bacillus subtilis (strain 168) Lipoprotein LipO Proteins 0.000 description 1
- 108700026810 Bacteria SecB Proteins 0.000 description 1
- 241000589969 Borreliella burgdorferi Species 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 101150044789 Cap gene Proteins 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 102100038909 Caveolin-2 Human genes 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 101100290057 Drosophila virilis Mal-B1 gene Proteins 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000740981 Homo sapiens Caveolin-2 Proteins 0.000 description 1
- 102000009786 Immunoglobulin Constant Regions Human genes 0.000 description 1
- 108010009817 Immunoglobulin Constant Regions Proteins 0.000 description 1
- 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 1
- 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 101150062031 L gene Proteins 0.000 description 1
- 241001417534 Lutjanidae Species 0.000 description 1
- 208000016604 Lyme disease Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000713869 Moloney murine leukemia virus Species 0.000 description 1
- 241000713862 Moloney murine sarcoma virus Species 0.000 description 1
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 208000002740 Muscle Rigidity Diseases 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- 108700015872 N-acetyl-nor-muramyl-L-alanyl-D-isoglutamine Proteins 0.000 description 1
- 108700020354 N-acetylmuramyl-threonyl-isoglutamine Proteins 0.000 description 1
- 241000588649 Neisseria lactamica Species 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108700006640 OspA Proteins 0.000 description 1
- 101710105714 Outer surface protein A Proteins 0.000 description 1
- 101150093715 P4 gene Proteins 0.000 description 1
- 101150093941 PORA gene Proteins 0.000 description 1
- 241001631646 Papillomaviridae Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108010013639 Peptidoglycan Proteins 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 101710118538 Protease Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241001068295 Replication defective viruses Species 0.000 description 1
- 241000714474 Rous sarcoma virus Species 0.000 description 1
- 239000012722 SDS sample buffer Substances 0.000 description 1
- 238000010847 SEQUEST Methods 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 229920002305 Schizophyllan Polymers 0.000 description 1
- 108091003202 SecA Proteins Proteins 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 241000713896 Spleen necrosis virus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 1
- PRTVVLKKLCSOAR-UHFFFAOYSA-N [O].OCCO Chemical compound [O].OCCO PRTVVLKKLCSOAR-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910021502 aluminium hydroxide Inorganic materials 0.000 description 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- KLOHDWPABZXLGI-YWUHCJSESA-M ampicillin sodium Chemical compound [Na+].C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)=CC=CC=C1 KLOHDWPABZXLGI-YWUHCJSESA-M 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 230000030741 antigen processing and presentation Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229960003150 bupivacaine Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical group 0.000 description 1
- 238000005277 cation exchange chromatography Methods 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004182 chemical digestion Methods 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 229950001485 cocarboxylase Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000024835 cytogamy Effects 0.000 description 1
- 238000005947 deacylation reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000001739 density measurement Methods 0.000 description 1
- 238000011026 diafiltration Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- KAKKHKRHCKCAGH-UHFFFAOYSA-L disodium;(4-nitrophenyl) phosphate;hexahydrate Chemical compound O.O.O.O.O.O.[Na+].[Na+].[O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 KAKKHKRHCKCAGH-UHFFFAOYSA-L 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 108700004025 env Genes Proteins 0.000 description 1
- 101150030339 env gene Proteins 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 230000000799 fusogenic effect Effects 0.000 description 1
- 238000001476 gene delivery Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 108060003552 hemocyanin Proteins 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 230000009851 immunogenic response Effects 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000005040 ion trap Methods 0.000 description 1
- MVFCKEFYUDZOCX-UHFFFAOYSA-N iron(2+);dinitrate Chemical compound [Fe+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O MVFCKEFYUDZOCX-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- SXQFCVDSOLSHOQ-UHFFFAOYSA-N lactamide Chemical compound CC(O)C(N)=O SXQFCVDSOLSHOQ-UHFFFAOYSA-N 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- 229960001708 magnesium carbonate Drugs 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- OUHCLAKJJGMPSW-UHFFFAOYSA-L magnesium;hydrogen carbonate;hydroxide Chemical compound O.[Mg+2].[O-]C([O-])=O OUHCLAKJJGMPSW-UHFFFAOYSA-L 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- JMUHBNWAORSSBD-WKYWBUFDSA-N mifamurtide Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCC)COP(O)(=O)OCCNC(=O)[C@H](C)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O JMUHBNWAORSSBD-WKYWBUFDSA-N 0.000 description 1
- 229960005225 mifamurtide Drugs 0.000 description 1
- 108700007621 mifamurtide Proteins 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- ZAHQPTJLOCWVPG-UHFFFAOYSA-N mitoxantrone dihydrochloride Chemical compound Cl.Cl.O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO ZAHQPTJLOCWVPG-UHFFFAOYSA-N 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229940045641 monobasic sodium phosphate Drugs 0.000 description 1
- 229940035032 monophosphoryl lipid a Drugs 0.000 description 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
- 229940031348 multivalent vaccine Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229940052778 neisseria meningitidis Drugs 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000006548 oncogenic transformation Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000026792 palmitoylation Effects 0.000 description 1
- 229940049547 paraxin Drugs 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 238000013326 plasmid cotransfection Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 108700004029 pol Genes Proteins 0.000 description 1
- 101150088264 pol gene Proteins 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 108010055896 polyornithine Proteins 0.000 description 1
- 229920002714 polyornithine Polymers 0.000 description 1
- 210000004896 polypeptide structure Anatomy 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000000734 protein sequencing Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 101150066583 rep gene Proteins 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000009991 scouring Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 208000018316 severe headache Diseases 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 1
- 230000004960 subcellular localization Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- YXVCLPJQTZXJLH-UHFFFAOYSA-N thiamine(1+) diphosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N YXVCLPJQTZXJLH-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 108010087967 type I signal peptidase Proteins 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2414—Alpha-amylase (3.2.1.1.)
- C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2465—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase (3.2.1.22)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
- C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/22—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Neisseriaceae (F), e.g. Acinetobacter
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
Abstract
本发明涉及奈瑟球菌属ORF2086蛋白、交叉反
应免疫原性蛋白,可从奈瑟氏球菌属菌株分离或用重组方法制
备,包括其免疫原性部分、其生物学等价物、免疫特异性结合
上述蛋白质的抗体以及编码上述蛋白质的核酸序列,以及在有
效对抗脑膜炎奈瑟氏球菌血清组B感染的免疫原性组合物中
的应用。
Description
发明领域
本发明涉及奈瑟氏球菌属ORF2086蛋白(亚科A和亚科B),它可从奈瑟氏球菌属的菌株以及免疫原性部分和/或所述蛋白的生物学等价物分离,所述菌株包括脑膜炎奈瑟氏球菌(Neisseria meningitidis)(血清组A、B、C、D、W-135、X、Y、Z和29E)、淋病奈瑟氏球菌(Neisseria gonorrhoeae)和乳糖奈瑟氏球菌(Neisserialactamica)菌株。本发明还涉及免疫特异性结合所述蛋白质、免疫原性蛋白和/或生物学等价物的抗体。此外,本发明涉及分离含有编码任何上述蛋白质、免疫原性部分、生物学等价物和/或抗体的核酸序列的多核苷酸。此外,本发明涉及免疫原性组合物及其在预防、治疗和/或诊断由脑膜炎奈瑟氏球菌引起的脑膜炎球菌感染,尤其是由脑膜炎奈瑟氏球菌血清组b引起的脑膜炎球菌性疾病中的应用,以及制备所述组合物的方法。本发明涉及重组形式和分离自天然来源的形式,以及脂质化和非脂质化的形式。
发明背景
尽管可利用抗生素,但脑膜炎球菌性脑膜炎仍是一种可以使儿童和青少年在数小时内死亡的疾病。Pizza等,2000,Science 287:1816-1820。脑膜炎以脑膜发炎为特征,这会导致剧烈头痛、发烧、丧失食欲、对光和声不耐受、肌肉僵硬,尤其是颈部肌肉僵硬,严重时会导致抽搐、呕吐和谵妄,从而导致死亡。脑膜炎球菌性脑膜炎症状突然出现,最终将导致脑膜炎球菌性败血症,其特征为出血性皮疹。如果有任何存活机会都要紧急进行快速诊断和用大剂量抗生素立即治疗。《Bantam医学词典》(Bantam Medical Dictionary),第三版,302,200。
脑膜炎球菌性脑膜炎是由脑膜炎奈瑟氏球菌(脑膜炎球菌)引起的,这是一种革兰氏阴性、有荚膜的细菌,被分成几个病原血清组,包括A、B、C、D、W-135、X、Y、Z和29E。脑膜炎奈瑟氏球菌的血清组B菌株是全世界脑膜炎球菌性疾病的主要原因。例如医学文献中报道,在美国和欧洲,婴儿和儿童的细菌性脑膜炎约50%是由血清组b引起的。目前还没有预防由脑膜炎奈瑟氏球菌血清组b引起的脑膜炎球菌性疾病的疫苗。
自从Goldschneider等的工作以来,30多年前,开发预防血清组B脑膜炎球菌性疾病的免疫原性组合物对于研究人员是一种挑战。Goldschneider等,1969,J.Exp.Med 129(6):1307-26;Goldschneider等,1969,J.Exp.Med 129(6):1327-48;Gotschlich等,1969,J.Exp.Med.129(6):1385-95;和Gotschlich等,1969,J.Exp.Med.129(6):1367-84。与血清组A疾病不同,二战后,这种疾病在北美洲实际上已经消失,Achtman,M.,1995,Trends in Microbiology 3(5):186-92,由血清组B和C生物引起的疾病在很多经济发达国家仍旧是一种地方病。疾病的发病率<1/100,000,而在流行时,高危人群中地方病的发病率200/100,000是罕见的。
已经开发了抗脑膜炎奈瑟氏球菌血清组A和C的基于多糖结合物的疫苗,这种疫苗似乎有效预防疾病。目前已经有用血清组A、C、Y和W-135荚膜多糖制造的免疫原性组合物。Ambrosch等,1983,“一种新型四价的免疫原性和副作用”,Bulletinof the World Health Organization 61(2):317-23。然而,这种免疫原性组合物引发一种不依赖T-细胞的免疫应答,这在儿童中无效,且不能对付造成50%以上脑膜炎球菌性疾病的血清组B菌株。
其它人也试图用荚膜多糖开发免疫原性组合物。最近,将血清组C荚膜物质与蛋白质结合制成的血清组C疾病的免疫原性组合物在欧洲已被许可使用。然而,血清组B荚膜不适合作为疫苗候选物,因为这种荚膜多糖是由聚唾液酸构成的,它与发育中的人神经组织上的碳水化合物部分类似。这种糖部分被识别为自身抗原,因此对人的免疫原性弱。
外膜蛋白(OMP)被开发作为血清组B疾病疫苗抗原的替代品。与PorA两个可变区结合的单克隆抗体确定了脑膜炎球菌的血清亚分类方案。PorA蛋白因此作为脑膜炎球菌菌株的血清亚分类抗原(Abdillahi等,1988,Microbial Pathogenesis4(1):27-32),并被作为血清组B免疫原性组合物的组分而被广泛研究(Poolman,1996,Adv.Exp.Med.Biol.397:73-7),因为它们可引发杀菌抗体(Saukkonen,1987,Microbial Pathogenesis 3(4):261-7)。杀菌抗体被认为是保护作用的指示剂,任何新的免疫原性组合物候选物都应该能够引发这些功能性抗体。
人和动物研究表明,血清亚分类抗原PorA引发杀菌抗体。然而,对PorA的免疫应答通常是血清亚型特异的。特别地,血清亚分类数据表明,由PorA制得的免疫原性组合物需要各个血清亚型的PorA都被这样一种免疫原性组合物覆盖,可能多达6-9个。因此,将需要6-9个PorA来覆盖70-80%血清组B菌株。因此,这种蛋白质的可变特性需要一种多价疫苗组合物来抵抗足量的脑膜炎球菌血清亚型临床隔离群。
开发血清组B脑膜炎球菌的免疫原性组合物非常困难,最近,一些研究小组测序了代表血清组A和B菌株的基因组以帮助鉴定新型免疫原性组合物的候选物。Tettelin,2000,Science,287(5459):1809-15;Pizza等,2000,Science287:1816-1820。即便了解了奈瑟氏球菌的基因组,鉴定新型免疫原性组合物候选物也是一种挑战过程,因为现在还没有合适的数学算法。实际上,一项最近的报道声称,尽管已经鉴定了数百个包含理论跨膜区的开放阅读框(“ORFs”),与表达、纯化、诱导表面反应和功能活性抗体有关的问题使研究者只发现了七种血清组B脑膜炎球菌性免疫原性组合物的候选物。参见同前。其中一种已知。
因此,需要一种免疫原性组合物,这种组合物可以(1)引发多种奈瑟氏球菌菌株的杀菌抗体;(2)与多个菌株的表面反应;(3)赋予抗生物攻击(live challenge)的被动保护;和/或(4)防止集落形成。
发明概述
为满足这些要求和其它要求,本发明提供了奈瑟氏球菌ORF2086蛋白(“2086蛋白”),包括2086亚科A蛋白和2086亚科B蛋白。各个2086蛋白都是可以分离自天然奈瑟氏球菌菌株的蛋白,包括脑膜炎奈瑟氏球菌(血清组A、B、C、D、W-135、X、Y、Z和29E),淋病奈瑟氏球菌和乳糖奈瑟氏球菌菌株。2086蛋白也可用重组技术制备。
特别地,本发明提供了2086蛋白、其免疫原性部分和/或其生物学等价物,与上述任一免疫特异性结合的抗体,以及包含编码上述任一的核酸序列的多核苷酸。本发明包括组合物、免疫原性组合物及其在预防、治疗和/或诊断脑膜炎球菌感染,尤其是脑膜炎奈瑟氏球菌引起的脑膜炎球菌性疾病中的应用,以及制备所述组合物的方法。这里所述2086蛋白包括重组形式和分离自天然来源的形式以及脂质化和非脂质化的形式。
本发明意外地且有利地提供了组合物,所述组合物(1)引发多种奈瑟氏球菌菌株的杀菌抗体,所述菌株如脑膜炎奈瑟氏球菌、淋病奈瑟氏球菌和/或乳糖奈瑟氏球菌菌株;(2)与多个菌株的表面反应;(3)赋予抗生物攻击的被动保护;和/或(4)防止集落形成,以及使用所述组合物的方法和制备所述组合物的方法。下面描述了本发明的各种实施方案。
附图简述
图1a描述了SDS-PAGE凝胶,它描述了实验获得的蛋白质组分的两种主要蛋白,该实验是为了鉴定奈瑟氏菌的膜蛋白提取物能够引发抗异源菌株的杀菌抗体。
图1B描述了通过蛋白酶消化和反相N-末端测序分析TMAE流过组分鉴定两种主要蛋白的实验结果。
图2描述了纯化方案和用SDS-PAGE确定rLP2086的均一性。
图3描述了通过LC-MS/MS和相应的SDS-PAGE分析TMAE流过组分鉴定两种主要蛋白和一种次要蛋白的实验结果。
图4是2086蛋白重组表达的SDS-PAGE凝胶。
图5是质粒pPX7340的示意图,如这里的实施例所述。
图6是质粒pPX7328的示意图,如这里的实施例所述。
图7是质粒pPX7343示意图,如这里的实施例所述。
图8描述了各种菌株2086基因的N-末端区域。
图9A是鉴定奈瑟氏球菌菌株中免疫原性组分最初步骤的流程图。
图9B是鉴定奈瑟氏球菌菌株中免疫原性组分最终步骤的流程图。
图10A是pBAD阿拉伯糖可诱导启动子的示意图,它驱动P4信号/ORF2086融合蛋白的表达以表达rP2086的脂质化形式,如这里的实施例所述。
图10B是用于重组表达ORF2086的非脂质化形式的pET9a-T7载体的示意图。
图11A是代表表达rLP2086蛋白的大肠杆菌B全细胞裂解物的照片。
图11B是代表表达rP2086蛋白的大肠杆菌B全细胞裂解物的照片。
图12是显示ORF2086蛋白亚科和类别的结构的系统树。
图13是rLP2086亚科A抗血清的全细胞ELISA数据的图示。
图14是rLP2086亚科B抗血清的全细胞ELISA数据的图示。
图15是rLP2086混合研究(mixing study)-WCE效价结果的图示。
图16是rLP2086/rPorA混合研究-WCE效价结果的图示。
图17是显示rLP2086鼠抗血清对P2086亚科B脑膜炎奈瑟氏球菌全细胞裂解物反应性的Western印迹。
图18是显示rLP2086鼠抗血清对P2086亚科A脑膜炎奈瑟氏球菌和乳糖奈瑟氏球菌全细胞裂解物反应性的Western印迹。
序列概述
用于研究的序列的SEQ ID NOS.:
SEQ ID NO:1当与天然前导序列结合时,编码L3 6275菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:2用天然前导序列制备的L3 6275菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:3当与P4前导序列结合时,编码L3 6275菌株的成熟2086蛋白的氨基酸序列的核酸序列
SEQ ID NO:4用P4前导序列制备的L3 6275菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:5编码L3 6275菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:6L3 6275菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:7当与天然前导序列结合时,编码CDC2369菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:8用天然前导序列制备的CDC2369菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:9当与P4前导序列结合时,编码CDC2369菌株的成熟2086蛋白的氨基酸序列的核酸序列
SEQ ID NO:10用P4前导序列制备的CDC2369菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:11编码CDC2369菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:12 CDC2369菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:13当与天然前导序列结合时,编码CDC1034菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:14用天然前导序列制备的CDC1034菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:15当与P4前导序列结合时,编码CDC1034菌株的成熟2086蛋白的氨基酸序列的核酸序列
SEQ ID NO:16用P4前导序列制备的CDC1034菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:17编码CDC1034菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:18 CDC1034菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:19当与天然前导序列结合时,编码L4 891菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:20用天然前导序列制备的L4 891菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:21当与P4前导序列结合时,编码L4 891菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:22用P4前导序列制备的L4 891菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:23编码L4 891菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:24 L4 891菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:25当与天然前导序列结合时,编码B16B6菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:26用天然前导序列制备的B16B6菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:27当与P4前导序列结合时,编码B16B6菌株的成熟2086蛋白的氨基酸序列的核酸序列
SEQ ID NO:28用P4前导序列制备的B16B6菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:29编码B16B6菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:30 B16B6菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:31当与天然前导序列结合时,编码W135(ATCC35559)菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:32用天然前导序列制备的W135(ATCC35559)菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:33当与P4前导序列结合时,编码W135(ATCC35559)菌株的成熟2086蛋白的氨基酸序列的核酸序列
SEQ ID NO:34用P4前导序列制备的W135(ATCC35559)菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:35编码W135(ATCC35559)菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:36W135(ATCC35559)菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:37当与天然前导序列结合时,编码C11菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:38用天然前导序列制备的C11菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:39当与P4前导序列结合时,编码C11菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:40用P4前导序列制备的C11菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:41编码C11菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:42 C11菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:43当与天然前导序列结合时,编码Y(ATCC35561)菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:44用天然前导序列制备的Y(ATCC35561)菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:45当与P4前导序列结合时,编码Y(ATCC35561)菌株的成熟2086蛋白的氨基酸序列的核酸序列
SEQ ID NO:46用P4前导序列制备的Y(ATCC35561)菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:47编码Y(ATCC35561)菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:48 Y(ATCC35561)菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:49当与天然前导序列结合时,编码M98 250732菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:50用天然前导序列制备的M98 250732菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:51当与P4前导序列结合时,编码M98 250732菌株的成熟2086蛋白的氨基酸序列的核酸序列
SEQ ID NO:52用P4前导序列制备的M98 250732菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:53编码M98 250732菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:54 M98 250732菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:55当与天然前导序列结合时,编码M98 250771菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:56用天然前导序列制备的M98 250771菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:57当与P4前导序列结合时,编码M98 250771菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:58用P4前导序列制备的M98 250771菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:59编码M98 250771菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:60 M98 250771菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:61当与天然前导序列结合时,编码CDC1135菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:62用天然前导序列制备的CDC1135菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:63当与P4前导序列结合时,编码CDC1135菌株的成熟2086蛋白的氨基酸序列的核酸序列
SEQ ID NO:64用P4前导序列制备的CDC1135菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:65编码CDC1135菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:66CDC1135菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:67当与天然前导序列结合时,编码M97 252153菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:68用天然前导序列制备的M97 252153菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:69当与P4前导序列结合时,编码M97 252153菌株的成熟2086蛋白的氨基酸序列的核酸序列
SEQ ID NO:70用P4前导序列制备的M97 252153菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:71编码M97 252153菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:72 M97 252153菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:73当与天然前导序列结合时,编码CDC1610菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:74用天然前导序列制备的CDC1610菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:75当与P4前导序列结合时,编码CDC1610菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:76用P4前导序列制备的CDC1610菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:77编码CDC1610菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:78 CDC1610菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:79当与天然前导序列结合时,编码CDC1492菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:80用天然前导序列制备的CDC1492菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:81当与P4前导序列结合时,编码CDC1492菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:82用P4前导序列制备的CDC1492菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:83编码CDC1492菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:84 CDC1492菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:85当与天然前导序列结合时,编码L8 M978菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:86用天然前导序列制备的L8 M978菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:87当与P4前导序列结合时,编码L8 M978菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:88用P4前导序列制备的L8 M978菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:89编码L8 M978菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:90 L8 M978菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:91当与天然前导序列结合时,编码M97 252988菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:92用天然前导序列制备的M97 252988菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:93当与P4前导序列结合时,编码M97 252988菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:94用P4前导序列制备的M97 252988菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:95编码M97 252988菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:96M97 252988菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:97当与天然前导序列结合时,编码M97 252697菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:98用天然前导序列制备的M97 252697菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:99当与P4前导序列结合时,编码M97 252697菌株的成熟2086蛋白的氨基酸序列的核酸序列
SEQ ID NO:100用P4前导序列制备的M97 252697菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:101编码M97 252697菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:102 M97 252697菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:103当与天然前导序列结合时,编码6557菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:104用天然前导序列制备的6557菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:105当与P4前导序列结合时,编码6557菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:106用P4前导序列制备的6557菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:107编码6557菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:108 6557菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:109当与天然前导序列结合时,编码2996菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:110用天然前导序列制备的2996菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:111当与P4前导序列结合时,编码2996菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:112用P4前导序列制备的2996菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:113编码2996菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:114 2996菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:115当与天然前导序列结合时,编码M97 252976菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:116用天然前导序列制备的M97 252976菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:117当与P4前导序列结合时,编码M97 252976菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:118用P4前导序列制备的M97 252976菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:119编码M97 252976菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:120 M97 252976菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:121当与天然前导序列结合时,编码M97 251854菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:122用天然前导序列制备的M97 251854菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:123当与P4前导序列结合时,编码M97 251854菌株的成熟2086蛋白的氨基酸序列的核酸序列
SEQ ID NO:124用P4前导序列制备的M97 251854菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:125编码M97 251854菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:126M97 251854菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:127当与天然前导序列结合时,编码CDC1521菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:128用天然前导序列制备的CDC1521菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:129当与P4前导序列结合时,编码CDC1521菌株的成熟2086蛋白的氨基酸序列的核酸序列
SEQ ID NO:130用P4前导序列制备的CDC1521菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:131编码CDC1521菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:132 CDC1521菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:133当与天然前导序列结合时,编码M98 250622菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:134用天然前导序列制备的M98 250622菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:135当与P4前导序列结合时,编码M98 250622菌株的成熟2086蛋白的氨基酸序列的核酸序列
SEQ ID NO:136用P4前导序列制备的M98 250622菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:137编码M98 250622菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:138 M98 250622菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:139当与天然前导序列结合时,编码870446菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:140用天然前导序列制备的870446菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:141当与P4前导序列结合时,编码870446菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:142用P4前导序列制备的870446菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:143编码870446菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:144 870446菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:145当与天然前导序列结合时,编码M97 253248菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:146用天然前导序列制备的M97 253248菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:147当与P4前导序列结合时,编码M97 253248菌株的成熟2086蛋白的氨基酸序列的核酸序列
SEQ ID NO:148用P4前导序列制备的M97 253248菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:149编码M97 253248菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:150 M97 253248菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:151当与天然前导序列结合时,编码M98 250809菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:152用天然前导序列制备的M98 250809菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:153当与P4前导序列结合时,编码M98 250809菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:154用P4前导序列制备的M98 250809菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:155编码M98 250809菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:156M98 250809菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:157当与天然前导序列结合时,编码L5 M981菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:158用天然前导序列制备的L5 M981菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:159当与P4前导序列结合时,编码L5 M981菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:160用P4前导序列制备的L5 M981菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:161编码L5 M981菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:162 L5 M981菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:163当与天然前导序列结合时,编码NMB菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:164用天然前导序列制备的NMB菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:165当与P4前导序列结合时,编码NMB菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:166用P4前导序列制备的NMB菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:167编码NMB菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:168 NMB菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:169当与天然前导序列结合时,编码M98 250572菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:170用天然前导序列制备的M98 250572菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:171当与P4前导序列结合时,编码M98 250572菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:172用P4前导序列制备的M98 250572菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:173编码M98 250572菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:174 M98 250572菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:175当与天然前导序列结合时,编码A4 Sanford;M97 251836PART;M97 251957;M97 251985;M97 252060;M97 251870;M97 251994;M98 250024;M97 251905;M97 251876;M97 251898;或M97 251830菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:176用天然前导序列制备的A4 Sanford;M97 251836PART;M97251957;M97 251985;M97 252060;M97 251870;M97 251994;M98 250024;M97 251905;M97 251876;M97 251898;或M97 251830菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:177当与P4前导序列结合时,编码A4 Sanford;M97 251836PART;M97 251957;M97 251985;M97 252060;M97 251870;M97 251994;M98 250024;M97 251905;M97 251876;M97 251898;或M97 251830菌株的成熟2086蛋白的氨基酸序列的核酸序列
SEQ ID NO:178用P4前导序列制备的A4 Sanford;M97 251836PART;M97 251957;M97 251985;M97 252060;M97 251870;M97 251994;M98 250024;M97 251905;M97 251876;M97 251898;或M97 251830菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:179编码A4 Sanford;M97 251836PART;M97 251957;M97 251985;M97 252060;M97 251870;M97 251994;M98 250024;M97 251905;M97 251876;M97 251898;或M97 251830菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:180 A4 Sanford;M97 251836PART;M97 251957;M97 251985;M97252060;M97 251870;M97 251994;M98 250024;M97 251905;M97 251876;M97 251898;或M97 251830菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:181当与天然前导序列结合时,编码CDC937菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:182用天然前导序列制备的CDC937菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:183当与P4前导序列结合时,编码CDC937菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:184用P4前导序列制备的CDC937菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:185编码CDC937菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:186CDC937菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:187当与天然前导序列结合时,编码M97 252097菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:188用天然前导序列制备的M97 252097菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:189当与P4前导序列结合时,编码M97 252097菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:190用P4前导序列制备的M97 252097菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:191编码M97 252097菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:192 M97 252097菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:193当与天然前导序列结合时,编码870227菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:194用天然前导序列制备的870227菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:195当与P4前导序列结合时,编码870227菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:196用P4前导序列制备的870227菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:197编码870227菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:198 870227菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:199当与天然前导序列结合时,编码H355菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:200用天然前导序列制备的H355菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:201当与P4前导序列结合时,编码H355菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:202用P4前导序列制备的H355菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:203编码H355菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:204 H355菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:205当与天然前导序列结合时,编码H44_76菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:206用天然前导序列制备的H44_76菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:207用P4前导序列制备的H44_76菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:208编码H44_76菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:209当与P4前导序列结合时,编码H44_76菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:210 H44_76菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:211当与天然前导序列结合时,编码8529菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:212用天然前导序列制备的8529菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:213当与P4前导序列结合时,编码8529菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:214用P4前导序列制备的8529菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:215编码8529菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:2168529菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:217当与天然前导序列结合时,编码6940菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:218用天然前导序列制备的6940菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:219当与P4前导序列结合时,编码6940菌株的成熟2086蛋白的氨基酸序列的核酸序列
SEQ ID NO:220用P4前导序列制备的6940菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:221编码6940菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:222 6940菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:223当与天然前导序列结合时,编码M982菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:224用天然前导序列制备的M982菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:225当与P4前导序列结合时,编码M982菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:226用P4前导序列制备的M982菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:227编码M982菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:228 M982菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:229当与天然前导序列结合时,编码880049菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:230用天然前导序列制备的880049菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:231当与P4前导序列结合时,编码880049菌株的成熟2086蛋白的氨基酸序列的核酸序列
SEQ ID NO:232用P4前导序列制备的880049菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:233编码880049菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:234 880049菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:235当与天然前导序列结合时,编码M97 253524、M97 251885和M97 251926菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:236用天然前导序列制备的M97 253524、M97 251885和M97 251926菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:237当与P4前导序列结合时,编码M97 253524、M97 251885和M97251926菌株的成熟2086蛋白的氨基酸序列的核酸序列
SEQ ID NO:238用P4前导序列制备的M97 253524、M97 251885和M97 251926菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:239编码M97 253524、M97 251885和M97 251926菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:240 M97 253524、M97 251885和M97 251926菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:241当与天然前导序列结合时,编码M98 250670菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:242用天然前导序列制备的M98 250670菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:243当与P4前导序列结合时,编码M98 250670菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:244用P4前导序列制备的M98 250670菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:245编码M98 250670菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:246M98 250670菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:247当与天然前导序列结合时,编码CDC1573菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:248用天然前导序列制备的CDC1573菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:249当与P4前导序列结合时,编码CDC1573菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:250用P4前导序列制备的CDC1573菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:251编码CDC1573菌株的成熟2086蛋白的氨基酸序列的核酸序列。
SEQ ID NO:252 CDC1573菌株的成熟2086蛋白的氨基酸序列。
SEQ ID NO:253编码乳酰胺奈瑟氏球菌菌株的2086蛋白的氨基酸序列的部分核酸序列。
SEQ ID NOS:254-259与蛋白质的2086家族的蛋白结合的氨基酸序列。
SEQ ID NOS:260-278与2086亚科A的蛋白结合的氨基酸序列。
SEQ ID NOS:279-299与2086亚科B的蛋白结合的氨基酸序列。
SEQ ID NO:300是与本发明实施方案所述2086蛋白家族(“2086蛋白”)相应的氨基酸共有序列。
SEQ ID NO:301是与本发明实施方案所述2086蛋白亚科A相应的氨基酸共有序列。
SEQ ID NO:302是与本发明实施方案所述2086蛋白亚科B相应的氨基酸共有序列。
SEQ ID NO:303带有BamHI限制位点的反向引物的核酸序列(化合物编号:4623)。
SEQ ID NO:304带有NdeI限制位点的正向引物的核酸序列(化合物编号:4624)。
SEQ ID NO:305正向引物的核酸序列(化合物编号:4625)。
SEQ ID NO:306正向引物的核酸序列(化合物编号:5005)。
SEQ ID NO:307反向引物的核酸序列(化合物编号:5007)。
SEQ ID NO:308带有BglII限制位点的反向引物的核酸序列(化合物编号:5135)。
SEQ ID NO:309带有BamHI限制位点的正向引物的核酸序列(化合物编号:5658)。
SEQ ID NO:310带有SphI限制位点的反向引物的核酸序列(化合物编号:5660)。
SEQ ID NO:311带有BamHI限制位点的正向引物的核酸序列(化合物编号:6385)。
SEQ ID NO:312带有BglII和NdeI限制位点的正向引物的核酸序列(化合物编号:6406)。
SEQ ID NO:313正向引物的核酸序列(化合物编号:6470)。
SEQ ID NO:314反向引物的核酸序列(化合物编号:6472)。
SEQ ID NO:315带有BamHI限制位点的正向引物的核酸序列(化合物编号6473)。
SEQ ID NO:316带有BglII和NdeI限制位点的正向引物的核酸序列(化合物编号:6474)。
SEQ ID NO:317正向引物的核酸序列(化合物编号:6495)。
SEQ ID NO:318反向引物的核酸序列(化合物编号:6496)。
SEQ ID NO:319带有SphI限制位点的反向引物的核酸序列(化合物编号:6543)。
SEQ ID NO:320带有BglII限制位点的反向引物的核酸序列(化合物编号:6605)。
SEQ ID NO:321带有BglII和NdeI限制位点的正向引物的核酸序列(化合物编号:6721)。
SEQ ID NO:322 P4前导序列的核酸序列。
SEQ ID NO:323天然2086前导序列变体1的核酸序列。
SEQ ID NO:324天然2086前导序列变体2的核酸序列。
SEQ ID NO:325天然2086前导序列变体3的核酸序列。
SEQ ID NO:326天然2086前导序列变体4的核酸序列。
SEQ ID NO:327 P4431的氨基酸序列。
SEQ ID NO:328 P5163的氨基酸序列。
SEQ ID NO:329是本发明实施方案的氨基酸序列。
发明详述
一类新的具有抗脑膜炎奈瑟氏球菌血清组B的交叉功能杀菌活性的抗原可避免对多价PorA的需求以进行抗感染免疫。这种抗原被意外识别并在这里被描述和要求权利。首先在脑膜炎球菌菌株的可溶性外膜蛋白(sOMP)的复杂混合物中观察到这种抗原。通过一系列分级和蛋白质纯化步骤直到感兴趣的蛋白质混合物仅含有少数蛋白而发现这种抗原的杀菌活性。通过N-末端氨基酸测序和肽作图鉴定了这种混合物中的主要蛋白质。具有杀菌活性的感兴趣的蛋白质被鉴定为ORF2086蛋白,这是一种脂质化蛋白质(也被称为LP2086)。“ORF2086蛋白”是指一种由奈瑟氏球菌属的开放阅读框2086(ORF2086)编码的蛋白质。
新的免疫原性组合物在这里是指分离自脑膜炎奈瑟氏球菌的基于奈瑟氏球菌属ORF2086蛋白(也称为“2086蛋白”或“ORF2086”蛋白质,在这里可替换使用,或P2086(指非脂质化蛋白)和LP2086(指蛋白的脂质化形式))的候选物,它通过合并细胞分级分离,不同洗涤剂提取、蛋白质纯化,以及制备抗血清并用多种菌株进行杀菌活性测定而鉴定。作为潜在的免疫原性组合物和上述参考资料中所述诊断方法的替代品,本发明涉及组合物以及通过使用蛋白质、其免疫原性部分和其生物学等价物,及编码所述多肽、蛋白质和等价物的基因以及与其免疫特异性结合的抗体治疗和/或预防脑膜炎球菌感染的方法。
根据本发明的实施方案,基于上述试剂显示的交叉反应性或非菌株特异性,包括分离的多肽、其免疫原性部分和/或其生物学等价物的基于2086蛋白的免疫原性试剂被意外确定为免疫原性候选物。特别地,所述候选物出乎意料地被鉴定出具有以下能力:(1)引发多种奈瑟氏球菌和/或淋球菌菌株的杀菌抗体;(2)与多个菌株的表面反应;(3)赋予抗生物攻击的被动保护;和/或(4)防止集落形成。因此,本发明提供了包含所述免疫原性试剂的免疫原性组合物,包括分离的多肽、其免疫原性部分和/或其生物学等价物,以及使用它们抵抗脑膜炎奈瑟氏球菌感染的方法。(参见这里的实施例1用于鉴定2086蛋白的方法。)
术语“非菌株特异”在这里指抗原引发抗一种以上脑膜炎奈瑟氏球菌菌株(例如异源脑膜炎球菌菌株)的免疫应答效应的特性。术语“交叉反应”在这里可与术语“非菌株特异”互换使用。术语“免疫原性非菌株特异性脑膜炎奈瑟氏球菌抗原”在这里描述可分离自脑膜炎奈瑟氏球菌的抗原,尽管它也可分离自其它细菌(例如其它奈瑟氏球菌菌株,如淋球菌菌株),或用重组技术制备。
本发明的2086蛋白包括脂质化和非脂质化的蛋白。此外,本发明还试图将与各个蛋白质相应的不成熟蛋白或前蛋白用作中间化合物/组合物。
根据本发明的实施,本发明还提供了与上述免疫原性试剂免疫特异结合的抗体。此外,本发明涉及包含编码上述任一的核酸序列的分离的多核苷酸。因此,本发明提供了组合物和/或免疫原性组合物以及它们在预防、治疗和/或诊断脑膜炎球菌性脑膜炎,尤其是血清组B脑膜炎球菌性疾病中的应用,以及制备所述组合物的方法。
本发明的组合物具有高免疫原性并能够引发杀菌抗体的产生。这些抗体与异源血清组、血清型和血清亚型的脑膜炎球菌菌株交叉反应。因此,本发明的组合物克服了以前脑膜炎奈瑟氏球菌疫苗的不足,它具有对异源奈瑟氏球菌菌株引发杀菌抗体的能力。因此,本发明提供了可与较少组分结合而产生保护作用的免疫原性组合物,这种保护作用可与先前使用的试剂相比,这是本发明的其它优点。所述组合物或免疫原性试剂(例如多肽、免疫原性部分或片段和生物学等价物等,但不限于此)可单独使用或与其它抗原或试剂一起使用以引发对脑膜炎球菌感染和疾病的免疫保护,以及引发对其它病原体引起的感染和/或疾病的免疫保护。由于减少了抗多种菌株所需的抗原的数量,这样就简化了用来抗脑膜炎球菌感染的免疫原性组合物的设计。实际上,纯化的2086蛋白将显著地并出乎意料地减少提供足够的引起脑膜炎球菌性疾病的菌株的免疫原性所需的蛋白数量。所述2086蛋白可在大肠杆菌中作为脂蛋白重组表达,这是蛋白质的野生形式,其表达水平远高于天然脑膜炎球菌。
由于发现来自一种菌株的抗2086蛋白的抗体可杀死不相关的(即异源的)菌株,我们试图表征大量异源菌株以确定存在“2086同源物”,并确定序列保守的水平。尽管用PCR测得约70%的菌株具有2086同源物,这种同源物可用扩增起始2086基因的引物从菌株8529扩增,但其余约30%对这种测试呈阴性。余下的约30%被发现含有与来自2086基因的起始8529仅有约60%氨基酸序列同源性的2086同源物。其它引物被确定可从这些约30%的菌株扩增2086同源物。所测脑膜炎奈瑟氏球菌菌株属于亚科A或亚科B,这取决于可扩增2086同源物的引物。这些实验的细节描述在下面的实施例5中。
2086蛋白在各种血清亚型中的存在情况
为确定脑膜炎奈瑟氏球菌菌株之间2086基因的序列保守水平,克隆了亚科A和B的一些代表的全长基因并进行了DNA序列分析。用这里所述的引物,例如参见表IV,鉴定了24种表达不同血清亚型抗原且也表达共享蛋白P2086的血清组B脑膜炎球菌菌株。这些序列的例子在这里提供并作为成熟DNA序列显示(即在半胱氨酸残基切除所有脂蛋白信号序列)。例如参见偶数编号的SEQ ID NOS:2-252的氨基酸序列,但不限于此。
由于2086蛋白不大量出现在野生型菌株中,它是杀菌抗体的靶。这些抗体不同于响应PorA产生的抗体,能够杀死表达异源血清亚型的菌株。
2086蛋白的抗体还可被动保护幼鼠免遭脑膜炎球菌攻击(见表VII)。2086蛋白的重组表达使得可用2086蛋白作为免疫原性组合物以预防脑膜炎球菌性疾病。临床实验中所有新近的脑膜炎球菌性免疫原性组合物的候选物都是含有许多不同蛋白的复杂混合物或外膜蛋白制品。提供血清亚型特异性的PorA蛋白质需要一种免疫原性组合物中含有6-9种变异体以覆盖约70-80%疾病相关的血清亚型。相反,这里清楚证明,一种2086蛋白的抗血清能够杀死6种血清亚型的代表,在西欧和美国它们引起约65%的疾病隔离群。因此,纯化的2086蛋白具有减少提供足够覆盖引起脑膜炎球菌性疾病的血清亚型的免疫原性组合物所需的蛋白数量的潜力。
蛋白质、免疫原性蛋白和生物学等价物
本发明提供的2086蛋白是分离的蛋白质。术语“分离的”是指用人手从天然状态改变。如果“分离的”组合物或物质在自然界存在,则它已经被改变或从其原始环境除去,或者两者同时发生。例如天然出现在活动物中的多肽或多核苷酸不是“分离的”,但相同的分离自其天然状态共存物质的相同多肽或多核苷酸是“分离的”,如这里所用的术语。因此,术语“分离的蛋白质”在这里包括分离自天然来源的蛋白和用重组技术制备的蛋白,以及与其它抗原和/或添加剂组合的蛋白,添加剂如药学上可接受的载体、缓冲剂、佐剂等。
根据本发明的实施方案,2086蛋白、其免疫原性部分和/或其生物学等价物包含以下任何氨基酸序列:
ADIGxGLADA(SEQ ID NO:254),其中,x是任何氨基酸;
IGxGLADALT(SEQ ID NO:255),其中,x是任何氨基酸;
SLNTGKLKND(SEQ ID NO:256);
SLNTGKLKNDKxSRFDF(SEQ ID NO:257,其中,x是任何氨基酸);
SGEFQxYKQ(SEQ ID NO:258),其中,x是任何氨基酸;或
IEHLKxPE(SEQ ID NO:259),其中,x是任何氨基酸。
根据本发明的实施方案,2086亚科A蛋白质,其免疫原性部分和/或其生物学等价物包含以下任何氨基酸序列:
GGGVAADIGx(SEQ ID NO:260),其中,x是任何氨基酸;
SGEFQIYKQ(SEQ ID NO:261);
HSAVVALQIE(SEQ ID NO:262);
EKINNPDKID(SEQ ID NO:263);
SLINQRSFLV(SEQ ID NO:264);
SGLGGEHTAF(SEQ ID NO:265);
GEHTAFNQLP(SEQ ID NO:266);
SFLVSGLGGEH(SEQ ID NO:267);
EKINNPDKIDSLINQRSFLVSGLGGEHTAFNQLP(SEQ ID NO:268);
GKAEYHGKAF(SEQ ID NO:269);
YHGKAFSSDD(SEQ ID NO:270);
GKAEYHGKAFSSDD(SEQ ID NO:271);
IEHLKTPEQN(SEQ ID NO:272);
KTPEQNVELA(SEQ ID NO:273);
IEHLKTPEQNVELA(SEQ ID NO:274);
AELKADEKSH(SEQ ID NO:275);
AVILGDTRYG(SEQ ID NO:276);
AELKADEKSHAVILGDTRYG(SEQ ID NO:277);或
EEKGTYHLAL(SEQ ID NO:278)。
2086亚科B蛋白质、其免疫原性部分和/或其生物学等价物,包含以下任何如本发明实施方案所述的氨基酸序列:
LITLESGEFQ(SEQ ID NO:279);
SALTALQTEQ(SEQ ID NO:280);
FQVYKQSHSA(SEQ ID NO:281);
LITLESGEFQVYKQSHSALTALQTEQ(SEQ ID NO:282);
IGDIAGEHTS(SEQ ID NO:283);
EHTSFDKLPK(SEQ ID NO:284);
IGDIAGEHTSFDKLPK(SEQ ID NO:285);
ATYRGTAFGS(SEQ ID NO:286);
DDAGGKLTYT(SEQ ID NO:287);
IDFAAKQGHG(SEQ ID NO:288);
KIEHLKSPEL(SEQ ID NO:289);
ATYRGTAFGSDDAGGKLTYTIDFAAKQGHGKIEHLKSPELNV(SEQ ID NO:290);
HAVISGSVLY(SEQ ID NO:291);
KGSYSLGIFG(SEQ ID NO:292);
VLYNQDEKGS(SEQ ID NO:293);
HAVISGSVLYNQDEKGSYSLGIFG(SEQ ID NO:294);
AQEVAGSAEV(SEQ ID NO:295);
IHHIGLAAKQ(SEQ ID NO:296);
VETANGIHHI(SEQ ID NO:297);
AQEVAGSAEVETANGIHHIGLAAKQ(SEQ ID NO:298);或
VAGSAEVETANGIHHIGLAAKQ(SEQ ID NO:299)。
所述2086蛋白包括以下如本发明实施方案所述的共有序列和/或其免疫原性部分。
2086蛋白共有序列(SEQ ID NO:300):
CSSG-----GGGVxADIGxGLADALTxPxDxKDKxLxSLTLxxSxxxNxxLxLxAQGA
EKTxxxGD---SLNTGKLKNDKxSRFDFxxxIxVDGxxITLxSGEFQxYKQxHSAxx
ALQxExxxxxxxxxxxxxxRxFxxxxxxGEHTxFxxLPxx-xAxYxGxAFxSDDxxGxLxYx
IDFxxKQGxGxIEHLKxPExNVxLAxxxxKxDEKxHAVIxGxxxYxxxEKGxYxLxxxGxxAQExAGxAxVxxxxxxHxIxxAxKQ
在上述共有序列中,“x”表示任何氨基酸,氨基酸位置5-9的区域是任何0-5个氨基酸,氨基酸位置67-69的区域是任何0-3个氨基酸,同时氨基酸位置156是任何0-1个氨基酸。氨基酸位置5-9的区域优选包含0、4或5个氨基酸。氨基酸位置67-69的区域优选包含0或3个氨基酸。特别值得一提的是,这种共有序列说明了2086蛋白的高变异性。根据理论,但不局限于此,这种高变异性被认为提供了有利且未预料的交叉反应性。
根据本发明的一个实施方案,所述2086蛋白以免疫原性、非病原的和非菌株特异为特征。此外,根据本发明再一个实施方案,这些蛋白意外地具有免疫原性,尽管约2%-约40%是非保守的。
术语“非保守的”在这里指可以发生插入、取代和/或缺失的氨基酸数目占蛋白质中总氨基酸数目的百分比。例如,如果蛋白质有40%是非保守的并有例如263个氨基酸,则蛋白质中有105个氨基酸位置上的氨基酸可以发生取代。同样,如果蛋白质有10%是非保守的并有例如约280个氨基酸,则有28个氨基酸位置上的氨基酸可发生取代。所述2086蛋白不包含蛋白质免疫原性的氨基酸残基也可发生缺失。
此外,可基于不同区域的同源性将所述2086蛋白分成亚科。例如,下面提供了共有序列的两个亚科,亚科A和亚科B,但不局限于此:
2086亚科A序列(SEQ ID 301)
CSSG----GGGVAADIGxGLADALTxPxDxKDKxLxSLTLxxSxxxNxxLxLxAQGA
EKTxxxGD---SLNTGKLKNDKxSRFDFxxxIxVDGQxITLxSGEFQIYKQxHSAVV
ALQIEKINNPDKIDSLINQRSFLVSGLGGEHTAFNQLPxGKAEYHGKAFSSDDxxGxLxYxIDFxxKQGxGxIEHLKTPEQNVELAxAELKADEKSHAVILGDTRYGxEEKGTYHLALxGDRAQEIAGxATVKIxEKVHEIxIAxKQ
“x”是任何氨基酸。
氨基酸位置5-8的区域是任何0-4个氨基酸。
氨基酸位置66-68的区域是任何0-3个氨基酸。
氨基酸位置5-8的区域优选包含0或4个氨基酸。氨基酸位置66-68的区域优选包含0或3个氨基酸。
2086亚科B(SEQ ID 302)
CSSGGGG-----VxADIGxGLADALTAPLDHKDKxLxSLTLxxSxxxNxxLxLxAQ
GAEKTYGNGDSLNTGKLKNDKVSRFDFIRQIEVDGxLITLESGEFQVYKQSHSALTALQTEQxQDxExSxKMVAKRxFxIGDIAGEHTSFDKLPKxxxATYRGTAFGSDDAGGKLTYTIDFAAKQGHGKIEHLKSPELNVxLAxxYIKPDEKxHAVISGSVLYNQDEKGSYSLGIFGxxAQEVAGSAEVETANGIHHIGLAAKQ
“x”是任何氨基酸。
氨基酸位置8-12的区域是任何0-5个氨基酸。
氨基酸位置8-12的区域优选包含0或5个氨基酸。
根据本发明的实施方案,2086蛋白亚科可再分成簇(cluster)。例如根据本发明的一个实施方案,提供了以下以下簇:偶数编号的SEQ ID NOS:2-12;偶数编号的SEQ ID NOS:14-24;偶数编号的SEQ ID NOS:26-42;偶数编号的SEQ ID NOS:50-60;偶数编号的SEQ ID NOS:62-108;偶数编号的SEQ ID NOS:110-138;偶数编号的SEQ ID NOS:140-156;偶数编号的SEQ ID NOS:158-174和偶数编号的SEQ IDNOS:224-252。
本发明的多肽序列可与偶数编号的SEQ ID NOS:2-252的参考序列相同,即100%相同,或与参考序列相比有一定数目的氨基酸改变,即同一性百分比小于100%。这种改变包括至少一种氨基酸缺失、取代(包括保守性和非保守性取代)或插入。这种改变可发生在参考多肽序列的氨基或羧基末端位置,或那些末端位置之间的任何地方,分散在参考氨基酸序列的各个氨基酸中间或在参考氨基酸序列内的一个或多个毗连基团中。
因此,本发明还提供了含有与序列表中所含氨基酸序列(即偶数编号的SEQ IDNOS:2-252)相同序列的蛋白质。根据特定的序列,序列的同一性程度优选大于60%(例如60%,70%,80%,90%,95%,97%,99%,99.9%或更高)。这些同源蛋白包括突变体和等位基因变异体。
在本发明优选的实施方案中,所述2086蛋白或其它2086多肽(例如免疫学部分或生物学等价物)产生对同源和至少一种异源脑膜炎球菌菌株的杀菌抗体。特别地,2086多肽的抗体被动保护幼鼠免遭脑膜炎球菌的侵袭,例如鼻内的。在更加优选的实施方案中,所述2086多肽可使幼鼠抵抗同源菌株和至少一种异源菌株。所述多肽可选自上述序列,如偶数编号的SEQ ID NOS:2-252,或者所述多肽可以是所列多肽的任何免疫学片段或生物学等价物。优选地,所述多肽选自上述序列中任何偶数编号的SEQ ID NOS:2-252。
本发明还涉及所述2086多肽的等位基因变体或其它变异体,这是生物学等价物。合适的生物学等价物能够(1)引发对同源菌株和至少一种异源奈瑟氏球菌菌株和/或淋球菌菌株的杀菌抗体;(2)与同源菌株和至少一种异源奈瑟氏球菌菌株和/或淋球菌菌株的表面反应;(3)赋予抗生物攻击的被动保护;和/或(4)防止集落形成。
合适的生物学等价物与这里所述2086多肽之一(即偶数编号的SEQ ID NOS:2-252)至少有约60%,优选至少约70%,更优选至少约75%,再优选约80%,再优选约85%,再优选约90%,再优选约95%或再优选约98%,或再优选约99%类似,这使得所述等价物能够引发与本发明的2086蛋白实质上相同的免疫原性特性。
或者,所述生物学等价物与偶数编号的SEQ ID NOS:2-252中的2086蛋白之一有实质上相同的免疫原性特性。更加本发明的一个实施方案,所述生物学等价物与偶数编号的SEQ ID NOS 2-252的有相同的免疫原性特性。
通过产生本发明蛋白质的变异体和修饰物得到了生物学等价物。这些蛋白质的变异体和修饰物是通过插入、缺失或取代一个或多个氨基酸来改变氨基酸序列而获得的。氨基酸序列被修饰,例如通过取代以产生实质上相同质量或改进质量的多肽。优选的引入变化的方法包括通过定点诱变产生多肽的核酸序列的预定突变。
修饰和变化可发生在本发明多肽的结构中,这样获得的的分子仍具有脑膜炎奈瑟氏球菌的免疫原性。例如,但不限于此,在未丧失免疫原性的序列中,某些氨基酸可被其它氨基酸取代(包括非保守性取代和保守性取代)。由于多肽的相互作用能力和性质确定了多肽的生物学功能活性,多肽序列(或者,当然,其指定的DNA编码序列)中可发生许多氨基酸序列的取代,然而,所得多肽具有类似特性。本发明包括这里所述多肽结构以及编码所述多肽的核酸序列的任何变化,其中,所述多肽保持免疫原性。根据这里提供的指导,精通此领域的技术人员能够很容易地修饰所述多肽和多核苷酸。
例如某些可变区被确定可允许有取代或缺失。如上所述,根据本发明的一个实施方案,所述2086共有序列显示了2086蛋白家族的保守和非保守性区域。
在作出这些变化时,可采用精通此领域的技术人员已知的任何技术。例如,但不限于此,可考虑氨基酸的亲水指数。在对多肽赋予生物活性功能时,亲水氨基酸指数的重要性在此领域中通常被理解。Kyte等,1982.J.Mol.Bio.157:105-132。
基于亲水性,也可进行类似氨基酸的取代,尤其是生物功能等价多肽或如此产生的肽要用于免疫学实施方案时。美国专利4,554,101描述了多肽的最大局部平均亲水性,这由其毗邻氨基酸的亲水性控制,与其免疫原性相关,即与多肽的生物学特性相关,在此将此专利并入以供参考。
所述多肽的生物学等价物也可通过定点诱变制备。定点诱变是通过特定诱变指定的DNA来制备第二代多肽或来自其序列的生物功能等价多肽或肽的有用技术。这种改变可发生在需要氨基酸取代的地方。这种技术还提供制备和测试序列变异体的能力,例如结合上述一种或多种想法,在DNA中引入一个或多个核苷酸序列变化。定点诱变可通过使用特定的寡核苷酸序列产生突变体,所述序列编码所需突变的DNA序列和足够数量的毗邻核苷酸,以提供足够大小的引物序列和序列复杂性从而在横贯缺失连接的两侧上形成稳定的双链体。通常,长度约为17-25个核苷酸的引物是优选的,序列连接的两侧约有5-10个残基被改变。
通常,定点诱变技术是本领域熟知的。应该意识到的是,该技术通常采用噬菌体载体,它可以以单链和双链形式存在。通常,这里所述的定点诱变是通过首先获得单链载体而进行的,该载体的序列中包含编码所有或部分所选脑膜炎奈瑟氏球菌多肽序列的DNA序列。制备了带有所需突变序列的寡核苷酸引物(例如合成的)。然后将该引物退火形成单链载体,并用酶如大肠杆菌聚合酶I Klenow片段延伸,以完全合成带有突变的链。因此形成了杂双链体,其中第一条链编码最初的非突变序列,第二条链带有所需突变。然后用这种杂双链体载体来转化合适的细胞,如大肠杆菌细胞,并选择包含带有该突变的重组载体的克隆。市售的试剂盒可提供需要的所有试剂,除但寡核苷酸引物外。
所述2086多肽包括任何与具有偶数编号的SEQ ID NOS 2-252之一的氨基酸序列的2086蛋白有足够的序列相似性和/或生物学等价的蛋白或多肽。此外,本发明的2086多肽不限于特定来源。因此,本发明提供一般检测和从各种来源分离多肽。同样,基于本文提供的指导,所述2086多肽可用重组方法制备,这是本领域技术人员熟知的,或用此领域已知的任何其它合成方法制备。
本发明预料,将所述2086多肽切割成片段将有利于进一步用于结构或功能分析或用于产生如2086相关多肽和2086特异性抗体的试剂。这可通过用肽酶如如内切蛋白酶glu-C(Boehringer,Indianapolis,IN)处理纯化或未纯化的脑膜炎奈瑟氏球菌多肽而实现。另一种方法是用CNBr处理,这样可以从天然脑膜炎奈瑟氏球菌2086多肽中产生肽片段。也可用重组技术来产生2086蛋白的特定片段。
术语“变异体”在这里分别是指不同于参考多核苷酸或多肽但保留实质特性的多核苷酸或多肽。多核苷酸的典型变异体的核苷酸序列与参考多核苷酸不同。变异体核苷酸序列的变化可以改变或不改变参考多核苷酸编码的多肽的氨基酸序列。核苷酸变化可导致参考序列编码的多肽中的氨基酸取代、添加、缺失、融合和截短,如下所述。多肽的典型变异体的氨基酸序列不同于参考多肽。通常,差异是有限的,因此参考多肽和变异体的序列总体而言非常类似,且在许多区域是相同的(即生物学等价物)。变异体和参考多肽的氨基酸序列可以不同,这包括一种或多种任何组合的取代、添加、缺失。取代或插入的氨基酸残基可由或不可由遗传密码编码。多核苷酸或多肽的变异体可以是天然存在的如等位基因变异体,或者可以是非天然存在的变异体。非天然存在的多核苷酸和多肽的变异体可通过诱变技术或通过直接合成制备。
“同一性”是本领域已知的,它是指通过序列比较确定的两个或多个多肽序列或两个或多个多核苷酸序列之间的关系。在此领域中,“同一性”还指多肽或多核苷酸序列之间序列相关的程度,这可通过在所述序列的链之间进行配对而确定。“同一性”和“相似性”可用已知的方法计算,这些方法包括但不限于以下文献中描述的方法:《计算分子生物学》(Computational Molecular Biology),Lesk,A.M.编,牛津大学出版社,纽约,1988;《生物计算:信息学和基因组计划》(Biocomputing:Informatics and Genome Projects),Smith,D.W.编,学术出版社,纽约,1993;《序列数据的计算机分析》(Computer Analysis of Sequence Data),第I部分,Griffin,A.M.和Griffin,H.G.编,Humana Press,新泽西州,1994;《分子生物学中的序列分析》(Sequence Analysis in Molecular Biology),von Heinje,G.,学术出版社,1987;和《序列分析引物》(Sequence Analysis Primer),Gribskov,M.和Devereux,J.编,M Stockton Press,纽约,1991;和Carillo,H.和Lipman,D.,SIAMJ.Applied Math.,48:1073(1988)。优选的确定同一性的方法是要得到测试序列之间的最大匹配。确定同一性和相似性的方法被编成公众可获得的计算机程序。优选的确定两个序列之间同一性和相似性的计算机程序方法包括但不限于GCG程序包(Devereux,J.等,1984)、BLASTP、BLASTN和FASTA(Altschul,S.F.等,1990)。BLASTX程序可从NCBI以及其它来源(BLAST手册,Altschul,S.等,NCBI NLM NIHBethesda,Md.20894;Altschul,S.等,1990)获得。也可用熟知的Smith Waterman算法来确定同一性。
例如,但不局限于此,本发明的氨基酸序列可与参考序列—偶数编号的SEQ IDNOS:2-252相同,即100%相同,或者与参考序列相比可包含一些氨基酸改变,这样同一性百分比就小于100%。这种改变选自至少一种氨基酸缺失、取代(包括保守性和非保守性取代)或插入,其中,所述改变可发生在参考多肽序列的氨基或羧基末端位置,或这些末端位置之间的任何地方,独立地分散在参考序列的氨基酸中间或在参考序列内的一个或多个毗连基团中。将SEQ ID NOS:2-252的氨基酸总数乘以各自的同一性百分比的分数(除以100),然后将所述SEQ ID NOS:2-252中任一氨基酸总数减去该结果就可得到给定的同一性百分比的氨基酸改变的数目,或:
na=xa-(xa·y),
其中,na是氨基酸改变的数目,xa是SEQ ID NOS:2-252中的氨基酸总数,y是,例如用0.70表示70%,0.80表示80%,0.85表示85%,等等,且其中任何非整数的xa·y的结果在从xa中减去之前都被减小成最接近的整数。
在优选的实施方案中,上述多肽选自偶数编号的SEQ ID NOS 2-252所列出的蛋白质,如2086蛋白的成熟形式。2086蛋白或等价物等可以是脂质化或非脂质化的。
ORF 2086可在带有天然ORF 2086信号序列的大肠杆菌中表达。然而,需要找到改进蛋白质表达的方法。根据本发明的实施方案,前导序列产生蛋白质的脂质化形式。例如,下面描述了使用非典型流感嗜血杆菌(Haemophilus influenzae)P4蛋白的信号序列以提高表达。
细菌脂蛋白的加工以含有信号序列的前体或脂蛋白质(prolipoprotein)的合成开始,该信号序列依次含有共有序列脂蛋白加工/修饰位点。这种脂蛋白质最初通过常规的Sec系统位于革兰氏阴性菌的内膜或革兰氏阳性菌的膜上。一旦通过Sec系统位于膜,所述脂蛋白质就在共有序列位点被信号肽酶II切割,暴露的N-末端半胱氨酸残基被甘油酸化(glycerated)和酰化。Hayashi等,1990,“细菌中的脂蛋白”,J.Bioenerg.Biomembr.Jun;22(3):451-71;Oudega等,1993,“一种小的脂蛋白—细菌素释放蛋白的表达和膜插入所需的大肠杆菌SecB、SecA和SecY蛋白”,J.Bacteriol.Mar;175(5):1543-7;Sankaran等,1995,“细菌脂蛋白的修饰”,Methods Enzymol.250:683-97。
在革兰氏阴性菌中,脂质化蛋白质转运到外膜是由独特的具有膜特异性的ABC转运蛋白系统介导的,这种特异性取决于脂蛋白位置2上的分选信号。Yakushi等,2000,“一种新的ABC转运蛋白介导从膜中分离脂质修饰的蛋白质”,Nat CellBiol.Apr;2(4):212-8。
与细菌脂蛋白及其信号序列融合已被用于在细菌表面展示重组蛋白。美国专利号5,583,038和6,130,085。交换脂蛋白信号序列可增加脂蛋白的产生。De等,2000,“在大肠杆菌中表达的肺炎链球菌棕榈酰化的肺炎球菌性非表面粘附素A的纯化和鉴定”,Vaccine,Mar 6;18(17):1811-21。
已知蛋白质的细菌脂质化可增加或改变对蛋白质的免疫应答。Erdile等,1993,“附加的脂质在布氏疏螺旋体OspA免疫原性中的作用”,Infect.Immun.Jan;61(1):81-90;Snapper等,1995,“在对T细胞依赖型II抗原的体液免疫应答中细菌脂蛋白可替代细胞因子”,J.Immunol.Dec 15;155(12):5582-9。然而,细菌脂蛋白的表达可因加工的严格而复杂化。Pollitt等,1986,“大肠杆菌主要外膜脂蛋白的信号肽切割位点氨基酸取代的效果”,J.Biol.Chem.Feb 5;261(4):1835-7;Lunn等,1987,“脂蛋白质信号肽突变对大肠杆菌中杂交体前脂-β-内酰胺酶分泌的作用”,J.Biol.Chem.Jun 15;262(17):8318-24;Klein等,1988,“细菌脂蛋白信号序列的特殊性质”,Protein Eng.Apr;2(1):15-20。细菌脂蛋白的表达也可因其它问题而复杂化,如毒性和低表达水平。Gomez等,1994,“当在大肠杆菌中表达时枯草芽孢杆菌脂蛋白LplA核苷酸使细胞裂解”,Microbiology.Aug;140(Pt 8):1839-45;Hansson等,1995,“截短和全长形式的莱姆病疏螺旋体外表面蛋白A在大肠杆菌中的表达”,Protein Expr.Purif.Feb;6(1):15-24;Yakushi等,1997,“错误定位的主要外膜脂蛋白和大肠杆菌的肽聚糖之间共价连接的致死率”,J.Bacteriol.May;179(9):2857-62。
非可分型流感嗜血杆菌表达称为P4的脂蛋白(也称为蛋白质“e”)。采用天然P4信号序列P4蛋白的重组形式在大肠杆菌中高度表达。美国专利号5,955,580。当用天然P4信号序列取代大肠杆菌表达载体中的天然ORF 2086信号序列时,ORF 2086的表达水平增加。
用异源P4信号序列增加表达的概念可延伸到其它细菌脂蛋白。特别地,分析细菌基因组能够鉴定许多可能感兴趣的ORF试图。在异源宿主细胞如大肠杆菌中表达各个带有其天然信号序列的ORF将产生各种使用多种信号序列固有的问题,包括稳定性、相容性等等。为使这些问题最小化,P4信号序列被用来表达各个感兴趣的ORF。如上所述,P4信号序列可改进异源2086ORF的表达。通过删除感兴趣的ORF的天然信号序列并将P4信号序列连接到ORF构建了表达载体。然后用表达载体转化、转染或感染合适的宿主细胞,与使用ORF的天然信号序列进行表达相比,ORF的表达增加了。
用缺少原始前导序列的蛋白质或是用未指定宿主细胞中脂肪酸酰化位点的部分序列代替的前导序列产生了非脂质化的形式。
除非另有说明,本发明2086蛋白的各种形式在这里被称为“2086”蛋白。同样,除非另有说明,“2086多肽”是指2086蛋白以及上述免疫原性部分或其生物学等价物。
用10%-20%梯度SDS聚丙烯酰胺凝胶(SDS-PAGE)测得全长分离和纯化的脑膜炎奈瑟氏球菌2086蛋白的表观分子量约为28-35kDa。更具体的,用质谱测得这种蛋白质的分子量约为26,000-30,000道尔顿。
优选地,所述2086多肽和编码这种多肽的核酸被用于预防或减轻脑膜炎奈瑟氏球菌和/或其它菌种引起的感染。
抗体
本发明的蛋白质,包括氨基酸序列SEQ ID NOS:2-252,其片段及其类似物或表达它们的细胞,也被用作免疫原以产生对本发明的多肽免疫特异的抗体。本发明包括免疫特异性多肽的抗体以及使用所述抗体来检测脑膜炎奈瑟氏球菌的存在情况,提供被动保护或测量细胞、细胞或组织提取物、或生物液体中多肽的量或浓度。
本发明的抗体包括多克隆抗体、单克隆抗体、嵌合抗体和抗独特型抗体。多克隆抗体是来自用抗原免疫的动物血清的不同群体的抗体分子。单克隆抗体是特定抗原的大体均一群体的抗体。单克隆抗体可用精通此领域的技术人员已知的方法获得,例如Kohler和Milstein,1975,Nature 256:495-497和美国专利号4,376,110。这种抗体可以是任何免疫球蛋白类别,包括IgG、IgM、IgE、IgA、GILD及其任何亚类。
嵌合抗体是一种分子,其不同部分来自不同的动物种类,例如那些具有鼠单克隆抗体可变区和人免疫球蛋白恒定区的分子。嵌合抗体及其生产方法在本领域已知(Cabilly等,1984,Proc.Natl.Acad.Sci.USA 81:3273-3277;Morrison等,1984,Proc.Natl.Acad.Sci.USA 81:6851-6855;Boulianne等,1984,Nature 312:643-646;Cabilly等,欧洲专利申请125023(1984年11月14日公开);Taniguchi等,欧洲专利申请171496(1985年2月19日公开);Morrison等,欧洲专利申请173494(1986年3月5日公开);Neuberger等,PCT申请WO 86/01533(1986年3月13日公开);Kudo等,欧洲专利申请184187(1986年6月11日公开);Morrison等,欧洲专利申请173494(1986年3月5日公开);Sahagan等,1986,J.Immunol.137:1066-1074;Robinson等,PCT/US86/02269(1987年5月7日公开);Liu等,1987,Proc.Natl.Acad.Sci.USA 84:3439-3443;Sun等,1987,Proc.Natl.Acad.Sci.USA 84:214-218;Better等,1988,Science240:1041-1043)。在此将其全文并入以供参考。
抗独特型(抗-Id)抗体是识别通常与抗体的抗原结合位点结合的独特决定子的抗体。抗-Id抗体通过用已制备抗-Id的单克隆抗体免疫作为单克隆抗体来源的相同种类和基因型的动物(如小鼠品系)来制备。被免疫的动物将通过产生这些同种型决定子的抗体(抗-Id抗体)识别并响应免疫抗体的独特型决定子。
因此,所产生的抗本发明多肽的单克隆抗体可用于在合适的动物中诱导抗-Id抗体。来自这种免疫小鼠的脾细胞可用于产生分泌抗-Id单克隆抗体的抗-Id杂交瘤。此外,所述抗-Id抗体可与载体如匙孔_血蓝蛋白(KLH)结合以及用于免疫其它BALB/c小鼠。这些小鼠的血清将含有抗-抗-Id抗体,它具有最终对R-PTP酶表位特异的mAb的结合特性。因此可评价这种抗-Id抗体的独特型表位,或与表位结构类似的一些“独特型表位”,如酿脓链球菌(Streptococcus pyogenes)多肽。
术语“抗体”还包括完整的分子以及片段,如能够结合抗原的Fab片段。Fab片段缺乏完整抗体的Fc片段,能够更迅速地从循环中清除,且与完整抗体相比有更小的非特异性组织结合(Wahl等,1983,J.Nucl.Med.24:316-325)。按照用于完整抗体分子的方法,Fab和用于本发明的其它抗体片段也可用来检测和定量脑膜炎奈瑟氏球菌多肽。
本发明的抗体,如抗独特型(“抗-Id”)抗体,可用于在哺乳动物宿主中治疗或预防奈瑟氏球菌属感染的方法,包括给予免疫有效量的抗体,如上所述对多肽特异的抗体。所述抗-Id抗体也可用作“免疫原”以诱导另一动物中的免疫应答,产生所谓抗-抗-Id抗体。抗-抗-Id可与诱导抗-Id的原始mAb有相同的表位。因此,通过使用mAb的独特型决定子的抗体就可以鉴定表达相同特异性的抗体的其它克隆。
抗体被用于多种方法,例如用来确定蛋白质被表达,或用来确定蛋白质在哪里被表达。例如,可将标记的抗体(例如FACS的荧光标记)与完整的细菌一起培养,细菌表面上标记的存在确定了蛋白质的位置。
可采用常规方法将多肽或带有表位的片段、类似物或细胞用于动物以获得所产生的抗本发明多肽的抗体。为制备单克隆抗体,可使用任何技术,这些技术可提供由连续细胞系培养物产生的抗体。
多核苷酸
和本发明的蛋白质一样,本发明的多核苷酸可包含与任何奇数编号的SEQ IDNOS:1-253的参考序列相同,即100%同一的核酸序列,或者,与参考序列相比,它可包含许多核苷酸改变。这种改变选自至少一种核苷酸缺失、取代(包括转换和颠换)或插入,其中,所述改变可发生在参考核苷酸序列的5’或3’末端位置,或那些末端位置之间的任何地方,独立地分散在参考序列的核苷酸中间或在参考序列的一个或多个毗连基团中。核苷酸改变的数目可将任何奇数编号的SEQ ID NOS:1-253的核苷酸总数乘以各自的百分比同一性的数字百分比(除以100)来确定,并从所述序列中的所述核苷酸总数减去该乘积。
例如,但不限于此,分离的脑膜炎奈瑟氏球菌多核苷酸包含与SEQ ID NOS:1-253的任何核酸序列、其简并变异体或其片段有至少70%同一性的多核苷酸序列,其中,所述多核苷酸序列在核酸序列SEQ ID NOS:1-253的整个多核苷酸区域最多可包含nn个核酸变化,其中nn是最大变化数,它通过以下公式计算:
nn=xn-(xn·y),
其中,xn是SEQ ID NOS:1-253中的核酸总数,y的值为0.70,其中任何非整数的xn·y的乘积在从xn中减去之前都被减小到最接近的整数。当然,y也可以是0.80(表示80%)、0.85(表示85%)、0.90(表示90%)、0.95(表示95%)等等。编码包含SEQ IDNOS:2-252中任何氨基酸序列的多肽的多核苷酸序列的改变可在此编码序列中产生无义、错义或移码突变,从而改变由经过这种变化的多核苷酸编码的多肽。
本发明的一些实施方案涉及编码2086蛋白和抗2086蛋白的抗体的多核苷酸(这里称为“2086多核苷酸”或“ORF2086多核苷酸”)。在优选的实施方案中,本发明的分离的多核苷酸包含与选自奇数编号的SEQ ID NO:1-SEQ ID NOS:253之一的核苷酸序列有至少95%同一性的核苷酸序列,其简并变异体或其片段。“简并变异体”在这里指由于遗传密码的简并而与奇数编号的SEQ ID NOS:1-SEQ ID NOS:253(及其片段)的核苷酸序列不同的多核苷酸,但它仍编码与奇数编号的SEQ ID NOS:1-253的核苷酸序列编码的相同的2086蛋白(即偶数编号的SEQ ID NOS:2-252)。
在其它实施方案中,所述多核苷酸与选自奇数编号的SEQ ID NOS:1-253之一的核苷酸序列、其简并变异体或其片段互补。在另一个实施方案中,所述多核苷酸选自DNA、染色体DNA、cDNA和RNA,还可包含异源核苷酸。在另一个实施方案中,分离的多核苷酸在高严格杂交条件下与选自SEQ ID NOS:1-253之一、其补体、其简并变异体或其片段的核苷酸序列杂交。再在其它实施方案中,所述多核苷酸在中等严格杂交条件下发生杂交。
所述2086多核苷酸可获自天然、合成或半合成来源;此外,所述核苷酸序列可以是天然产生的序列,或者可以通过突变与这种天然产生的序列发生关系,包括单个或多个碱基取代、缺失、插入和倒位,只要所述核酸分子包含能够作为上述2086免疫原性多肽进行表达的序列。所述核酸分子可以是单链或双链、线性或共价闭合环状形式的RNA、DNA。所述核苷酸序列可包含位于其附近的表达控制序列,这种控制序列通常来自异源来源。通常,本发明核酸序列的重组表达将在所述核酸序列末端使用终止密码子序列,如TAA。
本发明还包括能够在降低的严格条件下,更优选在严格条件下,最优选在高严格条件下与这里所述多核苷酸杂交的多核苷酸。严格条件的例子显示在下面的严格条件表中:高严格条件是至少和例如条件A-F一样严格的条件;严格条件是至少和例如条件G-L一样严格的条件;降低的严格条件是至少和例如条件M-R一样严格的条件。
严格条件—表I
严格条件 | 多核苷酸杂交体 | 杂交体长度(bp)I | 杂交温度和缓冲液H | 洗涤温度和缓冲液H |
A | DNA:DNA | >50 | 65EC;1xSSC或42EC;1xSSC,50%甲酰胺 | 65EC;0.3xSSC |
B | DNA:DNA | <50 | TB;1xSSC | TB;1xSSC |
C | DNA:RNA | >50 | 67EC;1xSSC或45EC;1xSSC,50%甲酰胺 | 67EC;0.3xSSC |
D | DNA:RNA | <50 | TD;1xSSC | TD;1xSSC |
E | RNA:RNA | >50 | 70EC;1xSSC或50EC;1xSSC,50%甲酰胺 | 70EC;0.3xSSC |
F | RNA:RNA | <50 | TF;1xSSC | Tf;1xSSC |
G | DNA:DNA | >50 | 65EC;4xSSC或42EC;4xSSC,50%甲酰胺 | 65EC;1xSSC |
H | DNA:DNA | <50 | TH;4xSSC | TH;4xSSC |
I | DNA:RNA | >50 | 67EC;4xSSC或45EC;4xSSC,50%甲酰胺 | 67EC;1xSSC |
J | DNA:RNA | <50 | TJ;4xSSC | TJ;4xSSC |
K | RNA:RNA | >50 | 70EC;4xSSC或50EC;4xSSC,50%甲酰胺 | 67EC;1xSSC |
L | RNA:RNA | <50 | TL;2xSSC | TL;2xSSC |
M | DNA:DNA | >50 | 50EC;4xSSC或40EC;6xSSC,50%甲酰胺 | 50EC;2xSSC |
N | DNA:DNA | <50 | TN;6xSSC | TN;6xSSC |
O | DNA:RNA | >50 | 55EC;4xSSC或42EC;6xSSC,50%甲酰胺 | 55EC;2xSSC |
P | DNA:RNA | <50 | TP;6xSSC | TP;6xSSC |
Q | RNA:RNA | >50 | 60EC;4xSSC或45EC;6xSSC,50%甲酰胺 | 60EC;2xSSC |
R | RNA:RNA | <50 | TR;4xSSC | TR;4xSSC |
bpI:杂交体长度是对杂交多核苷酸的杂交区域的预计。当多核苷酸与未知序列的靶多核苷酸杂交时,杂交体长度假定为杂交多核苷酸的长度。当与已知序列的多核苷酸杂交时,杂交体长度可通过对比多核苷酸序列以及识别区域或最佳序列互补性的区域来确定。
缓冲液H:可用SSPE(1xSSPE是0.15M NaCl、10mM NaH2PO4和1.25mM EDTA,pH7.4)代替杂交和洗涤缓冲液中的SSC(1xSSC是0.15M NaCl和15mM柠檬酸钠);在杂交完成后洗涤15分钟。
TB-TR:预计长度小于50个碱基对的杂交体的杂交温度应比杂交体的熔化温度(Tm)低5-10EC,其中Tm用以下公式确定。对于长度小于18个碱基对的杂交体,Tm(EC)=2(碱基A+碱基T的数目)+4(碱基G+碱基C的数目)。对于长度在18和49个碱基对之间的杂交体,Tm(EC)=81.5+16.6(log10[Na+])+0.41(%G+C)-(600/N),N是杂交体中碱基的数目,[Na+]是杂交缓冲液中钠离子的浓度(1xSSC的[Na+]=0.165M)。
多核苷酸杂交的严格条件的其它例子提供在Sambrook,J.,E.F.Fritsch和T.Maniatis,1989,“分子克隆实验手册”(Molecular Clone:A LaboratoryManual),Cold Spring Harbor Laboratory Press,Cold Spring Harbor,NY,第9和11章,以及“新编分子生物学实验指南”(Current Protocols in MolecularBiology),1995,F.M.Ausubel等编,John Wiley & Sons,Inc.,2.10和6.3-6.4节,在此并入以供参考。
本发明还提供了与这些多核苷酸完全互补的多核苷酸,同时还提供了反义序列。本发明的反义序列,也称为反义寡核苷酸,包括阻断编码本发明多肽的多核苷酸表达的内部产生和外部施用的序列。本发明的反义序列包含例如约15-20个碱基对。例如,所述反义序列可设计成通过防止启动子结合上游未翻译序列或通过防止核酶结合而防止编码本发明多肽的转录物翻译来抑制转录。
本发明的多核苷酸可用许多方法制备(例如通过化学合成,从DNA文库、从生物自身制备)并可有各种形式(例如单链、双链、载体、探针、引物)。术语“多核苷酸”包括DNA和RNA,以及它们的类似物,如含有经过修饰的主链的那些。
根据本发明进一步的实施方案,本发明的多核苷酸包括DNA文库,如cDNA文库。
融合蛋白
本发明还涉及融合蛋白。“融合蛋白”指由两个通常无关的融合基因或其片段编码的蛋白质。例如融合蛋白包含免疫球蛋白分子恒定区的不同部分和其它免疫原性蛋白质或其部分。许多情况下,将免疫球蛋白Fc区作为融合蛋白的一部分对用于治疗和诊断是有利的,这会导致例如改进的药物动力学特性(参见例如EP 0 232 262A1)。另一方面,在一些应用中,需要能在融合蛋白表达、检测和纯化后除去Fc部分。本发明的2086多核苷酸可用于重组生产本发明的多肽,所述多核苷酸的阅读框中可包括成熟多肽的编码序列本身,或成熟多肽的编码序列和其它编码序列,如编码前导序列或分泌序列、前-或原-或前蛋白原序列的编码序列,或其它融合肽部分。例如可编码便于纯化2086多肽或融合多肽的标记序列(参见Gentz等,1989,在此全文并入以供参考)。因此,在本发明的实施方案中制备了编码融合多肽的多核苷酸,所述融合多肽允许表达产物的His-tag纯化。所述多核苷酸还可含有非编码5’和3’序列,如转录的非翻译序列,剪接和聚腺苷酸化信号。这种融合的多肽可用下述重组DNA克隆载体转化/转染或感染宿主细胞来产生,它随后可分离自宿主细胞以得到大体上不含其它宿主细胞蛋白的融合多肽。
免疫原性组合物
本发明一方面提供了包含至少一种2086蛋白或编码所述蛋白的核酸的免疫原性组合物。上述物质能够(1)引发多种菌株的杀菌抗体;(2)与多个菌株的表面反应;(3)赋予抗生物攻击的被动保护;和/或(4)防止集落形成。
这种免疫原性组合物的制剂是精通此领域的技术人员熟知的。本发明的免疫原性组合物优选包括药学上可接受的载体。合适的药学上可接受的载体和/或稀释剂包括任何和所有常规的溶剂、分散介质、填充剂、固体载体、含水溶液、包衣、抗菌剂和抗真菌剂、等渗剂和吸收延迟剂等。合适的药学上可接受的载体包括以下一种或多种,例如水、盐水、磷酸缓冲盐水、葡萄糖、甘油、乙醇等,以及它们的组合。药学上可接受的载体还可包括少量助剂,如润湿剂或乳化剂、防腐剂或缓冲剂,它们可提高抗体的储存期或效用。药学上可接受的载体的制备和使用是此领域熟知的。除了与活性成分不相容的任何常规介质或试剂外,可将它们用于本发明的免疫原性组合物。
这种免疫原性组合物可胃肠外施用,例如通过注射,皮下注射或肌肉内注射,以及口服或鼻内给予。Wolff等和Sedegah等描述了肌肉内免疫接种的方法。其它给药方式采用了例如口服制剂、肺部制剂、栓剂和经皮应用,但不限于此。口服制剂,例如包括通常使用的赋形剂,如药物级的甘露醇、乳糖、淀粉、硬脂酸镁、糖精钠、纤维素、碳酸镁等,但不限于此。
本发明的免疫原性组合物可包括一种或多种佐剂,包括但不限于氢氧化铝、磷酸铝、STIMULONTM QS-21(Aquila生物制药公司,Framingham,MA);MPLTM(3-O-脱酰化单磷酰脂A;Corixa,Hamilton,MT),529(一种氨基烷基葡糖胺磷酸盐化合物,Corixa,Hamilton,MT),IL-12(Genetics Institute,Cambridge,MA);GM-CSF(Immunex公司,西雅图,华盛顿);N-乙酰-胞壁酰-L-苏氨酰-D-异谷氨酰胺(thr-MDP);N-乙酰-正-胞壁酰-L-丙氨酰-D-异谷氨酰胺(CGP 11637,也称为正-MDP);N-乙酰胞壁酰-L-丙氨酰-D-异谷氨酰-L-丙氨酸-2-(1’-2’-二棕榈酰-sn-甘油-3-羟基磷酰氧基-乙胺)(CGP 19835A,称为MTP-PE)和霍乱毒素。其它可使用的是霍乱毒素的无毒衍生物,包括其A亚基和/或结合物或遗传工程构建的脑膜炎奈瑟氏球菌多肽和霍乱毒素的融合体或其B亚基(“CTB”),类霍乱原(pro choleragenoid)、真菌多糖,包括裂裥菌素、胞壁酰二肽、胞壁酰二肽(“MDP”)衍生物、佛波酯、大肠杆菌的不耐热毒素、嵌段聚合物或皂苷。
在一些优选的实施方案中,本发明的蛋白质被用于供口服施用的免疫原性组合物,所述组合物包括粘膜佐剂,用来治疗或预防人类宿主的脑膜炎奈瑟氏球菌感染。粘膜佐剂可以是霍乱毒素;但优选可用于本发明的霍乱毒素外的粘膜佐剂包括霍乱全毒素的无毒衍生物,其中,所述A亚基是诱变的、化学修饰的霍乱毒素,或通过修饰霍乱毒素氨基酸序列产生的相关蛋白质。欲了解特别适合用于制备本发明的免疫原性组合物的特定霍乱毒素可参见突变型霍乱全毒素E29H,如公开的国际申请WO 00/18434所述,在此将其全文并入以供参考。它们可加到本发明的多肽中或与本发明的多肽结合。可对其它具有粘膜佐剂或具有输递特性的分子,如大肠杆菌的不耐热毒素(LT),采用同样的技术。可以使用的其它具有粘膜佐剂或具有输递特性的化合物如胆汁;聚阳离子如DEAE-葡聚糖和聚鸟氨酸;洗涤剂如十二烷基苯磺酸钠;脂质结合物质;抗生素如链霉素;维生素A和其它可改变粘膜表面结构或功能完整性的化合物。其它粘膜活性化合物包括微生物组织的衍生物如MDP;吖啶和甲腈咪胍。如上所述,也可使用STIMULONTM QS-21、MPL和IL-12。
本发明的免疫原性组合物可以ISCOMS(免疫刺激复合物)、含有ISCOMS的CTB、脂质体的形式输递,或包囊在丙烯酸酯或聚(DL-丙交酯-共-糖苷)等化合物中以形成大小适合吸附的微球体。本发明的蛋白质也可掺入油性乳剂中。
多抗原
所述免疫原性试剂,包括本发明的蛋白质、多核苷酸和等价物,可作为免疫原性组合物的唯一活性免疫原施用,或者所述组合物可包括其它活性免疫原,包括其它奈瑟氏球菌属免疫原性多肽,或一种或多种其它微生物病原体(例如病毒、朊病毒、细菌或真菌,但不限于此)的免疫活性蛋白质或荚膜多糖。所述组合物可包含一种或多种所需蛋白质、片段或所选适应症所需的药物化合物。同样,本发明的组合物在所述免疫原性组合物中使用了一种或多种核酸,还可包括编码上述蛋白质相同的多种类的核酸。
本发明包括任何多抗原或多价免疫原性组合物。例如,本发明的组合物可包含两种或多种2086蛋白的组合物,2086蛋白和一种或多种PorA蛋白的组合物,2086蛋白和脑膜炎球菌血清组A、C、Y和W135多糖和/或多糖结合物的组合物,2086蛋白和脑膜炎球菌与肺炎球菌组合的组合物,或任何上述适合粘膜输送形式的组合。精通此领域的技术人员能够配制这种多抗原或多价免疫组合物。
本发明还涉及多免疫方案(multi-immunization regimen),其中,任何可有效抗病原体的组合物都可用于其中或与本发明的组合物结合。例如,但不限于此,作为多免疫方案的一部分,可给予患者本发明的免疫原性组合物和其它免疫组合物以使其对肺炎链球菌(S.Pneumoniae)免疫。精通此领域的技术人员能够选择可与本发明的免疫原性组合物联合使用的免疫原性组合物以制定和实施多免疫方案。
本发明的特定实施方案涉及将一种或多种本发明的多肽,或编码多肽的核酸用于组合物,或作为预防或减轻肺炎链球菌感染的治疗方法的一部分。可以将2086多肽或2086多核苷酸与任何抗肺炎链球菌感染的免疫原性组合物联合。也可将2086多肽或2086多核苷酸与任何其它基于蛋白质或多糖的脑膜炎球菌疫苗联合。
所述2086多肽、片段和等价物可用作结合的免疫原性组合物的一部分;其中一种或多种蛋白质或多肽可与载体结合以产生具有抗几种血清型和/或抗一些疾病的免疫原性特性的组合物。或者,所述2086多肽之一还可用作其它免疫原性多肽的载体蛋白。
本发明还涉及在哺乳动物中诱导免疫应答的方法,所述方法包括向所述哺乳动物提供本发明的免疫原性组合物的步骤。所述免疫原性组合物对被处理的动物或人呈抗原性,这样,这种组合物中所含的免疫有效量的多肽就可产生所需的抗脑膜炎奈瑟氏球菌感染的免疫应答。涉及治疗方法(包括减轻或防止人类的脑膜炎奈瑟氏球菌感染)的优选实施方案包含给予人类免疫有效量的组合物。
术语“免疫有效量”在这里是指哺乳类宿主(优选人)的给药量,以单剂量或部分系列剂量的形式,足以至少使被治疗个体的免疫系统产生减轻细菌感染的临床表现的应答。这可使细菌负载的程度最小降低到预防感染。理想的是,被治疗个体不出现更严重的细菌感染的临床表现。所述剂量可根据个体的特定症状而改变。该量可用常规方法或用精通此领域的技术人员已知的方法确定。
本发明另一特别方面涉及使用免疫原性组合物作为表达本发明蛋白质的载体或质粒或其免疫原性蛋白。因此,本发明再一方面提供了在哺乳动物中诱导免疫应答的方法,所述方法包括为哺乳动物提供表达至少一种分离的2086多肽的载体或质粒。可用活的载体,尤其是活的重组细菌、病毒或其它活的试剂,将本发明的蛋白质输送到哺乳动物,所述载体含有作为外源多肽的多肽或免疫原性蛋白表达必需的遗传物质。
根据本发明的其它实施方案,提供了在哺乳动物中诊断细菌性脑膜炎的方法,包括:检测所述哺乳动物或所述哺乳动物组织样品中免疫复合物的存在情况,所述哺乳动物或组织样品与含有抗体的抗体组合物接触,所述抗体免疫特异性结合至少一种包含SEQ ID NOS:2-252中任何偶数编号的氨基酸序列的多肽;其中,所述哺乳动物或组织样品在适合形成免疫复合物的条件下与抗体组合物接触。
病毒和非病毒载体
优选的载体,尤其是用于体外和体内细胞测定的载体,是病毒载体,如慢病毒、反转录病毒、疱疹病毒、腺病毒、腺伴随病毒、牛痘病毒、杆状病毒和其它具有所需细胞向性的重组病毒。因此,可用病毒载体或通过直接引入DNA将编码2086蛋白或其免疫原性片段的核酸引入体内先体外后体内或体外。靶组织中的表达可受到转基因载体靶向特定细胞的影响,如用病毒载体或受体配体,或使用组织特异性启动子,或这两者。定向基因送递描述在PCT出版物WO 95/28494中,在此将其全文并入以供参考。
通常用于体内或先体外后体内寻靶和治疗过程的病毒载体是基于DNA的载体和反转录病毒载体。构建和使用病毒载体的方法是本领域已知的(例如Miller和Rosman,Bio Technology,1992,7:980-990)。优选的是,所述病毒载体是复制缺陷的,即它们不能在靶细胞中自主复制。优选的是,所述复制缺陷型病毒是最小病毒,即仅保留包裹基因组以产生病毒颗粒所必需的其基因组序列。
DNA病毒载体包括减毒或缺陷的DNA病毒,例如但不限于单纯疱疹病毒(HSV)、乳头瘤病毒、EB病毒(EBV)、腺病毒、腺伴随病毒(AAV)等。完全或几乎完全缺乏病毒基因的缺陷型病毒是优选的。缺陷型病毒在引入细胞后不会传染。使用缺陷型病毒载体可以将细胞施用于特定的局部区域而不担心载体可感染其它细胞。因此,特异性组织可被特定地寻靶。特定载体的例子包括但不限于缺陷型疱疹病毒1(HSV1)载体(Kaplitt等,Molec.Cell.Neurosci.,1991,2:320-330)、缺乏糖蛋白L基因的缺陷型疱疹病毒载体或其它缺陷型疱疹病毒载体(PCT出版物WO94/21807和WO 92/05263);减毒的腺病毒载体,如Stratford-Perricaudet等描述的载体(J.Clin.Invest.,1992,90:626-630;也可参见La Salle等,Science,1993,259:988-990);和缺陷型腺伴随病毒载体(Samulski等,J.Virol.,1987,61:3096-3101;Samulski等,J.Virol.,1989,63:3822-3828;Lebkowski等,Mol.Cell.Biol.,1988,8:3988-3996),在此将它们全文并入以供参考。
许多公司大批生产病毒载体,包括但不限于Avigen公司(Alameda,CA;AAV载体),Cell Genesys(Foster City,CA;反转录病毒、腺病毒、AAV载体和慢病毒载体),Clontech(反转录病毒和杆状病毒载体),Genovo公司(Sharon Hill,PA;腺病毒和AAV载体),Genvec(腺病毒载体),IntroGene(荷兰莱顿;腺病毒载体),Molecular Medicine(反转录病毒、腺病毒、AAV和疱疹病毒载体),Norgen(腺病毒载体),Oxford BioMedica(英国牛津;慢病毒载体),以及Transgene(法国斯特拉斯堡;腺病毒、牛痘病毒、反转录病毒和慢病毒载体),在此将其全文并入以供参考。
腺病毒载体.腺病毒是真核DNA病毒,它可被修饰以有效传递本发明的核酸到各种细胞类型。腺病毒有各种血清型。在这些血清型中,本发明优选2型或5型人腺病毒(Ad 2或Ad 5)或动物来源的腺病毒(参见PCT出版物WO 94/26914)。可用于本发明的那些动物来源的腺病毒包括来自犬、牛、鼠(例如:Mav1,Beard等,Virology,1990,75-81)、羊、猪、鸟和猿(例如:SAV)的腺病毒。优选的是,所述动物来源的腺病毒是犬腺病毒,更优选的是CAV2腺病毒(例如Manhattan或A26/61菌株,ATCCVR-800,例如)。描述了各种复制缺陷型腺病毒和最小腺病毒载体(PCT出版物WO 94/26914、WO 95/02697、WO 94/28938、WO 94/28152、WO 94/12649、WO 95/02697、WO 96/22378)。本发明所述的复制缺陷型重组腺病毒可用本领域的技术人员已知的任何方法制备(Levrero等,Gene,1991,101:195;欧洲出版物EP 185 573;Graham,EMBO J.,1984,3:2917;Graham等,J.Gen.Virol.,1977,36:59)。重组腺病毒用标准分子生物学技术回收和纯化,这些技术是精通此领域的技术人员熟知的。
腺伴随病毒.腺伴随病毒(AAV)是相对较小的DNA病毒,它可以稳定和位点于一的方式整合到被感染的细胞基因组中。它们能够感染多种细胞而不会对细胞的生长、形态和分化造成任何影响,且它们似乎与人类病理学无关。AAV基因组已被克隆、测序和鉴定。已经描述使用来自AAV的载体在体外和体内转移基因(参见PCT出版物WO 91/18088和WO 93/09239;美国专利号4,797,368和5,139,941;欧洲出版物EP 488 528)。本发明所述的复制缺陷型重组AAV可通过将质粒共转染到被人辅助病毒(例如腺病毒)感染的细胞系来制备,所述质粒含有侧翼有两个AVV末端反向重复(ITR)区域的感兴趣的核酸序列,并带有AVV衣壳化基因(rep和cap基因)。产生的AAV重组体然后用标准技术纯化。
反转录病毒载体.在本发明的其它实施方案中,所述核酸可被引入反转录病毒载体,如美国专利号5,399,346;Mann等,Cell.,1983,33:153;美国专利号4,650,764和4,980,289;Markowitz等,J.Virol.,1988,62:1120;美国专利号5,124,263;欧洲出版物EP 453 242和EP 178 220;Bernstein等,Genet.Eng.,1985,7:235;McCormick,BioTechnology,1985,3:689;PCT出版物WO 95/07358;以及Kuo等,Blood,1993,82:845中所述,在此将它们全文并入以供参考。所述反转录病毒是感染分化细胞的整合病毒。所述反转录病毒基因组包括两个LTR,一个衣壳化序列和三个编码区(gag、pol和env)。在重组反转录病毒载体中,gag、pol和env基因通常被完全或部分删除,并被感兴趣的异源核酸序列替代。这些载体可从不同类型的反转录病毒构建,比如HIV、MoMuLV(“Moloney鼠白血病病毒”)、MSV(“Moloney鼠肉瘤病毒”)、HaSV(“Harvey肉瘤病毒”);SNV(“脾坏死病毒”);RSV(“Rous肉瘤病毒”)和Friend病毒。合适的包装细胞系已在现有技术中描述,尤其是细胞系PA317(美国专利号4,861,719);PsiCRIP细胞系(PCT出版物WO90/02806)和GP+envAm-12细胞系(PCT出版物WO 89/07150)。此外,重组反转录病毒载体可在LTR中包含修饰以抑制转录活性,以及延伸的衣壳化序列(encapsidation sequence),它可包含部分gag基因(Bender等,J.Virol.,1987,61:1639)。重组反转录病毒载体用此领域的一般技术人员已知的标准技术纯化。
可构建反转录病毒载体以作为感染性颗粒或进行单轮转染。第一种情况下,病毒被修饰以保留除引起致癌转化特性外其所有的基因,并表达异源基因。操作非感染性病毒载体以破坏病毒包装信号,但保留包装构建的共引入病毒所需的结构基因含有异源基因和包装信号。因此,所产生的病毒颗粒不能产生其它病毒。
也可通过DNA病毒引入反转录病毒载体,这可复制一次反转录病毒并增强转染效率(参见PCT出版物WO 95/22617,WO 95/26411,WO 96/39036和WO 97/19182)。
慢病毒载体.在本发明另一个实施方案中,可将慢病毒载体用作在一些组织类型中直接传递和持续表达转基因的试剂,这些组织包括脑、视网膜、肌肉、肝脏和血液。载体可有效转导这些组织中分化和未分化的细胞,并影响感兴趣的基因的长期表达。综述可参见Naldini,Curr.Opin.Biotechnol.,1998,9:457-63;也可参见Zufferey等,J.Virol.,1998,72:9873-80)。慢病毒包装细胞系是可以获得的且通常在此领域中已知。它们有助于生产用于基因治疗的高效价慢病毒载体。一个例子是四环素可诱导的VSV-G假型慢病毒包装细胞系,这种细胞系可产生使效价大于106IU/mL至少3-4天的病毒颗粒(Kafri等,J.Virol.,1999,73:576-584)。为在体外和体内有效转导未分化的细胞,需浓缩由可诱导细胞系产生的载体。
非病毒载体.在本发明的另一个实施方案中,所述载体可通过脂转染作为裸DNA引入体内,或者和其它有助于转染的试剂(肽、聚合物等)。合成的阳离子脂质可用来制备供体内转染编码标记的基因的脂质体(Felgner等,Proc.Natl.Acad.Sci.U.S.A.,1987,84:7413-7417;Felgner和Ringold,Science,1989,337:387-388;见Mackey等,Proc.Natl.Acad.Sci.U.S.A.,1988,85:8027-8031;Ulmer等,Science,1993,259:1745-1748)。用来转移核酸的有用的脂类化合物和组合物描述在PCT专利出版物WO 95/18863和WO 96/17823,以及美国专利号5,459,127中。为进行寻靶,脂类可以与其它分子化学结合(参见Mackey等,同上)。寻靶肽,例如激素或神经递质,以及蛋白质如抗体,或非肽分子可与脂质体化学结合。
其它分子也有助于体内转染核酸,例如阳离子寡肽(例如PCT专利出版物WO95/21931),衍生自DNA结合蛋白的肽(例如PCT专利出版物WO 96/25508),或阳离子聚合物(例如PCT专利出版物WO 95/21931)。
可以将载体作为裸DNA质粒引入体内。可用此领域已知的方法将用于疫苗目的或基因治疗的裸DNA载体引入所需的宿主细胞,这些方法如电穿孔、微注射、细胞融合、DEAE葡聚糖、磷酸钙沉淀、使用基因枪或使用DNA载体转运蛋白(例如Wu等,J.Biol.Chem.,1992,267:963-967;Wu和Wu,J.Biol.Chem.,1988,263:14621-14624;加拿大专利申请2,012,311号;Williams等,Proc.Natl.Acad.Sci.USA,1991,88:2726-2730)。也可采用受体介导的DNA传递法(Curiel等,Hum.GeneTher.,1992,3:147-154;Wu和Wu,J.Biol.Chem.,1987,262:4429-4432)。美国专利号5,580,859和5,589,466揭示了在哺乳动物中传递外源DNA序列,未使用有助于转染的试剂。最近,描述了一种相对电压低、效率高的体内DNA转移技术,称为电转移(electrotransfer)(Mir等,C.P.Acad.Sci.,1988,321:893;PCT出版物WO 99/01157;WO 99/01158;WO 99/01175)。因此,本发明的其它实施方案涉及在人类中诱导免疫应答的方法,所述方法包括给予所述人类一定量的编码本发明2086多肽的DNA分子,任选用有助于转染的试剂,其中所述多肽在表达时保留了免疫原性,因此将其掺入免疫原性组合物并给予人类时能提供保护,而不会因人类被奈瑟氏球菌属病原体,如脑膜炎奈瑟氏球菌,再次感染而加重疾病。有助于转染的试剂是此领域已知的,包括布比卡因和其它局部麻醉剂(例如参见美国专利号5,739,118)和阳离子聚胺(如国际专利申请WO 96/10038所述),在此将其并入以供参考。
本发明还涉及抗体,可以是单抗体克隆或多克隆抗体,具体是上述2086多肽。这种抗体可用精通此领域的技术人员熟知的方法产生。
细菌表达系统和质粒
本发明还提供了重组DNA分子,如载体或质粒,它包括具有启动子序列和起始密码子序列的表达控制序列以及编码本发明多肽的核苷酸序列,所述核苷酸序列位于3’至启动子和起始密码子序列。另一方面,本发明提供了能够表达2086多肽的重组DNA克隆载体,包括具有启动子序列和起始密码子序列的表达控制序列以及编码2086多肽的核苷酸序列,所述核苷酸序列位于3’至启动子和起始密码子序列。再一方面,本发明提供了含有上述重组DNA克隆载体和/或重组DNA分子的宿主细胞。合适的表达控制序列和宿主细胞/克隆载体的组合是此领域熟知的,并通过例子在Sambrook等(1989)中描述。
一旦通过用含有相应2086多核苷酸的质粒转化、转染或感染克隆载体或宿主细胞构建了表达所需的本发明多肽的重组DNA克隆载体和/或宿主细胞,就可在使多肽表达的条件下培养克隆载体或宿主细胞。然后用精通此领域的技术人员熟知的技术分离得到大体上没有污染的宿主细胞组分的多肽。
以下实施例是为了证实本发明的优选实施方案。精通此领域的技术人员应该知道,实施例中公开的技术在实施本发明时发挥了较好的作用,因此可认为是优选的实施方式。然而,在阅读此说明书后,在不背离本发明精神或范围的情况下,那些精通此领域的技术人员能够对所述特定实施方案做出许多改变而仍能得到一样或类似的结果。
实施例
实施例1
鉴定能够引发抗异源菌株杀菌抗体的奈瑟氏球菌膜蛋白提取物:
参考下面的表II,耗竭LOS的外膜蛋白制品显示可引发杀菌抗体。这些抗体通常针对各个菌株的PorA。来自血清组B脑膜炎球菌菌株8529(B:15:P1.7b,3)的耗竭LOS的外膜蛋白制品在这种方式中是独特的,因为它们出乎意料地对几种异源菌株引发杀菌抗体。
表II
对脑膜炎奈瑟氏球菌不同菌株的抗-sOMPS的BC活性
抗血清第6周 | H44/76 | 5315 | H355 | M982 | 880049 | 8529* | NMB |
血清亚型 | P1.7,16 | P1.5 | P1.15 | P1.9 | P1.4 | P1.3 | P1.5,2 |
sOMPs H44/7625μgQS-21 20μg | 1,000 | <50 | <50 | <50 | <50 | 980 | <50 |
sOMPs 5315 25μgQS-21 20μg | 50 | <50 | <50 | <50 | <50 | 2170 | <50 |
sOMPs H355 25μgQS-21 20μg | <50 | <50 | 450 | <50 | <50 | 860 | <50 |
sOMPs M982 25μgQS-21 20μg | 92 | <50 | <50 | 300 | <50 | 1100 | <50 |
sOMPs 880049 25μgQS-21 20μg | 50 | <50 | <50 | <50 | <50 | 1190 | <50 |
sOMPs 8529 25μgQS-21 20μg | 1,000 | <50 | 450 | 50 | 215 | >4050(81.7) | <50 |
sOMPs 299625μgQS-21 20μg | <50 | <50 | <50 | <50 | <50 | 790 | 148 |
全细胞对照血清25μg 3DMPL 25μg | 450 | 50 | 100 | 500 | 150 | >1350(66.0) | 952 |
为便于分离和鉴定可引发异源杀菌抗体的抗原,我们试图确定哪种洗涤剂对于提取抗原最佳。
菌株和培养条件
将冷冻管中的脑膜炎奈瑟氏球菌菌株8529在GC平板上划线。(所述脑膜炎球菌菌株8529来自RIVM,Bilthoven,荷兰)。将平板在36℃/5%CO2下培养7.5h。将一些菌落接种到含有50mL改进的Frantz培养基+GC添加物的烧瓶。36℃下将烧瓶在空气摇床中以200RPM振荡培养4.5h。用5ml接种到含有450mL改进的Frantz培养基+GC添加物的Fernbach烧瓶中。36℃下将烧瓶在空气摇床中以100RPM振荡培养11h。将所有450mL接种到含有8.5L改进的Frantz培养基+GC添加物的10L发酵罐中。
改进的Frantz培养基的成分:
谷氨酸 1.3g/L
半胱氨酸 0.02
磷酸二氢钠,7水合物 10
氯化钾 0.09
氯化钠 6
氯化铵 1.25
透析的酵母提取物(YE) 40mL
(25%YE溶液,用5体积蒸馏水透析过夜,然后高压灭菌)
GC添加物100X,无菌过滤
葡萄糖 400g/L
谷氨酸 10
辅羧化酶 0.02
硝酸铁 0.5
在发酵时控制以下参数:温度=36℃;pH=7.4;溶解氧=20%。加入几滴P-2000消泡剂以控制泡沫产生。使培养物生长到稳定期。在OD650=5.25离心收获细胞。从约8.5L培养物中通常收集到总数为100-300克湿细胞浆。
从可引发异源杀菌抗体的脑膜炎球菌中部分纯化外膜蛋白组分:
将100克湿重细胞悬浮于湿重5倍体积10mM HEPES-NaOH,pH7.4,1mM Na2EDTA中,并通过装有约18,000psi室的110Y微流化器进行细胞裂解。将细胞裂解物澄清并在10℃以300,000xg离心分离细胞包膜。用匀浆器悬浮然后按上述离心,用相同的缓冲液洗涤细胞包膜两次。然后用320mL加有10mM HEPES-NaOH,pH7.4,1mM MgCl2的320mL 1%(w/v)Triton X-100提取细胞包膜。参考下表III,用TritonX-100和两性洗涤剂3-14顺序示差洗涤剂提取,然后免疫小鼠,我们就可以确定Triton提取物能最佳提取感兴趣的候选物。然后在BioRad Rotophor装置中通过制备型等电聚焦(IEF)分离这种Triton X-100提取物,它对表III所列五种菌株中的四种菌株可引发杀菌抗体应答。两性电解质浓度是1%pH3-10与1%pH4-6混合。如表III所示,发现一些组分能够引发异源杀菌反应。通过杀菌测定可知,获自IEF的组分,其pH范围集中在5.5-7.8,可引发对大多数菌株的异源应答。将收集的IEF组分浓缩并通过乙醇沉淀除去两性电解质。在阴离子交换柱上以约5.5-7.8的pH范围吸附一些所得蛋白质以获得进一步的纯化,并比较用吸附和未吸附的蛋白质免疫小鼠后所得的杀菌活性。再参考表II,尽管许多蛋白被吸附到阴离子交换树脂,但未被柱吸附的蛋白可引发更多的异源杀菌抗体。
表III
BC50靶菌株 | ||||||
方法 | 组分 | H44/7 | 88004 | H355 | 539* | M982 |
耗竭LOS sOMPs | 1,00 | 215 | 450 | NC | 50 | |
洗涤剂提取 | 胞质提取物 | 200 | NT | NT | NT | NT |
TX-100 | >800 | >800 | >800 | >800 | <25 | |
两性洗涤剂3-12 | 400 | >25 | 100 | 400 | <25 | |
两性洗涤剂3-14 | <25 | NT | NT | NT | NT | |
两性洗涤剂3-14+NaCl | <25 | NT | NT | NT | NT | |
十二烷基肌氨酸钠 | <25 | NT | NT | NT | NT | |
两性洗涤剂3-14+加热 | <25 | NT | NT | NT | NT | |
制备IEF | 组分1-3(pH2.3-3.9) | 50 | NT | NT | NT | NT |
组分4(pH4.1) | >800 | <25 | 100 | <25 | NT | |
组分5(pH4.3) | >800 | <25 | 100 | 200 | NT | |
组分6(pH4.5) | 400 | NT | NT | NT | NT | |
组分7(pH4.8) | <25 | NT | NT | NT | NT | |
组分8-9(pH5.0-5.3) | <25 | NT | NT | NT | NT | |
组分10-17(pH5.5-7.8) | >800 | 200 | <800 | <800 | NT | |
阴离子交换 | 吸附的 | 400 | NT | 100 | 100 | NT |
未吸附的 | >6,40 | NT | <800 | <800 | NT |
NT:未测试
临床分离物539是8529的同源菌株,分离自同一次爆发流行。
如图1A所示,通过SDS-PAGE确定未吸附的组分中有两种主要蛋白。为鉴定这些蛋白,进行了两种类型的分析。一种分析是进行有限蛋白酶解降解(参见图1A和图1B)然后分离肽并直接蛋白质测序。另一种分析是进行SDS-PAGE然后进行凝胶切除、蛋白酶解消化和LC-MS/MS(液相层析串联质谱)(参见图3)以获得感兴趣的制品组分的质谱信息。(参见该部分下面所描述的肽作图和测序法)
用Zagursky和Russell在Biotechnology,2001,31:636-659中描述的方法和算法分析脑膜炎奈瑟氏球菌A Sanger基因组序列。这种分析产生了12,000多个可能的开放阅读框(ORF)。直接的序列数据和上述质谱数据都说明未吸附组分的主要成分相当于Sanger数据库分析中存在的一些ORF的产物。用这种方法鉴定的三种主要蛋白质相当于ORF 4431、5163和2086(参见图1B和3)。
虽然ORF 4431是在所述组分中鉴定的最主要蛋白质,但在动物模型中,对重组脂质化的4431的小鼠抗体并不能杀菌和提供保护性应答。其它对ORF 5163的分析正在进行。
上述制品的第二种最主要的成分相当于ORF 2086的产物。
免疫原性方法:
制备抗血清:
除了提到的方法,用25μg总蛋白并用20μg QS-21作为佐剂配制了蛋白质组合物/疫苗。通过皮下(臂部)注射在第0和4周给6-8周龄的雌性Swiss-Webster小鼠施用0.2mL剂量。在第0和4周收集血液并在第6周进行最终的放血。
杀菌测定:
基本按以下描述进行杀菌测定(参见Mountzouros和Howell,2000,J.Clin.Microbiol.38(8):2878-2884)。SBA的补体介导的抗体依赖型杀菌效价表示为测定中杀死50%靶细胞的测试血清的最高稀释度的倒数(BC50效价)。
用来鉴定2086蛋白的方法:
溴化氰切割和片段的直接测序:
阴离子交换未吸附组分(AEUF)的溴化氰切割。用90%冷乙醇沉淀AEUF并用10mg/mL加有70%甲酸的溴化氰稀释至蛋白质浓度为1mg/mL。反应在室温下,黑暗中进行过夜。用真空离心蒸发浓缩器干燥切割的产物,测定用HE/0.1%还原的TX-100溶解。用SDS-PAGE然后通过N-末端氨基酸测序来鉴定该组分的成分。
蛋白酶消化/反相/N-末端测序以鉴定组分:
用GluC(V8)、LysC或ArgC消化AEUF。蛋白质与酶的比例是30μg蛋白质比1μg酶。消化在37℃进行过夜。消化的蛋白质混合物(30μg)通过7微米的AquaporeRF-300柱并用加有0.1%三氟乙酸的10-95%乙腈梯度洗脱,手工收集洗脱峰。同时进行没有蛋白质的空白,并从样品色谱图中除去空白的峰。用质谱仪分析只在样品中出现的峰,并对那些给出清晰质谱的样品进行N-末端氨基酸测序。
N-末端氨基酸测序:
从印迹上切下条带,将蛋白质样品从SDS凝胶转移到PVDF膜,用酰胺黑(10%乙酸、0.1%酰胺黑溶于去离子水)染色并用10%乙酸脱色。然后用甲醇清洁的解剖刀或小型Exacto刀从所有十个泳道切下所需的蛋白质条带,并置于AppliedBiosystems 477A型蛋白质测序仪的反应管中。为直接测序溶液中的样品,需装上Prosorb管并用60μL甲醇润湿PVDF。用50μL去离子水冲洗PVDF并将样品(50μL)加到PVDF上。用50μL去离子水冲洗样品后,取出Prosorb PVDF,干燥并置于Applied Biosystems 477A蛋白质测序仪的反应管中。对于这两种方法,然后都在最佳印迹条件下运行Applied Biosystems N-末端测序仪12轮或更多循环(1轮空白,1轮标准物,对需要鉴定的残基进行10轮或更多循环)并在Applied Biosystems120A PTH分析器上进行PTH-氨基酸检测。在模拟图表记录仪上收集循环并用工具软件计算数据。通过比较PTH-氨基酸的标准设置和它们在分析仪上各自的保留时间用类似物和数字数据进行氨基酸排布(半胱氨酸残基在转化时被破坏且没有检测)。用一个残基可获得多个序列信息,基于信号强度作出主要和次要排布。
LC-MS/MS
用SDS-聚丙烯酰胺凝胶电泳进一步分析通过IEF纯化的蛋白质样品。用考马斯蓝染色显现蛋白质,并手工切除感兴趣的条带,然后还原、烷基化并用自动的凝胶内胰蛋白酶消化器(1)以胰蛋白酶原位消化(Promega,Madison,WI)。消化后,用Savant Speed Vac浓缩器(ThermoQuest,Holdbrook,NY)将肽提取物浓缩至最终体积为10-20μL。
用自动微量电喷雾反相HPLC分析肽提取物。简言之,微量电喷雾界面由50cm长,内径75um,喷嘴直径8um的熔融硅喷雾针(New Objective,Cambridge MA)构成,喷雾针中装有长度为10cm的10um C18反相珠(YMC,Wilmington,NC)。Picofrit针安装于光导纤维支架(Melles Griot,Irvine,CA),固定在位于质谱仪检测器前面的自制基座上。柱的后部垂直通过钛接头为电喷雾界面提供电连接。所述接头与一定长度的与FAMOS自动取样器(LC-Packings,San Francisco,CA)相通的熔融硅毛细管(FSC)连接,所述取样器连接HPLC溶剂泵(ABI 140C,Perkin-Elmer,Norwalk,CT)。所述HPLC溶剂泵以50μL/min流量输送,用PEEK微紧固分离T形管(microtight splittingtee)(Upchurch Scientific,Oak Harbor,WA)将流量降至250nL/min,然后用FSC转换线输送到自动取样器。所述LC泵和自动取样器分别用其内部使用者程序控制。将样品插入塑料的自动取样器小管,密闭并用5μL加样环注射。
微细管HPLC-质谱:
通过微量电喷雾HPLC系统用50分钟0-50%溶剂B(A:0.1M HoAc,B:90%MeCN/0.1M HoAc)梯度分离来自凝胶内消化液的提取的肽。在Finnigan LCQ离子阱质谱仪(ThermoQuest,San Jose,CA)上进行肽分析,喷雾电压为1.5kV,加热的毛细管温度为150℃。用设备提供的数据获取软件以自动MS/MS模式获得数据。获取方法包括1MS扫描(375-1200m/z),然后MS/MS扫描MS扫描中含量最丰富的三种离子。采用动态排除(dynamic exclusion)和同位素排除(isotope exclusion)功能来增加被分析的肽离子数量(设定:3amu=排除宽度,3min=排除持续时间,30secs=预排除持续时间,3amu=同位素排除宽度)。采用来自脑膜炎奈瑟氏球菌(获自Sanger)完整基因组的蛋白质数据库,用Finnigan Bioworks数据分析软件包(ThermoQuest,San Jose,CA)包括的SEQUEST计算机算法进行自动分析MS/MS数据。研究结果在图3中说明。
实施例2
重组脂质化P2086(rLP2086)的克隆:
A.)天然前导序列:
原料:
通过PCR从血清组B脑膜炎奈瑟氏球菌菌株8529的临床分离物扩增ORF 2086基因。该菌株的血清组、血清型和血清亚型显示在括号内;8529(B:15,P1:7b,3)。这种脑膜炎球菌菌株获自RIVM,Bilthoven,荷兰。脑膜炎球菌菌株8529的成熟2086蛋白基因序列如SEQ ID.NO:212所提供。
PCR扩增和克隆策略:
ORF 2086的可视检测说明,这种基因有一个潜在的脂蛋白信号序列。用专利的隐蔽马尔科夫模型(Hidden Markov Model)脂蛋白算法分析证实ORF 2086含有脂蛋白信号序列。为以更像天然的构象重组表达P2086,设计了扩增具有完整脂蛋白信号序列的全长基因的寡核苷酸引物,该引物基于对脑膜炎奈瑟氏球菌A ORF 2086的Sanger序列分析(5’引物-CT ATT CTG CAT ATG ACT AGG AGC;3’引物-GCGCGGATCC TTA CTG CTT GGC GGC AAG ACC),它们分别是SEQ ID NO:304(化合物编号:4624)和SEQ ID NO:303(化合物编号:4623)(也可参见这里的表IV)。通过聚合酶链式反应(PCR)[ABI 2400热循环仪,Applied Biosystems,Foster City,CA]从脑膜炎奈瑟氏球菌菌株8529扩增2086基因。将正确大小的扩增产物连接并克隆入pCR2.1-TOPO(Invitrogen)。质粒DNA用NdeI和BamHI限制性消化,凝胶纯化并连接入pET-27b(+)载体(Novagen)。
采用β-氰乙基亚磷酰胺(Applied Biosystems,Foster City CA),在PerSeptiveBiosystems寡核苷酸合成仪(Applied Biosystems,Foster City CA)上合成上述寡核苷酸引物。用于PCR扩增ORF 2086基因家族的引物列于表IV,它显示了本发明引物的非限制性例子。
表IV:引物
SEQ ID NO.(化合物编号) | 引物 | 序列 | 限制位点 |
303(4623) | 反向 | GCGCGGATCCTTACTGCTTGGCGGCAAGACC | BamHI |
304(4624) | 正向 | CTATTCTGCATATGACTAGGAGC | NdeI |
305(4625) | 正向 | AGCAGCGGAGGCGGCGGTGTC | |
306(5005) | 正向 | TGCCGATGCACTAACCGCACC | |
307(5007) | 反向 | CGTTTCGCAACCATCTTCCCG | |
308(5135) | 反向 | GAGATCTCACTCACTCATTACTGCTTGGCGGCAAGACCGATATG | BglII |
309(5658) | 正向 | GCGGATCCAGCGGAGGGGGTGGTGTCGCC | BamHI |
310(5660) | 反向 | GCGCATGCTTACTGCTTGGCGGCAAGACCGATATG | SphI |
311(6385) | 正向 | GCGGATCCAGCGGAGGCGGCGGAAGC | BamHI |
312(6406) | 正向 | GCGCAGATCTCATATGAGCAGCGGAGGGGGTGGTGTCGCCGCCGAYATWGGTGCGGGGCTTGCCG | BglII和NdeI |
313(6470) | 正向 | CTATTCTGCGTATGACTAG | |
314(6472) | 反向 | GTCCGAACGGTAAATTATCGTG |
SEQ ID NO.(化合物编号) | 引物 | 序列 | 限制位点 |
315(6473) | 正向 | GCGGATCCAGCGGAGGCGGCGGTGTCGCC | BamHI |
316(6474) | 正向 | GAGATCTCATATGAGCAGCGGAGGCGGCGGAAGC | BglII和NdeI |
317(6495) | 正向 | GACAGCCTGATAAACC | |
318(6496) | 反向 | GATGCCGATTTCGTGAACC | |
319(6543) | 反向 | GCGCATGCCTACTGTTTGCCGGCGATG | SphI |
320(6605) | 反向 | GAGATCTCACTCACTCACTACTGTTTGCCGGCGATGCCGATTTC | BglII |
321(6721) | 正向 | GCGCAGATCTCATATGAGCAGCGGAGGCGGCGGAAGCGGAGGCGGCGGTGTCACCGCCGACATAGGCACG | BglII和NdeI |
利用天然前导序列表达rLP2086脂蛋白:
参考图5,将质粒pPX7340转化/转染或感染入BLR(DE3)pLysS宿主细胞(LifeSciences)。选择一个转化体并接种到50mL含有2%葡萄糖、卡那霉素(30μg/mL)、氯霉素(30μg/mL)和四环素(12μg/mL)的Terrific肉汤中。过夜培养物的OD600为6.0。将过夜培养物稀释到1升含有1%甘油和相同抗生素的Terrific肉汤中。起始OD600为0.4。2小时后OD600为1.6,取出先诱导的样品。将OD600=1的细胞离心并除去上清。将全细胞团重悬于150μL Tris-EDTA缓冲液和150μL 2xSDS-PAGE样品缓冲液。加入IPTG至最终浓度为1mM。3.5小时后按所述取出后诱导的样品并用SDS-PAGE分析(参见图4)。
rLP2086的纯化:
差示洗涤剂提取后从大肠杆菌溶解rLP2086。与天然环境中的P2086不同,rLP2086不被Triton X-100或两性洗涤剂3-12显著溶解。rLP2086可被十二烷基肌氨酸钠溶解,表明它与大肠杆菌外膜组分的相互作用不同于它在脑膜炎奈瑟氏球菌中的相互作用。一旦用与天然蛋白质类似的方法纯化溶解的rLP2086,可通过在pH8用阴离子交换树脂吸附除去许多污染的大肠杆菌蛋白。尽管比其理论pI大了半个pH单位,rLP2086在pH8仍未被吸附。在pH4.5用阳离子交换树脂吸附rLP2086获得了进一步纯化。
SDS-PAGE后rLP2086的均一性显示在图2中。通过MALDI-TOF质谱分析确定rLP2086的质量为27,836。该质量与理论质量27,100相差736,这接近细菌脂蛋白常见的N-末端脂质修饰的质量。天然2086和rLP2086似乎都有外膜脂蛋白。试图阻断N-末端测序,这与末端修饰相一致。
纯化方法:
将表达P2086的BLR DE3 pLysS细胞的冷冻颗粒重悬于10mM HEPES-NaOH/1mMEDTA/1μg/mL Pefabloc SC蛋白酶抑制剂(Roche)pH7.4(HEP),每克湿细胞重量用20mL,并用微流化器(Microfluidics公司,110Y型)裂解细胞。细胞裂解物在150,000xg离心1小时。颗粒用HEP洗涤两次并离心两次,所得膜颗粒冷冻过夜。所述颗粒用10mM HEPES-NaOH/1mM MgCl2/1%TX-100 pH7.4溶解30分钟,接着在150,000xg离心30分钟。该过程重复三次。膜颗粒如上述用50mM Tris-HCl/5mMEDTA/1%两性洗涤剂3-12 pH8洗涤两次,接着用50mM Tris-HCl/5mM EDTA/1%两性洗涤剂3-14 pH8和50mM Tris-HCl/5mM EDTA/1%两性洗涤剂3-14/0.5M NaClpH8各洗涤两次。
然后rLP2086用50mM Tris-HCl/5mM EDTA/1%十二烷基肌氨酸钠pH8溶解。这种十二烷基肌氨酸钠提取物被调至1%两性洗涤剂3-14(Z3-14),并用过量30倍的50mM Tris-HCl/5mM EDTA/1%Z3-14透析两次。经过透析的rLP2086提取物用90%乙醇沉淀以除去残余的十二烷基肌氨酸钠,并用50mM Tris-HCl/5mM EDTA/1%Z3-14 pH8(TEZ)溶解。离心除去不溶物,将上清液通过阴离子交换层析柱,rLP2086被收集在未结合的组分中。然后未结合物用过量30倍的25mM NaAc/1%Z3-14 pH4.5透析两次并通过阳离子交换层析柱。rLP2086用0-0.3M NaCl梯度洗脱并通过SDS-PAGE分析(考马斯染色)。通过激光光密度测定法确定rLP2086库为84%纯。
抗血清对rLP2086亚科B的表面反应性和杀菌活性
参考表VII,通过全细胞ELISA测试了来自亚科B菌株8529的纯化的rLP2086的抗血清对所有10种2086亚科B菌株的表面反应性。检测了10种中9种表达异源血清亚型抗原-PorA的2086亚科B菌株的杀菌活性。这些菌株是引起整个西欧、美国、澳大利亚和新西兰血清组B脑膜炎球菌性疾病的代表性菌株。通过全细胞ELISA,在杀菌测定中唯一一种未被杀死的菌株870227与抗-rLP2086(亚科B)血清强烈反应,说明这种菌株表达一种带有P2086中常见表位的蛋白质。
还通过全细胞ELISA测试了表VII所列2086亚科A菌株的表面反应性。这三种菌株中的两种似乎有非常低的反应性,说明一些2086亚科A菌株可能不与rLP2086亚科B产生的抗体交叉反应。还对菌株870446、NMB和6557进行PCR扩增以鉴定菌株8529的2086亚科B基因。未检测到2086亚科B的PCR扩增产物。
免疫原性方法:
制备抗血清:
如上述实施例1中所述制备疫苗。但使用剂量为10μg。
全细胞酶联免疫吸附测定(ELISA):
用无菌0.01M磷酸盐、0.137M NaCl、0.002M KCl(PBS)将脑膜炎奈瑟氏球菌全细胞悬液稀释至620nm的光密度为0.1。在Nunc Bac T 96孔板(Cat#2-69620)的每个孔中加入0.1mL该悬液。室温下使细胞在平板上干燥3天,然后覆盖、倒转并储存在4℃。平板用洗涤缓冲液(0.01M Tris-HCl,0.139M NaCl/KCl,0.1%十二烷基聚(氧乙烯二醇醚)n,n=23(Brij-35_,购自ICI Americas,Inc.,Wilmington,Delaware),pH7.0-7.4)洗涤三次。在PBS,0.05%Tween-20/叠氮化物中制备抗血清的稀释液并将0.1mL转移到涂布的平板中。平板在37℃培育2小时。平板用洗涤缓冲液洗涤三次。羊-抗-鼠IgG AP(Southern Biotech)以1∶1500稀释在PBS/0.05%Tween-20中,在每个孔中加入0.1mL,并将平板在37℃培育2小时。洗涤平板(如上所述)。通过将对-硝基苯基磷酸盐(Sigma)在1M二乙醇胺/0.5mMMgCl2中稀释至1mg/mL制备底物溶液。在平板的每个孔中加入0.1mL底物并在室温下培育1小时。用50μL/孔3N NaOH终止反应并在405nm以690nm作为参照阅读平板。
B.)P4前导序列:
PCR扩增和克隆策略:
为最优化rLP2086的表达,2086基因从非可分型(nontypable)流感嗜血杆菌的P4信号序列之后克隆(Green等,1991)。用于脂蛋白克隆的引物列在表IV中并用化合物编号:5658、5660、6473、6543和6385鉴别。ORF 2086从脑膜炎奈瑟氏球菌B菌株8529扩增,用编号为5658和5660的化合物作为引物。ORF 2086从脑膜炎奈瑟氏球菌血清组B菌株CDC1573扩增,用编号为6385和5660的化合物作为引物。ORF 2086从脑膜炎奈瑟氏球菌血清组B菌株2996扩增,用编号为6473和6543的化合物作为引物。N-末端(5’)引物设计成与2086基因的成熟区域同源(从恰好位于半胱氨酸下游氨基酸位置3上的丝氨酸残基开始)。将限制位点BamHI(GGATTC)引入每个N-末端引物的5’末端,导致在成熟蛋白质的氨基酸位置2上插入甘氨酸残基。C-末端(3’)引物设计成与2086基因的C-末端同源,且为了克隆的目的,包括终止密码子以及SphI位点。来自各个脑膜炎奈瑟氏球菌B菌株的扩增片段被克隆入中间载体并通过序列分析筛选。
用BamHI和SphI限制性酶(New England Biolabs,(NEB))消化正确克隆的质粒DNA。选择载体pLP339(由申请人的受让人提供)作为表达载体。这种载体采用pBAD18-Cm骨架(Beckwith等,1995)并含有非可分型流感嗜血杆菌的P4脂蛋白信号序列和P4基因(Green等,1991)。所述pLP339载体用限制性酶BamHI部分消化然后用SphI消化。扩增的2086片段(BamHI/SphI)分别连接入pLP339载体(部分BamHI/SphI)。这种克隆策略将成熟2086基因置于P4脂蛋白信号序列之后。仍BamHI位点留在所P4信号序列和2086基因之间的克隆连接中(参见图7所示的质粒构建物)。以下是BamHI克隆连接处序列的例子:
[P4信号序列]-TGT GGA TCC-[保留的2086成熟核酸序列]
[P4信号序列]-Cys Gly Ser-[保留的2086成熟氨基酸序列]
参考图7,各个扩增的片段被克隆入含有P4前导序列的经过修饰的pBAD18-Cm载体。对表达rP4LP2086(重组P4脂质化2086)的重组大肠杆菌BLR pPX7343进行发酵以试图通过添加额外的葡萄糖增加细胞密度。发酵罐中装满如Sambrook所述的10L完全M9基本培养基,补充1%葡萄糖。
发酵罐中葡萄糖的最初浓度为45g/L。在发酵罐中接种至起始OD约为0.25。在约OD 25时加入20g/L葡萄糖。在OD 63.4葡萄糖耗尽时用1%阿拉伯糖诱导培养物。诱导后继续发酵3小时。在诱导后t=0、1、2、3时保留样品并用BSA测定蛋白质的量。在t=3时,蛋白质产量约为0.35g/L,和7%的总细胞蛋白质。从约10L培养物中共收获895克湿细胞浆。
用上述实施例2的A部分中同样的方法进行rP4LP2086的纯化。
实施例3
非脂质化的成熟2086蛋白的发育遗传学:
为进一步评价2086蛋白的免疫原性,进行了P2086的非脂质化形式的克隆和表达。
ORF 2086的PCR基因扩增:
用于PCR扩增非脂质化的2086基因的寡核苷酸列在引物表表IV中。来自菌株8529的2086基因可用化合物编号5135和6406(SEQ ID NO分别为308和312)鉴别的引物扩增,如该表所述。来自菌株CDC1573的2086基因可用化合物编号5135和6474(SEQ ID NO分别为308和316)鉴别的引物扩增。来自菌株2996的2086基因可用化合物编号6406和6605(SEQ ID NO分别为312和320)鉴别的引物扩增。
这些引物的特征包括,每个引物中有一个合成的BglII限制位点,化合物编号6406和6474中有一个合成的NdeI限制位点,且化合物编号5135和6605中存在的所有三个阅读框中都有终止密码子。引物编号6406和6474扩增在第二个氨基酸终止密码子(ACG)上融合了一个ATG(Met)的2086基因,它代表成熟2086多肽的单个氨基酸取代(代替TGC Cys)。
所述PCR克隆载体是TOPO-PCR2.1,Invitrogen,Valencia,CA。
用于表达非脂质化的2086蛋白的载体是来自Novagen,Madison,WI的pET9a。
所述大肠杆菌克隆菌株是Top10,Invitrogen,Carlsbad,CA。
所述大肠杆菌表达菌株是BLR(DE3)pLysS,Novagen,Madison,WI。
用于克隆目的的培养基是Sambrook等所述的Terrific肉汤液体或琼脂培养基,用1%无菌葡萄糖代替甘油,并加有合适的抗生素(氨苄青霉素或卡那霉素)。
质粒纯化采用Qiagen Spin Miniprep试剂盒(Valencia,CA)。
制备供非脂质化的2086表达的生产菌株或细胞系:
所述2086基因通过聚合酶链式反应(PCR)[AmpliTaq和ABI 2400热循环仪,Applied Biosystems,Foster City,CA]从来源于脑膜炎球菌菌株8529的染色体DNA扩增。2086基因的PCR扩增每个反应中采用的两种寡核苷酸引物由化合物编号6474和5135(SEQ ID NO分别是316和308)鉴别。扩增的2086PCR产物直接克隆入TOPO-PCR2.1克隆载体,并在补充有100μg/ml氨苄青霉素和20μg/ml X-Gal的Terrific肉汤琼脂上选择。选择白色集落并使其生长。用Qiagen微制备试剂盒制备质粒DNA并筛选用于PCR片段插入的质粒。对PCR插入质粒进行DNA测序(Big Dye化学在ABI377测序仪上进行,Applied Biosystems,Foster City,CA)。
用BglII限制性酶消化显示正确DNA序列的质粒,并用GeneClean II纯化试剂盒(Bio101,Carlsbad,CA)凝胶纯化BglII片段。将纯化的BglII片段克隆入表达载体pET9a的BamHI位点。在添加有30μg/ml卡那霉素的Terrific肉汤平板上选择pET9a/2086克隆。使卡那霉素抗性克隆生长并制备微制备质粒DNA。筛选BamHI位点中的2086基因的合适取向的质粒。正确取向的质粒代表T7-抗原融合到2086基因的氨基末端(rP2086T7)。这些rP2086T7基因融合体被转化入BLR(DE3)pLysS,在Terrific肉汤/Kan平板上选择,在Terrific肉汤中生长并用1mM IPTG(异丙基β-D-硫代吡喃半乳糖苷)诱导以表达rP2086T7融合蛋白。所述rP2086T7融合蛋白以高水平表达。
然后对这些融合质粒进行NdeI限制性消化,这样可删除T7-抗原并通过载体将成熟2086基因直接连接到ATG起始密码子上。将这些NdeI删除的质粒转化入Top10细胞并在Terrific肉汤/Kan平板上选择。使备选克隆生长并制备微制备质粒DNA。对质粒DNA进行DNA测序以确定缺失和2086基因序列的完整性。通过质粒图谱展示的这些质粒被称为pPX7328(图6)。将显示正确DNA序列的质粒转化入BLR(DE3)pLysS,在Terrific肉汤/Kan平板上选择,在Terrific肉汤中生长并用IPTG诱导以表达2086蛋白。当除去T7-Tag时,pET9载体在菌株BLR(DE3)pLysS中不表达成熟2086蛋白。
生产非脂质化的2086蛋白:
用纯化的质粒DNA来转化表达菌株BLR(DE3)pLysS。携带该质粒的BLR(DE3)pLysS细胞对卡那霉素有抗性并可通过加入1mM IPTG来诱导表达高水平的PorA蛋白。rP2086T7融合蛋白可作为不溶性包涵体在大肠杆菌细胞系BLR(DE3)pLysS中表达,表达量约占总蛋白质的40%。这种纯化的融合蛋白被用来免疫小鼠和产生显著水平的抗异源脑膜炎球菌菌株的杀菌抗体(参见表V)。
2086非脂质化基因的诱变:
在2086基因的5’末端进行PCR引物诱变。进行中的表达研究以确定当成熟的rP2086T7显示高表达水平时是否可除去T7-Tag。
非脂质化rP2086T7的纯化:
用微流化器在10mM Hepes-NaOH/5mM EDTA/1mM Pefabloc SC pH7.4中裂解表达非脂质化rP2086T7的大肠杆菌BLR(DE3)pLysS细胞。细胞溶解物在18,000xg离心30分钟。包涵体颗粒用50mM Tris-HCl/5mM EDTA/1%TritonX-100 pH8洗涤三次,每次洗涤后在24,000xg离心30分钟。包涵体颗粒然后用50mM Tris-HCl/5mMEDTA/1%两性洗涤剂3-14 pH8洗涤两次,每次洗涤后在24,000xg离心15分钟。包涵体颗粒然后用50mM Tris-HCl/5mM EDTA/4M尿素pH8溶解2小时,接着通过离心除去不溶物。将上清(溶解的rP2086T7)分成四个等分样品。用储备溶液将一份样品调至50mM Tris-HCl/5mM EDTA/250mM NaCl/2M尿素pH8(无洗涤剂),一份调至50mM Tris-HCl/5mM EDTA/250mM NaCl/2M尿素/1%氢化的Triton X-100pH8(TX-100),一份调至50mM Tris-HCl/5mM EDTA/250mM NaCl/2M尿素/1%两性洗涤剂3-12 pH8(Z3-12),一份调至50mM Tris-HCl/5mM EDTA/250mM NaCl/2M尿素/1%两性洗涤剂3-14 pH8(Z3-14)。为除去尿素,将样品透析以使各自的缓冲液均不含尿素。然后将样品透析以使各自的缓冲液均不含尿素并使NaCl浓度降至60mMNaCl。在2,000xg离心15分钟除去不溶物,所得上清(重折叠的rP2086T7)被用于进一步的实验。用考马斯染色SDS-PAGE和激光光密度测定发现rP2086T7的均一性为91-95%。
免疫原性过程—如实施例2所述
这种纯化的融合蛋白被用来免疫小鼠和产生显著水平的抗异源脑膜炎球菌菌株的杀菌抗体。(见下表V):
表V:产生P2086T7的鼠抗体的杀菌效价
小鼠血清 | 描述 | 异源菌株/H44/76 |
AF780第6周 | r2086T7,10μg | 3200 |
第0周收集 | Pre-免疫血清 | 10 |
AE203第6周 | rLP2086,10μg(阳性对照)* | 6400 |
(*用rLP2086免疫小鼠产生的阳性对照血清)
实施例4
ORF 2086的嵌合克隆的开发
菌株CDC-1573的2086基因的N-末端区域含有一个在菌株8529和2996的2086基因中不存在的重复区段(参见图8)。说明这种重复区段负责提高重组2086蛋白从两种基于大肠杆菌的表达系统(pET和pBAD)的表达水平。与采用相同系统的菌株8529和2996的2086基因的重组表达水平相比,CDC-1573 2086基因的重组蛋白表达水平明显超过在pET和pBAD表达系统中的表达水平。除了这种重复区段,所有三种菌株的2086基因的N-末端区域都是相对同源的。因此,可以合理地设想将CDC-1573 N-末端融合到菌株8529和2996的2086基因,当使用pET和pBAD系统时从这些基因表达的重组2086蛋白的水平将增加。
材料和方法:
菌株8529和2996的染色体DNA被纯化并被用作嵌合2086基因的PCR扩增的模板。化合物编号为6721和5135的PCR引物(SEQ ID NO分别为321和308)被用来从菌株8529扩增嵌合2086基因,化合物编号为6721和6605的PCR引物(SEQ IDNO分别为321和320)被用来从菌株2996扩增嵌合2086基因。将PCR产物直接克隆入PCR2.1 TOPO载体(Invitrogen),然后通过DNA序列分析筛选以鉴别完整的嵌合2086基因。然后用BglII从PCR2.1载体切除该基因并将所述BglII片段插入质粒pET9a的BamHI位点。筛选具有合适取向的质粒插入物然后对其进行NdeI消化。在pET9a载体的协助下,线性NdeI片段自身连接(self-ligated)以实现含有T7-tag序列的小NdeI片段的缺失。这种缺失使T7启动子直接连接嵌合2086基因的5’末端。将NdeI删除的质粒转化入大肠杆菌菌株BL21(DE3)并利用IPTG诱导筛选表达嵌合2086蛋白的卡那霉素抗性集落。
最初的研究表明,当在pET9a系统表达时,菌株2996的嵌合2086基因表达的重组蛋白约为天然2996/2086基因的两倍。尚未测试pBAD系统。
尽管只进行了一项实验,但数据表明提高了嵌合2086基因的功效。菌株8529和2996的2086基因产生的CDC-1573 N-末端融合体提高重组2086蛋白的表达。
实施例5
2086 PCR筛选脑膜炎奈瑟氏球菌菌株:
为确定2086基因在临床分离物中的保守性,对88种脑膜炎奈瑟氏球菌菌株进行PCR扩增。
ORF 2086的最初PCR鉴定采用表IV所列的引物(参见上述实施例2),由化合物编号:4623、4624和4625(SEQ ID NO分别为303、304和305)鉴别。这些引物是基于Sanger氏的脑膜炎奈瑟氏球菌血清组A序列设计的。为便于筛选大量的菌株,设计了2086基因的内部引物。用新设计的由化合物编号5005和5007(SEQ ID NOS.306和307)鉴别的内部2086引物通过PCR筛选总共88种脑膜炎奈瑟氏球菌菌株。这些引物使申请人能够从88种脑膜炎奈瑟氏球菌菌株中的63种鉴定2086基因(约70%),(参见表VI-A)。
Sanger氏的脑膜炎奈瑟氏球菌血清组A序列和TIGR氏的脑膜炎奈瑟氏球菌血清组B序列中2086基因周围的扩展区被检测和排列。设计的引物与2086基因的上游和下游区域相符合。目的是用这些引物从多种脑膜炎奈瑟氏球菌菌株来扩增大于全长2086基因的序列以进行序列比较。用化合物编号6470和6472(SEQ ID NO分别为313和314)PCR扩增一种菌株(6557),得到低产量的产物。菌株6557扩增的产物被克隆并对质粒DNA进行序列分析。结果表明一种新型2086基因具有的序列变异性比以前所见的大。菌株6557的2086基因在氨基酸水平上与其它菌株序列约75%相同一。有趣的是,菌株6557是先前通过上述2086 PCR筛选被测试为阴性的30%的菌株之一。
设计了对菌株6557内的C-末端可变区特异的内部引物。这些引物被用于在先前通过2086 PCR筛选被测试为阴性的约30%的菌株中筛选更加可变的2086基因。用这些新鉴定的内部2086引物(由化合物编号6495和6496;SEQ ID NO分别为159和160鉴别)通过PCR筛选所有脑膜炎奈瑟氏球菌菌株(n=88)。只有约30%先前通过2086 PCR被测试为阴性的脑膜炎奈瑟氏球菌菌株在此筛选中呈PCR阳性。一组从上述PCR阴性(约30%)菌株扩增的基因代表了一种新型2086基因或2086基因的第二家族,这里称为2086亚科A。用8529衍生引物从约70%的菌株扩增的一组2086基因在这里被称为亚科B。
2086基因的亚科A用奇数编号的SEQ ID NOS:1-173为例证,但不限于此。2086基因的亚科B用奇数编号的SEQ ID NOS:175-251为例证,但不限于此。
用于PCR扩增研究的脑膜炎奈瑟氏球菌菌株选自下面的表VI-A和表VI-B。表中所列菌株被作为脑膜炎奈瑟氏球菌菌株的例子,但不限于此。表VI-A所列菌株归入2086蛋白亚科A,表VI-B所列菌株归入2086蛋白亚科B。各表所列菌株是通过血清亚型分类的。如表中所述,这些菌株获自以下四种来源:MPHL-曼彻斯特公众健康实验室(Manchester Public Health Laboratory),曼彻斯特英国;RIVM,比尔特霍芬,荷兰;衣阿华大学(University of Iowa)医学院微生物系,衣阿华城,衣阿华州;和沃尔特里德陆军研究院(Walter Reed Army Institute of Research),华盛顿特区。
表VI-A
菌株 | 血清亚型 | 来源 |
M97 251854 | B:4z,PI:4 | MPHL |
M98 250622 | B:2b,PI:10 | MPHL |
M98 250572 | B:2b,PI:10 | MPHL |
M98 250771 | B:4z,PI.22,14 | MPHL |
M98 250732 | B:4z,PI.22,14a | MPHL |
M98 250809 | B:15,PI:7,16 | MPHL |
M97 252697 | B:1,PI:6,P1.18,25 | MPHL |
M97 252988 | B:4,PI:6,P1.18,25,6 | MPHL |
M97 252976 | B:4,PI:6,P1.18,25 | MPHL |
M97 252153 | B:4,PI:6,P1.18,25 | MPHL |
M97 253248 | B:15,PI:7,NT,16 | MPHL |
CDC1610 | P1:NT 4(15),P1.18-7,16-14 | CDC |
CDC1521 | P1.6,3 2b(4) | CDC |
CDC1034 | P1.7 4(15) | CDC |
菌株 | 血清亚型 | 来源 |
L8 | P1.7,1 15(4) | Walter Reed |
CDC1492 | P1.7,1 4(15) | CDC |
870446 | P1.12a,13 | RIVM |
CDC2369 | P1.(9),14 | CDC |
6557 | P1.(9),14,P1.22a,14a | RIVM |
2996 | P1.5,2,P1.5a,2c | RIVM |
NmB | P1.5,2,P1.5a,2c | UIOWA |
L3 | P1.5,2 | Walter Reed |
B16B6 | P1.5,2 | RIVM |
CDC1135 | CDC | |
L5 | P1.NT,P1.21-6,1 | Walter Reed |
L4 | P1.21,16 | Walter Reed |
W135 | Walter Reed | |
C11 | C:16,P1.7,1 | CDC |
Y | Walter Reed |
表VI-B
菌株 | 血清亚型 | 来源 |
M98 250670 | B:1,PI:4 | MPHL |
M98 250024 | B:1,PI:4 | MPHL |
M97 253524 | B:1,PI:4 | MPHL |
M97 252060 | B:1,PI:4 | MPHL |
M97 251870 | B:4z,PI:4 | MPHL |
M97 251836 | B:4z,PI:4 | MPHL |
M97 251830 | B:4z,PI:4 | MPHL |
M97 251905 | B:4z,PI:4 | MPHL |
M97 251898 | B:4z,PI:4 | MPHL |
M97 251885 | B:4z,PI:4 | MPHL |
M97 251876 | B:4z,PI:4 | MPHL |
菌株 | 血清亚型 | 来源 |
M97 251994 | B:4z,PI:4 | MPHL |
M97 251985 | B:4z,PI:4 | MPHL |
M97 251957 | B:4z,PI:4 | MPHL |
M97 251926 | B:4z,PI:4 | MPHL |
M97 252045 | B:4z,PI:4 | MPHL |
M97 252038 | B:4z,PI:4 | MPHL |
M97 252026 | B:4z,PI:4 | MPHL |
M97 252010 | B:4z,PI:4 | MPHL |
M97 252098 | B:4z,PI:4 | MPHL |
M97 252083 | B:4z,PI:4 | MPHL |
M97 252078 | B:4z,PI:4 | MPHL |
M98 250735 | B:4z,PI:15 | MPHL |
M98 250797 | B:4z,PI:15 | MPHL |
M98 250768 | B:4z,PI:15 | MPHL |
M98 250716 | B:2b,PI:10 | MPHL |
M98 250699 | B:4z,PI:10 | MPHL |
M98 250393 | B:4z,PI:10 | MPHL |
M98 250173 | B:4z,PI:10 | MPHL |
M97 253462 | B:4z,PI:14 | MPHL |
M98 250762 | B:15,PI:7,16 | MPHL |
M98 250610 | B:15,PI:7,16 | MPHL |
M98 250626 | B:15,PI:7,16 | MPHL |
M97 250571 | B:15,PI:16 | MPHL |
M97 252097 | B:15,PI:16,P1.7b,16 | MPHL |
M97 253092 | B:1,PI:6 | MPHL |
M97 252029 | B:15,PI:7,NT | MPHL |
M97 251875 | B:15,PI:7,NT | MPHL |
CDC1127 | PI.7,16 4(15) | CDC |
CDC982 | PI.7,16 4(15) | CDC |
菌株 | 血清亚型 | 来源 |
CDC1359 | PI.7,16 4(15) | CDC |
CDC798 | PI.7,16 15(4) | CDC |
CDC1078 | PI.7,16 15(4) | CDC |
CDC1614 | PI.7,16 15(4) | CDC |
CDC1658 | PI.7,16 15(4) | CDC |
H44/76 | PI.7,16 15(4) | RIVM |
CDC1985 | P1.7,13 4(15) | CDC |
L6 | P1.7,1 ?(4) | Walter Reed |
CDC1573 | P1.7,1 4(15) | CDC |
L7 | P1.7,(9),1 | Walter Reed |
CDC937 | P1.7,3,P1. 7b,3 | CDC |
8529 | P1.7,3,P1.7b,3 | RIVM |
880049 | P1.7b,4 | RIVM |
CDC2367 | P1.15 4(15) | CDC |
H355 | P1.19,15 | RIVM |
CDC1343 | P1.14 4(15) | CDC |
M982 | P1.22,9 | RIVM |
870227 | P1.5c,10 | RIVM |
B40 | P1.5c,10 | RIVM |
5315 | P1.5c,10 | RIVM |
CDC983 | P1.5,2 | CDC |
CDC852 | P1.5,2 | CDC |
6940 | P1.18,25(6) | RIVM |
A4 |
其它菌株可以容易地作为来自受感染个体的分离物获得。
实施例6
rLP2086-8529抗血清抗脑膜炎球菌菌株的反应性
下表VII显示了上述rLP2086的交叉反应和交叉保护能力。如下表所述,rLP2086用包括全细胞ELISA(WCE)效价、杀菌测定(BCA)和幼鼠(IR)测定在内的各种技术处理并分析以确定多克隆抗体抗2086蛋白的细菌细胞表面反应性。
表VII
rLP2086-8529抗血清抗多种脑膜炎球菌菌株的反应性
菌株 | 血清亚型 | WCE | BC | IR |
2086亚科A | ||||
870446 | P1.12a,13 | 808,615 | >800 | |
NmB | P1.5a,2c | 47,954 | <100 | |
6557 | P1.22a,14a | 169,479 | <25 | - |
2086亚科B | ||||
880049 | P1.7b,4 | 1,402,767 | 100 | + |
H44/76 | P1.7,16 | 8,009,507 | >6400 | |
H355 | P1.19,15 | 10,258,475 | 3,200 | + |
6940 | P1.18,25(6) | 5,625,410 | 800 | |
870227 | P1.5c,10 | 4,213,324 | <25 | + |
252097 | P1.7b,16 | 10,354,512 | >800 | |
539/8529 | P1.7b,3 | 11,635,737 | 3,200 | |
M982 | P1.22,9 | 1,896,800 | 800 | |
CDC-1573 | P1.7a,1 | 208,259 | 25 | |
CDC-937 | P1.7b,(3) | 9,151,863 | >800 |
+在菌血症中降低大于10倍
-在菌血症中降低小于10倍
实施例7
制备了表达ORF 2086蛋白的各种构建物。下表VIII是为了显示本发明实施例和阐明本发明实施方案的目的提供的r2086构建物的表,但不限于此。
表VIII
r2086构建物概述
构建物 | 启动子 | 前导区 | 表达 | 提取 | 载体 | %总蛋白质 |
pPX7340 | T7 | 天然 | 考马斯 | 十二烷基肌氨酸钠可溶 | pET27b | 2.5%加工过的脂蛋白 |
pPX7341 | T7 | P4 | 考马斯 | 十二烷基肌氨酸钠可溶 | pET27b | 5%加工过的脂蛋白 |
pPX7343 | 阿拉伯糖 | P4 | 考马斯 | 十二烷基肌氨酸钠可溶 | pBAD18cm | 7-10%加工过的脂蛋白 |
pPX7325 | T7 | T7-tag融合/成熟 | 考马斯 | 包涵体 | pET9a | 40-50%成熟蛋白质 |
pPX7328 | T7 | 成熟 | 考马斯 | 可溶 | pET9a | 10%成熟蛋白质 |
实施例8
用LSO耗竭外膜蛋白进行的进一步研究鉴定了产生ProA以外的外膜蛋白的其它菌株,这些外膜蛋白能够引发表达异源血清亚型菌株的杀菌抗体。以下描述了进一步的研究以鉴定如本发明一个实施方案所述的其它蛋白,尤其是外膜脂蛋白,这种蛋白可减少脑膜炎球菌性免疫原性组合物中所需的蛋白质的数量。这些进一步的研究可补充上述实施例中所述的研究。
亚细胞分级、差示洗涤剂提取、等电聚焦和离子交换层析与免疫和抗多种菌株的杀菌测定结合使用以鉴定感兴趣的一小组蛋白质。主要组分的直接测序表明N-末端被阻断。通过直接测序化学消化和蛋白酶解消化所得的多肽获得了内部蛋白质序列。脑膜炎球菌菌株组A的基因组序列下载自Sanger中心并由我们的生物信息学小组用现有和有专利权的算法进行分析以产生可查询的数据库。肽序列数据表明ORF 2086是感兴趣的。基于这种orf的引物被用于从菌株8529中PCR P2086基因。基因序列分析,事实是N-末端被阻断,及其亚细胞定位表明,P2086是脂质化的外膜蛋白(LP2086)。采用流感嗜血杆菌(H.influenzae P4)信号序列,rLP2086-8529和其它脑膜炎球菌菌株的变异体被作为脂蛋白在大肠杆菌中重组表达。这些重组蛋白是通过差示洗涤剂提取分离自大肠杆菌细胞膜的,用离子交换层析纯化并被用于免疫小鼠。鼠抗-LP2086血清能够促进抗脑膜炎奈瑟氏球菌几种不同血清亚型菌株的杀菌活性。对许多脑膜炎奈瑟氏球菌菌株的P2086基因进一步分析显示,这些序列分成称为亚科A和亚科B的两组(参见图12)。抗亚科B蛋白的抗血清是对九种表达亚科B蛋白的菌株和一种表达亚科A蛋白的菌株杀菌的。亚科A抗血清是对亚科A的菌株杀菌的。一种rPorA和一种rLP2086的混合物引发的互补抗体使疫苗扩展超出单由蛋白质诱导的范围。
通过这些观察可得到以下结论。rLP2086抗原能够引发对表达异源PorA和异源P2086蛋白的脑膜炎球菌菌株的杀菌抗体。无论是单独施用或与其它奈瑟氏球菌属抗原结合,抗原的P2086家族都可能是有效的疫苗或免疫原性物质。
以下详细描述了上述研究。发现一种可溶性外膜蛋白(sOMPs)的复杂混合物可引发对表达异源PorA蛋白的菌株的PorA非依赖性杀菌抗体。对免疫活性组分采用差示洗涤剂提取、等电聚焦和离子交换层析然后免疫小鼠的方法。
在每个步骤中,测定血清的表面反应性和抗不同菌株的杀菌活性,这些菌株含有代表全世界脑膜炎球菌性疾病流行病学的血清亚型抗原。
分离和免疫步骤被用来鉴定用于脑膜炎奈瑟氏球菌组b的新型交叉反应免疫原性候选物。
产生PorA缺陷型菌株—将porA染色体基因座克隆入菌株2996的质粒pPX7016。在此质粒内,porA启动子、S/D盒和前38个N-末端密码子被删除并被自身所含的KanR表达盒代替。质粒用限制性酶线性化并自然转化入血清亚型菌株PI:5,2;PI:9;PI:7,16;PI:15;PI:4;PI:3和PI:10。选择卡那霉素抗性转化体并在ELISA中通过血清亚型特异性单克隆筛选PorA的丧失。
杀菌测定:见Mountzourous,K.T.和Howell,A.P.《在对脑膜炎奈瑟氏球菌组B进行的基于荧光的血清杀菌测定中检测补体介导的抗体依赖的杀菌活性》(Detectionof Complement-Mediated Antibody-Dependent Bactericidal Activity in aFlourescence-Based Serum Bactericidal Assay for Group B Neisseriameningitidis).J Clin Microbiol.2000;38:2878-2884。
全细胞酶联免疫吸附测定(ELISA):
用无菌0.01M磷酸盐、0.137M NaCl、0.002M KCl(PBS)将脑膜炎奈瑟氏球菌全细胞悬液稀释至620nm的光密度为0.1。在Nunc Bac T 96孔板(Cat#2-69620)的每个孔中加入0.1mL该悬液。37℃下使细胞在平板上干燥过夜,然后覆盖、倒转并储存在4℃。平板用洗涤缓冲液(0.01M Tris-HCl,0.139M NaCl/KCl,0.1%Brij-35,pH7.0-7.4)洗涤三次。在PBS,0.05%Tween-20/叠氮化合物中制备抗血清的稀释液并将0.1mL转移到涂布的平板中,平板在37℃培育2小时。平板用洗涤缓冲液洗涤三次。羊-抗-鼠IgGAP(Southern Biotech)以1∶1500稀释在PBS/0.05%Tween-20,在每个孔中加入0.1mL,并将平板在37℃培育2小时。洗涤平板(如上所述)。通过将对-硝基苯基磷酸盐(Sigma)在二乙醇胺中稀释至1mg/ml制备底物溶液。在平板的每个孔中加入0.1mL底物并在室温下培育1小时。用50μL/孔3N NaOH终止反应并在405nm处以690nm作为参照阅读平板。
重组PorA的诱导:BLR(DE3)/pET9a菌株于37℃在补充有Kan-30和2%葡萄糖的HySoy肉汤(Sheffield Products)中生长过夜。早上,O/N培养物以1/20稀释在HySoy肉汤(补充有Kan-30和1%甘油)并在37℃生长1小时。加入最终浓度为1mM的IPTG诱导这些培养物。使培养物再生长2-3小时然后收获。
重组PorA的纯化:rPorA用8M尿素溶解自大肠杆菌包涵体,并用不含尿素的缓冲液透析以使其重折叠。然后通过渗滤浓缩重折叠的rPorA并用G25柱将缓冲液交换成NaPO4 pH6。然后将经过透析的rPorA加到阳离子交换柱(S Fractogel)并用1M NaCl洗脱。
菌株8529(P1.7-2,3)的sOMPs在小鼠中引发对表达异源血清亚型的菌株的PorA非依赖性杀菌活性。下表IX显示了所研究菌株中的杀菌活性。
表IX
测试菌株 | 血清亚型 | BC50效价1 |
539539 PorA- | P1.7-2,3NST2 | 12801080 |
H44/76H44/76PorA- | P1.7,16NST | 32852620 |
H355H355 PorA- | P1.19,15NST | >1350>1350 |
880049880049 PorA- | P1.7-2,4NST | 29085 |
M982M982 PorA- | P1.22,9NST | 85<50 |
制备sOMPs:用TX-100、两性洗涤剂3-14和两性洗涤剂3-14+0.5M NaCl提取脑膜炎奈瑟氏球菌细胞膜。将上述sOMPs溶解在两性洗涤剂3-14/0.5M NaCl提取物中。用精通此领域的技术人员熟知的技术进行提取,例如参见美国专利号6,355,253,在此将其并入以供参考。
免疫原性:在第0周和4周用辅助有20μg QS-21的25μg总蛋白免疫雌性Swiss-Webster小鼠。在第6周放血并进行数据分析。
1杀菌(BC50)效价表示为可使活细胞计数减少50%的抗血清稀释度的倒数。第0周正常小鼠血清的BC50效价<25。
2NST=非血清亚型可分(Serosubtypable)
下表X总结了亚科A和亚科B的重组脂质化P2086(rLP2086)的纯化和特性鉴定。
亚科A rLP2086的纯化
表X
rLP2086变异体 | A.A.同源性(%)1 | 理论pI | 纯度(%)2 |
870446 | 75 | 6.1 | 80 |
2996 | 71 | 5.9 | 95 |
M97 252988 | 71 | 6.3 | 96 |
C11 | 68 | 6.4 | 82 |
M98 250771 | 62 | 6.1 | 83 |
亚科B rLP2086的纯化
表XI
rLP2086变异体 | A.A.同源性(%)1 | 理论pI | 纯度(%)2 |
8529 | 100 | 7.5 | 96 |
M982 | 94 | 6.3 | 96 |
88049 | 92 | 6.2 | 90 |
CDC1573 | 87 | 5.6 | 93 |
纯化方法:用TX-100(除rLP2086-8529用十二烷基肌氨酸钠或尿素溶解)从大肠杆菌细胞膜溶解所有变异体。在Tris-HCl或NaPO4缓冲液中结合阴离子交换(TMAE)、大小排阻和/或阳离子交换(S Fractogel)色谱获得进一步纯化。
1与菌株8529的P2086比较所得的氨基酸同源性
2通过SDS-PAGE和胶体考马斯染色带(Simply Blue染色)的激光光密度测定法确定纯度
亚科B成员rLP2086-8529对同源和异源菌株测试的免疫原性
下表XII显示了亚科B成员rLP2086-8529对同源和异源菌株测试的免疫原性
表XII
靶菌株 | P2086亚科 | 靶菌株血清亚型 | A.A.同源性a | 全细胞ELISAb效价 | BC50效价c |
539 | B | P1.7-2,3 | 100 | >1,458,000 | 3,200 |
H44/76 | B | P1.7,16 | 100 | >1,458,000 | 3,200 |
H355 | B | P1.19,15 | 100 | >1,458,000 | 3,200 |
CDC937 | B | P1.7-2,3-4 | 100 | >1,458,000 | >800 |
M97 252097 | B | P1.7-2,16 | 100 | >1,458,000 | >800 |
870227 | B | P1.5-2,10 | 100 | >1,458,000 | <25 |
6940 | B | P1.18,25,6 | 97 | 900,162 | >800 |
M982 | B | P1.22,9 | 94 | 435,909 | 200 |
880049 | B | P1.7-2,4 | 92 | 349,912 | 400 |
CDC1573 | B | P1.7-1,1 | 87 | 102,508 | 25 |
870446 | A | P1.12-1,13 | 71 | 389,829 | 800 |
M98 250771 | A | P1.22,14 | 62 | 139,397 | <25 |
NmB | A | P1.5-1,2-2 | 71 | <2,000 | <25 |
疫苗接种步骤:在第0周和第4周用10μg rLP2086-8529+20μg QS-21免疫6-8周龄雌性Swiss-Webster小鼠。在第6周放血并进行数据分析。
a与rLP2086-8529相比P2086的氨基酸同源性
b终点效价表示为吸收值=0.1时稀释度的倒数
cBC50效价表示为可使活细胞计数减少50%的抗血清稀释度的倒数。第0周正常小鼠血清的BC50效价<10
表XIII显示了亚科B成员rLP2086-2996对同源和异源菌株测试的免疫原性。
表XIII
靶菌株 | P2086亚科 | 靶菌株血清亚型 | A.A.同源性a | 全细胞ELISAb效价 | BC50效价c |
NmB | A | P1.5-1,2-2 | 99.6 | 8,979 | <25 |
870446 | A | P1.12-1,13 | 99 | <1,458,000 | >800 |
M97 252697 | A | P1.18,25,6 | 98 | 320,732 | >800 |
6557 | A | P1.22-1,14-1 | 98 | 17,319 | <25 |
M98 250732 | A | P1.22,14-1 | 89 | 241,510 | >800 |
M98 250771 | A | P1.22,14 | 89 | 447,867 | 800 |
H44/76 | B | P1.7,16 | 72 | 56,386 | <25 |
疫苗接种步骤:在第0周和第4周用10μg rLP2086-2996+20μg QS-21免疫6-8周龄雌性Swiss-Webster小鼠。在第6周放血并进行数据分析。
a与rLP2086-2996相比P2086的氨基酸同源性
b终点效价表示为吸收值=0.1时稀释度的倒数
c杀菌(BC50)效价表示为可使活细胞计数减少50%的抗血清稀释度的倒数。第0周正常小鼠血清的BC50效价<10
下表XIV显示,当混合并测定杀菌活性时对rLP2086和rPorA的抗血清是互补的。
表XIV
抗血清 | H44/76(P1.7,16) | NMB(P1.5-1,2-2) | 880049(P1.7-2,4) | H355(P1.19,15) | 870227(P1.5-2,10) | 6557(P1.22-1,14-1) |
抗-rLP2086+三种rPorA抗血清 | >3,200 | >800 | 200 | >800 | 200 | 200 |
对照 | ||||||
抗-rLP2086 | 6,400 | <25 | 100 | 3,200 | <25 | <25 |
相应的单价rPorA抗血清 | - | 1,600 | - | - | 200 | 400 |
疫苗接种步骤:在第0周和第4周用10μg rLP2086-8529/20μg QS-21或15μgrPorA/100μg MPL免疫6-8周龄雌性Swiss-Webster小鼠。在第6周放血并进行数据分析。
a杀菌(BC50)效价表示为可使活细胞计数减少50%的抗血清稀释度的倒数。第0周正常小鼠血清的BC50效价<10
下表XV显示rLP2086亚科和两种rPorAs的混合物在小鼠中引发杀菌抗体。
表XV
H44/76 | 6940 | 880049 | M982 | M98250771 | M98250732 | M97252697 | 870446 | NmB | 6557 | |
SfBb | SfB | SfB | SfB | SfAb | SfA | SfA | SfA | SfA | SfA | |
P1.7,16 | P1.1825,6 | P1.7-2,4 | P1.22,9 | P1.22,14 | P1.22,14-1 | P1.18,25,6 | P1.12-1,13 | P1.5-1,2-2 | P1.22-1,14-1 | |
抗原 | ||||||||||
rLP2086-8529+rLP2086-2996 | >800 | >800 | 200 | 400 | 800 | >800 | >800 | >800 | - | <25 |
rLP2086-8529+rLP2086-2996+rP1.5-1,2-2+rP1.22-1,14-1 | >800 | 800 | 100 | 200 | 400 | 400 | >800 | >800 | >800 | 200 |
单价对照c | >800 | >800 | 200 | 400 | 800 | >800 | >800 | >800 | >800 | 800 |
疫苗接种步骤:在第0周和第4周用10μg各蛋白质+20μg QS-21免疫6-8周龄雌性Swiss-Webster小鼠。在第6周放血并进行数据分析。
a杀菌(BC50)效价表示为可使活细胞计数减少50%的抗血清稀释度的倒数。第0周正常小鼠血清的BC50效价<10
bSfA-亚科A,SfB-亚科B
c相关单价对照:rLP2086-8529、rLP2086-2996、rP1.5-1,2-2或rP1.22-1,14-1抗血清
下面总结了上述研究的结果。抗-rLP2086抗血清对13/16测试菌株是杀菌的。11种表达不同血清亚型的菌株被抗-P2086血清杀死。抗-rLP2086血清的杀菌活性与抗-rPorA血清互补。P2086和PorA的混合物在小鼠中引发互补的杀菌抗体。差示洗涤剂吸取、纯化和免疫与抗许多菌株的功能抗体测定结合可用来鉴定新的疫苗候选物。P2086被鉴定为可引发抗P2086和rPorA异源菌株的杀菌抗体。因此,蛋白质的2086家族在单独或与其它奈瑟氏球菌属抗原联合时都是有用的疫苗。
实施例9
根据上述实施例。通过PCR筛选了不同血清组的其它脑膜炎球菌菌株以了解ORF2086基因的存在情况。最后筛选出100种脑膜炎球菌菌株。下面描述了该研究和所有的结果。这些结果补充了上述实施例的数据。
两组对C-末端可变区特异的内部PCR引物被用来区别亚科A和B的基因序列。存在约350bp的PCR扩增产物说明2086基因序列在染色体中存在。所有菌株产生预期大小的单一PCR产物。55种全长ORF 2086基因的核苷酸序列被测定、对比(DNAStar MegAlign)并用来产生系统树(参见图12)。
这些2086基因中的9种作为rLP2086脂蛋白在pBAD阿拉伯糖可诱导启动子系统中重组表达,这些基因中的3种作为rP2086非脂质化的蛋白质在IPTG可诱导的pET系统中重组表达。在大肠杆菌B中表达这些重组蛋白。纯化的重组蛋白被用来免疫小鼠,并测定小鼠抗血清的血清IgG效价和它对多种异源脑膜炎球菌菌株的杀菌活性。
从完整脑膜炎球菌性细胞、纯化的染色体DNA或质粒DNA模板之一的PCR扩增ORF 2086。
将9种ORF 2086基因克隆入pLP339载体,该载体将嗜血杆菌P4前导序列融合到ORF 2086基因的5’末端。大肠杆菌菌株BLR被用作宿主菌株以从pBAD/ORF2086克隆重组表达rP2086的脂质化形式(参见图10A)。pBAD阿拉伯糖可诱导启动子驱动P4信号/ORF 2086融合蛋白表达rP2086的脂质化形式。三种缺乏信号序列的P2086基因被克隆入pET9载体在高度活化的T7噬菌体启动子的后面。大肠杆菌菌株BL21(DE3)被用作宿主菌株以从pET9a/ORF 2086克隆重组表达ORF 2086的非脂质化形式(参见图10B)。在加入IPTG控制lacUV5启动子的情况下大肠杆菌菌株BL21中的DE3溶源体可被诱导表达T7 RNA聚合酶。参见WCE;FEMS Micro.Lett.,48(1987)367-371和BCA;J.Clin.Microbiol.,38(2000)2878-2884。
基因ORF 2086从55种不同的脑膜炎奈瑟氏球菌菌株中被克隆和测序。其核苷酸序列被对比(DNAStar MegAlign)并用来产生系统树(参见图12)。该系统树揭示了ORF 2086基因核苷酸序列的两个不同的亚科。基因的这两个亚科在其5’末端是类似的,但在其3’末端附近变化很大。尽管似乎有显著的变异性,但该基因的某些关键区域在不同菌株中是高度同源的。这些保守性区域可为蛋白质提供功能连续性并可能有待开发作为疫苗靶点的交叉保护性表位的征兆。
从一些血清组B脑膜炎球菌菌株克隆2086基因并在有和没有脂质化信号序列时表达。参考图11A和11B,凝胶照片显示了表达r2086蛋白的大肠杆菌B的全细胞裂解物。与T7-Tag融合的非脂质化形式以最高水平表达。T7-Tag序列可为mRNA提供稳定性并显著提高翻译的多肽水平。这种融合蛋白似乎沉积在包涵体中并可用已知的方法简单地纯化和重折叠。P2086的脂质化和非脂质化形式以约占总细胞蛋白质的5-8%的水平表达,T7-Tag融合体除外,它以约50%总蛋白质的水平表达rP2086。蛋白质的非脂质化形式似乎是可溶的并定位在胞质中。蛋白质的脂质化形式似乎与膜组分有关并被洗涤剂溶解。
脑膜炎奈瑟氏球菌B菌株8529的重组脂质化的2086蛋白一贯地引发大于非脂质化形式的血清IgG效价(参见下表XVI),这与增强的对同源和异源脑膜炎球菌菌株的杀菌活性水平有关(参见下表XVII)。天然脂质化形式的蛋白质可有高级的三级结构以进行抗原呈递和/或附着的脂质可作为刺激较大免疫原性应答的佐剂。
表XVI
第6周由WCE引发的免疫应答,采用8529 rP2086(非脂质化)和
8529 rLP2086(脂质化)进行比较
小鼠血清 | 脑膜炎球菌菌株 | |||||
抗原(10μg) | 佐剂(20μg) | H44/76 | H355 | 870227 | 880049 | 870446 |
rP2088 | QS-21 | 273,238 | 212,947 | 102,694 | 69,124 | 21,466 |
rLP2086 | QS-21 | 5,384,306 | 4,819,061 | 2,930,946 | 1,307,091 | 886,056 |
表XVII
8529 rP2086引发的杀菌活性弱于8529 rLP2086
小鼠血清 | 脑膜炎球菌菌株 | ||||
抗原(10μg) | 佐剂(20μg) | H44/76 | H355 | 880049 | NMB |
rP2086 | QS-21 | 200 | 100 | <25 | <25 |
rLP2086 | QS-21 | 6,400 | 3,200 | 100 | <25 |
预免疫 | - | <10 | <10 | <10 | <10 |
阳性对照 | - | 1,600 | 100 | 200 | 1,600 |
下面总结了研究结果。所有被测脑膜炎奈瑟氏球菌B菌株似乎都含有一种2086样的基因。至少代表2086基因的两个家族:亚科A-约占菌株的30%和亚科B-约占菌株的70%。2086基因从55种脑膜炎奈瑟氏球菌菌株中被克隆和测序。亚科A的序列在DNA水平上约86-100%相同。亚科B的序列在DNA水平上约89.5-100%相同。亚科a内的序列与亚科b比较在DNA水平上约60.9%-74%相同。通过PCR筛选鉴定了以下菌株中的2086同源物:
脑膜炎奈瑟氏球菌A、B、C、W135、Y
乳糖奈瑟氏球菌
淋病奈瑟氏球菌FA1090
一些ORF 2086基因被克隆和重组表达
从9种脑膜炎球菌菌株表达P2086的脂质化形式。
这些重组蛋白已纯化并用来接种小鼠。
所得抗血清是杀菌的。
从上述9种菌株中的3种表达了P2086的非脂质化形式。
rLP2086一贯地引发大于rP2086的免疫应答。
rLP2086还可增强对同源和异源脑膜炎球菌菌株的杀菌活性。
实施例10
下表XVIII和XIX显示了这两个亚科成员的变异体的特性鉴定。
表XVIII
亚科A rLP2086变异体—特性鉴定
rLP2086-252988 | rLP2086-250771 | rLP2086-870446 | rLP2086-2996 | rLP2086-C11 | ||
生长培养基 | HySoy | HySoy | HySoy | HySoy | HySoy | |
溶解度 | rTX-100_Z3-12 | TX-100 | TX-100 | rTX-100_Z3-12 | rTX-100_Z3-12 | |
纯化步骤 | TMAESFractogelSEC | HQ PorosSEC | HQ PorosSEC | TMAESEC | TMAESFractogel | |
纯度(%) | 96 | 83 | 80 | 95 | 82 | |
产率(mg/g细胞颗粒) | 0.2 | 0.7 | 0.8 | 0.5(发酵罐) | 0.1 | |
大小 | SEC(Z3-12) | 134,000 | 155,000 | 132,000 | 163,000 | 126,000 |
MS | 27,897(712脂质) | - | - | 27,878(750脂质) | 28,139(682脂质) | |
热变性转换中点 | 66℃ | - | NT | 65℃ | 63℃ |
(TM)℃ | |||||
可用蛋白质(mg) | 2.7mg | 1mg(Z3-12) | 5.0mg | 44mg | 1.1mg |
8529序列同源性(%) | 71 | 62 | 71 | 72 | 68 |
表XIX
亚科B rLP2086变异体—特性鉴定
rLP2086-8529 | rLP2086-M982 | rLP2086-880049 | rLP2086-CDC1573 | ||
生长培养基 | Apollon(Sanford) | Apollon | HySoy | HySoy | |
溶解度 | 4M尿素_Z3-12 | rTX-100_Z3-12 | rTX-100_Z3-12 | rTX-100 | |
纯化步骤 | TMAES Fractogel | TMAES Fractogel | TMAESFractogel | TMAESEC | |
纯度(%) | 96 | 96 | 90 | 93 | |
产率(mg/g细胞颗粒) | 0.2(发酵罐) | 1.6(发酵罐) | 0.4 | 1.0 | |
大小 | SEC(Z3-12) | 95,000 | 110,000150,000 | 100,000 | 120,000 |
MS | 27,785(822脂质) | 27,719(711脂质) | 28,044(819脂质) | 28,385(823脂质) | |
热变性转换终点(TM)℃ | 70℃ | 75℃ | 62℃ | NT | |
可用蛋白质(mg) | 尿素-34mgSarc-36mg | 库1-47mg库2-17mg | 3.6mg | 4.9mg | |
8529序列同源性(%) | 100 | 94 | 92 | 87 |
下表XX提供了2086亚科a的荧光血清杀菌测定的结果。
表XX
描述 | 250771 | 870446 | 6557 | NMB | M98250732 | M97252697 |
rLP2086-252988,10μg | >800(99%)* | >800(99%)* | <25 | - | >800(99%)* | >800(93%)* |
rLP2086-C11,10μg | 200 | >880(91%)* | <25 | - | 200 | 400 |
rLP2086-250771,10μg | >800(92%)* | >800(99%)* | <25 | - | >800(96%)* | >800(84%)* |
rLP2086-870446,10μg | 400 | >800(99%)* | <25 | - | 400 | 400 |
rLP2086-2996,10μg | 800 | >800(99%)* | <25 | - | >800(93%)* | >800(72%)* |
rLP2086-8529+rLP2086-2996,10μg | 800 | >800(99%)* | <25 | - | >800(80%)* | >800(72%)* |
rLP2086-8529+rP1.22a,14a+rP1.5a,2c,10μg | - | 800 | 200 | >800(98%)* | - | - |
rLP2086-8529+rLP2086-2996+rP1.22a,14a+rP1.5a,2c,10μg | 400 | >800(99%)* | 200 | >800(99%)* | 400 | >800(88%)* |
NMB/rLP2086-8529小泡,20μg | - | 100 | - | 400 | - | - |
rP1.22a,14a,10μg | 25 | - | 800 | - | 100 | - |
rP1.5a,2c,10μg | - | - | - | >800(99%)* | - | - |
rLP2086-8529,10μg | - | 800 | - | - | - | - |
rP1.22a,14a,25μg | 200 | - | - | - | 800 | - |
rP1.18,25.6,5μg | - | - | - | - | - | - |
nP1.22,9(M982),25μg | - | - | 100 | - | - | - |
预免疫小鼠血清(阴性对照) | <10 | <10 | <10 | <10 | <10 | <10 |
800 | 400 | 800 | 1600 | ** | ** |
备注:
*百分比说明1∶800稀释时%BC活性。
**阳性对照不存在。
-未测试的血清
实施例11
下面进一步证实P2086在奈瑟氏球菌属菌株中表达,并提供了P2086在一些菌株中表达的特定例子。
将用平板培养物的细胞制备的细胞裂解物重悬于SDS样品缓冲液并在98℃加热4分钟。在10-20%预制凝胶(ICN)上加样,每个孔中约有30-50μg总蛋白质,并在175V跑电泳。将凝胶转移到硝基纤维素膜,然后在Tris-缓冲盐水(Blotto)中加入5%奶粉,用它将膜封闭30分钟。采用的第一抗体是在小鼠中抗单个rLP2086变异体的多克隆抗血清库。
参考图17和18,Western印迹显示了rLP2086鼠抗血清对P2086亚科A和B的全细胞裂解物的反应性。对于亚科A的细胞裂解物印迹,用rLP2086-250771将抗rLP2086-2996、-870446和-250771的抗血清以1/500稀释在Blotto中,其它抗血清以1/1000稀释在Blotto中。对于亚科B的细胞裂解物印迹,所用抗血清抗rLP2086-8529(以1/1000稀释在Blotto中)、-CDC1573、-M982和-880049(这三种以1/500稀释在Blotto中)。将第一抗血清和印迹在4℃培养过夜。洗涤印迹,羊-抗-鼠AP2第二以1/500加入Blotto,并将印迹在室温培育30分钟。洗涤后,用BCIP/NBT膜磷酸酶底物系统(KPL)显现印迹。
参考文献
本文以上引用的参考文献在下面列出,并全文纳入以供参考:
1.1997.Case definitions for Infectious Conditions Under Public Health Surveillance.CDC..
2.1995 Sambrook,J.和D.W.Russell.1995.Current Protocols in Molecular Biology.John Wiley & Sons,Inc.,New York
3.1994.Griffin,A.M.和Griffin,H.G.编,Computer Analysis of Sequence Data,PartI.Humana Press,New Jersey.
4.1993.Smith,D.W.编,Biocomputing:Informatics and Genome Projects.AcademicPress,New York
5.1991.Gribskov,M.和Devereux,J.编,Sequence Analysis Primer.Stockton Press,New York.
6.1988.Lesk,A.M.编,Computational Molecular Biology.Oxford University Press,New York.
7.Abdillahi,H.和J.T.Poolman.1988.Neisseria meningitidis group B serosubtypingusing monoclonal antibodies in whole-cell ELISA.Microbial Pathogenesis 4(1):27-32.
8.Achtman,M.1995.Epidemic spread and antigenic variability of Neisseriameningitidis.Trends in Microbiology 3(5):186-92.
9.Alm,R.A.,L.S.Ling,D.T.Moir,B.L.King,E.D.Brown,P.C.Doig,D.R.Smith,B.Noonan,B.C.Guild,B.L.deJonge,G.Carmel,P.J.Tummino,A.Caruso,M.Uria-Nickelsen,D.M.Mills,C.Ives,R.Gibson,D.Merberg,S.D.Mills,Q.Jiang,D.E.Taylor,G.F.Vovis和T.J.Trust.1999.Genomic-sequence comparison of two unrelated isolates ofthe human gastric pathogen Helicobacter pylori[published erratum appears in Nature1999 Feb 25;397(6721):719.Nature.397:176-80.
10.Altschul,S.F.,T.L.Madden,A.A.Schaffer,J.Zhang,Z.Zhang,W.Miller和D.J.Lipman.1997.Gapped BLAST and PSI-BLAST:a new generation of proteindatabase search programs.Nucleic Acids Res.25:3389-402.
11.Anderson,T.F.1951.Techniques for the preservation of three-dimensionalstructure in preparing specimens for the electron microscope.Trans N Y Acad Sci.13:130-134.
12.Ambrosch,F.,G.Wiedermann,P.Crooy和A.M.George.1983.Immunogenicityand side-effects of a new tetravalent meningococcal polysaccharide vaccine.Bulletin ofthe World Health Organization 61(2):317-23.
13.Benson,G.1999.Tandem repeats finder:a program to analyze DNA sequences.Nucleic Acids Res.27:573-80.
14.Carillo,H.,D.Lipman和J.Siam.1988.Applied Math 48:1073.
15.Chen,C.C.和P.P.Cleary.1989.Cloning and expression of the streptococcal C5apeptidase gene in Escherichia coli:linkage to the type 12 M protein gene.Infect.Immun.57:1740-1745.
16.Chmouryguina,I.,A.Suvorov,P.Ferrieri和P.P.Cleary.1996.Conservation of theC5a peptidase genes in group A and B streptococci.Infect.Immun.64:2387-2390.
17.Cockerill,F.R.,3rd,R.L.Thompson,J.M.Musser,P.M.Schlievert,J.Talbot,K.E.Holley,W.S.Harmsen,D.M.Ilstrup,P.C.Kohner,M.H.Kim,B.Frankfort,.M.Manahan,J.M.Steckelberg,F.Roberson和W.R.Wilson.1998.Molecular,serological,and clinicalfeatures of 16 consecutive cases of invasive streptococcal disease.SoutheasternMinnesota Streptococcal Working Group.Clin Infect Dis.26:1448-58.
18.Courtney,H.S.,Y.Li,J.B.Dale和D.L.Hasty.1994.Cloning,sequencing,andexpression of a fibronectin/fibrinogen-binding protein from group A streptococci.InfectImmun.62:3937-46.
19.Cserzo,M.,E.Wallin,I.Simon,G.von Heijne和A.Elofsson.1997.Prediction oftransmembrane alpha-helices in prokaryotic membrane proteins:the dense alignmentsurface metho D.Protein Engineering.10:673-6.
20.Cunningham,M.W.和A.Quinn.1997.Immunological crossreactivity between theclass I epitope of streptococcal M protein and myosin.Adv Exp Med Biol.418:887-92.
21.Dale,J.B.,R.W.Baird,H.S.Courtney,D.L.Hasty和M.S.Bronze.1994.Passiveprotection of mice against group A streptococcal pharyngeal infection by lipoteichoicaciD.J Infect Dis.169:319-23.
22.Dale,J.B.,M.Simmons,E.C.Chiang和E.Y.Chiang.1996.Recombinant,octavalent group A streptococcal M protein vaccine.Vaccine.14:944-8.
23.Dale,J.B.,R.G.Washburn,M.B.Marques和M.R.Wessels.1996.Hyaluronatecapsule and surface M protein in resistance to opsonization of group A streptococci.Infect Immun.64:1495-501.
24.Eddy,S.R.1996.Hidden Markov models.Cur Opin Struct Bio.6:361-5.
25.Ellen,R.P.和R.J.Gibbons.1972.M protein-associated adherence of StreptococcusPyogenes to epithelial surfaces:prerequisite for virulence.Infect Immun.5:826-830.
26.Eng,J.K.,A.L.McCormack和J.R.Yates,第三版,1994.An approach to correlatetandem mass-spectral data of peptides with amino-acid-sequences in a protein database.Am Soc Mass Spectrometry.5:976-89.
27.Fischetti,V.A.,V.Pancholi和O.SchneewinD.1990.Conservation of a hexa-peptide sequence in the anchor region of surface proteins from gram-positive cocci.MolMicrobiol.4:1603-5.
28.Fogg,G.C.和M.G.Caparon.1997.Constitutive expression of fibronectin bindingin Streptococcus pyogenes as a result of anaerobic activation of rofA.JBacteriol.179:6172-80.
29.Foster,T.J.和M.Hook.1998.Surface protein adhesins of Staphylococcus aureus.Trends Microbiol.6:484-8.
30.Fraser,C.M.,S.Casjens,W.M.Huang,G.G.Sutton,R.Clayton,R.Lathigra,O.White,K.A.Ketchum,R.Dodson,E.K.Hickey,M.Gwinn,B.Dougherty,J.F.Tomb,.D.Fleischmann,D.Richardson,J.Peterson,A.R.Kerlavage,J.Quackenbush,S.Salzberg,M.Hanson,R.vanVugt,N.Palmer,M.D.Adams,J.31.Gocayne,J.C.Venter等,1997.Genomic sequence ofa Lyme disease spirochaete,Borrelia burgdorferi[见注释].Nature.390:580-6.
32.Goldschneider,I.,E.C.Gotschlich和M.S.Artenstein.1969.Human immunity tothe meningococcus.I.The role of humoral antibodies.Journal of Experimental Medicine129(6):1307-26.
33.Goldschneider,I.,E.C.Gotschlich和M.S.Artenstein.1969.Human immunity tothe meningococcus.II.Development of natural immunity.Journal of ExperimentalMedicine 129(6):1327-48.
34.Gotschlich,E.C.,I.Goldschneider和M.S.Artenstein.1969.Human immunity tothe meningococcus.IV.Immunogenicity of group A and group C meningococcal poly-saccharides in human volunteers.Journal of Experimental Medicine 129(6):1367-84.
35.Gotschlich,E.C.,I.Goldschneider和M.S.Artenstein.1969.Human immunity tothe meningococcus.V.The effect of immunization with meningococcal group Cpolysaccharide on the carrier state.Journal of Experimental Medicine 129(6):1385-95.
36.Hacker,J.,G.Blum-Oehler,I.Muhldoffer和H.Tschape.1997.Pathogenicityislands of virulent bacteria:structure,function and impact on microbial evolution.MolMicrobiol.23:1089-97.
37.Hanski,E.和M.Caparon.1992.Protein F,a fibronectin-binding protein,is anadhesion of the group A streptococcus Streptococcus pyogenes.Proc Natl Acad Sci.,USA.89:6172-76.
38.Hanski,E.,P.A.Horwitz和M.G.Caparon.1992.Expression of protein F,thefibronectin-binding protein of Streptococcus pyogenes JRS4,in heterologousstreptococcal and enterococcal strains promotes their adherence to respiratory epithelialcells.Infect Immun.60:5119-5125.
39.Hernandez-Sanchez,J.,J.G.Valadez,J.V.Herrera,C.Ontiveros和G.Guarneros.1998.lambda bar minigene-mediated inhibition of protein synthesis involves accu-mulation of peptidyl-tRNA and starvation for tRNA.EMBO Journal.17:3758-65.
40.Huang,T.T.,H.Malke和J.J.Ferretti.1989.The streptokinase gene of group Astreptococci:cloning,expression in Escherichia coli,and sequence analysis.MolMicrobiol.3:197-205.
41.Hynes,W.L.,A.R.Dixon,S.L.Walton和L.J.Aridgides.2000.The extracellularhyaluronidase gene(hylA)of Streptococcus pyogenes.FEMS Microbiol Lett.184:109-12.
42.Hynes,W.L.,L.Hancock和J.J.Ferretti.1995.Analysis of a second bacteriophagehyaluronidase gene from Streptococcus pyogenes:evidence for a third hyaluronidaseinvolved in extracellular enzymatic activity.Infect Immun.63:3015-20.
43.Isberg,R.R.和G.Tran Van Nhieu.1994.Binding and internalization ofmicroorganisms by integrin receptors.Trends Microbio.2:10-4.
44.Jones,K.F.和V.A.Fischetti.1988.The importance of the location of antibodybinding on the M6 protein for opsonization and phagocytosis of group A M6streptococci.J Exp MeD.167:1114-23.
45.Kihlberg,B.M.,M.Collin,A.Olsen和L.Bjorck.1999.Protein H,anantiphagocytic surface protein in Streptococcus pyogenes.Infect Immun.67:1708-14.
46.Koebnik,R.1995.Proposal for a peptidoglycan-associating alpha-helical motif inthe C-terminal regions of some bacterial cell-surface proteins[letter;comment].Molecular Microbiology.16:1269-70.
47.Kuipers,O.P.,H.J.Boot和W.M.de Vos.1991.Improved site-directed muta-genesis method using PCR.Nucleic Acids Res.19:4558.
48.Kyte,J.和R.F.Doolittle.1982.A simple method for displaying the hydropathiccharacter of a protein.Journal of Molecular Biology 157:105-132.
49.Landt,O.,H.P.Grunert和U.Hahn.1990.A general method for rapid site-directedmutagenesis using the polymerase chain reaction.Gene 96:125-128.
50.Loessner,M.J.,S.Gaeng和S.Scherer.1999.Evidence for a holin-like protein genefully embedded out of frame in the endolysin gene of Staphylococcus aureusbacteriophage 187.J Bacteriol.181:4452-60.
51.Lukashin,A.V.和M.Borodovsky.1998.GeneMark.hmm:new solutions for genefinding.Nucleic Acids Res.26:1107-15.
52.Lukomski,S.,C.A.Montgomery,J.Rurangirwa,R.S.Geske,J.P.Barrish,G.J.Adams和J.M.Musser.1999.Extracellular cysteine protease produced by Streptococcuspyogenes participates in the pathogenesis of invasive skin infection and dissemination inmice.Infect Immun.67:1779-88.
53.Madore,D.V.1998.Characterization of immune response as an indicator ofHaemophilus influenzae type b vaccine efficacy.Pediatr Infect Dis J.17:S207-10.
54.Matsuka,Y.V.,S.Pillai,S.Gubba,J.M.Musser和S.B.OlmsteD.1999.Fibrinogencleavage by the Streptococcus pyogenes extracellular cysteine protease and generationof antibodies that inhibit enzyme proteolytic activity.Infect Immun.67:4326-33.
55.Mazmanian,S.K.,G.Liu,H.Ton-That和O.SchneewinD.1999.Staphylococcusaureus sortase,an enzyme that anchors surface proteins to the cell wall.Science.285:760-3.
56.McAtee,C.P.,K.E.Fry和D.E.Berg.1998.Identification of potential diagnosticand vaccine candidates of Helicobacter pylori by″proteome″technologies.Helico-bacter.3:163-9.
57.McAtee,C.P.,M.YLim,K.Fung,M.Velligan,K.Fry,T.Chow和D.E.Berg.1998.Identification of potential diagnostic and vaccine candidates of Helicobacter pyloriby two-dimensional gel electrophoresis,sequence analysis,and serum profiling.ClinDiagn Lab Immunol.5:537-42.
58.McAtee,C.P.,M.Y.Lim,K.Fung,M.Velligan,K.Fry,T.P.Chow和D.E.Berg.1998.Characterization of a Helicobacter Pylori vaccine candidate by proteometechniques.J Chromatogr B Biomed Sci Appl.714:325-33.
59.Mejlhede,N.,J.FAtkins和J.NeuharD.1999.Ribosomal-1 frameshifting duringdecoding of Bacillus subtilis cdd occurs at the sequence CGA AAG.J.Bacteriol.181:2930-7.
60.Molinari,G.,S.R.Talay,P.Valentin-Weigand,M.Rohde和G.S.Chhatwal.1997.The fibronectin-binding protein of Streptococcus pyogenes,SfbI,is involved in theinternalization of group A streptococci by epithelial cells.Infect Immun.65:1357-63.
61.Mountzouros,K.T.和A.P.Howell.2000.Detection of complement-mediatedantibody-dependent bactericidal activity in a fluorescence-based serum bactericidalassay for group B Neisseria meningitidis.J.Clin.Microbiol.38(8):2878-2884.
62.Nakai,K.和M.Kanehisa.1991.Expert system for predicting protein localizationsites in gram-negative bacteria.Proteins.11:95-110.
63.Navarre,W.W.和O.SchneewinD.1999.Surface proteins of gram-positive bacteriaand mechanisms of their targeting to the cell wall envelope.Microbiol Mol BiolRev.63:174-229.
64.Nielsen,H.,J.Engelbrecht,S.Brunak和G.von Heijne.1997.Identification ofprokaryotic and eukaryotic signal peptides and prediction of their cleavage sites.ProteinEngineering.10:1-6.
65.Nizet,V.,B.Beall,D.J.Bast,V.Datta,L.Kilburn,D.E.Low和J.C.De Azavedo.2000.Genetic locus for streptolysin S production by group A streptococcus.InfectImmun.68:4245-54.
66.Nordstrand,A.,W.M.McShan,J.J.Ferretti,S.E.Holm和M.Norgren.2000.Allelesubstitution of the streptokinase gene reduces the nephritogenic capacity of group Astreptococcal strain NZ131.Infect Immun.68:1019-25.
67.Olmsted,S.B.,S.L.Erlandsen,G.M.Dunny和C.L.Wells.1993.High-resolutionvisualization by field emission scanning electron microscopy of Enterococcus faecalissurface proteins encoded by the pheromone-inducible conjugative plasmid pCF10.JBacteriol.175:6229-37.
68.Park,J.和S.A.Teichmann.1998.DIVCLUS:an automatic method in theGEANFAMMER package that finds homologous domains in single-and multi-domainproteins.Bioinformatics.14:144-50.
69.Parkhill,J.,M.Achtman,K.D.James,S.D.Bentley,C.Churcher,S.R.Klee,G.Morelli,D.Basham,D.Brown,T.Chillingworth,R.M.Davies,P.Davis,K.Devlin,T.Feltwell,N.Hamlin,S.Holroyd,K.Jagels,S.Leather,S.Moule,K.Mungall,M.A.Quail,M.A.Rajandream,K.M.Rutherford,M.Simmonds,J.Skelton,S.Whitehead,B.G.Spratt和B.G.Barrell.2000.Complete DNA sequence of a serogroup A strain of Neisseriameningitidis Z2491[见注释].Nature.404:502-6.
70.Pierschbacher,M.D.和E.Ruoslahti.1987.Influence of stereochemistry of thesequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion.J Biol Chem.262:17294-8.
71.Pizza,M.,V.Scarlato,V.Masignani,M.M.Giuliani,B.Arico,M.Comanducci,G.T.Jennings,L.Baldi,E.Bartolini,B.Capecchi,C.L.Galeotti,E.Luzzi,R.Manetti,Marchetti,M.Mora,S.Nuti,G.Ratti,L.Santini,S.Savino,M.Scarselli,E.Storni,P.Zuo,M.Broeker,E.Hundt,B.Knapp,E.Blair,T.Mason,H.Tettelin,D.W.Hood,.C.Jeffries,N.J.Saunders,D.M.Granoff,J.C.Venter,E.R.Moxon,G.Grandi和R.Rappuoli.2000.Identification of vaccine candidates against serogroup Bmeningococcus by whole-genome sequencing.Science 287(5459):1816-20.
72.Podbielski,A.,A.Flosdorff和J.Weber-Heynemann.1995.The group A strep-tococcal virR49 gene controls expression of four structural vir regulon genes.InfectImmun.63:9-20.
73.Poolman,J.T.1996.Bacterial outer membrane protein vaccines.The menin-gococcal example.Advances in Experimental Medicine & Biology 397:73-7.
74.Proft,T.,S.Louise Moffatt,C.J.Berkahn和J.D.Fraser.1999.Identification andCharacterization of Novel Superantigens from Streptococcus pyogenes.J Exp Med.189:89-102.
75.Pugsley,A.P.1993.The complete general secretory pathway in gram-negativebacteria.Microbiol Rev.57:50-108.
76.Quinn,A.,K.Ward,V.A.Fischetti,M.Hemric和M.W.Cunningham.1998.Immunological relationship between the class I epitope of streptococcal M protein andmyosin.Infect Immun.66:4418-24.
77.Reda,K.B.,V.Kapur,D.Goela,J.G.Lamphear,J.M.Musser和R.R.Rich.1996.Phylogenetic distribution of streptococcal superantigen SSA allelic variants providesevidence for horizontal transfer of ssa within Streptococcus pyogenes.Infect Immun.64:1161-5.
78.Sambrook,J.和D.W.Russell.2001.Molecular cloning a laboratory manual,第三版,第3卷,Cold Spring Harbor Laboratory Press,Cold Spring Harbor,New York.
79.Salzberg,S.L.,A.L.Delcher,S.Kasif和O.White.1998.Microbial gene identifi-cation using interpolated Markov models.Nucleic Acids Res.26:544-8.
80.Saukkonen,K.,H.Abdillahi,J.T.Poolman和M.Leinonen.1987.Protectiveefficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins ofNeisseria meningitidis B:15:P1.16 in infant rat infection model:new prospects forvaccine development.Microbial Pathogenesis 3(4):261-7.
81.Sedegah et al.1994.Immunology.91,9866-9870.
82.Sonnenberg,M.G.和J.T.Belisle.1997.Definition of Mycobacterium tuberculosisculture filtrate proteins by two-dimensional polyacrylamide gel electrophoresis,N-terminal amino acid sequencing和electrospray mass spectrometry.InfectImmun.65:4515-24.
83.Sonnhammer,E.L.,S.R.Eddy和R.Durbin.1997.Pfam:a comprehensive databaseof protein domain families based on seed alignments.Proteins.28:405-20.
84.Stevens,D.L.1995.Streptococcal toxic-shock syndrome:spectrum of disease,pathogenesis,and new concepts in treatment.Emerg Infect Dis.1:69-78.
85.Stockbauer,K.E.,L.Magoun,M.Liu,E.H.Burns,Jr.,S.Gubba,S.Renish,X.Pan,S.C.Bodary,E.Baker,J.Coburn,J.M.Leong和J.M.Musser.1999.A natural variant of thecysteine protease virulence factor of group A streptococcus with an arginine-glycine-aspartic acid(RGD)motif preferentially binds human integrins alphavbeta3 andalphaIIbbeta3 Proc Natl Acad Sci.,USA.96:242-7.
86.Tettelin,H.,N.J.Saunders,J.Heidelberg,A.C.Jeffries,K.E.Nelson,J.A.Eisen,K.A.Ketchum,D.W.Hood,J.F.Peden,R.J.Dodson,W.C.Nelson,M.L.Gwinn,R.DeBoy,J.D.Peterson,E.K.Hickey,D.H.Haft,S.L.Salzberg,O.White,R.D.Fleiscbmann,B.A.Dougherty,T.Mason,A.Ciecko,D.S.Parksey,E.Blair,H.Cittone,E.B.Clark,M.D.Cotton,T.R.Utterback,H.Khouri,H.Qin,J.Vamathevan,J.Gill,V.Scarlato,V.Masignani,M.Pizza,G.Grandi,L.Sun,H.O.Smith,C.M.Fraser,E.R.Moxon,R.Rappuoli和J.C.Venter.2000.Complete genome sequence of Neisseria meningitidisserogroup B strain MC58.Science 287(5459):1809-15.
87.Ton-That,H.,G.Liu,S.K.Mazmanian,K.F.Faull和O.SchneewinD.1999.Purification and characterization of sortase,the transpeptidase that cleaves surfaceproteins of Staphylococcus aureus at the LPXTG motif.Proc Natl Acad Sci USA.96:12424-12429.
88.von Heinje,G.1987.Sequence Analysis in Molecular Biology.Academic Press,New York.
89.Weldingh,K.,I.Rosenkrands,S.Jacobsen,P.B.Rasmussen,M.J.Elhay和P.Andersen.1998.Two-dimensional electrophoresis for analysis of Mycobacteriumtuberculosis culture filtrate and purification and characterization of six novelproteins.Infect Immun.66:3492-500.
90.Wolff et al.1990.Science.247,1465-1468.
91.Yutsudo,T.,K.Okumura,M.Iwasaki,A.Hara,S.Kamitani,W.Minamide,H.Igarashi和Y.Hinuma.1994.The gene encoding a new mitogenic factor in aStreptococcus pyogenes strain is distributed only in group A streptococci.Infection andImmunity.62:4000-4004.
92.Zagursky,R.J.and D.Russell.2001.Bioinformatics:Use in Bacterial VaccineDiscovery.Bio Techniques.31:636-659.
序列表
<110>G.泽洛特尼克(zlotnick,Gary)
L.弗莱切(Fletcher,Leah)
J.法利(John,Farley)
L.伯恩非尔德(Bernfield,Liesel)
R.扎古斯基(Zagursky,Robert)
B.麦特卡尔夫(Metcalf,Benjamin)
<120>预防和治疗脑膜炎球菌性疾病的新型免疫原性组合物
<130>38523.000016
<150>US 60/328,101
<151>2001-10-11
<150>US 60/406,934
<151>2002-08-30
<160>329
<170>PatentIn version 3.1
<210>1
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>1
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accacaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacggaca aaccatcacg ctggcaagcg gcgaatttca aatatacaaa 300
cagaaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggcggaga acataccgcc 420
ttcaaccaac tgcctgacgg caaagccgag tatcacggca aagcattcag ctccgacgac 480
ccgaacggca ggctgcacta ctccattgat tttaccaaaa aacagggtta cggcagaatc 540
gaacacctga aaacgcccga gcagaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>2
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>2
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Thr Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Thr Ile Thr Leu Ala Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asn His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln Gly
165 170 175
Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>3
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>3
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccacac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg aagtggacgg acaaaccatc acgctggcaa gcggcgaatt tcaaatatac 300
aaacagaacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggcgg agaacatacc 420
gccttcaacc aactgcctga cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gacccgaacg gcaggctgca ctactccatt gattttacca aaaaacaggg ttacggcaga 540
atcgaacacc tgaaaacgcc cgagcagaat gtcgagcttg cctccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcggcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gcccaagaaa tcgccggctc ggcaaccgtg 720
aagataaggg aaaaggttca cgaaatcggc atcgccggca aacagtag 768
<210>4
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>4
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Thr Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Thr Ile Thr Leu Ala Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asn His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln
165 170 175
Gly Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val
225 230 235 240
Lys Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250 255
<210>5
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>5
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accacaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacggaca aaccatcacg ctggcaagcg gcgaatttca aatatacaaa 300
cagaaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggcggaga acataccgcc 420
ttcaaccaac tgcctgacgg caaagccgag tatcacggca aagcattcag ctccgacgac 480
ccgaacggca ggctgcacta ctccattgat tttaccaaaa aacagggtta cggcagaatc 540
gaacacctga aaacgcccga gcagaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>6
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>6
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Thr Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Thr Ile Thr Leu Ala Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asn His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln Gly
165 170 175
Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>7
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>7
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accacaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacggaca aaccatcacg ctggcaagcg gcgaatttca aatatacaaa 300
cagaaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggcggaga acataccgcc 420
ttcaaccaac tgcctgacgg caaagccgag tatcacggca aagcattcag ctccgacgac 480
ccgaacggca ggctgcacta ctccattgat tttaccaaaa aacagggtta cggcagaatc 540
gaacacctga aaacgcccga gcagaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggcccggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccagcaaac agtag 765
<210>8
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>8
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Thr Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Thr Ile Thr Leu Ala Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asn His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln Gly
165 170 175
Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Pro Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Ser Lys Gln
245 250
<210>9
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>9
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccacac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg aagtggacgg acaaaccatc acgctggcaa gcggcgaatt tcaaatatac 300
aaacagaacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggcgg agaacatacc 420
gccttcaacc aactgcctga cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gacccgaacg gcaggctgca ctactccatt gattttacca aaaaacaggg ttacggcaga 540
atcgaacacc tgaaaacgcc cgagcagaat gtcgagcttg cctccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcggcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gcccaagaaa tcgccggccc ggcaaccgtg 720
aagataaggg aaaaggttca cgaaatcggc atcgccagca aacagtag 768
<210>10
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>10
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Thr Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Thr Ile Thr Leu Ala Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asn His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln
165 170 175
Gly Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Gly Glu G1u Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Pro Ala Thr Val
225 230 235 240
Lys Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Ser Lys Gln
245 250 255
<210>11
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>11
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accacaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacggaca aaccatcacg ctggcaagcg gcgaatttca aatatacaaa 300
cagaaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggcggaga acataccgcc 420
ttcaaccaac tgcctgacgg caaagccgag tatcacggca aagcattcag ctccgacgac 480
ccgaacggca ggctgcacta ctccattgat tttaccaaaa aacagggtta cggcagaatc 540
gaacacctga aaacgcccga gcagaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggcccggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccagcaaac agtag 765
<210>12
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>12
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Thr Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Thr Ile Thr Leu Ala Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asn His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln Gly
165 170 175
Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Pro Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Ser Lys Gln
245 250
<210>13
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>13
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcggag tggacggaca aaccatcacg ctggcaagcg gcgaatttca aatatacaaa 300
cagaaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggcggaga acataccgcc 420
ttcaaccaac tgcctgacgg caaagccgag tatcacggca aagcattcag ctccgacgac 480
ccgaacggca ggctgcacta ctccattgat tttaccaaaa aacagggtta cggcagaatc 540
gaacacctga aaacgcccga gcagaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>14
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>14
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Gly Val Asp Gly Gln Thr Ile Thr Leu Ala Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asn His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln Gly
165 170 175
Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>15
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>15
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg gagtggacgg acaaaccatc acgctggcaa gcggcgaatt tcaaatatac 300
aaacagaacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggcgg agaacatacc 420
gccttcaacc aactgcctga cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gacccgaacg gcaggctgca ctactccatt gattttacca aaaaacaggg ttacggcaga 540
atcgaacacc tgaaaacgcc cgagcagaat gtcgagcttg cctccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcggcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gcccaagaaa tcgccggctc ggcaaccgtg 720
aagataaggg aaaaggttca cgaaatcggc atcgccggca aacagtag 768
<210>16
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>16
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Gly Val Asp Gly Gln Thr Ile Thr Leu Ala Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asn His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln
165 170 175
Gly Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val
225 230 235 240
Lys Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250 255
<210>17
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>17
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcggag tggacggaca aaccatcacg ctggcaagcg gcgaatttca aatatacaaa 300
cagaaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggcggaga acataccgcc 420
ttcaaccaac tgcctgacgg caaagccgag tatcacggca aagcattcag ctccgacgac 480
ccgaacggca ggctgcacta ctccattgat tttaccaaaa aacagggtta cggcagaatc 540
gaacacctga aaacgcccga gcagaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>18
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>18
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Gly Val Asp Gly Gln Thr Ile Thr Leu Ala Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asn His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln Gly
165 170 175
Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>19
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>19
tgcagcagca gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacggaca aaccatcacg ctggcaagcg gcgaatttca aatatacaaa 300
cagaaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggcggaga acataccgcc 420
ttcaaccaac tgcctgacgg caaagccgag tatcacggca aagcattcag ctccgacgac 480
ccgaacggca ggctgcacta ctccattgat tttaccaaaa aacagggtta cggcagaatc 540
gaacacctga aaacgcccga gcagaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>20
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>20
Cys Ser Ser Arg Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Thr Ile Thr Leu Ala Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asn His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln Gly
165 170 175
Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>21
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>21
tgcggatcca gcagaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg aagtggacgg acaaaccatc acgctggcaa gcggcgaatt tcaaatatac 300
aaacagaacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggcgg agaacatacc 420
gccttcaacc aactgcctga cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gacccgaacg gcaggctgca ctactccatt gattttacca aaaaacaggg ttacggcaga 540
atcgaacacc tgaaaacgcc cgagcagaat gtcgagcttg cctccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcggcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gcccaagaaa tcgccggctc ggcaaccgtg 720
aagataaggg aaaaggttca cgaaatcggc atcgccggca aacagtag 768
<210>22
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>22
Cys Gly Ser Ser Arg Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Thr Ile Thr Leu Ala Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asn His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln
165 170 175
Gly Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val
225 230 235 240
Lys Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250 255
<210>23
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>23
atgagcagca gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacggaca aaccatcacg ctggcaagcg gcgaatttca aatatacaaa 300
cagaaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggcggaga acataccgcc 420
ttcaaccaac tgcctgacgg caaagccgag tatcacggca aagcattcag ctccgacgac 480
ccgaacggca ggctgcacta ctccattgat tttaccaaaa aacagggtta cggcagaatc 540
gaacacctga aaacgcccga gcagaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>24
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>24
Met Ser Ser Arg Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Thr Ile Thr Leu Ala Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asn His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln Gly
165 170 175
Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>25
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>25
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgt tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgac 480
ccgaacggca ggctgcacta ctccattgat tttaccaaaa aacagggtta cggcagaatc 540
gaacacctga aaacgcccga gcagaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>26
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>26
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Phe Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Ash Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln Gly
165 170 175
Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>27
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>27
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgttcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaaatatac 300
aaacaggacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggtgg agaacatacc 420
gccttcaacc aactgcccag cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gacccgaacg gcaggctgca ctactccatt gattttacca aaaaacaggg ttacggcaga 540
atcgaacacc tgaaaacgcc cgagcagaat gtcgagcttg cctccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcggcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gcccaagaaa tcgccggctc ggcaaccgtg 720
aagataaggg aaaaggttca cgaaatcggc atcgccggca aacagtag 768
<210>28
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>28
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Phe Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln
165 170 175
Gly Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val
225 230 235 240
Lys Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250 255
<210>29
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>29
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgt tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgac 480
ccgaacggca ggctgcacta ctccattgat tttaccaaaa aacagggtta cggcagaatc 540
gaacacctga aaacgcccga gcagaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>30
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>30
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Phe Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln Gly
165 170 175
Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>31
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>31
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgac 480
ccgaacggca ggctgcacta ctccattgat tttaccaaaa aacagggtta cggcagaatc 540
gaacacctga aaacgcccga gcagaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>32
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>32
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln Gly
165 170 175
Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>33
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>33
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaaatatac 300
aaacaggacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggtgg agaacatacc 420
gccttcaacc aactgcccag cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gacccgaacg gcaggctgca ctactccatt gattttacca aaaaacaggg ttacggcaga 540
atcgaacacc tgaaaacgcc cgagcagaat gtcgagcttg cctccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcggcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gcccaagaaa tcgccggctc ggcaaccgtg 720
aagataaggg aaaaggttca cgaaatcggc atcgccggca aacagtag 768
<210>34
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>34
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln
165 170 175
Gly Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val
225 230 235 240
Lys Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250 255
<210>35
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>35
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgac 480
ccgaacggca ggctgcacta ctccattgat tttaccaaaa aacagggtta cggcagaatc 540
gaacacctga aaacgcccga gcagaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>36
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>36
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln Gly
165 170 175
Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>37
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>37
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgac 480
ccgaacggca ggctgcacta ctccattgat tttaccaaaa aacagggtta cggcagaatc 540
gaacacctga aaacgcccga gcagaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>38
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>38
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln Gly
165 170 175
Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>39
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>39
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaaatatac 300
aaacaggacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggtgg agaacatacc 420
gccttcaacc aactgcccag cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gacccgaacg gcaggctgca ctactccatt gattttacca aaaaacaggg ttacggcaga 540
atcgaacacc tgaaaacgcc cgagcagaat gtcgagcttg cctccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcggcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gcccaagaaa tcgccggctc ggcaaccgtg 720
aagataaggg aaaaggttca cgaaatcggc atcgccggca aacagtag 768
<210>40
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>40
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln
165 170 175
Gly Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val
225 230 235 240
Lys Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250 255
<210>41
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>41
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgac 480
ccgaacggca ggctgcacta ctccattgat tttaccaaaa aacagggtta cggcagaatc 540
gaacacctga aaacgcccga gcagaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgecgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>42
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>42
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln Gly
165 170 175
Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>43
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>43
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgac 480
ccgaacggca ggctgcacta ctccattgat tttaccaaaa aacagggtta cggcagaatc 540
gaacacctga aaacgcccga gcagaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>44
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>44
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln Gly
165 170 175
Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>45
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>45
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaaatatac 300
aaacaggacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggtgg agaacatacc 420
gccttcaacc aactgcccag cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gacccgaacg gcaggctgca ctactccatt gattttacca aaaaacaggg ttacggcaga 540
atcgaacacc tgaaaacgcc cgagcagaat gtcgagcttg cctccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcggcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gcccaagaaa tcgccggctc ggcaaccgtg 720
aagataaggg aaaaggttca cgaaatcggc atcgccggca aacagtag 768
<210>46
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>46
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln
165 170 175
Gly Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val
225 230 235 240
Lys Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250 255
<210>47
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>47
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgac 480
ccgaacggca ggctgcacta ctccattgat tttaccaaaa aacagggtta cggcagaatc 540
gaacacctga aaacgcccga gcagaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>48
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>48
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Pro Asn Gly Arg Leu His Tyr Ser Ile Asp Phe Thr Lys Lys Gln Gly
165 170 175
Tyr Gly Arg Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>49
<211>786
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>49
tgcagcagcg gaagcggaag cggaggcggc ggtgtcgccg ccgacatcgg cacagggctt 60
gccgatgcac taactgcgcc gctcgaccat aaagacaaag gtttgaaatc cctgacattg 120
gaagactcca tttcccaaaa cggaacactg accctgtcgg cacaaggtgc ggaaaaaact 180
ttcaaagtcg gcgacaaaga caacagtctc aatacaggca aattgaagaa cgacaaaatc 240
agccgcttcg actttgtgca aaaaatcgaa gtggacggac aaaccatcac gctggcaagc 300
ggcgaatttc aaatatacaa acaggaccac tccgccgtcg ttgccctaca gattgaaaaa 360
atcaacaacc ccgacaaaat cgacagcctg ataaaccaac gctccttcct tgtcagcggt 420
ttgggcggag aacataccgc cttcaaccaa ctgcccagcg gcaaagccga gtatcacggc 480
aaagcattca gctccgacga tgccggcgga aaactgacct ataccataga ttttgccgcc 540
aaacagggac acggcaaaat cgaacacctg aaaacacccg agcagaatgt cgagcttgcc 600
tccgccgaac tcaaagcaga tgaaaaatca cacgccgtca ttttgggcga cacgcgctac 660
ggcagcgaag aaaaaggcac ttaccacctc gctcttttcg gcgaccgagc ccaagaaatc 720
gccggctcgg caaccgtgaa gataagggaa aaggttcacg aaatcggcat cgccggcaaa 780
cagtag 786
<210>50
<211>261
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>50
Cys Ser Ser Gly Ser Gly Ser Gly Gly Gly Gly Val Ala Ala Asp Ile
1 5 10 15
Gly Thr Gly Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp
20 25 30
Lys Gly Leu Lys Ser Leu Thr Leu Glu Asp Ser Ile Ser Gln Asn Gly
35 40 45
Thr Leu Thr Leu Ser Ala Gln Gly Ala Glu Lys Thr Phe Lys Val Gly
50 55 60
Asp Lys Asp Asn Ser Leu Asn Thr Gly Lys Leu Lys Asn Asp Lys Ile
65 70 75 80
Ser Arg Phe Asp Phe Val Gln Lys Ile Glu Val Asp Gly Gln Thr Ile
85 90 95
Thr Leu Ala Ser Gly Glu Phe Gln Ile Tyr Lys Gln Asp His Ser Ala
100 105 110
Val Val Ala Leu Gln Ile Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp
115 120 125
Ser Leu Ile Asn Gln Arg Ser Phe Leu Val Ser Gly Leu Gly Gly Glu
130 135 140
His Thr Ala Phe Asn Gln Leu Pro Ser Gly Lys Ala Glu Tyr His Gly
145 150 155 160
Lys Ala Phe Ser Ser Asp Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile
165 170 175
Asp Phe Ala Ala Lys Gln Gly His Gly Lys Ile Glu His Leu Lys Thr
180 185 190
Pro Glu Gln Asn Val Glu Leu Ala Ser Ala Glu Leu Lys Ala Asp Glu
195 200 205
Lys Ser His Ala Val Ile Leu Gly Asp Thr Arg Tyr Gly Ser Glu Glu
210 215 220
Lys Gly Thr Tyr His Leu Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile
225 230 235 240
Ala Gly Ser Ala Thr Val Lys Ile Arg Glu Lys Val His Glu Ile Gly
245 250 255
Ile Ala Gly Lys Gln
260
<210>51
<211>789
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>51
tgcggatcca gcggaagcgg aagcggaggc ggcggtgtcg ccgccgacat cggcacaggg 60
cttgccgatg cactaactgc gccgctcgac cataaagaca aaggtttgaa atccctgaca 120
ttggaagact ccatttccca aaacggaaca ctgaccctgt cggcacaagg tgcggaaaaa 180
actttcaaag tcggcgacaa agacaacagt ctcaatacag gcaaattgaa gaacgacaaa 240
atcagccgct tcgactttgt gcaaaaaatc gaagtggacg gacaaaccat cacgctggca 300
agcggcgaat ttcaaatata caaacaggac cactccgccg tcgttgccct acagattgaa 360
aaaatcaaca accccgacaa aatcgacagc ctgataaacc aacgctcctt ccttgtcagc 420
ggtttgggcg gagaacatac cgccttcaac caactgccca gcggcaaagc cgagtatcac 480
ggcaaagcat tcagctccga cgatgccggc ggaaaactga cctataccat agattttgcc 540
gccaaacagg gacacggcaa aatcgaacac ctgaaaacac ccgagcagaa tgtcgagctt 600
gcctccgccg aactcaaagc agatgaaaaa tcacacgccg tcattttggg cgacacgcgc 660
tacggcagcg aagaaaaagg cacttaccac ctcgctcttt tcggcgaccg agcccaagaa 720
atcgccggct cggcaaccgt gaagataagg gaaaaggttc acgaaatcgg catcgccggc 780
aaacagtag 789
<210>52
<211>262
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>52
Cys Gly Ser Ser Gly Ser Gly Ser Gly Gly Gly Gly Val Ala Ala Asp
1 5 10 15
Ile Gly Thr Gly Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys
20 25 30
Asp Lys Gly Leu Lys Ser Leu Thr Leu Glu Asp Ser Ile Ser Gln Asn
35 40 45
Gly Thr Leu Thr Leu Ser Ala Gln Gly Ala Glu Lys Thr Phe Lys Val
50 55 60
Gly Asp Lys Asp Asn Ser Leu Asn Thr Gly Lys Leu Lys Asn Asp Lys
65 70 75 80
Ile Ser Arg Phe Asp Phe Val Gln Lys Ile Glu Val Asp Gly Gln Thr
85 90 95
Ile Thr Leu Ala Ser Gly Glu Phe Gln Ile Tyr Lys Gln Asp His Ser
100 105 110
Ala Val Val Ala Leu Gln Ile Glu Lys Ile Asn Asn Pro Asp Lys Ile
115 120 125
Asp Ser Leu Ile Asn Gln Arg Ser Phe Leu Val Ser Gly Leu Gly Gly
130 135 140
Glu His Thr Ala Phe Asn Gln Leu Pro Ser Gly Lys Ala Glu Tyr His
145 150 155 160
Gly Lys Ala Phe Ser Ser Asp Asp Ala Gly Gly Lys Leu Thr Tyr Thr
165 170 175
Ile Asp Phe Ala Ala Lys Gln Gly His Gly Lys Ile Glu His Leu Lys
180 185 190
Thr Pro Glu Gln Asn Val Glu Leu Ala Ser Ala Glu Leu Lys Ala Asp
195 200 205
Glu Lys Ser His Ala Val Ile Leu Gly Asp Thr Arg Tyr Gly Ser Glu
210 215 220
Glu Lys Gly Thr Tyr His Leu Ala Leu Phe Gly Asp Arg Ala Gln Glu
225 230 235 240
Ile Ala Gly Ser Ala Thr Val Lys Ile Arg Glu Lys Val His Glu Ile
245 250 255
Gly Ile Ala Gly Lys Gln
260
<210>53
<211>786
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>53
atgagcagcg gaagcggaag cggaggcggc ggtgtcgccg ccgacatcgg cacagggctt 60
gccgatgcac taactgcgcc gctcgaccat aaagacaaag gtttgaaatc cctgacattg 120
gaagactcca tttcccaaaa cggaacactg accctgtcgg cacaaggtgc ggaaaaaact 180
ttcaaagtcg gcgacaaaga caacagtctc aatacaggca aattgaagaa cgacaaaatc 240
agccgcttcg actttgtgca aaaaatcgaa gtggacggac aaaccatcac gctggcaagc 300
ggcgaatttc aaatatacaa acaggaccac tccgccgtcg ttgccctaca gattgaaaaa 360
atcaacaacc ccgacaaaat cgacagcctg ataaaccaac gctccttcct tgtcagcggt 420
ttgggcggag aacataccgc cttcaaccaa ctgcccagcg gcaaagccga gtatcacggc 480
aaagcattca gctccgacga tgccggcgga aaactgacct ataccataga ttttgccgcc 540
aaacagggac acggcaaaat cgaacacctg aaaacacccg agcagaatgt cgagcttgcc 600
tccgccgaac tcaaagcaga tgaaaaatca cacgccgtca ttttgggcga cacgcgctac 660
ggcagcgaag aaaaaggcac ttaccacctc gctcttttcg gcgaccgagc ccaagaaatc 720
gccggctcgg caaccgtgaa gataagggaa aaggttcacg aaatcggcat cgccggcaaa 780
cagtag 786
<210>54
<211>261
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>54
Met Ser Ser Gly Ser Gly Ser Gly Gly Gly Gly Val Ala Ala Asp Ile
1 5 10 15
Gly Thr Gly Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp
20 25 30
Lys Gly Leu Lys Ser Leu Thr Leu Glu Asp Ser Ile Ser Gln Asn Gly
35 40 45
Thr Leu Thr Leu Ser Ala Gln Gly Ala Glu Lys Thr Phe Lys Val Gly
50 55 60
Asp Lys Asp Asn Ser Leu Asn Thr Gly Lys Leu Lys Asn Asp Lys Ile
65 70 75 80
Ser Arg Phe Asp Phe Val Gln Lys Ile Glu Val Asp Gly Gln Thr Ile
85 90 95
Thr Leu Ala Ser Gly Glu Phe Gln Ile Tyr Lys Gln Asp His Ser Ala
100 105 110
Val Val Ala Leu Gln Ile Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp
115 120 125
Ser Leu Ile Asn Gln Arg Ser Phe Leu Val Ser Gly Leu Gly Gly Glu
130 135 140
His Thr Ala Phe Asn Gln Leu Pro Ser Gly Lys Ala Glu Tyr His Gly
145 150 155 160
Lys Ala Phe Ser Ser Asp Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile
165 170 175
Asp Phe Ala Ala Lys Gln Gly His Gly Lys Ile Glu His Leu Lys Thr
180 185 190
Pro Glu Gln Asn Val Glu Leu Ala Ser Ala Glu Leu Lys Ala Asp Glu
195 200 205
Lys Ser His Ala Val Ile Leu Gly Asp Thr Arg Tyr Gly Ser Glu Glu
210 215 220
Lys Gly Thr Tyr His Leu Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile
225 230 235 240
Ala Gly Ser Ala Thr Val Lys Ile Arg Glu Lys Val His Glu Ile Gly
245 250 255
Ile Ala Gly Lys Gln
260
<210>55
<211>786
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>55
tgcagcagcg gaagcggaag cggaggcggc ggtgtcgccg ccgacatcgg cacagggctt 60
gccgatgcac taactgcgcc gctcgaccat aaagacaaag gtttgaaatc cctgacattg 120
gaagactcca tttcccaaaa cggaacactg accctgtcgg cacaaggtgc ggaaaaaact 180
ttcaaagtcg gcgacaaaga caacagtctc aatacaggca aattgaagaa cgacaaaatc 240
agccgcttcg actttgtgca aaaaatcgaa gtggacggac aaaccatcac gctggcaagc 300
ggcgaatttc aaatatacaa acaggaccac tccgccgtcg ttgccctaca gattgaaaaa 360
atcaacaacc ccgacaaaat cgacagcctg ataaaccaac gctccttcct tgtcagcggt 420
ttgggcggag aacataccgc cttcaaccaa ctgcccagcg gcaaagccga gtatcacggc 480
aaagcattca gctccgacga tgccggcgga aaactgacct ataccataga ttttgccgcc 540
aaacagggac acggcaaaat cgaacacctg aaaacacccg agcagaatgt cgagcttgcc 600
tccgccgaac tcaaagcaga tgaaaaatca cacgccgtca ttttgggcga cacgcgctac 660
ggcagcgaag aaaaaggcac ttaccacctc gctcttttcg gcgaccgagc ccaagaaatc 720
gccggctcgg caaccgtgaa gataagggaa aaggttcacg aaatcggcat cgccggcaaa 780
cagtag 786
<210>56
<211>261
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>56
Cys Ser Ser Gly Ser Gly Ser Gly Gly Gly Gly Val Ala Ala Asp Ile
1 5 10 15
Gly Thr Gly Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp
20 25 30
Lys Gly Leu Lys Ser Leu Thr Leu Glu Asp Ser Ile Ser Gln Asn Gly
35 40 45
Thr Leu Thr Leu Ser Ala Gln Gly Ala Glu Lys Thr Phe Lys Val Gly
50 55 60
Asp Lys Asp Asn Ser Leu Asn Thr Gly Lys Leu Lys Asn Asp Lys Ile
65 70 75 80
Ser Arg Phe Asp Phe Val Gln Lys Ile Glu Val Asp Gly Gln Thr Ile
85 90 95
Thr Leu Ala Ser Gly Glu Phe Gln Ile Tyr Lys Gln Asp His Ser Ala
100 105 110
Val Val Ala Leu Gln Ile Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp
115 120 125
Ser Leu Ile Asn Gln Arg Ser Phe Leu Val Ser Gly Leu Gly Gly Glu
130 135 140
His Thr Ala Phe Asn Gln Leu Pro Ser Gly Lys Ala Glu Tyr His Gly
145 150 155 160
Lys Ala Phe Ser Ser Asp Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile
165 170 175
Asp Phe Ala Ala Lys Gln Gly His Gly Lys Ile Glu His Leu Lys Thr
180 185 190
Pro Glu Gln Asn Val Glu Leu Ala Ser Ala Glu Leu Lys Ala Asp Glu
195 200 205
Lys Ser His Ala Val Ile Leu Gly Asp Thr Arg Tyr Gly Ser Glu Glu
210 215 220
Lys Gly Thr Tyr His Leu Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile
225 230 235 240
Ala Gly Ser Ala Thr Val Lys Ile Arg Glu Lys Val His Glu Ile Gly
245 250 255
Ile Ala Gly Lys Gln
260
<210>57
<211>789
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>57
tgcggatcca gcggaagcgg aagcggaggc ggcggtgtcg ccgccgacat cggcacaggg 60
cttgccgatg cactaactgc gccgctcgac cataaagaca aaggtttgaa atccctgaca 120
ttggaagact ccatttccca aaacggaaca ctgaccctgt cggcacaagg tgcggaaaaa 180
actttcaaag tcggcgacaa agacaacagt ctcaatacag gcaaattgaa gaacgacaaa 240
atcagccgct tcgactttgt gcaaaaaatc gaagtggacg gacaaaccat cacgctggca 300
agcggcgaat ttcaaatata caaacaggac cactccgccg tcgttgccct acagattgaa 360
aaaatcaaca accccgacaa aatcgacagc ctgataaacc aacgctcctt ccttgtcagc 420
ggtttgggcg gagaacatac cgccttcaac caactgccca gcggcaaagc cgagtatcac 480
ggcaaagcat tcagctccga cgatgccggc ggaaaactga cctataccat agattttgcc 540
gccaaacagg gacacggcaa aatcgaacac ctgaaaacac ccgagcagaa tgtcgagctt 600
gcctccgccg aactcaaagc agatgaaaaa tcacacgccg tcattttggg cgacacgcgc 660
tacggcagcg aagaaaaagg cacttaccac ctcgctcttt tcggcgaccg agcccaagaa 720
atcgccggct cggcaaccgt gaagataagg gaaaaggttc acgaaatcgg catcgccggc 780
aaacagtag 789
<210>58
<211>262
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>58
Cys Gly Ser Ser Gly Ser Gly Ser Gly Gly Gly Gly Val Ala Ala Asp
1 5 10 15
Ile Gly Thr Gly Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys
20 25 30
Asp Lys Gly Leu Lys Ser Leu Thr Leu Glu Asp Ser Ile Ser Gln Asn
35 40 45
Gly Thr Leu Thr Leu Ser Ala Gln Gly Ala Glu Lys Thr Phe Lys Val
50 55 60
Gly Asp Lys Asp Asn Ser Leu Asn Thr Gly Lys Leu Lys Asn Asp Lys
65 70 75 80
Ile Ser Arg Phe Asp Phe Val Gln Lys Ile Glu Val Asp Gly Gln Thr
85 90 95
Ile Thr Leu Ala Ser Gly Glu Phe Gln Ile Tyr Lys Gln Asp His Ser
100 105 110
Ala Val Val Ala Leu Gln Ile Glu Lys Ile Asn Asn Pro Asp Lys Ile
115 120 125
Asp Ser Leu Ile Asn Gln Arg Ser Phe Leu Val Ser Gly Leu Gly Gly
130 135 140
Glu His Thr Ala Phe Asn Gln Leu Pro Ser Gly Lys Ala Glu Tyr His
145 150 155 160
Gly Lys Ala Phe Ser Ser Asp Asp Ala Gly Gly Lys Leu Thr Tyr Thr
165 170 175
Ile Asp Phe Ala Ala Lys Gln Gly His Gly Lys Ile Glu His Leu Lys
180 185 190
Thr Pro Glu Gln Asn Val Glu Leu Ala Ser Ala Glu Leu Lys Ala Asp
195 200 205
Glu Lys Ser His Ala Val Ile Leu Gly Asp Thr Arg Tyr Gly Ser Glu
210 215 220
Glu Lys Gly Thr Tyr His Leu Ala Leu Phe Gly Asp Arg Ala Gln Glu
225 230 235 240
Ile Ala Gly Ser Ala Thr Val Lys Ile Arg Glu Lys Val His Glu Ile
245 250 255
Gly Ile Ala Gly Lys Gln
260
<210>59
<211>786
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>59
atgagcagcg gaagcggaag cggaggcggc ggtgtcgccg ccgacatcgg cacagggctt 60
gccgatgcac taactgcgcc gctcgaccat aaagacaaag gtttgaaatc cctgacattg 120
gaagactcca tttcccaaaa cggaacactg accctgtcgg cacaaggtgc ggaaaaaact 180
ttcaaagtcg gcgacaaaga caacagtctc aatacaggca aattgaagaa cgacaaaatc 240
agccgcttcg actttgtgca aaaaatcgaa gtggacggac aaaccatcac gctggcaagc 300
ggcgaatttc aaatatacaa acaggaccac tccgccgtcg ttgccctaca gattgaaaaa 360
atcaacaacc ccgacaaaat cgacagcctg ataaaccaac gctccttcct tgtcagcggt 420
ttgggcggag aacataccgc cttcaaccaa ctgcccagcg gcaaagccga gtatcacggc 480
aaagcattca gctccgacga tgccggcgga aaactgacct ataccataga ttttgccgcc 540
aaacagggac acggcaaaat cgaacacctg aaaacacccg agcagaatgt cgagcttgcc 600
tccgccgaac tcaaagcaga tgaaaaatca cacgccgtca ttttgggcga cacgcgctac 660
ggcagcgaag aaaaaggcac ttaccacctc gctcttttcg gcgaccgagc ccaagaaatc 720
gccggctcgg caaccgtgaa gataagggaa aaggttcacg aaatcggcat cgccggcaaa 780
cagtag 786
<210>60
<211>261
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>60
Met Ser Ser Gly Ser Gly Ser Gly Gly Gly Gly Val Ala Ala Asp Ile
1 5 10 15
Gly Thr Gly Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp
20 25 30
Lys Gly Leu Lys Ser Leu Thr Leu Glu Asp Ser Ile Ser Gln Asn Gly
35 40 45
Thr Leu Thr Leu Ser Ala Gln Gly Ala Glu Lys Thr Phe Lys Val Gly
50 55 60
Asp Lys Asp Asn Ser Leu Asn Thr Gly Lys Leu Lys Asn Asp Lys Ile
65 70 75 80
Ser Arg Phe Asp Phe Val Gln Lys Ile Glu Val Asp Gly Gln Thr Ile
85 90 95
Thr Leu Ala Ser Gly Glu Phe Gln Ile Tyr Lys Gln Asp His Ser Ala
100 105 110
Val Val Ala Leu Gln Ile Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp
115 120 125
Ser Leu Ile Asn Gln Arg Ser Phe Leu Val Ser Gly Leu Gly Gly Glu
130 135 140
His Thr Ala Phe Asn Gln Leu Pro Ser Gly Lys Ala Glu Tyr His Gly
145 150 155 160
Lys Ala Phe Ser Ser Asp Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile
165 170 175
Asp Phe Ala Ala Lys Gln Gly His Gly Lys Ile Glu His Leu Lys Thr
180 185 190
Pro Glu Gln Asn Val Glu Leu Ala Ser Ala Glu Leu Lys Ala Asp Glu
195 200 205
Lys Ser His Ala Val Ile Leu Gly Asp Thr Arg Tyr Gly Ser Glu Glu
210 215 220
Lys Gly Thr Tyr His Leu Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile
225 230 235 240
Ala Gly Ser Ala Thr Val Lys Ile Arg Glu Lys Val His Glu Ile Gly
245 250 255
Ile Ala Gly Lys Gln
260
<210>61
<211>789
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>61
tgcagcagcg gaggcggcgg aagcggaggc ggcggtgtcg ccgccgacat cggcacgggg 60
cttgccgatg cactaactgc gccgctcgac cataaagaca aaggtttgaa atccctgaca 120
ttggaagact ctattcccca aaacggaaca ctaaccctgt cggcacaagg tgcggaaaaa 180
actttcaaag ccggcgacaa agacaacagc ctcaacacgg gcaaactgaa gaacgacaaa 240
atcagccgct tcgactttgt gcaaaaaatc gaagtggacg gacaaaccat cacgctggca 300
agcggcgaat ttcaaatata caaacaggac cactccgccg tcgttgccct acagattgaa 360
aaaatcaaca accccgacaa aatcgacagc ctgataaacc aacgctcctt ccttgtcagc 420
ggtttgggcg gagaacatac cgccttcaac caactgcccg gcggcaaagc cgagtatcac 480
ggcaaagcat tcagctccga cgacccgaac ggcaggctgc actactccat tgattttacc 540
aaaaaacagg gttacggcgg aatcgaacac ctgaaaacac ccgagcaaaa tgtcgagctt 600
gcctccgccg aactcaaagc agatgaaaaa tcacacgccg tcattttggg cgacacgcgc 660
tacggcagcg aagaaaaagg cacttaccac ctcgcccttt tcggcgaccg cgcccaagaa 720
atcgccggct cggcaaccgt gaagataggg gaaaaggttc acgaaatcgg catcgccggc 780
aaacagtag 789
<210>62
<211>262
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>62
Cys Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Val Ala Ala Asp
1 5 10 15
Ile Gly Thr Gly Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys
20 25 30
Asp Lys Gly Leu Lys Ser Leu Thr Leu Glu Asp Ser Ile Pro Gln Asn
35 40 45
Gly Thr Leu Thr Leu Ser Ala Gln Gly Ala Glu Lys Thr Phe Lys Ala
50 55 60
Gly Asp Lys Asp Asn Ser Leu Asn Thr Gly Lys Leu Lys Asn Asp Lys
65 70 75 80
Ile Ser Arg Phe Asp Phe Val Gln Lys Ile Glu Val Asp Gly Gln Thr
85 90 95
Ile Thr Leu Ala Ser Gly Glu Phe Gln Ile Tyr Lys Gln Asp His Ser
100 105 110
Ala Val Val Ala Leu Gln Ile Glu Lys Ile Asn Asn Pro Asp Lys Ile
115 120 125
Asp Ser Leu Ile Asn Gln Arg Ser Phe Leu Val Ser Gly Leu Gly Gly
130 135 140
Glu His Thr Ala Phe Asn Gln Leu Pro Gly Gly Lys Ala Glu Tyr His
145 150 155 160
Gly Lys Ala Phe Ser Ser Asp Asp Pro Asn Gly Arg Leu His Tyr Ser
165 170 175
Ile Asp Phe Thr Lys Lys Gln Gly Tyr Gly Gly Ile Glu His Leu Lys
180 185 190
Thr Pro Glu Gln Asn Val Glu Leu Ala Ser Ala Glu Leu Lys Ala Asp
195 200 205
Glu Lys Ser His Ala Val Ile Leu Gly Asp Thr Arg Tyr Gly Ser Glu
210 215 220
Glu Lys Gly Thr Tyr His Leu Ala Leu Phe Gly Asp Arg Ala Gln Glu
225 230 235 240
Ile Ala Gly Ser Ala Thr Val Lys Ile Gly Glu Lys Val His Glu Ile
245 250 255
Gly Ile Ala Gly Lys Gln
260
<210>63
<211>792
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>63
tgcggatcca gcggaggcgg cggaagcgga ggcggcggtg tcgccgccga catcggcacg 60
gggcttgccg atgcactaac tgcgccgctc gaccataaag acaaaggttt gaaatccctg 120
acattggaag actctattcc ccaaaacgga acactaaccc tgtcggcaca aggtgcggaa 180
aaaactttca aagccggcga caaagacaac agcctcaaca cgggcaaact gaagaacgac 240
aaaatcagcc gcttcgactt tgtgcaaaaa atcgaagtgg acggacaaac catcacgctg 300
gcaagcggcg aatttcaaat atacaaacag gaccactccg ccgtcgttgc cctacagatt 360
gaaaaaatca acaaccccga caaaatcgac agcctgataa accaacgctc cttccttgtc 420
agcggtttgg gcggagaaca taccgccttc aaccaactgc ccggcggcaa agccgagtat 480
cacggcaaag cattcagctc cgacgacccg aacggcaggc tgcactactc cattgatttt 540
accaaaaaac agggttacgg cggaatcgaa cacctgaaaa cacccgagca aaatgtcgag 600
cttgcctccg ccgaactcaa agcagatgaa aaatcacacg ccgtcatttt gggcgacacg 660
cgctacggca gcgaagaaaa aggcacttac cacctcgccc ttttcggcga ccgcgcccaa 720
gaaatcgccg gctcggcaac cgtgaagata ggggaaaagg ttcacgaaat cggcatcgcc 780
ggcaaacagt ag 792
<210>64
<211>263
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>64
Cys Gly Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Val Ala Ala
1 5 10 15
Asp Ile Gly Thr Gly Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His
20 25 30
Lys Asp Lys Gly Leu Lys Ser Leu Thr Leu Glu Asp Ser Ile Pro Gln
35 40 45
Asn Gly Thr Leu Thr Leu Ser Ala Gln Gly Ala Glu Lys Thr Phe Lys
50 55 60
Ala Gly Asp Lys Asp Asn Ser Leu Asn Thr Gly Lys Leu Lys Asn Asp
65 70 75 80
Lys Ile Ser Arg Phe Asp Phe Val Gln Lys Ile Glu Val Asp Gly Gln
85 90 95
Thr Ile Thr Leu Ala Ser Gly Glu Phe Gln Ile Tyr Lys Gln Asp His
100 105 110
Ser Ala Val Val Ala Leu Gln Ile Glu Lys Ile Asn Asn Pro Asp Lys
115 120 125
Ile Asp Ser Leu Ile Asn Gln Arg Ser Phe Leu Val Ser Gly Leu Gly
130 135 140
Gly Glu His Thr Ala Phe Asn Gln Leu Pro Gly Gly Lys Ala Glu Tyr
145 150 155 160
His Gly Lys Ala Phe Ser Ser Asp Asp Pro Asn Gly Arg Leu His Tyr
165 170 175
Ser Ile Asp Phe Thr Lys Lys Gln Gly Tyr Gly Gly Ile Glu His Leu
180 185 190
Lys Thr Pro Glu Gln Asn Val Glu Leu Ala Ser Ala Glu Leu Lys Ala
195 200 205
Asp Glu Lys Ser His Ala Val Ile Leu Gly Asp Thr Arg Tyr Gly Ser
210 215 220
Glu Glu Lys Gly Thr Tyr His Leu Ala Leu Phe Gly Asp Arg Ala Gln
225 230 235 240
Glu Ile Ala Gly Ser Ala Thr Val Lys Ile Gly Glu Lys Val His Glu
245 250 255
Ile Gly Ile Ala Gly Lys Gln
260
<210>65
<211>789
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>65
atgagcagcg gaggcggcgg aagcggaggc ggcggtgtcg ccgccgacat cggcacgggg 60
cttgccgatg cactaactgc gccgctcgac cataaagaca aaggtttgaa atccctgaca 120
ttggaagact ctattcccca aaacggaaca ctaaccctgt cggcacaagg tgcggaaaaa 180
actttcaaag ccggcgacaa agacaacagc ctcaacacgg gcaaactgaa gaacgacaaa 240
atcagccgct tcgactttgt gcaaaaaatc gaagtggacg gacaaaccat cacgctggca 300
agcggcgaat ttcaaatata caaacaggac cactccgccg tcgttgccct acagattgaa 360
aaaatcaaca accccgacaa aatcgacagc ctgataaacc aacgctcctt ccttgtcagc 420
ggtttgggcg gagaacatac cgccttcaac caactgcccg gcggcaaagc cgagtatcac 480
ggcaaagcat tcagctccga cgacccgaac ggcaggctgc actactccat tgattttacc 540
aaaaaacagg gttacggcgg aatcgaacac ctgaaaacac ccgagcaaaa tgtcgagctt 600
gcctccgccg aactcaaagc agatgaaaaa tcacacgccg tcattttggg cgacacgcgc 660
tacggcagcg aagaaaaagg cacttaccac ctcgcccttt tcggcgaccg cgcccaagaa 720
atcgccggct cggcaaccgt gaagataggg gaaaaggttc acgaaatcgg catcgccggc 780
aaacagtag 789
<210>66
<211>262
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>66
Met Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Val Ala Ala Asp
1 5 10 15
Ile Gly Thr Gly Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys
20 25 30
Asp Lys Gly Leu Lys Ser Leu Thr Leu Glu Asp Ser Ile Pro Gln Asn
35 40 45
Gly Thr Leu Thr Leu Ser Ala Gln Gly Ala Glu Lys Thr Phe Lys Ala
50 55 60
Gly Asp Lys Asp Asn Ser Leu Asn Thr Gly Lys Leu Lys Asn Asp Lys
65 70 75 80
Ile Ser Arg Phe Asp Phe Val Gln Lys Ile Glu Val Asp Gly Gln Thr
85 90 95
Ile Thr Leu Ala Ser Gly Glu Phe Gln Ile Tyr Lys Gln Asp His Ser
100 105 110
Ala Val Val Ala Leu Gln Ile Glu Lys Ile Asn Asn Pro Asp Lys Ile
115 120 125
Asp Ser Leu Ile Asn Gln Arg Ser Phe Leu Val Ser Gly Leu Gly Gly
130 135 140
Glu His Thr Ala Phe Asn Gln Leu Pro Gly Gly Lys Ala Glu Tyr His
145 150 155 160
Gly Lys Ala Phe Ser Ser Asp Asp Pro Asn Gly Arg Leu His Tyr Ser
165 170 175
Ile Asp Phe Thr Lys Lys Gln Gly Tyr Gly Gly Ile Glu His Leu Lys
180 185 190
Thr Pro Glu Gln Asn Val Glu Leu Ala Ser Ala Glu Leu Lys Ala Asp
195 200 205
Glu Lys Ser His Ala Val Ile Leu Gly Asp Thr Arg Tyr Gly Ser Glu
210 215 220
Glu Lys Gly Thr Tyr His Leu Ala Leu Phe Gly Asp Arg Ala Gln Glu
225 230 235 240
Ile Ala Gly Ser Ala Thr Val Lys Ile Gly Glu Lys Val His Glu Ile
245 250 255
Gly Ile Ala Gly Lys Gln
260
<210>67
<211>774
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>67
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaggt ttgaaatccc tgacattgga agactccatt 120
tcccaaaacg gaacactgac cctgtcggca caaggtgcgg aaaaaacttt caaagtcggc 180
gacaaagaca acagtctcaa tacaggcaaa ttgaagaacg acaaaatcag ccgcttcgac 240
tttgtgcaaa aaatcgaagt ggacggacaa accatcacgc tggcaagcgg cgaatttcaa 300
atatacaaac agaaccactc cgccgtcgtt gccctacaga ttgaaaaaat caacaacccc 360
gacaaaatcg acagcctgat aaaccaacgc tccttccttg tcagcggttt gggcggagaa 420
cataccgcct tcaaccaact gcccggcggc aaagccgagt atcacggcaa agcattcagc 480
tccgacgatg ccggcggaaa actgacctat accatagatt ttgccgccaa acagggacac 540
ggcaaaatcg aacacctgaa aacacccgag caaaatgtcg agcttgccgc cgccgaactc 600
aaagcagatg aaaaatcaca cgccgtcatt ttgggcgaca cgcgctacgg cagcgaagaa 660
aaaggcactt accacctcgc ccttttcggc gaccgcgctc aagaaatcgc cggctcggca 720
accgtgaaga taggagaaaa ggttcacgaa atcagcatcg ccggcaaaca gtag 774
<210>68
<211>257
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>68
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu Lys
20 25 30
Ser Leu Thr Leu Glu Asp Ser Ile Ser Gln Asn Gly Thr Leu Thr Leu
35 40 45
Ser Ala Gln Gly Ala Glu Lys Thr Phe Lys Val Gly Asp Lys Asp Asn
50 55 60
Ser Leu Asn Thr Gly Lys Leu Lys Asn Asp Lys Ile Ser Arg Phe Asp
65 70 75 80
Phe Val Gln Lys Ile Glu Val Asp Gly Gln Thr Ile Thr Leu Ala Ser
85 90 95
Gly Glu Phe Gln Ile Tyr Lys Gln Asn His Ser Ala Val Val Ala Leu
100 105 110
Gln Ile Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn
115 120 125
Gln Arg Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe
130 135 140
Asn Gln Leu Pro Gly Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser
145 150 155 160
Ser Asp Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala
165 170 175
Lys Gln Gly His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn
180 185 190
Val Glu Leu Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala
195 200 205
Val Ile Leu Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr
210 215 220
His Leu Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala
225 230 235 240
Thr Val Lys Ile Gly Glu Lys Val His Glu Ile Ser Ile Ala Gly Lys
245 250 255
Gln
<210>69
<21l>777
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>69
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa ggtttgaaat ccctgacatt ggaagactcc 120
atttcccaaa acggaacact gaccctgtcg gcacaaggtg cggaaaaaac tttcaaagtc 180
ggcgacaaag acaacagtct caatacaggc aaattgaaga acgacaaaat cagccgcttc 240
gactttgtgc aaaaaatcga agtggacgga caaaccatca cgctggcaag cggcgaattt 300
caaatataca aacagaacca ctccgccgtc gttgccctac agattgaaaa aatcaacaac 360
cccgacaaaa tcgacagcct gataaaccaa cgctccttcc ttgtcagcgg tttgggcgga 420
gaacataccg ccttcaacca actgcccggc ggcaaagccg agtatcacgg caaagcattc 480
agctccgacg atgccggcgg aaaactgacc tataccatag attttgccgc caaacaggga 540
cacggcaaaa tcgaacacct gaaaacaccc gagcaaaatg tcgagcttgc cgccgccgaa 600
ctcaaagcag atgaaaaatc acacgccgtc attttgggcg acacgcgcta cggcagcgaa 660
gaaaaaggca cttaccacct cgcccttttc ggcgaccgcg ctcaagaaat cgccggctcg 720
gcaaccgtga agataggaga aaaggttcac gaaatcagca tcgccggcaa acagtag 777
<210>70
<211>258
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>70
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu
20 25 30
Lys Ser Leu Thr Leu Glu Asp Ser Ile Ser Gln Asn Gly Thr Leu Thr
35 40 45
Leu Ser Ala Gln Gly Ala Glu Lys Thr Phe Lys Val Gly Asp Lys Asp
50 55 60
Asn Ser Leu Asn Thr Gly Lys Leu Lys Asn Asp Lys Ile Ser Arg Phe
65 70 75 80
Asp Phe Val Gln Lys Ile Glu Val Asp Gly Gln Thr Ile Thr Leu Ala
85 90 95
Ser Gly Glu Phe Gln Ile Tyr Lys Gln Asn His Ser Ala Val Val Ala
100 105 110
Leu Gln Ile Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile
115 120 125
Asn Gln Arg Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala
130 135 140
Phe Asn Gln Leu Pro Gly Gly Lys Ala Glu Tyr His Gly Lys Ala Phe
145 150 155 160
Ser Ser Asp Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala
165 170 175
Ala Lys Gln Gly His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln
180 185 190
Asn Val Glu Leu Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His
195 200 205
Ala Val Ile Leu Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr
210 215 220
Tyr His Leu Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser
225 230 235 240
Ala Thr Val Lys Ile Gly Glu Lys Val His Glu Ile Ser Ile Ala Gly
245 250 255
Lys Gln
<210>71
<211>774
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>71
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaggt ttgaaatccc tgacattgga agactccatt 120
tcccaaaacg gaacactgac cctgtcggca caaggtgcgg aaaaaacttt caaagtcggc 180
gacaaagaca acagtctcaa tacaggcaaa ttgaagaacg acaaaatcag ccgcttcgac 240
tttgtgcaaa aaatcgaagt ggacggacaa accatcacgc tggcaagcgg cgaatttcaa 300
atatacaaac agaaccactc cgccgtcgtt gccctacaga ttgaaaaaat caacaacccc 360
gacaaaatcg acagcctgat aaaccaacgc tccttccttg tcagcggttt gggcggagaa 420
cataccgcct tcaaccaact gcccggcggc aaagccgagt atcacggcaa agcattcagc 480
tccgacgatg ccggcggaaa actgacctat accatagatt ttgccgccaa acagggacac 540
ggcaaaatcg aacacctgaa aacacccgag caaaatgtcg agcttgccgc cgccgaactc 600
aaagcagatg aaaaatcaca cgccgtcatt ttgggcgaca cgcgctacgg cagcgaagaa 660
aaaggcactt accacctcgc ccttttcggc gaccgcgctc aagaaatcgc cggctcggca 720
accgtgaaga taggagaaaa ggttcacgaa atcagcatcg ccggcaaaca gtag 774
<210>72
<211>257
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>72
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu Lys
20 25 30
Ser Leu Thr Leu Glu Asp Ser Ile Ser Gln Asn Gly Thr Leu Thr Leu
35 40 45
Ser Ala Gln Gly Ala Glu Lys Thr Phe Lys Val Gly Asp Lys Asp Asn
50 55 60
Ser Leu Asn Thr Gly Lys Leu Lys Asn Asp Lys Ile Ser Arg Phe Asp
65 70 75 80
Phe Val Gln Lys Ile Glu Val Asp Gly Gln Thr Ile Thr Leu Ala Ser
85 90 95
Gly Glu Phe Gln Ile Tyr Lys Gln Asn His Ser Ala Val Val Ala Leu
100 105 110
Gln Ile Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn
115 120 125
Gln Arg Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe
130 135 140
Asn Gln Leu Pro Gly Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser
145 150 155 160
Ser Asp Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala
165 170 175
Lys Gln Gly His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn
180 185 190
Val Glu Leu Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala
195 200 205
Val Ile Leu Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr
210 215 220
His Leu Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala
225 230 235 240
Thr Val Lys Ile Gly Glu Lys Val His Glu Ile Ser Ile Ala Gly Lys
245 250 255
Gln
<210>73
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>73
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacttga aaacacccga gcaaaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttctcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatt gccggcaaac agtag 765
<210>74
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>74
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Leu Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>75
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>75
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaaatatac 300
aaacaggacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggtgg agaacatacc 420
gccttcaacc aactgcccag cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gatgctggcg gaaaactgac ctataccata gatttcgccg ccaaacaggg acacggcaaa 540
atcgaacact tgaaaacacc cgagcaaaat gtcgagcttg cctccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcggcga agaaaaaggc 660
acttaccacc tcgcccttct cggcgaccgc gcccaagaaa tcgccggctc ggcaaccgtg 720
aagataaggg aaaaggttca cgaaatcggc attgccggca aacagtag 768
<210>76
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>76
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Leu Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val
225 230 235 240
Lys Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250 255
<210>77
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>77
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacttga aaacacccga gcaaaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttctcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatt gccggcaaac agtag 765
<210>78
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>78
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Leu Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>79
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>79
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacttga aaacacccga gcaaaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>80
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>80
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>81
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>81
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaaatatac 300
aaacaggacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggtgg agaacatacc 420
gccttcaacc aactgcccag cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gatgctggcg gaaaactgac ctataccata gatttcgccg ccaaacaggg acacggcaaa 540
atcgaacact tgaaaacacc cgagcaaaat gtcgagcttg cctccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcggcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gcccaagaaa tcgccggctc ggcaaccgtg 720
aagataaggg aaaaggttca cgaaatcggc atcgccggca aacagtag 768
<210>82
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>82
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val
225 230 235 240
Lys Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250 255
<210>83
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>83
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacttga aaacacccga gcaaaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>84
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>84
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>85
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>85
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacttga aaacacccga gcaaaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>86
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>86
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>87
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>87
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaaatatac 300
aaacaggacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggtgg agaacatacc 420
gccttcaacc aactgcccag cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gatgctggcg gaaaactgac ctataccata gatttcgccg ccaaacaggg acacggcaaa 540
atcgaacact tgaaaacacc cgagcaaaat gtcgagcttg cctccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcggcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gcccaagaaa tcgccggctc ggcaaccgtg 720
aagataaggg aaaaggttca cgaaatcggc atcgccggca aacagtag 768
<210>88
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>88
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val
225 230 235 240
Lys Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250 255
<210>89
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>89
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacttga aaacacccga gcaaaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>90
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>90
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>9l
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>91
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacttga aaacacccga gcaaaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>92
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>92
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>93
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>93
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaaatatac 300
aaacaggacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggtgg agaacatacc 420
gccttcaacc aactgcccag cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gatgctggcg gaaaactgac ctataccata gatttcgccg ccaaacaggg acacggcaaa 540
atcgaacact tgaaaacacc cgagcaaaat gtcgagcttg cctccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcggcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gcccaagaaa tcgccggctc ggcaaccgtg 720
aagataaggg aaaaggttca cgaaatcggc atcgccggca aacagtag 768
<210>94
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>94
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val
225 230 235 240
Lys Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250 255
<210>95
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>95
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacttga aaacacccga gcaaaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>96
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>96
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>97
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>97
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacttga aaacacccga gcaaaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtaa 765
<210>98
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>98
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>99
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>99
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaaatatac 300
aaacaggacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggtgg agaacatacc 420
gccttcaacc aactgcccag cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gatgctggcg gaaaactgac ctataccata gatttcgccg ccaaacaggg acacggcaaa 540
atcgaacact tgaaaacacc cgagcaaaat gtcgagcttg cctccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcggcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gcccaagaaa tcgccggctc ggcaaccgtg 720
aagataaggg aaaaggttca cgaaatcggc atcgccggca aacagtaa 768
<210>100
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>100
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val
225 230 235 240
Lys Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250 255
<210>101
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>101
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcecagcgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacttga aaacacccga gcaaaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtaa 765
<210>102
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>102
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>103
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>103
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctta atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacttga aaacacccga gcaaaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>104
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>104
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>105
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>105
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc ttaatacggg caaattgaag aacgacaagg tcagccgttt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaaatatac 300
aaacaggacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggtgg agaacatacc 420
gccttcaacc aactgcccag cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gatgctggcg gaaaactgac ctataccata gatttcgccg ccaaacaggg acacggcaaa 540
atcgaacact tgaaaacacc cgagcaaaat gtcgagcttg cctccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcggcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gcccaagaaa tcgccggctc ggcaaccgtg 720
aagataaggg aaaaggttca cgaaatcggc atcgccggca aacagtag 768
<210>106
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>106
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val
225 230 235 240
Lys Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250 255
<210>107
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>107
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctta atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacttga aaacacccga gcaaaatgtc gagcttgcct ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcggcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataagggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>108
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>108
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ser Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Gly Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Arg Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>109
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>109
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg agaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggcggaga acataccgcc 420
ttcaaccaac tgcctgacgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacctga aaacacccga gcaaaatgtc gagcttgccg ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcagcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataggggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>110
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>110
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>111
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>111
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggagaaaac ttatggaaac 180
ggcgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaaatatac 300
aaacaggacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggcgg agaacatacc 420
gccttcaacc aactgcctga cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gatgctggcg gaaaactgac ctataccata gatttcgccg ccaaacaggg acacggcaaa 540
atcgaacacc tgaaaacacc cgagcaaaat gtcgagcttg ccgccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcagcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gcccaagaaa tcgccggctc ggcaaccgtg 720
aagatagggg aaaaggttca cgaaatcggc atcgccggca aacagtag 768
<210>112
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>112
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val
225 230 235 240
Lys Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250 255
<210>113
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>113
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg agaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggcggaga acataccgcc 420
ttcaaccaac tgcctgacgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacctga aaacacccga gcaaaatgtc gagcttgccg ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcagcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataggggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>114
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>114
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>115
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>115
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggcggaga acataccgcc 420
ttcaaccaac tgcctgacgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacctga aaacacccga gcaaaatgtc gagcttgccg ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcagcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataggggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>116
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>116
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>117
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>117
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaaatatac 300
aaacaggacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggcgg agaacatacc 420
gccttcaacc aactgcctga cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gatgctggcg gaaaactgac ctataccata gatttcgccg ccaaacaggg acacggcaaa 540
atcgaacacc tgaaaacacc cgagcaaaat gtcgagcttg ccgccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcagcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gcccaagaaa tcgccggctc ggcaaccgtg 720
aagatagggg aaaaggttca cgaaatcggc atcgccggca aacagtag 768
<210>118
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>118
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val
225 230 235 240
Lys Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250 255
<210>119
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>119
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggcggaga acataccgcc 420
ttcaaccaac tgcctgacgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaa tc 540
gaacacctga aaacacccga gcaaaatgtc gagcttgccg ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcagcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataggggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>120
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>120
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>121
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>121
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggcggaga acataccgcc 420
ttcaaccaac tgcctgacgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacctga aaacacccga gcaaaatgtc gagcttgccg ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcagcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataggggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>122
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>122
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>123
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>123
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaaatatac 300
aaacaggacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggcgg agaacatacc 420
gccttcaacc aactgcctga cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gatgctggcg gaaaactgac ctataccata gatttcgccg ccaaacaggg acacggcaaa 540
atcgaacacc tgaaaacacc cgagcaaaat gtcgagcttg ccgccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcagcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gcccaagaaa tcgccggctc ggcaaccgtg 720
aagatagggg aaaaggttca cgaaatcggc atcgccggca aacagtag 768
<210>124
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>124
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val
225 230 235 240
Lys Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250 255
<210>125
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>125
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggcggaga acataccgcc 420
ttcaaccaac tgcctgacgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacctga aaacacccga gcaaaatgtc gagcttgccg ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcagcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataggggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>126
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>126
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>127
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>127
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggcggaga acataccgcc 420
ttcaaccaac tgcctgacgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacctga aaacacccga gcaaaatgtc gagcttgccg ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcagcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataggggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>128
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>128
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>129
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>129
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaaatatac 300
aaacaggacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggcgg agaacatacc 420
gccttcaacc aactgcctga cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gatgctggcg gaaaactgac ctataccata gatttcgccg ccaaacaggg acacggcaaa 540
atcgaacacc tgaaaacacc cgagcaaaat gtcgagcttg ccgccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcagcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gcccaagaaa tcgccggctc ggcaaccgtg 720
aagatagggg aaaaggttca cgaaatcggc atcgccggca aacagtag 768
<210>130
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>130
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val
225 230 235 240
Lys Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250 255
<210>131
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>131
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggcggaga acataccgcc 420
ttcaaccaac tgcctgacgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacctga aaacacccga gcaaaatgtc gagcttgccg ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcagcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataggggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>132
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>132
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>133
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>133
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggcggaga acataccgcc 420
ttcaaccaac tgcctgacgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacctga aaacacccga gcaaaatgtc gagcttgccg ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcagcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataggggaaa aggttcacga aatcggcatc gccggcaaac agtaa 765
<210>134
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>134
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>135
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>135
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaaatatac 300
aaacaggacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggcgg agaacatacc 420
gccttcaacc aactgcctga cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gatgctggcg gaaaactgac ctataccata gatttcgccg ccaaacaggg acacggcaaa 540
atcgaacacc tgaaaacacc cgagcaaaat gtcgagcttg ccgccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcagcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gcccaagaaa tcgccggctc ggcaaccgtg 720
aagatagggg aaaaggttca cgaaatcggc atcgccggca aacagtaa 768
<210>136
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>136
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val
225 230 235 240
Lys Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250 255
<210>137
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>137
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggcggaga acataccgcc 420
ttcaaccaac tgcctgacgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacctga aaacacccga gcaaaatgtc gagcttgccg ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcagcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataggggaaa aggttcacga aatcggcatc gccggcaaac agtaa 765
<210>138
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>138
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>139
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>139
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctta atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccacca aacagggaca cggcaaaatc 540
gaacacttga aaacacccga gcaaaatgtc gagcttgccg ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcagcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataggggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>140
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>140
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Thr Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>141
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>141
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc ttaatacggg caaattgaag aacgacaagg tcagccgttt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaaatatac 300
aaacaggacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggtgg agaacatacc 420
gccttcaacc aactgcccag cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gatgctggcg gaaaactgac ctataccata gatttcgcca ccaaacaggg acacggcaaa 540
atcgaacact tgaaaacacc cgagcaaaat gtcgagcttg ccgccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcagcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gcccaagaaa tcgccggctc ggcaaccgtg 720
aagatagggg aaaaggttca cgaaatcggc atcgccggca aacagtag 768
<210>142
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>142
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Thr Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val
225 230 235 240
Lys Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250 255
<210>143
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>143
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctta atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccacca aacagggaca cggcaaaatc 540
gaacacttga aaacacccga gcaaaatgtc gagcttgccg ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcagcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataggggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>144
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>144
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Thr Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>145
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>145
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctta atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccacca aacagggaca cggcaaaatc 540
gaacacttga aaacacccga gcaaaatgtc gagcttgccg ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcagcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataggggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>146
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>146
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Thr Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>147
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>147
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc ttaatacggg caaattgaag aacgacaagg tcagccgttt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaaatatac 300
aaacaggacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggtgg agaacatacc 420
gccttcaacc aactgcccag cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gatgctggcg gaaaactgac ctataccata gatttcgcca ccaaacaggg acacggcaaa 540
atcgaacact tgaaaacacc cgagcaaaat gtcgagcttg ccgccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcagcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gcccaagaaa tcgccggctc ggcaaccgtg 720
aagatagggg aaaaggttca cgaaatcggc atcgccggca aacagtag 768
<210>148
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>148
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Thr Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val
225 230 235 240
Lys Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250 255
<210>149
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>149
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctta atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccacca aacagggaca cggcaaaatc 540
gaacacttga aaacacccga gcaaaatgtc gagcttgccg ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcagcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataggggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>150
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>150
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Thr Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>151
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>151
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctta atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccacca aacagggaca cggcaaaatc 540
gaacacttga aaacacccga gcaaaatgtc gagcttgccg ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcagcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataggggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>152
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>152
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Thr Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>153
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>153
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc ttaatacggg caaattgaag aacgacaagg tcagccgttt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaaatatac 300
aaacaggacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggtgg agaacatacc 420
gccttcaacc aactgcccag cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gatgctggcg gaaaactgac ctataccata gatttcgcca ccaaacaggg acacggcaaa 540
atcgaacact tgaaaacacc cgagcaaaat gtcgagcttg ccgccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcagcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gcccaagaaa tcgccggctc ggcaaccgtg 720
aagatagggg aaaaggttca cgaaatcggc atcgccggca aacagtag 768
<210>154
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>154
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Thr Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val
225 230 235 240
Lys Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250 255
<210>155
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>155
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctta atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccagcgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccacca aacagggaca cggcaaaatc 540
gaacacttga aaacacccga gcaaaatgtc gagcttgccg ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcagcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataggggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>156
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>156
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Ser Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Thr Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>157
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>157
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgactataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctatag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccggcgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacctga aaacacccga gcaaaatgtc gagcttgccg ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcagcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgct caagaaatcg ccggctcggc aaccgtgaag 720
ataggggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>158
<211>253
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>158
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp Tyr Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Ile Glu Lys
100 105 110
Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser Phe
115 120 125
Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu Pro
130 135 140
Gly Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp Ala
145 150 155 160
Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly His
165 170 175
Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu Ala
180 185 190
Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu Gly
195 200 205
Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu Ala Leu
210 215 220
Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys Ile
225 230 235 240
Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>159
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>159
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacta taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaaatatac 300
aaacaggacc actccgccgt cgttgcccta tagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggtgg agaacatacc 420
gccttcaacc aactgcccgg cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gatgctggcg gaaaactgac ctataccata gatttcgccg ccaaacaggg acacggcaaa 540
atcgaacacc tgaaaacacc cgagcaaaat gtcgagcttg ccgccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcagcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gctcaagaaa tcgccggctc ggcaaccgtg 720
aagatagggg aaaaggttca cgaaatcggc atcgccggca aacagtag 768
<210>160
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>160
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp Tyr Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Gly Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>161
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>161
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgactataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctatag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggtggaga acataccgcc 420
ttcaaccaac tgcccggcgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacctga aaacacccga gcaaaatgtc gagcttgccg ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcagcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgct caagaaatcg ccggctcggc aaccgtgaag 720
ataggggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>162
<211>253
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>162
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp Tyr Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Ile Glu Lys
100 105 110
Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser Phe
115 120 125
Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu Pro
130 135 140
Gly Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp Ala
145 150 155 160
Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly His
165 170 175
Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu Ala
180 185 190
Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu Gly
195 200 205
Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu Ala Leu
210 215 220
Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys Ile
225 230 235 240
Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>163
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>163
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccgacg ctccttcctt gtcagcggtt tgggcggaga acataccgcc 420
ttcaaccaac tgcctgacgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacctga aaacacccga gcaaaatgtc gagcttgccg ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcagcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataggggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>164
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>164
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Arg Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>165
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>165
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaaatatac 300
aaacaggacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaaccg acgctccttc cttgtcagcg gtttgggcgg agaacatacc 420
gccttcaacc aactgcctga cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gatgctggcg gaaaactgac ctataccata gatttcgccg ccaaacaggg acacggcaaa 540
atcgaacacc tgaaaacacc cgagcaaaat gtcgagcttg ccgccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcagcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gcccaagaaa tcgccggctc ggcaaccgtg 720
aagatagggg aaaaggttca cgaaatcggc atcgccggca aacagtag 768
<210>166
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>166
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Arg Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val
225 230 235 240
Lys Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250 255
<210>167
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>167
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccgacg ctccttcctt gtcagcggtt tgggcggaga acataccgcc 420
ttcaaccaac tgcctgacgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacctga aaacacccga gcaaaatgtc gagcttgccg ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcagcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 720
ataggggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>168
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>168
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Arg Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Lys
225 230 235 240
Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>169
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>169
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggcggaga acataccgcc 420
ttcaaccaac tgcctgacgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacctga aaacacccga gcaaaatgtc gagcttgccg ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcagcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtggag 720
ataggggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>170
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>170
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Glu
225 230 235 240
Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>171
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>171
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaaatatac 300
aaacaggacc actccgccgt cgttgcccta cagattgaaa aaatcaacaa ccccgacaaa 360
atcgacagcc tgataaacca acgctccttc cttgtcagcg gtttgggcgg agaacatacc 420
gccttcaacc aactgcctga cggcaaagcc gagtatcacg gcaaagcatt cagctccgac 480
gatgctggcg gaaaactgac ctataccata gatttcgccg ccaaacaggg acacggcaaa 540
atcgaacacc tgaaaacacc cgagcaaaat gtcgagcttg ccgccgccga actcaaagca 600
gatgaaaaat cacacgccgt cattttgggc gacacgcgct acggcagcga agaaaaaggc 660
acttaccacc tcgccctttt cggcgaccgc gcccaagaaa tcgccggctc ggcaaccgtg 720
gagatagggg aaaaggttca cgaaatcggc atcgccggca aacagtag 768
<210>172
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>172
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile
100 105 110
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
115 120 125
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
130 135 140
Leu Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu
180 185 190
Leu Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile
195 200 205
Leu Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu
210 215 220
Ala Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val
225 230 235 240
Glu Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250 255
<210>173
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>173
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca aatatacaaa 300
caggaccact ccgccgtcgt tgccctacag attgaaaaaa tcaacaaccc cgacaaaatc 360
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggcggaga acataccgcc 420
ttcaaccaac tgcctgacgg caaagccgag tatcacggca aagcattcag ctccgacgat 480
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 540
gaacacctga aaacacccga gcaaaatgtc gagcttgccg ccgccgaact caaagcagat 600
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcagcgaaga aaaaggcact 660
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtggag 720
ataggggaaa aggttcacga aatcggcatc gccggcaaac agtag 765
<210>174
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>174
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Asp His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Asp Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly
165 170 175
His Gly Lys Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Ala Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Ser Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Phe Gly Asp Arg Ala Gln Glu Ile Ala Gly Ser Ala Thr Val Glu
225 230 235 240
Ile Gly Glu Lys Val His Glu Ile Gly Ile Ala Gly Lys Gln
245 250
<210>175
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>175
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggtgcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca agtgtacaaa 300
caaagccatt ccgccttaac cgcccttcag accgagcaag tacaagattc ggagcattca 360
gggaagatgg ttgcgaaacg ccagttcaga atcggcgata tagcgggtga acatacatct 420
tttgacaagc ttcccgaagg cggcagggcg acatatcgcg ggacggcatt cggttcagac 480
gatgccagtg gaaaactgac ctacaccata gatttcgccg ccaagcaggg acacggcaaa 540
atcgaacatt tgaaatcgcc agaactcaat gttgacctgg ccgcctccga tatcaagccg 600
gataaaaaac gccatgccgt catcagcggt tccgtccttt acaaccaagc cgagaaaggc 660
agttactctc taggcatctt tggcgggcaa gcccaggaag ttgccggcag cgcagaagtg 720
gaaaccgcaa acggcatacg ccatatcggt cttgccgcca agcagtaa 768
<210>176
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>176
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Val Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Leu Gln Thr Glu
100 105 110
Gln Val Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg Gln
115 120 125
Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Ser Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Asp
180 185 190
Leu Ala Ala Ser Asp Ile Lys Pro Asp Lys Lys Arg His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Gln Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Glu Thr Ala Asn Gly Ile Arg His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>177
<211>771
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>177
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggtgct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaagtgtac 300
aaacaaagcc attccgcctt aaccgccctt cagaccgagc aagtacaaga ttcggagcat 360
tcagggaaga tggttgcgaa acgccagttc agaatcggcg atatagcggg tgaacataca 420
tcttttgaca agcttcccga aggcggcagg gcgacatatc gcgggacggc attcggttca 480
gacgatgcca gtggaaaact gacctacacc atagatttcg ccgccaagca gggacacggc 540
aaaatcgaac atttgaaatc gccagaactc aatgttgacc tggccgcctc cgatatcaag 600
ccggataaaa aacgccatgc cgtcatcagc ggttccgtcc tttacaacca agccgagaaa 660
ggcagttact ctctaggcat ctttggcggg caagcccagg aagttgccgg cagcgcagaa 720
gtggaaaccg caaacggcat acgccatatc ggtcttgccg ccaagcagta a 771
<210>178
<211>256
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>178
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Val
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Leu Gln Thr
100 105 110
Glu Gln Val Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg
115 120 125
Gln Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys
130 135 140
Leu Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser
145 150 155 160
Asp Asp Ala Ser Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys
165 170 175
Gln Gly His Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val
180 185 190
Asp Leu Ala Ala Ser Asp Ile Lys Pro Asp Lys Lys Arg His Ala Val
195 200 205
Ile Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser
210 215 220
Leu Gly Ile Phe Gly Gly Gln Ala Gln Glu Val Ala Gly Ser Ala Glu
225 230 235 240
Val Glu Thr Ala Asn Gly Ile Arg His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>179
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>179
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggtgcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca agtgtacaaa 300
caaagccatt ccgccttaac cgcccttcag accgagcaag tacaagattc ggagcattca 360
gggaagatgg ttgcgaaacg ccagttcaga atcggcgata tagcgggtga acatacatct 420
tttgacaagc ttcccgaagg cggcagggcg acatatcgcg ggacggcatt cggttcagac 480
gatgccagtg gaaaactgac ctacaccata gatttcgccg ccaagcaggg acacggcaaa 540
atcgaacatt tgaaatcgcc agaactcaat gttgacctgg ccgcctccga tatcaagccg 600
gataaaaaac gccatgccgt catcagcggt tccgtccttt acaaccaagc cgagaaaggc 660
agttactctc taggcatctt tggcgggcaa gcccaggaag ttgccggcag cgcagaagtg 720
gaaaccgcaa acggcatacg ccatatcggt cttgccgcca agcagtaa 768
<210>180
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>180
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Val Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Leu Gln Thr Glu
100 105 110
Gln Val Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg Gln
115 120 125
Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Ser Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Asp
180 185 190
Leu Ala Ala Ser Asp Ile Lys Pro Asp Lys Lys Arg His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Gln Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Glu Thr Ala Asn Gly Ile Arg His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>181
<211>747
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>181
tgcagcagcg gagggggtgg tgtcgccgcc gacatcggtg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaggt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggt 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgc 240
caaatcgaag tggacgggca gctcattacc ttggagagtg gagagttcca agtatacaaa 300
caaagccatt ccgccttaac cgcctttcag accgagcaaa tacaagattc ggagcattcc 360
gggaagatgg ttgcgaaacg ccagttcaga atcggcgaca tagcgggcga acatacatct 420
tttgacaagc ttcccgaagg cggcagggcg acatatcgcg ggacggcgtt cggttcagac 480
gatgccggcg gaaaactgac ctacaccata gatttcgccg ccaagcaggg aaacggcaaa 540
atcgaacatt tgaaatcgcc agaactcaat gtcgacctgg ccgccgccga tatcaagccg 600
gatggaaaac gccatgccgt catcagcggt tccgtccttt acaaccaagc cgagaaaggc 660
agttactccc tcggtatctt tggcggaaaa gcccaggaag ttgccggcag cgcggaagtg 720
aaaaccgtaa acggcatacg ccatatc 747
<210>182
<211>249
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>182
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Phe Gln Thr Glu
100 105 110
Gln Ile Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg Gln
115 120 125
Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly Asn Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Asp
180 185 190
Leu Ala Ala Ala Asp Ile Lys Pro Asp Gly Lys Arg His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Lys Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Lys Thr Val Asn Gly Ile Arg His Ile
245
<210>183
<211>750
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>183
tgcggatcca gcggaggggg tggtgtcgcc gccgacatcg gtgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa ggtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggtgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgttt cgactttatc 240
cgccaaatcg aagtggacgg gcagctcatt accttggaga gtggagagtt ccaagtatac 300
aaacaaagcc attccgcctt aaccgccttt cagaccgagc aaatacaaga ttcggagcat 360
tccgggaaga tggttgcgaa acgccagttc agaatcggcg acatagcggg cgaacataca 420
tcttttgaca agcttcccga aggcggcagg gcgacatatc gcgggacggc gttcggttca 480
gacgatgccg gcggaaaact gacctacacc atagatttcg ccgccaagca gggaaacggc 540
aaaatcgaac atttgaaatc gccagaactc aatgtcgacc tggccgccgc cgatatcaag 600
ccggatggaa aacgccatgc cgtcatcagc ggttccgtcc tttacaacca agccgagaaa 660
ggcagttact ccctcggtat ctttggcgga aaagcccagg aagttgccgg cagcgcggaa 720
gtgaaaaccg taaacggcat acgccatatc 750
<210>184
<211>250
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>184
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Phe Gln Thr
100 105 110
Glu Gln Ile Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg
115 120 125
Gln Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys
130 135 140
Leu Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser
145 150 155 160
Asp Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys
165 170 175
Gln Gly Asn Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val
180 185 190
Asp Leu Ala Ala Ala Asp Ile Lys Pro Asp Gly Lys Arg His Ala Val
195 200 205
Ile Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser
210 215 220
Leu Gly Ile Phe Gly Gly Lys Ala Gln Glu Val Ala Gly Ser Ala Glu
225 230 235 240
Val Lys Thr Val Asn Gly Ile Arg His Ile
245 250
<210>185
<211>747
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>185
atgagcagcg gagggggtgg tgtcgccgcc gacatcggtg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaggt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggt 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgc 240
caaatcgaag tggacgggca gctcattacc ttggagagtg gagagttcca agtatacaaa 300
caaagccatt ccgccttaac cgcctttcag accgagcaaa tacaagattc ggagcattcc 360
gggaagatgg ttgcgaaacg ccagttcaga atcggcgaca tagcgggcga acatacatct 420
tttgacaagc ttcccgaagg cggcagggcg acatatcgcg ggacggcgtt cggttcagac 480
gatgccggcg gaaaactgac ctacaccata gatttcgccg ccaagcaggg aaacggcaaa 540
atcgaacatt tgaaatcgcc agaactcaat gtcgacctgg ccgccgccga tatcaagccg 600
gatggaaaac gccatgccgt catcagcggt tccgtccttt acaaccaagc cgagaaaggc 660
agttactccc tcggtatctt tggcggaaaa gcccaggaag ttgccggcag cgcggaagtg 720
aaaaccgtaa acggcatacg ccatatc 747
<210>186
<211>249
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>186
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Phe Gln Thr Glu
100 105 110
Gln Ile Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg Gln
115 120 125
Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly Asn Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Asp
180 185 190
Leu Ala Ala Ala Asp Ile Lys Pro Asp Gly Lys Arg His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Lys Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Lys Thr Val Asn Gly Ile Arg His Ile
245
<210>187
<211>747
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>187
tgcagcagcg gagggggtgg tgtcgccgcc gacatcggtg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaggt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggt 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgc 240
caaatcgaag tggacgggca gctcattacc ttggagagtg gagagttcca agtatacaaa 300
caaagccatt ccgccttaac cgcctttcag accgagcaaa tacaagattc ggagcattcc 360
gggaagatgg ttgcgaaacg ccagttcaga atcggcgaca tagcgggcga acatacatct 420
tttgacaagc ttcccgaagg cggcagggcg acatatcgcg ggacggcgtt cggttcagac 480
gatgccggcg gaaaactgac ctacaccata gatttcgccg ccaagcaggg aaacggcaaa 540
atcgaacatt tgaaatcgcc agaactcaat gtcgacctgg ccgccgccga tatcaagccg 600
gatggaaaac gccatgccgt catcagcggt tccgtccttt acaaccaagc cgagaaaggc 660
agttactccc tcggtatctt tggcggaaaa gcccaggaag ttgccggcag cgcggaagtg 720
aaaaccgtaa acggcatacg ccatatc 747
<210>188
<211>249
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>188
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Phe Gln Thr Glu
100 105 110
Gln Ile Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg Gln
115 120 125
Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly Asn Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Asp
180 185 190
Leu Ala Ala Ala Asp Ile Lys Pro Asp Gly Lys Arg His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Lys Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Lys Thr Val Asn Gly Ile Arg His Ile
245
<210>189
<211>750
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>189
tgcggatcca gcggaggggg tggtgtcgcc gccgacatcg gtgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa ggtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggtgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgttt cgactttatc 240
cgccaaatcg aagtggacgg gcagctcatt accttggaga gtggagagtt ccaagtatac 300
aaacaaagcc attccgcctt aaccgccttt cagaccgagc aaatacaaga ttcggagcat 360
tccgggaaga tggttgcgaa acgccagttc agaatcggcg acatagcggg cgaacataca 420
tcttttgaca agcttcccga aggcggcagg gcgacatatc gcgggacggc gttcggttca 480
gacgatgccg gcggaaaact gacctacacc atagatttcg ccgccaagca gggaaacggc 540
aaaatcgaac atttgaaatc gccagaactc aatgtcgacc tggccgccgc cgatatcaag 600
ccggatggaa aacgccatgc cgtcatcagc ggttccgtcc tttacaacca agccgagaaa 660
ggcagttact ccctcggtat ctttggcgga aaagcccagg aagttgccgg cagcgcggaa 720
gtgaaaaccg taaacggcat acgccatatc 750
<210>190
<211>250
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>190
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Phe Gln Thr
100 105 110
Glu Gln Ile Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg
115 120 125
Gln Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys
130 135 140
Leu Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser
145 150 155 160
Asp Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys
165 170 175
Gln Gly Asn Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val
180 185 190
Asp Leu Ala Ala Ala Asp Ile Lys Pro Asp Gly Lys Arg His Ala Val
195 200 205
Ile Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser
210 215 220
Leu Gly Ile Phe Gly Gly Lys Ala Gln Glu Val Ala Gly Ser Ala Glu
225 230 235 240
Val Lys Thr Val Asn Gly Ile Arg His Ile
245 250
<210>191
<211>747
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>191
atgagcagcg gagggggtgg tgtcgccgcc gacatcggtg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaggt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggt 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgc 240
caaatcgaag tggacgggca gctcattacc ttggagagtg gagagttcca agtatacaaa 300
caaagccatt ccgccttaac cgcctttcag accgagcaaa tacaagattc ggagcattcc 360
gggaagatgg ttgcgaaacg ccagttcaga atcggcgaca tagcgggcga acatacatct 420
tttgacaagc ttcccgaagg cggcagggcg acatatcgcg ggacggcgtt cggttcagac 480
gatgccggcg gaaaactgac ctacaccata gatttcgccg ccaagcaggg aaacggcaaa 540
atcgaacatt tgaaatcgcc agaactcaat gtcgacctgg ccgccgccga tatcaagccg 600
gatggaaaac gccatgccgt catcagcggt tccgtccttt acaaccaagc cgagaaaggc 660
agttactccc tcggtatctt tggcggaaaa gcccaggaag ttgccggcag cgcggaagtg 720
aaaaccgtaa acggcatacg ccatatc 747
<210>192
<211>249
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>192
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Phe Gln Thr Glu
100 105 110
Gln Ile Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg Gln
115 120 125
Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly Asn Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Asp
180 185 190
Leu Ala Ala Ala Asp Ile Lys Pro Asp Gly Lys Arg His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Lys Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Lys Thr Val Asn Gly Ile Arg His Ile
245
<210>193
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>193
tgcagcagcg gagggggtgg tgtcgccgcc gacatcggtg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaggt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggt 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgc 240
caaatcgaag tggacgggca gctcattacc ttggagagtg gagagttcca agtatacaaa 300
caaagccatt ccgccttaac cgcctttcag accgagcaaa tacaagattc ggagcattcc 360
gggaagatgg ttgcgaaacg ccagttcaga atcggcgaca tagcgggcga acatacatct 420
tttgacaagc ttcccgaagg cggcagggcg acatatcgcg ggacggcgtt cggttcagac 480
gatgccggcg gaaaactgac ctacaccata gatttcgccg ccaagcaggg aaacggcaaa 540
atcgaacatt tgaaatcgcc agaactcaat gtcgacctgg ccgccgccga tatcaagccg 600
gatggaaaac gccatgccgt catcagcggt tccgtccttt acaaccaagc cgagaaaggc 660
agttactccc tcggtatctt tggcggaaaa gcccaggaag ttgccggcag cgcggaagtg 720
aaaaccgtaa acggcatacg ccatatcggc cttgccgcca agcaataa 768
<210>194
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>194
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Phe Gln Thr Glu
100 105 110
Gln Ile Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg Gln
115 120 125
Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly Asn Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Asp
180 185 190
Leu Ala Ala Ala Asp Ile Lys Pro Asp Gly Lys Arg His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Lys Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Lys Thr Val Asn Gly Ile Arg His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>195
<211>771
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>195
tgcggatcca gcggaggggg tggtgtcgcc gccgacatcg gtgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa ggtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggtgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgttt cgactttatc 240
cgccaaatcg aagtggacgg gcagctcatt accttggaga gtggagagtt ccaagtatac 300
aaacaaagcc attccgcctt aaccgccttt cagaccgagc aaatacaaga ttcggagcat 360
tccgggaaga tggttgcgaa acgccagttc agaatcggcg acatagcggg cgaacataca 420
tcttttgaca agcttcccga aggcggcagg gcgacatatc gcgggacggc gttcggttca 480
gacgatgccg gcggaaaact gacctacacc atagatttcg ccgccaagca gggaaacggc 540
aaaatcgaac atttgaaatc gccagaactc aatgtcgacc tggccgccgc cgatatcaag 600
ccggatggaa aacgccatgc cgtcatcagc ggttccgtcc tttacaacca agccgagaaa 660
ggcagttact ccctcggtat ctttggcgga aaagcccagg aagttgccgg cagcgcggaa 720
gtgaaaaccg taaacggcat acgccatatc ggccttgccg ccaagcaata a 771
<210>196
<211>256
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>196
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Phe Gln Thr
100 105 110
Glu Gln Ile Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg
115 120 125
Gln Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys
130 135 140
Leu Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser
145 150 155 160
Asp Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys
165 170 175
Gln Gly Asn Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val
180 185 190
Asp Leu Ala Ala Ala Asp Ile Lys Pro Asp Gly Lys Arg His Ala Val
195 200 205
Ile Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser
210 215 220
Leu Gly Ile Phe Gly Gly Lys Ala Gln Glu Val Ala Gly Ser Ala Glu
225 230 235 240
Val Lys Thr Val Asn Gly Ile Arg His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>197
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>197
atgagcagcg gagggggtgg tgtcgccgcc gacatcggtg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaggt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggt 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgc 240
caaatcgaag tggacgggca gctcattacc ttggagagtg gagagttcca agtatacaaa 300
caaagccatt ccgccttaac cgcctttcag accgagcaaa tacaagattc ggagcattcc 360
gggaagatgg ttgcgaaacg ccagttcaga atcggcgaca tagcgggcga acatacatct 420
tttgacaagc ttcccgaagg cggcagggcg acatatcgcg ggacggcgtt cggttcagac 480
gatgccggcg gaaaactgac ctacaccata gatttcgccg ccaagcaggg aaacggcaaa 540
atcgaacatt tgaaatcgcc agaactcaat gtcgacctgg ccgccgccga tatcaagccg 600
gatggaaaac gccatgccgt catcagcggt tccgtccttt acaaccaagc cgagaaaggc 660
agttactccc tcggtatctt tggcggaaaa gcccaggaag ttgccggcag cgcggaagtg 720
aaaaccgtaa acggcatacg ccatatcggc cttgccgcca agcaataa 768
<210>198
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>198
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Phe Gln Thr Glu
100 105 110
Gln Ile Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg Gln
115 120 125
Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly Asn Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Asp
180 185 190
Leu Ala Ala Ala Asp Ile Lys Pro Asp Gly Lys Arg His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Lys Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Lys Thr Val Asn Gly Ile Arg His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>199
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>199
tgcagcagcg gagggggtgg tgtcgccgcc gacatcggtg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaggt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggt 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgc 240
caaatcgaag tggacgggca gctcattacc ttggagagtg gagagttcca agtatacaaa 300
caaagccatt ccgccttaac cgcctttcag accgagcaaa tacaagattc ggagcattcc 360
gggaagatgg ttgcgaaacg ccagttcaga atcggcgaca tagcgggcga acatacatct 420
tttgacaagc ttcccgaagg cggcagggcg acatatcgcg ggacggcgtt cggttcagac 480
gatgccggcg gaaaactgac ctacaccata gatttcgccg ccaagcaggg aaacggcaaa 540
atcgaacatt tgaaatcgcc agaactcaat gtcgacctgg ccgccgccga tatcaagccg 600
gatggaaaac gccatgccgt catcagcggt tccgtccttt acaaccaagc cgagaaaggc 660
agttactccc tcggtatctt tggcggaaaa gcccaggaag ttgccggcag cgcggaagtg 720
aaaaccgtaa acggcatacg ccatatcggc cttgccgcca agcaataa 768
<210>200
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>200
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Phe Gln Thr Glu
100 105 110
Gln Ile Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg Gln
115 120 125
Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly Asn Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Asp
180 185 190
Leu Ala Ala Ala Asp Ile Lys Pro Asp Gly Lys Arg His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Lys Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Lys Thr Val Asn Gly Ile Arg His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>201
<211>771
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>201
tgcggatcca gcggaggggg tggtgtcgcc gccgacatcg gtgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa ggtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggtgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgttt cgactttatc 240
cgccaaatcg aagtggacgg gcagctcatt accttggaga gtggagagtt ccaagtatac 300
aaacaaagcc attccgcctt aaccgccttt cagaccgagc aaatacaaga ttcggagcat 360
tccgggaaga tggttgcgaa acgccagttc agaatcggcg acatagcggg cgaacataca 420
tcttttgaca agcttcccga aggcggcagg gcgacatatc gcgggacggc gttcggttca 480
gacgatgccg gcggaaaact gacctacacc atagatttcg ccgccaagca gggaaacggc 540
aaaatcgaac atttgaaatc gccagaactc aatgtcgacc tggccgccgc cgatatcaag 600
ccggatggaa aacgccatgc cgtcatcagc ggttccgtcc tttacaacca agccgagaaa 660
ggcagttact ccctcggtat ctttggcgga aaagcccagg aagttgccgg cagcgcggaa 720
gtgaaaaccg taaacggcat acgccatatc ggccttgccg ccaagcaata a 771
<210>202
<211>256
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>202
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Phe Gln Thr
100 105 110
Glu Gln Ile Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg
115 120 125
Gln Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys
130 135 140
Leu Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser
145 150 155 160
Asp Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys
165 170 175
Gln Gly Asn Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val
180 185 190
Asp Leu Ala Ala Ala Asp Ile Lys Pro Asp Gly Lys Arg His Ala Val
195 200 205
Ile Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser
210 215 220
Leu Gly Ile Phe Gly Gly Lys Ala Gln Glu Val Ala Gly Ser Ala Glu
225 230 235 240
Val Lys Thr Val Asn Gly Ile Arg His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>203
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>203
atgagcagcg gagggggtgg tgtcgccgcc gacatcggtg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaggt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggt 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgc 240
caaatcgaag tggacgggca gctcattacc ttggagagtg gagagttcca agtatacaaa 300
caaagccatt ccgccttaac cgcctttcag accgagcaaa tacaagattc ggagcattcc 360
gggaagatgg ttgcgaaacg ccagttcaga atcggcgaca tagcgggcga acatacatct 420
tttgacaagc ttcccgaagg cggcagggcg acatatcgcg ggacggcgtt cggttcagac 480
gatgccggcg gaaaactgac ctacaccata gatttcgccg ccaagcaggg aaacggcaaa 540
atcgaacatt tgaaatcgcc agaactcaat gtcgacctgg ccgccgccga tatcaagccg 600
gatggaaaac gccatgccgt catcagcggt tccgtccttt acaaccaagc cgagaaaggc 660
agttactccc tcggtatctt tggcggaaaa gcccaggaag ttgccggcag cgcggaagtg 720
aaaaccgtaa acggcatacg ccatatcggc cttgccgcca agcaataa 768
<210>204
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>204
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Phe Gln Thr Glu
100 105 110
Gln Ile Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg Gln
115 120 125
Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly Asn Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Asp
180 185 190
Leu Ala Ala Ala Asp Ile Lys Pro Asp Gly Lys Arg His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Lys Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Lys Thr Val Asn Gly Ile Arg His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>205
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>205
tgcagcagcg gagggggtgg tgtcgccgcc gacatcggtg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaggt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggt 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgc 240
caaatcgaag tggacgggca gctcattacc ttggagagtg gagagttcca agtatacaaa 300
caaagccatt ccgccttaac cgcctttcag accgagcaaa tacaagattc ggagcattcc 360
gggaagatgg ttgcgaaacg ccagttcaga atcggcgaca tagcgggcga acatacatct 420
tttgacaagc ttcccgaagg cggcagggcg acatatcgcg ggacggcgtt cggttcagac 480
gatgccggcg gaaaactgac ctacaccata gatttcgccg ccaagcaggg aaacggcaaa 540
atcgaacatt tgaaatcgcc agaactcaat gtcgacctgg ccgccgccga tatcaagccg 600
gatggaaaac gccatgccgt catcagcggt tccgtccttt acaaccaagc cgagaaaggc 660
agttactccc tcggtatctt tggcggaaaa gcccaggaag ttgccggcag cgcggaagtg 720
aaaaccgtaa acggcatacg ccatatcggc cttgccgcca agcaataa 768
<210>206
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>206
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Phe Gln Thr Glu
100 105 110
Gln Ile Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg Gln
115 120 125
Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly Asn Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Asp
180 185 190
Leu Ala Ala Ala Asp Ile Lys Pro Asp Gly Lys Arg His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Lys Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Lys Thr Val Asn Gly Ile Arg His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>207
<211>771
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>207
tgcggatcca gcggaggggg tggtgtcgcc gccgacatcg gtgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa ggtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggtgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgttt cgactttatc 240
cgccaaatcg aagtggacgg gcagctcatt accttggaga gtggagagtt ccaagtatac 300
aaacaaagcc attccgcctt aaccgccttt cagaccgagc aaatacaaga ttcggagcat 360
tccgggaaga tggttgcgaa acgccagttc agaatcggcg acatagcggg cgaacataca 420
tcttttgaca agcttcccga aggcggcagg gcgacatatc gcgggacggc gttcggttca 480
gacgatgccg gcggaaaact gacctacacc atagatttcg ccgccaagca gggaaacggc 540
aaaatcgaac atttgaaatc gccagaactc aatgtcgacc tggccgccgc cgatatcaag 600
ccggatggaa aacgccatgc cgtcatcagc ggttccgtcc tttacaacca agccgagaaa 660
ggcagttact ccctcggtat ctttggcgga aaagcccagg aagttgccgg cagcgcggaa 720
gtgaaaaccg taaacggcat acgccatatc ggccttgccg ccaagcaata a 771
<210>208
<211>256
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>208
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Phe Gln Thr
100 105 110
Glu Gln Ile Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg
115 120 125
Gln Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys
130 135 140
Leu Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser
145 150 155 160
Asp Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys
165 170 175
Gln Gly Asn Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val
180 185 190
Asp Leu Ala Ala Ala Asp Ile Lys Pro Asp Gly Lys Arg His Ala Val
195 200 205
Ile Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser
210 215 220
Leu Gly Ile Phe Gly Gly Lys Ala Gln Glu Val Ala Gly Ser Ala Glu
225 230 235 240
Val Lys Thr Val Asn Gly Ile Arg His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>209
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>209
atgagcagcg gagggggtgg tgtcgccgcc gacatcggtg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaggt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggt 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgc 240
caaatcgaag tggacgggca gctcattacc ttggagagtg gagagttcca agtatacaaa 300
caaagccatt ccgccttaac cgcctttcag accgagcaaa tacaagattc ggagcattcc 360
gggaagatgg ttgcgaaacg ccagttcaga atcggcgaca tagcgggcga acatacatct 420
tttgacaagc ttcccgaagg cggcagggcg acatatcgcg ggacggcgtt cggttcagac 480
gatgccggcg gaaaactgac ctacaccata gatttcgccg ccaagcaggg aaacggcaaa 540
atcgaacatt tgaaatcgcc agaactcaat gtcgacctgg ccgccgccga tatcaagccg 600
gatggaaaac gccatgccgt catcagcggt tccgtccttt acaaccaagc cgagaaaggc 660
agttactccc tcggtatctt tggcggaaaa gcccaggaag ttgccggcag cgcggaagtg 720
aaaaccgtaa acggcatacg ccatatcggc cttgccgcca agcaataa 768
<210>210
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>210
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Phe Gln Thr Glu
100 105 110
Gln Ile Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg Gln
115 120 125
Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly Asn Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Asp
180 185 190
Leu Ala Ala Ala Asp Ile Lys Pro Asp Gly Lys Arg His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Lys Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Lys Thr Val Asn Gly Ile Arg His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>211
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>211
tgcagcagcg gagggggtgg tgtcgccgcc gacatcggtg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaggt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggt 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgc 240
caaatcgaag tggacgggca gctcattacc ttggagagtg gagagttcca agtatacaaa 300
caaagccatt ccgccttaac cgcctttcag accgagcaaa tacaagattc ggagcattcc 360
gggaagatgg ttgcgaaacg ccagttcaga atcggcgaca tagcgggcga acatacatct 420
tttgacaagc ttcccgaagg cggcagggcg acatatcgcg ggacggcgtt cggttcagac 480
gatgccggcg gaaaactgac ctacaccata gatttcgccg ccaagcaggg aaacggcaaa 540
atcgaacatt tgaaatcgcc agaactcaat gtcgacctgg ccgccgccga tatcaagccg 600
gatggaaaac gccatgccgt catcagcggt tccgtccttt acaaccaagc cgagaaaggc 660
agttactccc tcggtatctt tggcggaaaa gcccaggaag ttgccggcag cgcggaagtg 720
aaaaccgtaa acggcatacg ccatatcggt cttgccgcca agcagtaa 768
<210>212
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>212
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Phe Gln Thr Glu
100 105 110
Gln Ile Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg Gln
115 120 125
Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly Asn Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Asp
180 185 190
Leu Ala Ala Ala Asp Ile Lys Pro Asp Gly Lys Arg His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Lys Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Lys Thr Val Asn Gly Ile Arg His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>213
<211>771
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>213
tgcggatcca gcggaggggg tggtgtcgcc gccgacatcg gtgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa ggtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggtgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgttt cgactttatc 240
cgccaaatcg aagtggacgg gcagctcatt accttggaga gtggagagtt ccaagtatac 300
aaacaaagcc attccgcctt aaccgccttt cagaccgagc aaatacaaga ttcggagcat 360
tccgggaaga tggttgcgaa acgccagttc agaatcggcg acatagcggg cgaacataca 420
tcttttgaca agcttcccga aggcggcagg gcgacatatc gcgggacggc gttcggttca 480
gacgatgccg gcggaaaact gacctacacc atagatttcg ccgccaagca gggaaacggc 540
aaaatcgaac atttgaaatc gccagaactc aatgtcgacc tggccgccgc cgatatcaag 600
ccggatggaa aacgccatgc cgtcatcagc ggttccgtcc tttacaacca agccgagaaa 660
ggcagttact ccctcggtat ctttggcgga aaagcccagg aagttgccgg cagcgcggaa 720
gtgaaaaccg taaacggcat acgccatatc ggtcttgccg ccaagcagta a 771
<210>214
<211>256
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>214
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Phe Gln Thr
100 105 110
Glu Gln Ile Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg
115 120 125
Gln Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys
130 135 140
Leu Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser
145 150 155 160
Asp Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys
165 170 175
Gln Gly Asn Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val
180 185 190
Asp Leu Ala Ala Ala Asp Ile Lys Pro Asp Gly Lys Arg His Ala Val
195 200 205
Ile Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser
210 215 220
Leu Gly Ile Phe Gly Gly Lys Ala Gln Glu Val Ala Gly Ser Ala Glu
225 230 235 240
Val Lys Thr Val Asn Gly Ile Arg His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>215
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>215
atgagcagcg gagggggtgg tgtcgccgcc gacatcggtg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaggt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggt 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgc 240
caaatcgaag tggacgggca gctcattacc ttggagagtg gagagttcca agtatacaaa 300
caaagccatt ccgccttaac cgcctttcag accgagcaaa tacaagattc ggagcattcc 360
gggaagatgg ttgcgaaacg ccagttcaga atcggcgaca tagcgggcga acatacatct 420
tttgacaagc ttcccgaagg cggcagggcg acatatcgcg ggacggcgtt cggttcagac 480
gatgccggcg gaaaactgac ctacaccata gatttcgccg ccaagcaggg aaacggcaaa 540
atcgaacatt tgaaatcgcc agaactcaat gtcgacctgg ccgccgccga tatcaagccg 600
gatggaaaac gccatgccgt catcagcggt tccgtccttt acaaccaagc cgagaaaggc 660
agttactccc tcggtatctt tggcggaaaa gcccaggaag ttgccggcag cgcggaagtg 720
aaaaccgtaa acggcatacg ccatatcggt cttgccgcca agcagtaa 768
<210>216
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>216
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Phe Gln Thr Glu
100 105 110
Gln Ile Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg Gln
115 120 125
Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly Asn Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Asp
180 185 190
Leu Ala Ala Ala Asp Ile Lys Pro Asp Gly Lys Arg His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Lys Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Lys Thr Val Asn Gly Ile Arg His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>217
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>217
tgcagcagcg gagggggcgg tgtcgccgcc gacatcggtg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaggt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacaggca gctcattacc ttggagagcg gagagttcca agtgtacaaa 300
caaagccatt ccgccttaac cgcccttcag accgagcaag tacaagactc ggagcattcc 360
gggaagatgg ttgcgaaacg tcagttcaga atcggcgaca tagcgggtga acatacatct 420
tttgacaagc ttcccgaagg cggcagggcg acatatcgcg ggacggcgtt cggttcagac 480
gatgccggcg gaaaactgat ttacaccata gatttcgccg ctaagcaggg acacggtaaa 540
atcgaacatt tgaaatcgcc agaactcaat gtcgacctgg ccgccgccga tatcaagccg 600
gatgaaaaac accatgccgt catcagcggt tccgtccttt acaaccaagc cgagaaaggc 660
agttactccc tcggtatctt tggcggaaaa gcccaggaag ttgccggcag cgcggaagtg 720
aaaaccgtaa acggtatacg ccatatcggc cttgccgcca agcaataa 768
<210>218
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>218
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Arg Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Leu Gln Thr Glu
100 105 110
Gln Val Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg Gln
115 120 125
Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Ile Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Asp
180 185 190
Leu Ala Ala Ala Asp Ile Lys Pro Asp Glu Lys His His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Lys Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Lys Thr Val Asn Gly Ile Arg His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>219
<211>771
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>219
tgcggatcca gcggaggggg cggtgtcgcc gccgacatcg gtgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa ggtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc tcaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg aagtggacag gcagctcatt accttggaga gcggagagtt ccaagtgtac 300
aaacaaagcc attccgcctt aaccgccctt cagaccgagc aagtacaaga ctcggagcat 360
tccgggaaga tggttgcgaa acgtcagttc agaatcggcg acatagcggg tgaacataca 420
tcttttgaca agcttcccga aggcggcagg gcgacatatc gcgggacggc gttcggttca 480
gacgatgccg gcggaaaact gatttacacc atagatttcg ccgctaagca gggacacggt 540
aaaatcgaac atttgaaatc gccagaactc aatgtcgacc tggccgccgc cgatatcaag 600
ccggatgaaa aacaccatgc cgtcatcagc ggttccgtcc tttacaacca agccgagaaa 660
ggcagttact ccctcggtat ctttggcgga aaagcccagg aagttgccgg cagcgcggaa 720
gtgaaaaccg taaacggtat acgccatatc ggccttgccg ccaagcaata a 771
<210>220
<211>256
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>220
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Arg Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Leu Gln Thr
100 105 110
Glu Gln Val Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg
115 120 125
Gln Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys
130 135 140
Leu Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser
145 150 155 160
Asp Asp Ala Gly Gly Lys Leu Ile Tyr Thr Ile Asp Phe Ala Ala Lys
165 170 175
Gln Gly His Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val
180 185 190
Asp Leu Ala Ala Ala Asp Ile Lys Pro Asp Glu Lys His His Ala Val
195 200 205
Ile Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser
210 215 220
Leu Gly Ile Phe Gly Gly Lys Ala Gln Glu Val Ala Gly Ser Ala Glu
225 230 235 240
Val Lys Thr Val Asn Gly Ile Arg His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>221
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>221
atgagcagcg gagggggcgg tgtcgccgcc gacatcggtg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaggt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctca atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacaggca gctcattacc ttggagagcg gagagttcca agtgtacaaa 300
caaagccatt ccgccttaac cgcccttcag accgagcaag tacaagactc ggagcattcc 360
gggaagatgg ttgcgaaacg tcagttcaga atcggcgaca tagcgggtga acatacatct 420
tttgacaagc ttcccgaagg cggcagggcg acatatcgcg ggacggcgtt cggttcagac 480
gatgccggcg gaaaactgat ttacaccata gatttcgccg ctaagcaggg acacggtaaa 540
atcgaacatt tgaaatcgcc agaactcaat gtcgacctgg ccgccgccga tatcaagccg 600
gatgaaaaac accatgccgt catcagcggt tccgtccttt acaaccaagc cgagaaaggc 660
agttactccc tcggtatctt tggcggaaaa gcccaggaag ttgccggcag cgcggaagtg 720
aaaaccgtaa acggtatacg ccatatcggc cttgccgcca agcaataa 768
<210>222
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>222
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Arg Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Leu Gln Thr Glu
100 105 110
Gln Val Gln Asp Ser Glu His Ser Gly Lys Met Val Ala Lys Arg Gln
115 120 125
Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Glu Gly Gly Arg Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Ile Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Asp
180 185 190
Leu Ala Ala Ala Asp Ile Lys Pro Asp Glu Lys His His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Ala Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Lys Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Lys Thr Val Asn Gly Ile Arg His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>223
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>223
tgcagcagcg gagggggcgg tgtcgccgcc gacatcggtg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaggt ttgcagtctt taacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctta atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggaa gctcattacc ttggagagcg gagagttcca agtgtacaaa 300
caaagccatt ccgccttaac cgcccttcag accgagcaag tacaagactc ggaggattcc 360
gggaagatgg ttgcgaaacg ccagttcaga atcggcgaca tagcgggcga acatacatct 420
tttgacaagc ttcccaaagg cggcagtgcg acatatcgcg ggacggcgtt cggttcagac 480
gatgctggcg gaaaactgac ctatactata gatttcgccg ccaagcaggg acacggcaaa 540
atcgaacatt tgaaatcgcc cgaactcaat gtcgagcttg ccaccgccta tatcaagccg 600
gatgaaaaac gccatgccgt tatcagcggt tccgtccttt acaaccaaga cgagaaaggc 660
agttactccc tcggtatctt tggcgggcaa gcccaggaag ttgccggcag cgcggaagtg 720
gaaaccgcaa acggcataca ccatatcggt cttgccgcca agcagtaa 768
<210>224
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>224
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Lys Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Leu Gln Thr Glu
100 105 110
Gln Val Gln Asp Ser Glu Asp Ser Gly Lys Met Val Ala Lys Arg Gln
115 120 125
Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Lys Gly Gly Ser Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Glu
180 185 190
Leu Ala Thr Ala Tyr Ile Lys Pro Asp Glu Lys Arg His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Asp Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Gln Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Glu Thr Ala Asn Gly Ile His His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>225
<211>771
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>225
tgcggatcca gcggaggggg cggtgtcgcc gccgacatcg gtgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa ggtttgcagt ctttaacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc ttaatacggg caaattgaag aacgacaagg tcagccgctt cgactttatc 240
cgtcaaatcg aagtggacgg gaagctcatt accttggaga gcggagagtt ccaagtgtac 300
aaacaaagcc attccgcctt aaccgccctt cagaccgagc aagtacaaga ctcggaggat 360
tccgggaaga tggttgcgaa acgccagttc agaatcggcg acatagcggg cgaacataca 420
tcttttgaca agcttcccaa aggcggcagt gcgacatatc gcgggacggc gttcggttca 480
gacgatgctg gcggaaaact gacctatact atagatttcg ccgccaagca gggacacggc 540
aaaatcgaac atttgaaatc gcccgaactc aatgtcgagc ttgccaccgc ctatatcaag 600
ccggatgaaa aacgccatgc cgttatcagc ggttccgtcc tttacaacca agacgagaaa 660
ggcagttact ccctcggtat ctttggcggg caagcccagg aagttgccgg cagcgcggaa 720
gtggaaaccg caaacggcat acaccatatc ggtcttgccg ccaagcagta a 771
<210>226
<211>256
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>226
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Lys Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Leu Gln Thr
100 105 110
Glu Gln Val Gln Asp Ser Glu Asp Ser Gly Lys Met Val Ala Lys Arg
115 120 125
Gln Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys
130 135 140
Leu Pro Lys Gly Gly Ser Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser
145 150 155 160
Asp Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys
165 170 175
Gln Gly His Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val
180 185 190
Glu Leu Ala Thr Ala Tyr Ile Lys Pro Asp Glu Lys Arg His Ala Val
195 200 205
Ile Ser Gly Ser Val Leu Tyr Asn Gln Asp Glu Lys Gly Ser Tyr Ser
210 215 220
Leu Gly Ile Phe Gly Gly Gln Ala Gln Glu Val Ala Gly Ser Ala Glu
225 230 235 240
Val Glu Thr Ala Asn Gly Ile His His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>227
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>227
atgagcagcg gagggggcgg tgtcgccgcc gacatcggtg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaggt ttgcagtctt taacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctta atacgggcaa attgaagaac gacaaggtca gccgcttcga ctttatccgt 240
caaatcgaag tggacgggaa gctcattacc ttggagagcg gagagttcca agtgtacaaa 300
caaagccatt ccgccttaac cgcccttcag accgagcaag tacaagactc ggaggattcc 360
gggaagatgg ttgcgaaacg ccagttcaga atcggcgaca tagcgggcga acatacatct 420
tttgacaagc ttcccaaagg cggcagtgcg acatatcgcg ggacggcgtt cggttcagac 480
gatgctggcg gaaaactgac ctatactata gatttcgccg ccaagcaggg acacggcaaa 540
atcgaacatt tgaaatcgcc cgaactcaat gtcgagcttg ccaccgccta tatcaagccg 600
gatgaaaaac gccatgccgt tatcagcggt tccgtccttt acaaccaaga cgagaaaggc 660
agttactccc tcggtatctt tggcgggcaa gcccaggaag ttgccggcag cgcggaagtg 720
gaaaccgcaa acggcataca ccatatcggt cttgccgcca agcagtaa 768
<210>228
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>228
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Gly Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Lys Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Leu Gln Thr Glu
100 105 110
Gln Val Gln Asp Ser Glu Asp Ser Gly Lys Met Val Ala Lys Arg Gln
115 120 125
Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Lys Gly Gly Ser Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Glu
180 185 190
Leu Ala Thr Ala Tyr Ile Lys Pro Asp Glu Lys Arg His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Asp Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Gln Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Glu Thr Ala Asn Gly Ile His His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>229
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>229
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctta atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca agtgtacaaa 300
caaagccatt ccgccttaac cgcccttcag accgagcaag aacaagatcc agagcattcc 360
gggaagatgg ttgcgaaacg ccggttcaaa atcggcgaca tagcgggcga acatacatct 420
tttgacaagc ttcccaaaga cgtcatggcg acatatcgcg ggacggcgtt cggttcagac 480
gatgccggcg gaaaactgac ctatactata gattttgctg ccaaacaggg acacggcaaa 540
atcgaacatt tgaaatcgcc cgaactcaat gtcgagcttg ccaccgccta tatcaagccg 600
gatgaaaaac accatgccgt catcagcggt tccgtccttt acaatcaaga cgagaaaggc 660
agttactccc tcggtatctt tggcgggcaa gcccaggaag ttgccggcag cgcggaagtg 720
gaaaccgcaa acggcataca ccatatcggt cttgccgcca agcaataa 768
<210>230
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>230
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Leu Gln Thr Glu
100 105 110
Gln Glu Gln Asp Pro Glu His Ser Gly Lys Met Val Ala Lys Arg Arg
115 120 125
Phe Lys Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Lys Asp Val Met Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Glu
180 185 190
Leu Ala Thr Ala Tyr Ile Lys Pro Asp Glu Lys His His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Asp Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Gln Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Glu Thr Ala Asn Gly Ile His His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>231
<211>771
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>231
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc ttaatacggg caaattgaag aacgacaagg tcagccgttt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaagtgtac 300
aaacaaagcc attccgcctt aaccgccctt cagaccgagc aagaacaaga tccagagcat 360
tccgggaaga tggttgcgaa acgccggttc aaaatcggcg acatagcggg cgaacataca 420
tcttttgaca agcttcccaa agacgtcatg gcgacatatc gcgggacggc gttcggttca 480
gacgatgccg gcggaaaact gacctatact atagattttg ctgccaaaca gggacacggc 540
aaaatcgaac atttgaaatc gcccgaactc aatgtcgagc ttgccaccgc ctatatcaag 600
ccggatgaaa aacaccatgc cgtcatcagc ggttccgtcc tttacaatca agacgagaaa 660
ggcagttact ccctcggtat ctttggcggg caagcccagg aagttgccgg cagcgcggaa 720
gtggaaaccg caaacggcat acaccatatc ggtcttgccg ccaagcaata a 771
<210>232
<211>256
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>232
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Leu Gln Thr
100 105 110
Glu Gln Glu Gln Asp Pro Glu His Ser Gly Lys Met Val Ala Lys Arg
115 120 125
Arg Phe Lys Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys
130 135 140
Leu Pro Lys Asp Val Met Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser
145 150 155 160
Asp Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys
165 170 175
Gln Gly His Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val
180 185 190
Glu Leu Ala Thr Ala Tyr Ile Lys Pro Asp Glu Lys His His Ala Val
195 200 205
Ile Ser Gly Ser Val Leu Tyr Asn Gln Asp Glu Lys Gly Ser Tyr Ser
210 215 220
Leu Gly Ile Phe Gly Gly Gln Ala Gln Glu Val Ala Gly Ser Ala Glu
225 230 235 240
Val Glu Thr Ala Asn Gly Ile His His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>233
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>233
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctta atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca agtgtacaaa 300
caaagccatt ccgccttaac cgcccttcag accgagcaag aacaagatcc agagcattcc 360
gggaagatgg ttgcgaaacg ccggttcaaa atcggcgaca tagcgggcga acatacatct 420
tttgacaagc ttcccaaaga cgtcatggcg acatatcgcg ggacggcgtt cggttcagac 480
gatgccggcg gaaaactgac ctatactata gattttgctg ccaaacaggg acacggcaaa 540
atcgaacatt tgaaatcgcc cgaactcaat gtcgagcttg ccaccgccta tatcaagccg 600
gatgaaaaac accatgccgt catcagcggt tccgtccttt acaatcaaga cgagaaaggc 660
agttactccc tcggtatctt tggcgggcaa gcccaggaag ttgccggcag cgcggaagtg 720
gaaaccgcaa acggcataca ccatatcggt cttgccgcca agcaataa 768
<210>234
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>234
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Leu Gln Thr Glu
100 105 110
Gln Glu Gln Asp Pro Glu His Ser Gly Lys Met Val Ala Lys Arg Arg
115 120 125
Phe Lys Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Lys Asp Val Met Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Glu
180 185 190
Leu Ala Thr Ala Tyr Ile Lys Pro Asp Glu Lys His His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Asp Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Gln Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Glu Thr Ala Asn Gly Ile His His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>235
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>235
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctta atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca agtgtacaaa 300
caaagccatt ccgccttaac cgcccttcag accgagcaag aacaagatcc agagcattcc 360
gggaagatgg ttgcgaaacg ccggttcaaa atcggcgaca tagcgggcga acatacatct 420
tttgacaagc ttcccaaaga cgtcatggcg acatatcgcg ggacggcgtt cggttcagac 480
gatgccggcg gaaaactgac ctatactata gattttgctg ccaaacaggg acacggcaaa 540
atcgaacatt tgaaatcgcc cgaactcaat gtcgagcttg ccaccgccta tatcaagccg 600
gatgaaaaac accatgccgt catcagcggt tccgtccttt acaatcaaga cgagaaaggc 660
agttactccc tcggtatctt tggcgggcaa gcccaggaag ttgccggcag cgcggaagtg 720
gaaaccgcaa acggcataca ccatatcggt cttgccgcca agcaataa 768
<210>236
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>236
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Leu Gln Thr Glu
100 105 110
Gln Glu Gln Asp Pro Glu His Ser Gly Lys Met Val Ala Lys Arg Arg
115 120 125
Phe Lys Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Lys Asp Val Met Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Glu
180 185 190
Leu Ala Thr Ala Tyr Ile Lys Pro Asp Glu Lys His His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Asp Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Gln Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Glu Thr Ala Asn Gly Ile His His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>237
<211>771
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>237
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc ttaatacggg caaattgaag aacgacaagg tcagccgttt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaagtgtac 300
aaacaaagcc attccgcctt aaccgccctt cagaccgagc aagaacaaga tccagagcat 360
tccgggaaga tggttgcgaa acgccggttc aaaatcggcg acatagcggg cgaacataca 420
tcttttgaca agcttcccaa agacgtcatg gcgacatatc gcgggacggc gttcggttca 480
gacgatgccg gcggaaaact gacctatact atagattttg ctgccaaaca gggacacggc 540
aaaatcgaac atttgaaatc gcccgaactc aatgtcgagc ttgccaccgc ctatatcaag 600
ccggatgaaa aacaccatgc cgtcatcagc ggttccgtcc tttacaatca agacgagaaa 660
ggcagttact ccctcggtat ctttggcggg caagcccagg aagttgccgg cagcgcggaa 720
gtggaaaccg caaacggcat acaccatatc ggtcttgccg ccaagcaata a 771
<210>238
<211>256
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>238
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Leu Gln Thr
100 105 110
Glu Gln Glu Gln Asp Pro Glu His Ser Gly Lys Met Val Ala Lys Arg
115 120 125
Arg Phe Lys Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys
130 135 140
Leu Pro Lys Asp Val Met Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser
145 150 155 160
Asp Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys
165 170 175
Gln Gly His Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val
180 185 190
Glu Leu Ala Thr Ala Tyr Ile Lys Pro Asp Glu Lys His His Ala Val
195 200 205
Ile Ser Gly Ser Val Leu Tyr Asn Gln Asp Glu Lys Gly Ser Tyr Ser
210 215 220
Leu Gly Ile Phe Gly Gly Gln Ala Gln Glu Val Ala Gly Ser Ala Glu
225 230 235 240
Val Glu Thr Ala Asn Gly Ile His His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>239
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>239
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctta atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca agtgtacaaa 300
caaagccatt ccgccttaac cgcccttcag accgagcaag aacaagatcc agagcattcc 360
gggaagatgg ttgcgaaacg ccggttcaaa atcggcgaca tagcgggcga acatacatct 420
tttgacaagc ttcccaaaga cgtcatggcg acatatcgcg ggacggcgtt cggttcagac 480
gatgccggcg gaaaactgac ctatactata gattttgctg ccaaacaggg acacggcaaa 540
atcgaacatt tgaaatcgcc cgaactcaat gtcgagcttg ccaccgccta tatcaagccg 600
gatgaaaaac accatgccgt catcagcggt tccgtccttt acaatcaaga cgagaaaggc 660
agttactccc tcggtatctt tggcgggcaa gcccaggaag ttgccggcag cgcggaagtg 720
gaaaccgcaa acggcataca ccatatcggt cttgccgcca agcaataa 768
<210>240
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>240
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Leu Gln Thr Glu
100 105 110
Gln Glu Gln Asp Pro Glu His Ser Gly Lys Met Val Ala Lys Arg Arg
115 120 125
Phe Lys Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Lys Asp Val Met Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Glu
180 185 190
Leu Ala Thr Ala Tyr Ile Lys Pro Asp Glu Lys His His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Asp Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Gln Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Glu Thr Ala Asn Gly Ile His His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>241
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>241
tgcagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctta atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca agtgtacaaa 300
caaagccatt ccgccttaac cgcccttcag accgagcaag aacaagatcc agagcattcc 360
gggaagatgg ttgcgaaacg ccggttcaaa atcggcgaca tagcgggcga acatacatct 420
tttgacaagc ttcccaaaga cgtcatggcg acatatcgcg ggacggcgtt cggttcagac 480
gatgccggcg gaaaactgac ctatactata gattttgctg ccaaacaggg acacggcaaa 540
atcgaacatt tgaaatcgcc cgaactcaat gtcgagcttg ccaccgccta tatcaagccg 600
gatgaaaaac accatgccgt catcagcggt tccgtccttt acaatcaaga cgagaaaggc 660
agttactccc tcggtatctt tggcgggcaa gcccaggaag ttgccggcag cgcggaagtg 720
gaaaccgcaa acggcataca ccatatcggt cttgccgcca agcaa 765
<210>242
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>242
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Leu Gln Thr Glu
100 105 110
Gln Glu Gln Asp Pro Glu His Ser Gly Lys Met Val Ala Lys Arg Arg
115 120 125
Phe Lys Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Lys Asp Val Met Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Glu
180 185 190
Leu Ala Thr Ala Tyr Ile Lys Pro Asp Glu Lys His His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Asp Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Gln Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Glu Thr Ala Asn Gly Ile His His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>243
<211>768
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>243
tgcggatcca gcggaggcgg cggtgtcgcc gccgacatcg gcgcggggct tgccgatgca 60
ctaaccgcac cgctcgacca taaagacaaa agtttgcagt ctttgacgct ggatcagtcc 120
gtcaggaaaa acgagaaact gaagctggcg gcacaaggtg cggaaaaaac ttatggaaac 180
ggcgacagcc ttaatacggg caaattgaag aacgacaagg tcagccgttt cgactttatc 240
cgtcaaatcg aagtggacgg gcagctcatt accttggaga gcggagagtt ccaagtgtac 300
aaacaaagcc attccgcctt aaccgccctt cagaccgagc aagaacaaga tccagagcat 360
tccgggaaga tggttgcgaa acgccggttc aaaatcggcg acatagcggg cgaacataca 420
tcttttgaca agcttcccaa agacgtcatg gcgacatatc gcgggacggc gttcggttca 480
gacgatgccg gcggaaaact gacctatact atagattttg ctgccaaaca gggacacggc 540
aaaatcgaac atttgaaatc gcccgaactc aatgtcgagc ttgccaccgc ctatatcaag 600
ccggatgaaa aacaccatgc cgtcatcagc ggttccgtcc tttacaatca agacgagaaa 660
ggcagttact ccctcggtat ctttggcggg caagcccagg aagttgccgg cagcgcggaa 720
gtggaaaccg caaacggcat acaccatatc ggtcttgccg ccaagcaa 768
<210>244
<211>256
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>244
Cys Gly Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly
1 5 10 15
Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu
20 25 30
Gln Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys
35 40 45
Leu Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu
50 55 60
Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile
65 70 75 80
Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu
85 90 95
Phe Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Leu Gln Thr
100 105 110
Glu Gln Glu Gln Asp Pro Glu His Ser Gly Lys Met Val Ala Lys Arg
115 120 125
Arg Phe Lys Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys
130 135 140
Leu Pro Lys Asp Val Met Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser
145 150 155 160
Asp Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys
165 170 175
Gln Gly His Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val
180 185 190
Glu Leu Ala Thr Ala Tyr Ile Lys Pro Asp Glu Lys His His Ala Val
195 200 205
Ile Ser Gly Ser Val Leu Tyr Asn Gln Asp Glu Lys Gly Ser Tyr Ser
210 215 220
Leu Gly Ile Phe Gly Gly Gln Ala Gln Glu Val Ala Gly Ser Ala Glu
225 230 235 240
Val Glu Thr Ala Asn Gly Ile His His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>245
<211>765
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>245
atgagcagcg gaggcggcgg tgtcgccgcc gacatcggcg cggggcttgc cgatgcacta 60
accgcaccgc tcgaccataa agacaaaagt ttgcagtctt tgacgctgga tcagtccgtc 120
aggaaaaacg agaaactgaa gctggcggca caaggtgcgg aaaaaactta tggaaacggc 180
gacagcctta atacgggcaa attgaagaac gacaaggtca gccgtttcga ctttatccgt 240
caaatcgaag tggacgggca gctcattacc ttggagagcg gagagttcca agtgtacaaa 300
caaagccatt ccgccttaac cgcccttcag accgagcaag aacaagatcc agagcattcc 360
gggaagatgg ttgcgaaacg ccggttcaaa atcggcgaca tagcgggcga acatacatct 420
tttgacaagc ttcccaaaga cgtcatggcg acatatcgcg ggacggcgtt cggttcagac 480
gatgccggcg gaaaactgac ctatactata gattttgctg ccaaacaggg acacggcaaa 540
atcgaacatt tgaaatcgcc cgaactcaat gtcgagcttg ccaccgccta tatcaagccg 600
gatgaaaaac accatgccgt catcagcggt tccgtccttt acaatcaaga cgagaaaggc 660
agttactccc tcggtatctt tggcgggcaa gcccaggaag ttgccggcag cgcggaagtg 720
gaaaccgcaa acggcataca ccatatcggt cttgccgcca agcaa 765
<210>246
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>246
Met Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Ala Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Ser Leu Gln
20 25 30
Ser Leu Thr Leu Asp Gln Ser Val Arg Lys Asn Glu Lys Leu Lys Leu
35 40 45
Ala Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Leu Gln Thr Glu
100 105 110
Gln Glu Gln Asp Pro Glu His Ser Gly Lys Met Val Ala Lys Arg Arg
115 120 125
Phe Lys Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Lys Asp Val Met Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Glu
180 185 190
Leu Ala Thr Ala Tyr Ile Lys Pro Asp Glu Lys His His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Asp Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Gly Gln Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Glu Thr Ala Asn Gly Ile His His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>247
<211>783
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>247
tgcagcagcg gaggcggcgg aagcggaggc ggcggtgtca ccgccgacat cggcacgggg 60
cttgccgatg cactaactgc gccgctcgac cataaagaca aaggcttgaa atccctgaca 120
ttggaagact ccatttccca aaacggaaca ctgaccctgt cggcacaagg tgcggaaaaa 180
acttatggaa acggcgacag ccttaatacg ggcaaattga agaacgacaa ggtcagccgt 240
ttcgacttta tccgtcaaat cgaagtggac gggcagctca ttaccttgga gagcggagag 300
ttccaagtgt acaaacaaag ccattccgcc ttaaccgccc ttcagaccga gcaagaacaa 360
gatccagagc attccgagaa gatggttgcg aaacgccggt tcagaatcgg cgacatagcg 420
ggcgaacata catcttttga caagcttccc aaagacgtca tggcgacata tcgcgggacg 480
gcgttcggtt cagacgatgc cggcggaaaa ctgacctata ctatagattt tgctgccaaa 540
cagggacacg gcaaaatcga acatttgaaa tcgccggaac tcaatgtcga tctggccgtc 600
gcctatatca agccggatga aaaacaccat gccgtcatca gcggttccgt tctttacaac 660
caagacgaga aaggcagtta ctccctcggt atctttggcg aaaaagccca ggaagttgcc 720
ggcagcgcgg aagtggaaac cgcaaacggc atacaccata tcggtcttgc cgccaagcag 780
taa 783
<210>248
<211>260
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>248
Cys Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Val Thr Ala Asp
1 5 10 15
Ile Gly Thr Gly Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys
20 25 30
Asp Lys Gly Leu Lys Ser Leu Thr Leu Glu Asp Ser Ile Ser Gln Asn
35 40 45
Gly Thr Leu Thr Leu Ser Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn
50 55 60
Gly Asp Ser Leu Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg
65 70 75 80
Phe Asp Phe Ile Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu
85 90 95
Glu Ser Gly Glu Phe Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr
100 105 110
Ala Leu Gln Thr Glu Gln Glu Gln Asp Pro Glu His Ser Glu Lys Met
115 120 125
Val Ala Lys Arg Arg Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr
130 135 140
Ser Phe Asp Lys Leu Pro Lys Asp Val Met Ala Thr Tyr Arg Gly Thr
145 150 155 160
Ala Phe Gly Ser Asp Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp
165 170 175
Phe Ala Ala Lys Gln Gly His Gly Lys Ile Glu His Leu Lys Ser Pro
180 185 190
Glu Leu Asn Val Asp Leu Ala Val Ala Tyr Ile Lys Pro Asp Glu Lys
195 200 205
His His Ala Val Ile Ser Gly Ser Val Leu Tyr Asn Gln Asp Glu Lys
210 215 220
Gly Ser Tyr Ser Leu Gly Ile Phe Gly Glu Lys Ala Gln Glu Val Ala
225 230 235 240
Gly Ser Ala Glu Val Glu Thr Ala Asn Gly Ile His His Ile Gly Leu
245 250 255
Ala Ala Lys Gln
260
<210>249
<211>786
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>249
tgcggatcca gcggaggcgg cggaagcgga ggcggcggtg tcaccgccga catcggcacg 60
gggcttgccg atgcactaac tgcgccgctc gaccataaag acaaaggctt gaaatccctg 120
acattggaag actccatttc ccaaaacgga acactgaccc tgtcggcaca aggtgcggaa 180
aaaacttatg gaaacggcga cagccttaat acgggcaaat tgaagaacga caaggtcagc 240
cgtttcgact ttatccgtca aatcgaagtg gacgggcagc tcattacctt ggagagcgga 300
gagttccaag tgtacaaaca aagccattcc gccttaaccg cccttcagac cgagcaagaa 360
caagatccag agcattccga gaagatggtt gcgaaacgcc ggttcagaat cggcgacata 420
gcgggcgaac atacatcttt tgacaagctt cccaaagacg tcatggcgac atatcgcggg 480
acggcgttcg gttcagacga tgccggcgga aaactgacct atactataga ttttgctgcc 540
aaacagggac acggcaaaat cgaacatttg aaatcgccgg aactcaatgt cgatctggcc 600
gtcgcctata tcaagccgga tgaaaaacac catgccgtca tcagcggttc cgttctttac 660
aaccaagacg agaaaggcag ttactccctc ggtatctttg gcgaaaaagc ccaggaagtt 720
gccggcagcg cggaagtgga aaccgcaaac ggcatacacc atatcggtct tgccgccaag 780
cagtaa 786
<210>250
<211>261
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>250
Cys Gly Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Val Thr Ala
1 5 10 15
Asp Ile Gly Thr Gly Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His
20 25 30
Lys Asp Lys Gly Leu Lys Ser Leu Thr Leu Glu Asp Ser Ile Ser Gln
35 40 45
Asn Gly Thr Leu Thr Leu Ser Ala Gln Gly Ala Glu Lys Thr Tyr Gly
50 55 60
Asn Gly Asp Ser Leu Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser
65 70 75 80
Arg Phe Asp Phe Ile Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr
85 90 95
Leu Glu Ser Gly Glu Phe Gln Val Tyr Lys Gln Ser His Ser Ala Leu
100 105 110
Thr Ala Leu Gln Thr Glu Gln Glu Gln Asp Pro Glu His Ser Glu Lys
115 120 125
Met Val Ala Lys Arg Arg Phe Arg Ile Gly Asp Ile Ala Gly Glu His
130 135 140
Thr Ser Phe Asp Lys Leu Pro Lys Asp Val Met Ala Thr Tyr Arg Gly
145 150 155 160
Thr Ala Phe Gly Ser Asp Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile
165 170 175
Asp Phe Ala Ala Lys Gln Gly His Gly Lys Ile Glu His Leu Lys Ser
180 185 190
Pro Glu Leu Asn Val Asp Leu Ala Val Ala Tyr Ile Lys Pro Asp Glu
195 200 205
Lys His His Ala Val Ile Ser Gly Ser Val Leu Tyr Asn Gln Asp Glu
210 215 220
Lys Gly Ser Tyr Ser Leu Gly Ile Phe Gly Glu Lys Ala Gln Glu Val
225 230 235 240
Ala Gly Ser Ala Glu Val Glu Thr Ala Asn Gly Ile His His Ile Gly
245 250 255
Leu Ala Ala Lys Gln
260
<210>251
<211>783
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>251
atgagcagcg gaggcggcgg aagcggaggc ggcggtgtca ccgccgacat cggcacgggg 60
cttgccgatg cactaactgc gccgctcgac cataaagaca aaggcttgaa atccctgaca 120
ttggaagact ccatttccca aaacggaaca ctgaccctgt cggcacaagg tgcggaaaaa 180
acttatggaa acggcgacag ccttaatacg ggcaaattga agaacgacaa ggtcagccgt 240
ttcgacttta tccgtcaaat cgaagtggac gggcagctca ttaccttgga gagcggagag 300
ttccaagtgt acaaacaaag ccattccgcc ttaaccgccc ttcagaccga gcaagaacaa 360
gatccagagc attccgagaa gatggttgcg aaacgccggt tcagaatcgg cgacatagcg 420
ggcgaacata catcttttga caagcttccc aaagacgtca tggcgacata tcgcgggacg 480
gcgttcggtt cagacgatgc cggcggaaaa ctgacctata ctatagattt tgctgccaaa 540
cagggacacg gcaaaatcga acatttgaaa tcgccggaac tcaatgtcga tctggccgtc 600
gcctatatca agccggatga aaaacaccat gccgtcatca gcggttccgt tctttacaac 660
caagacgaga aaggcagtta ctccctcggt atctttggcg aaaaagccca ggaagttgcc 720
ggcagcgcgg aagtggaaac cgcaaacggc atacaccata tcggtcttgc cgccaagcag 780
taa 783
<210>252
<211>260
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>252
Met Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Val Thr Ala Asp
1 5 10 15
Ile Gly Thr Gly Leu Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys
20 25 30
Asp Lys Gly Leu Lys Ser Leu Thr Leu Glu Asp Ser Ile Ser Gln Asn
35 40 45
Gly Thr Leu Thr Leu Ser Ala Gln Gly Ala Glu Lys Thr Tyr Gly Asn
50 55 60
Gly Asp Ser Leu Asn Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg
65 70 75 80
Phe Asp Phe Ile Arg Gln Ile Glu Val Asp Gly Gln Leu Ile Thr Leu
85 90 95
Glu Ser Gly Glu Phe Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr
100 105 110
Ala Leu Gln Thr Glu Gln Glu Gln Asp Pro Glu His Ser Glu Lys Met
115 120 125
Val Ala Lys Arg Arg Phe Arg Ile Gly Asp Ile Ala Gly Glu His Thr
130 135 140
Ser Phe Asp Lys Leu Pro Lys Asp Val Met Ala Thr Tyr Arg Gly Thr
145 150 155 160
Ala Phe Gly Ser Asp Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp
165 170 175
Phe Ala Ala Lys Gln Gly His Gly Lys Ile Glu His Leu Lys Ser Pro
180 185 190
Glu Leu Asn Val Asp Leu Ala Val Ala Tyr Ile Lys Pro Asp Glu Lys
195 200 205
His His Ala Val Ile Ser Gly Ser Val Leu Tyr Asn Gln Asp Glu Lys
210 215 220
Gly Ser Tyr Ser Leu Gly Ile Phe Gly Glu Lys Ala Gln Glu Val Ala
225 230 235 240
Gly Ser Ala Glu Val Glu Thr Ala Asn Gly Ile His His Ile Gly Leu
245 250 255
Ala Ala Lys Gln
260
<210>253
<211>390
<212>DNA
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>253
gacagcctga taaaccaacg ctccttcctt gtcagcggtt tgggcggaga acataccgcc 60
ttcaaccaac tgcctgacgg caaagccgag tatcacggca aagcattcag ctccgacgat 120
gctggcggaa aactgaccta taccatagat ttcgccgcca aacagggaca cggcaaaatc 180
gaacacctga aaacacccga gcaaaatgtc gagcttgccg ccgccgaact caaagcagat 240
gaaaaatcac acgccgtcat tttgggcgac acgcgctacg gcagcgaaga aaaaggcact 300
taccacctcg cccttttcgg cgaccgcgcc caagaaatcg ccggctcggc aaccgtgaag 360
ataggggaaa aggttcacga aatcggcatc 390
<210>254
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<220>
<221>MISC_FEATURE
<222>(5)..(5)
<223>Xaa表示任何天然产生的L-氨基酸
<400>254
Ala Asp Ile Gly Xaa Gly Leu Ala Asp Ala
1 5 10
<210>255
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<220>
<221>MISC_FEATURE
<222>(3)..(3)
<223>Xaa表示任何天然产生的L-氨基酸
<400>255
Ile Gly Xaa Gly Leu Ala Asp Ala Leu Thr
1 5 10
<210>256
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>256
Ser Leu Asn Thr Gly Lys Leu Lys Asn Asp
1 5 10
<210>257
<211>17
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<220>
<221>MISC_FEATURE
<222>(12)..(12)
<223>Xaa表示任何天然产生的L-氨基酸
<400>257
Ser Leu Asn Thr Gly Lys Leu Lys Asn Asp Lys Xaa Ser Arg Phe Asp
1 5 10 15
Phe
<210>258
<211>9
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<220>
<221>MISC_FEATURE
<222>(6)..(6)
<223>Xaa表示任何天然产生的L-氨基酸
<400>258
Ser Gly Glu Phe Gln Xaa Tyr Lys Gln
1 5
<210>259
<211>8
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<220>
<221>MISC_FEATURE
<222>(6)..(6)
<223>Xaa表示任何天然产生的L-氨基酸
<400>259
Ile Glu His Leu Lys Xaa Pro Glu
1 5
<210>260
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<220>
<221>MISC_FEATURE
<222>(10)..(10)
<223>Xaa表示任何天然产生的L-氨基酸
<400>260
Gly Gly Gly Val Ala Ala Asp Ile Gly Xaa
1 5 10
<210>261
<211>9
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>261
Ser Gly Glu Phe Gln Ile Tyr Lys Gln
1 5
<210>262
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>262
His Ser Ala Val Val Ala Leu Gln Ile Glu
1 5 10
<210>263
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>263
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp
1 5 10
<210>264
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>264
Ser Leu Ile Asn Gln Arg Ser Phe Leu Val
1 5 10
<210>265
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>265
Ser Gly Leu Gly Gly Glu His Thr Ala Phe
1 5 10
<210>266
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>266
Gly Glu His Thr Ala Phe Asn Gln Leu Pro
1 5 10
<210>267
<211>11
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>267
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His
1 5 10
<210>268
<211>34
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>268
Glu Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg
1 5 10 15
Ser Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln
20 25 30
Leu Pro
<210>269
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>269
Gly Lys Ala Glu Tyr His Gly Lys Ala Phe
1 5 10
<210>270
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>270
Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
1 5 10
<210>271
<211>14
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>271
Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
1 5 10
<210>272
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>272
Ile Glu His Leu Lys Thr Pro Glu Gln Asn
1 5 10
<210>273
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>273
Lys Thr Pro Glu Gln Asn Val Glu Leu Ala
1 5 10
<210>274
<211>14
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>274
Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu Ala
1 5 10
<210>275
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>275
Ala Glu Leu Lys Ala Asp Glu Lys Ser His
1 5 10
<210>276
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>276
Ala Val Ile Leu Gly Asp Thr Arg Tyr Gly
1 5 10
<210>277
<211>20
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>277
Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu Gly Asp
1 5 10 15
Thr Arg Tyr Gly
20
<210>278
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>278
Glu Glu Lys Gly Thr Tyr His Leu Ala Leu
1 5 10
<210>279
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>279
Leu Ile Thr Leu Glu Ser Gly Glu Phe Gln
1 5 10
<210>280
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>280
Ser Ala Leu Thr Ala Leu Gln Thr Glu Gln
1 5 10
<210>281
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>281
Phe Gln Val Tyr Lys Gln Ser His Ser Ala
1 5 10
<210>282
<211>26
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>282
Leu Ile Thr Leu Glu Ser Gly Glu Phe Gln Val Tyr Lys Gln Ser His
1 5 10 15
Ser Ala Leu Thr Ala Leu Gln Thr Glu Gln
20 25
<210>283
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>283
Ile Gly Asp Ile Ala Gly Glu His Thr Ser
1 5 10
<210>284
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>284
Glu His Thr Ser Phe Asp Lys Leu Pro Lys
1 5 10
<210>285
<211>16
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>285
Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu Pro Lys
1 5 10 15
<210>286
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>286
Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser
1 5 10
<210>287
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>287
Asp Asp Ala Gly Gly Lys Leu Thr Tyr Thr
1 5 10
<210>288
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>288
Ile Asp Phe Ala Ala Lys Gln Gly His Gly
1 5 10
<210>289
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>289
Lys Ile Glu His Leu Lys Ser Pro Glu Leu
1 5 10
<210>290
<211>42
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>290
Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp Asp Ala Gly Gly Lys
1 5 10 15
Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln Gly His Gly Lys Ile
20 25 30
Glu His Leu Lys Ser Pro Glu Leu Asn Val
35 40
<210>291
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>291
His Ala Val Ile Ser Gly Ser Val Leu Tyr
1 5 10
<210>292
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>292
Lys Gly Ser Tyr Ser Leu Gly Ile Phe Gly
1 5 10
<210>293
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>293
Val Leu Tyr Asn Gln Asp Glu Lys Gly Ser
1 5 10
<210>294
<211>24
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>294
His Ala Val Ile Ser Gly Ser Val Leu Tyr Asn Gln Asp Glu Lys Gly
1 5 10 15
Ser Tyr Ser Leu Gly Ile Phe Gly
20
<210>295
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>295
Ala Gln Glu Val Ala Gly Ser Ala Glu Val
1 5 10
<210>296
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>296
Ile His His Ile Gly Leu Ala Ala Lys Gln
1 5 10
<210>297
<211>10
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>297
Val Glu Thr Ala Asn Gly Ile His His Ile
1 5 10
<210>298
<211>25
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>298
Ala Gln Glu Val Ala Gly Ser Ala Glu Val Glu Thr Ala Asn Gly Ile
1 5 10 15
His His Ile Gly Leu Ala Ala Lys Gln
20 25
<210>299
<211>22
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>299
Val Ala Gly Ser Ala Glu Val Glu Thr Ala Asn Gly Ile His His Ile
1 5 10 15
Gly Leu Ala Ala Lys Gln
20
<210>300
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<220>
<221>MISC_FEATURE
<222>(9)..(9)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(14)..(14)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(22)..(22)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(24)..(24)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(26)..(26)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(30)..(30)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(32)..(32)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(37)..(37)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(38)..(38)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(40)..(40)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(41)..(41)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(42)..(42)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(44)..(44)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(45)..(45)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(47)..(47)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(49)..(49)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(57)..(57)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(58)..(58)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(59)..(59)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(73)..(73)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(79)..(79)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(80)..(80)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(81)..(81)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(83)..(83)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(87)..(87)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(88)..(88)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(92)..(92)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(98)..(98)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(102)..(102)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(106)..(106)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(107)..(107)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(111)..(111)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(113)..(113)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(114)..(114)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(115)..(115)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(116)..(116)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(117)..(117)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(118)..(118)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(119)..(119)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(120)..(120)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(121)..(121)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(122)..(122)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(123)..(123)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(124)..(124)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(125)..(125)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(126)..(126)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(128)..(128)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(130)..(130)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(131)..(131)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(132)..(132)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(133)..(133)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(134)..(134)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(135)..(135)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(140)..(140)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(142)..(142)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(143)..(143)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(146)..(146)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(147)..(147)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(148)..(148)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(150)..(150)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(152)..(152)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(154)..(154)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(157)..(157)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(161)..(161)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(162)..(162)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(164)..(164)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(166)..(166)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(168)..(168)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(172)..(172)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(173)..(173)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(177)..(177)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(179)..(179)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(185)..(185)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(188)..(188)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(191)..(191)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(194)..(194)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(195)..(195)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(196)..(196)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(197)..(197)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(199)..(199)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(203)..(203)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(208)..(208)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(210)..(210)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(211)..(211)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(212)..(212)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(214)..(214)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(215)..(215)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(216)..(216)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(220)..(220)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(222)..(222)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(224)..(224)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(225)..(225)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(226)..(226)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(228)..(228)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(229)..(229)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(233)..(233)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(236)..(236)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(238)..(238)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(240)..(240)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(241)..(241)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(242)..(242)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(243)..(243)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(244)..(244)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(245)..(245)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(247)..(247)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(249)..(249)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(250)..(250)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(252)..(252)
<223>Xaa表示任何天然产生的L-氨基酸
<400>300
Cys Ser Ser Gly Gly Gly Gly Val Xaa Ala Asp Ile Gly Xaa Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Xaa Pro Xaa Asp Xaa Lys Asp Lys Xaa Leu Xaa
20 25 30
Ser Leu Thr Leu Xaa Xaa Ser Xaa Xaa Xaa Asn Xaa Xaa Leu Xaa Leu
35 40 45
Xaa Ala Gln Gly Ala Glu Lys Thr Xaa Xaa Xaa Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Xaa Ser Arg Phe Asp Phe Xaa Xaa
65 70 75 80
Xaa Ile Xaa Val Asp Gly Xaa Xaa Ile Thr Leu Xaa Ser Gly Glu Phe
85 90 95
Gln Xaa Tyr Lys Gln Xaa His Ser Ala Xaa Xaa Ala Leu Gln Xaa Glu
100 105 110
Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Arg Xaa
115 120 125
Phe Xaa Xaa Xaa Xaa Xaa Xaa Gly Glu His Thr Xaa Phe Xaa Xaa Leu
130 135 140
Pro Xaa Xaa Xaa Ala Xaa Tyr Xaa Gly Xaa Ala Phe Xaa Ser Asp Asp
145 150 155 160
Xaa Xaa Gly Xaa Leu Xaa Tyr Xaa Ile Asp Phe Xaa Xaa Lys Gln Gly
165 170 175
Xaa Gly Xaa Ile Glu His Leu Lys Xaa Pro Glu Xaa Asn Val Xaa Leu
180 185 190
Ala Xaa Xaa Xaa Xaa Lys Xaa Asp Glu Lys Xaa His Ala Val Ile Xaa
195 200 205
Gly Xaa Xaa Xaa Tyr Xaa Xaa Xaa Glu Lys Gly Xaa Tyr Xaa Leu Xaa
210 215 220
Xaa Xaa Gly Xaa Xaa Ala Gln Glu Xaa Ala Gly Xaa Ala Xaa Val Xaa
225 230 235 240
Xaa Xaa Xaa Xaa Xaa His Xaa Ile Xaa Xaa Ala Xaa Lys Gln
245 250
<210>301
<211>254
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<220>
<221>MISC_FEATURE
<222>(14)..(14)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(22)..(22)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(24)..(24)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(26)..(26)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(30)..(30)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(32)..(32)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(37)..(37)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(38)..(38)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(40)..(40)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(41)..(41)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(42)..(42)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(44)..(44)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(45)..(45)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(47)..(47)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(49)..(49)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(57)..(57)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(58)..(58)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(59)..(59)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(73)..(73)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(79)..(79)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(80)..(80)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(81)..(81)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(83)..(83)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(88)..(88)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(92)..(92)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(102)..(102)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(146)..(146)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(161)..(161)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(162)..(162)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(164)..(164)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(166)..(166)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(168)..(168)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(172)..(172)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(173)..(173)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(177)..(177)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(179)..(179)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(194)..(194)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(215)..(215)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(226)..(226)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(236)..(236)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(242)..(242)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(249)..(249)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(252)..(252)
<223>Xaa表示任何天然产生的L-氨基酸
<400>301
Cys Ser Ser Gly Gly Gly Gly Val Ala Ala Asp Ile Gly Xaa Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Xaa Pro Xaa Asp Xaa Lys Asp Lys Xaa Leu Xaa
20 25 30
Ser Leu Thr Leu Xaa Xaa Ser Xaa Xaa Xaa Asn Xaa Xaa Leu Xaa Leu
35 40 45
Xaa Ala Gln Gly Ala Glu Lys Thr Xaa Xaa Xaa Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Xaa Ser Arg Phe Asp Phe Xaa Xaa
65 70 75 80
Xaa Ile Xaa Val Asp Gly Gln Xaa Ile Thr Leu Xaa Ser Gly Glu Phe
85 90 95
Gln Ile Tyr Lys Gln Xaa His Ser Ala Val Val Ala Leu Gln Ile Glu
100 105 110
Lys Ile Asn Asn Pro Asp Lys Ile Asp Ser Leu Ile Asn Gln Arg Ser
115 120 125
Phe Leu Val Ser Gly Leu Gly Gly Glu His Thr Ala Phe Asn Gln Leu
130 135 140
Pro Xaa Gly Lys Ala Glu Tyr His Gly Lys Ala Phe Ser Ser Asp Asp
145 150 155 160
Xaa Xaa Gly Xaa Leu Xaa Tyr Xaa Ile Asp Phe Xaa Xaa Lys Gln Gly
165 170 175
Xaa Gly Xaa Ile Glu His Leu Lys Thr Pro Glu Gln Asn Val Glu Leu
180 185 190
Ala Xaa Ala Glu Leu Lys Ala Asp Glu Lys Ser His Ala Val Ile Leu
195 200 205
Gly Asp Thr Arg Tyr Gly Xaa Glu Glu Lys Gly Thr Tyr His Leu Ala
210 215 220
Leu Xaa Gly Asp Arg Ala Gln Glu Ile Ala Gly Xaa Ala Thr Val Lys
225 230 235 240
Ile Xaa Glu Lys Val His Glu Ile Xaa Ile Ala Xaa Lys Gln
245 250
<210>302
<211>255
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<220>
<221>MISC_FEATURE
<222>(9)..(9)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(14)..(14)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(30)..(30)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(32)..(32)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(37)..(37)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(38)..(38)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(40)..(40)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(41)..(41)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(42)..(42)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(44)..(44)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(45)..(45)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(47)..(47)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(49)..(49)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(87)..(87)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(114)..(114)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(117)..(117)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(119)..(119)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(121)..(121)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(128)..(128)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(130)..(130)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(147)..(147)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(148)..(148)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(149)..(149)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(192)..(192)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(195)..(195)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(196)..(196)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(204)..(204)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(229)..(229)
<223>Xaa表示任何天然产生的L-氨基酸
<220>
<221>MISC_FEATURE
<222>(230)..(230)
<223>Xaa表示任何天然产生的L-氨基酸
<400>302
Cys Ser Ser Gly Gly Gly Gly Val Xaa Ala Asp Ile Gly Xaa Gly Leu
1 5 10 15
Ala Asp Ala Leu Thr Ala Pro Leu Asp His Lys Asp Lys Xaa Leu Xaa
20 25 30
Ser Leu Thr Leu Xaa Xaa Ser Xaa Xaa Xaa Asn Xaa Xaa Leu Xaa Leu
35 40 45
Xaa Ala Gln G1y Ala Glu Lys Thr Tyr Gly Asn Gly Asp Ser Leu Asn
50 55 60
Thr Gly Lys Leu Lys Asn Asp Lys Val Ser Arg Phe Asp Phe Ile Arg
65 70 75 80
Gln Ile Glu Val Asp Gly Xaa Leu Ile Thr Leu Glu Ser Gly Glu Phe
85 90 95
Gln Val Tyr Lys Gln Ser His Ser Ala Leu Thr Ala Leu Gln Thr Glu
100 105 110
Gln Xaa Gln Asp Xaa Glu Xaa Ser Xaa Lys Met Val Ala Lys Arg Xaa
115 120 125
Phe Xaa Ile Gly Asp Ile Ala Gly Glu His Thr Ser Phe Asp Lys Leu
130 135 140
Pro Lys Xaa Xaa Xaa Ala Thr Tyr Arg Gly Thr Ala Phe Gly Ser Asp
145 150 155 160
Asp Ala Gly Gly Lys Leu Thr Tyr Thr Ile Asp Phe Ala Ala Lys Gln
165 170 175
Gly His Gly Lys Ile Glu His Leu Lys Ser Pro Glu Leu Asn Val Xaa
180 185 190
Leu Ala Xaa Xaa Tyr Ile Lys Pro Asp Glu Lys Xaa His Ala Val Ile
195 200 205
Ser Gly Ser Val Leu Tyr Asn Gln Asp Glu Lys Gly Ser Tyr Ser Leu
210 215 220
Gly Ile Phe Gly Xaa Xaa Ala Gln Glu Val Ala Gly Ser Ala Glu Val
225 230 235 240
Glu Thr Ala Asn Gly Ile His His Ile Gly Leu Ala Ala Lys Gln
245 250 255
<210>303
<211>31
<212>DNA
<213>人工序列
<220>
<223>引物
<400>303
gcgcggatcc ttactgcttg gcggcaagac c 31
<210>304
<211>23
<212>DNA
<213>人工序列
<220>
<223>引物
<400>304
ctattctgca tatgactagg agc 23
<210>305
<211>21
<212>DNA
<213>人工序列
<220>
<223>引物
<400>305
agcagcggag gcggcggtgt c 21
<210>306
<211>21
<212>DNA
<213>人工序列
<220>
<223>引物
<400>306
tgccgatgca ctaaccgcac c 21
<210>307
<211>21
<212>DNA
<213>人工序列
<220>
<223>引物
<400>307
cgtttcgcaa ccatcttccc g 21
<210>308
<211>44
<212>DNA
<213>人工序列
<220>
<223>引物
<400>308
gagatctcac tcactcatta ctgcttggcg gcaagaccga tatg 44
<210>309
<211>29
<212>DNA
<213>人工序列
<220>
<223>引物
<400>309
gcggatccag cggagggggt ggtgtcgcc 29
<210>310
<211>35
<212>DNA
<213>人工序列
<220>
<223>引物
<400>310
gcgcatgctt actgcttggc ggcaagaccg atatg 35
<210>311
<211>26
<212>DNA
<213>人工序列
<220>
<223>引物
<400>311
gcggatccag cggaggcggc ggaagc 26
<210>312
<211>65
<212>DNA
<213>人工序列
<220>
<223>引物
<220>
<221>misc_feature
<222>(46)..(46)
<223>″Y″是C或T
<220>
<221>misc_feature
<222>(49)..(49)
<223>″W″是A或T
<400>312
gcgcagatct catatgagca gcggaggggg tggtgtcgcc gccgayatwg gtgcggggct 60
tgccg 65
<210>313
<211>19
<212>DNA
<213>人工序列
<220>
<223>引物
<400>313
ctattctgcg tatgactag 19
<210>314
<211>22
<212>DNA
<213>人工序列
<220>
<223>引物
<400>314
gtccgaacgg taaattatcg tg 22
<210>315
<211>29
<212>DNA
<213>人工序列
<220>
<223>引物
<400>315
gcggatccag cggaggcggc ggtgtcgcc 29
<210>316
<211>34
<212>DNA
<213>人工序列
<220>
<223>引物
<400>316
gagatctcat atgagcagcg gaggcggcgg aagc 34
<210>317
<211>16
<212>DNA
<213>人工序列
<220>
<223>引物
<400>317
gacagcctga taaacc 16
<210>318
<211>19
<212>DNA
<213>人工序列
<220>
<223>引物
<400>318
gatgccgatt tcgtgaacc 19
<210>319
<211>27
<212>DNA
<213>人工序列
<220>
<223>引物
<400>319
gcgcatgcct actgtttgcc ggcgatg 27
<210>320
<211>44
<212>DNA
<213>人工序列
<220>
<223>引物
<400>320
gagatctcac tcactcacta ctgtttgccg gcgatgccga tttc 44
<210>321
<211>70
<212>DNA
<213>人工序列
<220>
<223>引物
<400>321
gcgcagatct catatgagca gcggaggcgg cggaagcgga ggcggcggtg tcaccgccga 60
cataggcacg 70
<210>322
<211>59
<212>DNA
<213>人工序列
<220>
<223>前导序列
<400>322
atgaaaacaa cgttaaaaat gaccgcactt gcggctcttt ctgcttttgt tttagctgg 59
<210>323
<211>75
<212>DNA
<213>人工序列
<220>
<223>前导序列
<400>323
atgactagga gcaaacctgt gaaccgaact gccttctgct gcctttccct gaccgccgcc 60
ctgattctga ccgcc 75
<210>324
<211>75
<212>DNA
<213>人工序列
<220>
<223>前导序列
<400>324
atgactagga gcaaacctgt gaaccgaact gccttctgct gcttttctct gaccgccgcc 60
ctgattctga ccgcc 75
<210>325
<211>75
<212>DNA
<213>人工序列
<220>
<223>前导序列
<400>325
atgactagga gcaaacctgt gaaccgaact accttctgtt gcctttctct gaccgccgcc 60
ctgattctga ccgcc 75
<210>326
<211>75
<212>DNA
<213>人工序列
<220>
<223>前导序列
<400>326
atgactagga gtaaacctgt gaatcgaact gccttctgct gcctttctct gaccactgcc 60
ctgattctga ccgcc 75
<210>327
<211>335
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>327
Cys Ser Pro Ala Ala Asp Ser Asn His Pro Ser Gly Gln Asn Ala Pro
1 5 10 15
Ala Asn Thr Glu Ser Asp Gly Lys Asn Ile Thr Leu Leu Asn Ala Ser
20 25 30
Tyr Asp Val Ala Arg Asp Phe Tyr Lys Glu Tyr Asn Pro Leu Phe Ile
35 40 45
Lys Thr Tyr Gln Ser Glu His Pro Gly Thr Ser Val Ser Ile Gln Gln
50 55 60
Ser His Gly Gly Ser Ser Lys Gln Ala Leu Ser Val Ala Asn Gly Leu
65 70 75 80
Gln Ala Asp Val Val Thr Met Asn Gln Ser Ser Asp Ile Asp Leu Leu
85 90 95
Glu Lys Lys Gly Leu Val Glu Lys Gly Trp Gln Gln Ala Leu Pro Asp
100 105 110
His Ala Ala Pro Tyr Thr Ser Thr Met Val Phe Leu Val Arg Lys Asn
115 120 125
Asn Pro Lys Gln Ile Arg Asp Trp Asn Asp Leu Ala Lys Asp Gly Val
130 135 140
Asn Ile Val Ile Ala Asn Pro Lys Thr Ser Gly Asn Gly Arg Tyr Ala
145 150 155 160
Phe Leu Gly Ala Tyr Gly Tyr Gly Leu Lys Thr Thr Asn Gly Asn Glu
165 170 175
Gln Glu Ala Gln Lys Leu Val Ala Ser Ile Leu Lys Asn Thr Pro Val
180 185 190
Phe Glu Asn Gly Gly Arg Ala Ala Thr Thr Thr Phe Thr Gln Arg Asn
195 200 205
Ile Gly Asp Val Leu Ile Thr Phe Glu Asn Glu Ala Asn Tyr Val Ser
210 215 220
Lys Lys Leu Thr Gln Gly Gln Phe Glu Ile Val Tyr Pro Ser Tyr Thr
225 230 235 240
Ile Ser Ala Glu Ser Pro Val Ala Val Val Asn Ser Val Val Ala Lys
245 250 255
Lys Gly Thr Gln Lys Thr Ala Arg Ala Tyr Leu Glu Tyr Leu Trp Ser
260 265 270
Glu Pro Ala Gln Glu Leu Ala Ala Ser Leu Tyr Leu Arg Pro Arg Asn
275 280 285
Pro Glu Val Leu Ala Arg His Lys Ala Asp Phe Pro Asp Leu Asp Thr
290 295 300
Phe Ser Pro Glu Glu Lys Phe Gly Gly Trp Asp Asn Ile Met Lys Thr
305 310 315 320
Tyr Phe Ala Asp Gly Gly Ile Phe Asp Arg Leu Thr Ala Gln Lys
325 330 335
<210>328
<211>68
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>328
Cys Ala Gly Thr Trp Glu Gly Ala Lys Gln Asp Thr Ala Arg Asn Leu
1 5 10 15
Asp Lys Thr Gln Ala Ala Ala Glu Arg Ala Ala Glu Gln Thr Gly Asn
20 25 30
Ala Val Glu Lys Gly Trp Asp Lys Thr Lys Glu Ala Val Lys Lys Gly
35 40 45
Gly Asn Ala Val Gly Arg Gly Ile Ser His Leu Gly Gly Lys Ile Glu
50 55 60
Asn Ala Thr Glu
65
<210>329
<211>21
<212>PRT
<213>脑膜炎奈瑟氏球菌(Neisseria meningitidis)
<400>329
Cys Met Lys Thr Thr Leu Lys Met Thr Ala Leu Ala Ala Leu Ser Ala
1 5 10 15
Phe Val Leu Ala Gly
20
Claims (344)
1.一种组合物,其特征在于,所述组合物包含:
(a)至少一种由奈瑟氏球菌属的开放阅读框(ORF2086)编码的蛋白质,所述开放阅读框编码交叉反应免疫原性抗原,所述交叉反应免疫原性抗原为受试者提供抗脑膜炎奈瑟氏球菌血清组B感染的免疫原性;或
(b)至少一种(a)中所述蛋白质的至少一种免疫原性部分;或
(c)至少一种(a)中所述蛋白质或(b)中所述免疫原性片段的至少一种生物学等价物。
2.如权利要求1所述的组合物,其中,至少一种蛋白质包含SEQ ID NOS:254-259中任何氨基酸序列。
3.如权利要求1所述的组合物,其中,至少一种蛋白质由任何奈瑟氏球菌菌株L3 6275、CDC2369、CDC1034、L4 891、B16B6、W135(ATCC35559)、C11、Y(ATCC35561)、M98 250732、M98 250771、CDC1135、M97 252153、CDC1610、CDC1492、L8 M978;M97 252988、M97 252697、6557、2996、M97 252976、M97 251854、CDC1521、M98250622、870446、M97 253248、M98 250809、L5 M981、NMB或M98 250572的ORF2086编码。
4.如权利要求1所述的组合物,其中,至少一种蛋白质包含SEQ ID NOS:260-278或279-299中任何氨基酸序列。
5.如权利要求1所述的组合物,其中,至少一种蛋白质由任何奈瑟氏球菌菌株880049、M982、CDC1573、M97 253524或M98 250670的ORF2086编码。
6.如权利要求1所述的组合物,其中,至少一种蛋白质包含任何偶数编号的SEQID NOS:2-174的氨基酸序列。
7.如权利要求6所述的组合物,还包含至少一种含有任何偶数编号的SEQ IDNOS:176-252的氨基酸序列的蛋白质。
8.如权利要求1所述的组合物,其中,至少一种蛋白质包含任何偶数编号的SEQID NOS:224-252的氨基酸序列。
9.如权利要求1所述的组合物,其中,所述至少一种蛋白质、免疫原性部分或生物学等价物是非病原的且基本上没有任何感染性杂质。
10.如权利要求1所述的组合物,其中,用质谱测得至少一种蛋白质的分子量约为26,000-30,000道尔顿。
11.如权利要求10所述的组合物,其中,用10%-20%SDS聚丙烯酰胺凝胶测得至少一种蛋白质的分子量约为28-35kDa。
12。如权利要求1所述的组合物,其中,所述组合物还包含药学上可接受的缓冲剂、稀释剂、佐剂或载体。
13.如权利要求1所述的组合物,其中,所述组合物还包含载体。
14.如权利要求1所述的组合物,其中,所述组合物还包含佐剂。
15.如权利要求14所述的组合物,其中,所述佐剂包含液体。
16.如权利要求1所述的组合物,其中,所述蛋白质是重组蛋白。
17.如权利要求1所述的组合物,其中,所述蛋白质分离自天然奈瑟氏球菌属。
18.如权利要求1所述的组合物,其中,所述蛋白质是脂蛋白。
19.如权利要求1所述的组合物,其中,所述蛋白质是非脂质化的。
20.如权利要求1所述的组合物,其中,所述组合物还包含至少一种PorA、PorB、运铁结合蛋白或混浊蛋白(Opc)。
21.如权利要求1所述的组合物,其中,所述组合物还包含至少一种奈瑟氏球菌属的其它表面抗原,所述其它表面抗原是非-ORF2086蛋白。
22.如权利要求1所述的组合物,其中,所述组合物还包含多糖。
23.如权利要求1所述的组合物,其中,所述组合物包含其它肽、多肽或蛋白质,所述组合物形成一种结合物,该结合物诱导哺乳动物对两种或多种细菌的免疫应答。
24.一种组合物,其特征在于,所述组合物包含:
至少一种包含SEQ ID NOS:254-259中任一的免疫原性蛋白质或多肽。。
25.如权利要求24所述的组合物,其中,用质谱测得至少一种蛋白质的分子量约为26,000-30,000道尔顿。
26.如权利要求25所述的组合物,其中,用10%-20%SDS聚丙烯酰胺凝胶测得至少一种蛋白质的分子量约为28-35kDa。
27.如权利要求24所述的组合物,其中,所述组合物还包含药学上可接受的缓冲剂、稀释剂、佐剂或载体。
28.如权利要求24所述的组合物,其中,所述组合物还包含载体。
29.如权利要求24所述的组合物,其中,所述组合物还包含佐剂。
30.如权利要求29所述的组合物,其中,所述佐剂包含液体。
31.如权利要求24所述的组合物,其中,所述蛋白质是非脂质化的。
32.如权利要求24所述的组合物,其中,所述蛋白质是重组蛋白。
33.如权利要求24所述的组合物,其中,所述蛋白质或多肽分离自天然奈瑟氏球菌属。
34.如权利要求24所述的组合物,其中,所述蛋白质是脂蛋白。
35.如权利要求24所述的组合物,其中,所述组合物还包含至少一种PorA、PorB、运铁结合蛋白或混浊蛋白(Opc)。
36.如权利要求24所述的组合物,其中,所述组合物还包含至少一种标瑟氏球菌属的其它表面抗原,所述其它表面抗原是非-ORF2086蛋白。
37.如权利要求24所述的组合物,其中,所述组合物还包含多糖。
38.如权利要求24所述的组合物,其中,所述组合物包含其它肽、多肽或蛋白质,所述组合物形成一种结合物,该结合物可诱导哺乳动物对两种或多种细菌的免疫应答。
39.一种组合物,其特征在于,所述组合物包含:
至少一种含有SEQ ID NOS:260-278中任一的免疫原性蛋白或多肽。
40.如权利要求39所述的组合物,其中,所述组合物还包含药学上可接受的缓冲剂、稀释剂、佐剂或载体。
41.一种组合物,其特征在于,所述组合物包含:
至少一种包含SEQ ID NOS:279-299中任一的免疫原性蛋白或多肽。
42.如权利要求41所述的组合物,其中,所述组合物还包含药学上可接受的缓冲剂、稀释剂、佐剂或载体。
43.一种组合物,其特征在于,所述组合物包含:
至少一种分离的蛋白,所述蛋白包含SEQ ID NO:300的氨基酸序列;
其中,x是任何氨基酸;
其中,所述氨基酸位置5-9的区域是任何0-5个氨基酸;
其中,所述氨基酸位置67-69的区域是任何0-3个氨基酸;和
其中,氨基酸位置156是任何0-1个氨基酸。
44.如权利要求43所述的组合物,其中,所述氨基酸位置5-9的区域包含0、4或5个氨基酸。
45.如权利要求43所述的组合物,其中,所述氨基酸位置67-69的区域包含0或3个氨基酸。
46.如权利要求43所述的组合物,其中,用质谱测得至少一种蛋白质的分子量约为26,000-30,000道尔顿。
47.如权利要求46所述的组合物,其中,用10%-20%SDS聚丙烯酰胺凝胶测得至少一种蛋白质的分子量约为28-35kDa。
48.如权利要求43所述的组合物,其中,所述组合物还包含药学上可接受的缓冲剂、稀释剂、佐剂或载体。
49.如权利要求43所述的组合物,其中,所述组合物还包含载体。
50.如权利要求43所述的组合物,其中,所述组合物还包含佐剂。
51.如权利要求50所述的组合物,其中,所述佐剂包含液体。
52.如权利要求43所述的组合物,其中,所述蛋白质是非脂质化的。
53.如权利要求43所述的组合物,其中,所述蛋白质是重组蛋白。
54.如权利要求43所述的组合物,其中,所述蛋白质分离自天然奈瑟氏球菌属。
55.如权利要求43所述的组合物,其中,所述蛋白质是脂蛋白。
56.如权利要求43所述的组合物,其中,所述组合物还包含至少一种Por A,Por B,运铁结合蛋白或混浊蛋白(Opc)。
57.如权利要求43所述的组合物,其中,所述组合物还包含至少一种奈瑟氏球菌属的其它表面抗原,所述其它表面抗原是非-ORF2086蛋白。
58.如权利要求43所述的组合物,其中,所述组合物还包含多糖。
59.如权利要求43所述的组合物,其中,所述组合物包含其它肽、多肽或蛋白质,所述组合物形成一种结合物,该结合物可诱导哺乳动物对两种或多种细菌的免疫应答。
60.一种组合物,其特征在于,所述组合物包含:
(a)至少一种包含任何偶数编号的SEQ ID NOS:2-252的氨基酸序列的蛋白质;
(b)至少一种由在严格条件下与包含任何奇数编号的SEQ ID NOS:1-253的核酸序列的多核苷酸杂交的多核苷酸编码的蛋白质;
(c)至少一种(a)或(b)中所述至少一种蛋白质的免疫原性部分;或
(d)至少一种(a)或(b)中所述至少一种蛋白质或(c)中所述一种免疫原性片段的生物学等价物。
61.如权利要求60所述的组合物,其中,至少一种蛋白质包含任何偶数编号的SEQ ID NOS:2-174的氨基酸序列。
62.如权利要求61所述的组合物,还包含至少一种含有任何偶数编号的SEQ IDNOS:176-252的氨基酸序列的蛋白质。
63.如权利要求60所述的组合物,其中,至少一种蛋白质包含任何偶数编号的SEQ ID NOS:2-12的氨基酸序列。
64.如权利要求60所述的组合物,其中,至少一种蛋白质包含任何偶数编号的SEQ ID NOS:14-24的氨基酸序列。
65.如权利要求60所述的组合物,其中,至少一种蛋白质包含任何偶数编号的SEQ ID NOS:26-42的氨基酸序列。
66.如权利要求60所述的组合物,其中,至少一种蛋白质包含任何偶数编号的SEQ ID NOS:50-60的氨基酸序列。
67.如权利要求60所述的组合物,其中,至少一种蛋白质包含任何偶数编号的SEQ ID NOS:62-108的氨基酸序列。
68.如权利要求60所述的组合物,其中,至少一种蛋白质包含任何偶数编号的SEQ ID NOS:110-138的氨基酸序列。
69.如权利要求60所述的组合物,其中,至少一种蛋白质包含任何偶数编号的SEQ ID NOS:140-156的氨基酸序列。
70.如权利要求60所述的组合物,其中,至少一种蛋白质包含任何偶数编号的SEQ ID NOS:158-174的氨基酸序列。
71.如权利要求60所述的组合物,其中,至少一种蛋白质包含任何偶数编号的SEQ ID NOS:224-252的氨基酸序列。
72.如权利要求60所述的组合物,其中,所述组合物还包含至少一种Por A,Por B,运铁结合蛋白或混浊蛋白(Opc)。
73.如权利要求60所述的组合物,其中,所述组合物还包含至少一种奈瑟氏球菌属的其它表面抗原,所述其它表面抗原是非-ORF2086蛋白。
74.如权利要求60所述的组合物,其中,用质谱测得至少一种蛋白质的分子量约为26,000-30,000道尔顿。
75.如权利要求74所述的组合物,其中,用10%-20%SDS聚丙烯酰胺凝胶测得至少一种蛋白质的分子量约为28-35kDa。
76.如权利要求60所述的组合物,其中,所述组合物还包含药学上可接受的缓冲剂、稀释剂、佐剂或载体。
77.如权利要求60所述的组合物,其中,所述组合物还包含载体。
78.如权利要求60所述的组合物,其中,所述组合物还包含佐剂。
79.如权利要求78所述的组合物,其中,所述佐剂包含液体。
80.如权利要求60所述的组合物,其中,所述蛋白质是非脂质化的。
81.如权利要求60所述的组合物,其中,所述蛋白质是重组蛋白。
82.如权利要求60所述的组合物,其中,所述蛋白质分离自天然奈瑟氏球菌属。
83.如权利要求60所述的组合物,其中,所述蛋白质是脂蛋白。
84.如权利要求60所述的组合物,其中,所述组合物还包含多糖。
85.如权利要求60所述的组合物,其中,所述组合物包含其它肽、多肽或蛋白质,所述组合物形成一种结合物,该结合物可诱导哺乳动物对两种或多种细菌的免疫应答。
86.一种组合物,其特征在于,所述组合物包含:
至少一种奈瑟氏球菌属的第一菌株的抗原,该抗原可使受试者对奈瑟氏球菌属的第二菌株的感染具有免疫原性。
87.如权利要求86所述的组合物,其中,所述第一菌株是奈瑟氏球菌属菌株,所述第二菌株是脑膜炎奈瑟氏球菌血清组B菌株。
88.如权利要求86所述的组合物,其中,所述第一菌株是L3 6275、CDC2369、CDC1034、L4 891、B16B6、W135(ATCC35559)、C11、Y(ATCC35561)、M98 250732、M98 250771、CDC1135、M97 252153、CDC1610、CDC1492、L8 M978;M97 252988、M97 252697、6557、2996、M97 252976、M97 251854、CDC1521、M98 250622、870446、M97 253248、M98 250809、L5 M981、NMB或M98 250572中任何菌株。
89.如权利要求86所述的组合物,其中,所述第一菌株是880049、M982、CDC1573、M97 253524或M98 250670中任何菌株。
90.如权利要求86所述的组合物,其中,所述蛋白质是重组蛋白。
91.如权利要求86所述的组合物,其中,所述蛋白质分离自天然奈瑟氏球菌属。
92.如权利要求86所述的组合物,其中,所述蛋白质是脂蛋白。
93.如权利要求86所述的组合物,其中,所述组合物还包含药学上可接受的缓冲剂、稀释剂、佐剂或载体。
94.如权利要求86所述的组合物,其中,所述组合物还包含载体。
95.如权利要求86所述的组合物,其中,所述组合物还包含佐剂。
96.如权利要求95所述的组合物,其中,所述佐剂包含液体。
97.如权利要求86所述的组合物,其中,所述蛋白质是非脂质化的。
98.如权利要求86所述的组合物,其中,所述组合物还包含多糖。
99.如权利要求86所述的组合物,其中,所述组合物包含其它肽、多肽或蛋白质,所述组合物形成一种结合物,该结合物可诱导哺乳动物对两种或多种病原体的免疫应答。
100.一种组合物,其特征在于,所述组合物包含:
至少一种含有氨基酸序列SEQ ID NO:301的分离的蛋白质;
其中,x是任何氨基酸;
其中,所述氨基酸位置5-8的区域是任何0-4个氨基酸;
其中,所述氨基酸位置66-68的区域是任何0-3个氨基酸。
101.如权利要求100所述的组合物,其中,用质谱测得至少一种蛋白质的分子量约为26,000-30,000道尔顿。
102.如权利要求101所述的组合物,其中,用10%-20%SDS聚丙烯酰胺凝胶测得至少一种蛋白质的分子量约为28-35kDa。
103.如权利要求100所述的组合物,其中,所述组合物还包含药学上可接受的缓冲剂、稀释剂、佐剂或载体。
104.如权利要求100所述的组合物,其中,所述组合物还包含载体。
105.如权利要求100所述的组合物,其中,所述组合物还包含佐剂。
106.如权利要求105所述的组合物,其中,所述佐剂包含液体。
107.如权利要求100所述的组合物,其中,所述蛋白质是非脂质化的。
108.如权利要求100所述的组合物,其中,所述蛋白质是重组蛋白。
109.如权利要求100所述的组合物,其中,所述蛋白质分离自天然奈瑟氏球菌属。
110.如权利要求100所述的组合物,其中,所述蛋白质是脂蛋白。
111.如权利要求100所述的组合物,其中,所述组合物还包含多糖。
112.如权利要求100所述的组合物,其中,所述组合物包含其它肽、多肽或蛋白质,所述组合物形成一种结合物,该结合物可诱导哺乳动物对两种或多种细菌的免疫应答。
113.如权利要求100所述的组合物,其中,所述氨基酸位置5-8的区域包含0或4个氨基酸。
114.如权利要求100所述的组合物,其中,所述氨基酸位置66-68的区域包含0或3个氨基酸。
115.一种组合物,其特征在于,所述组合物包含:
至少一种含有氨基酸序列SEQ ID NO:302的分离的蛋白质;
其中,x是任何氨基酸;
其中,所述氨基酸位置8-12的区域是任何0-5个氨基酸。
116.如权利要求115所述的组合物,其中,所述氨基酸位置8-12的区域包含0或5个氨基酸。
117.如权利要求115所述的组合物,其中,用质谱测得至少一种蛋白质的分子量约为26,000-30,000道尔顿。
118.如权利要求117所述的组合物,其中,用10%-20%SDS聚丙烯酰胺凝胶测得至少一种蛋白质的分子量约为28-35kDa。
119.如权利要求115所述的组合物,其中,所述组合物还包含药学上可接受的缓冲剂、稀释剂、佐剂或载体。
120.如权利要求115所述的组合物,其中,所述组合物还包含载体。
121.如权利要求115所述的组合物,其中,所述组合物还包含佐剂。
122.如权利要求121所述的组合物,其中,所述佐剂包含液体。
123.如权利要求115所述的组合物,其中,所述蛋白质是非脂质化的。
124.如权利要求115所述的组合物,其中,所述蛋白质是重组多肽。
125.如权利要求115所述的组合物,其中,所述蛋白质分离自天然来源。
126.如权利要求115所述的组合物,其中,所述组合物还包含多糖。
127.如权利要求115所述的组合物,其中,所述组合物包含其它肽、多肽或蛋白质,所述组合物形成一种结合物,该结合物可诱导哺乳动物对两种或多种细菌的免疫应答。
128.一种组合物,其特征在于,所述组合物包含:
至少一种免疫特异性结合以下任一的抗体:
(a)至少一种由奈瑟氏球菌属的开放阅读框(ORF2086)编码的蛋白质,所述开放阅读框编码交叉反应免疫原性抗原,所述交叉反应免疫原性抗原使受试者对脑膜炎奈瑟氏球菌血清组B感染具有免疫原性;或
(b)至少一种(a)中所述至少一种蛋白质的免疫原性部分;或
(c)至少一种(a)中所述至少一种蛋白质或(b)所述一种免疫原性片段的生物学等价物。
129.如权利要求128所述的组合物,其中,所述抗体是单克隆抗体。
130.如权利要求128所述的组合物,还包含药学上可接受的载体。
131.一种组合物,其特征在于,所述组合物包含:
至少一种免疫特异性结合以下任一的抗体:
(a)至少一种包含SEQ ID NOS:254-259中任一的蛋白质;或
(b)至少一种(a)中所述至少一种蛋白质的免疫原性部分;或
(c)至少一种(a)中所述至少一种蛋白质或(b)中所述一种免疫原性片段的生物学等价物。
132.如权利要求131所述的组合物,其中,至少一种蛋白质,其免疫原性部分或其生物学等价物包含任何SEQ ID NOS:260-299。
133.如权利要求131所述的组合物,其中,至少一种抗体是单克隆抗体。
134.一种组合物,其特征在于,所述组合物包含:
至少一种抗体,所述抗体免疫特异性结合至少一种包含氨基酸序列SEQ IDNO:300的分离的蛋白质;
其中,x是任何氨基酸;
其中,所述氨基酸位置5-9的区域是任何0-5个氨基酸;
其中,所述氨基酸位置67-69之间的区域是任何0-3个氨基酸;和
其中,氨基酸位置156是任何0-1个氨基酸。
135.如权利要求1所述的组合物34,其中,至少一种抗体是单克隆抗体。
136.一种组合物,其特征在于,所述组合物包含:
至少一种免疫特异性结合以下任一的抗体:
(a)至少一种含有任何偶数编号的SEQ ID NOS:2-252的氨基酸序列的蛋白质;或
(b)至少一种由在严格条件下与包含任何奇数编号的SEQ ID NOS:1-253的核酸序列的多核苷酸杂交的多核苷酸编码的蛋白质;
(c)至少一种(a)或(b)中所述至少一种蛋白质的免疫原性部分;或
(d)至少一种(a)或(b)中所述至少一种蛋白质或(c)中所述免疫原性片段的生物学等价物。
137.一种组合物,其特征在于,所述组合物包含:
至少一种多核苷酸,所述多核苷酸
(a)编码至少一种由奈瑟氏球菌属的开放阅读框(ORF2086)编码的蛋白质,或至少一种所述至少一种蛋白质的免疫原性部分或生物学等价物,所述开放阅读框编码交叉反应免疫原性抗原,且所述交叉反应免疫原性抗原使受试者具有抵抗脑膜炎奈瑟氏球菌血清组B感染的免疫原性;或
(b)在严格条件下与(a)中所述任何多核苷酸杂交。
138.如权利要求137所述的组合物,还包含P4前导序列(SEQ ID NO:322)。
139.如权利要求137所述的组合物,其中,所述组合物包含载体。
140.如权利要求139所述的组合物,其中,所述载体是质粒。
141.如权利要求139所述的组合物,其中,所述载体是噬菌体。
142.如权利要求137所述的组合物,其中,所述严格条件是高度严格southern杂交条件。
143.如权利要求137所述的组合物,还包含P4前导序列(SEQ ID NO:322)。
144.如权利要求137所述的组合物,其中,所述多核苷酸是重组多核苷酸。
145.如权利要求137所述的组合物,其中,所述多核苷酸分离自天然来源。
146.如权利要求137所述的组合物,其中,所述组合物还包含编码其它肽、多肽或蛋白质的核酸序列。
147.一种组合物,其特征在于,所述组合物包含:
至少一种多核苷酸,所述多核苷酸
(a)编码至少一种含有SEQ ID NOS:254-259、260-278或279-299中任一的分离的蛋白质,或
(b)在严格条件下与(a)中所述任何多核苷酸杂交。
148.如权利要求147所述的组合物,还包含P4前导序列(SEQ ID NO:322)。
149.如权利要求147所述的组合物,其中,所述组合物包含载体。
150.如权利要求147所述的组合物,其中,所述严格条件是高度严格Southern杂交条件。
151.如权利要求147所述的组合物,还包含P4前导序列(SEQ ID NO:322)。
152.如权利要求147所述的组合物,其中,所述多核苷酸是重组多核苷酸。
153.如权利要求147所述的组合物,其中,所述多核苷酸分离自天然来源。
154.如权利要求147所述的组合物,其中,所述组合物还包含编码其它肽、多肽或蛋白质的核酸序列。
155.一种组合物,其特征在于,所述组合物包含:
至少一种多核苷酸,所述多核苷酸
(a)编码至少一种含有氨基酸序列SEQ ID NO:300的蛋白质,x是任何氨基酸,氨基酸位置5-9的区域是任何0-5个氨基酸,氨基酸位置67-69的区域是任何0-3个氨基酸;且氨基酸位置156是任何0-1个氨基酸,或
(b)在严格条件下与(a)中所述任何多核苷酸杂交。
156.如权利要求155所述的组合物,还包含P4前导序列(SEQ ID NO:322)。
157.一种组合物,其特征在于,所述组合物包含:
(a)至少一种编码以下至少一种的多核苷酸:
(i)至少一种含有任何偶数编号的SEQ ID NOS:2-252的氨基酸序列的蛋白质;
(ii)至少一种由在严格条件下与含有任何奇数编号的SEQ ID NOS:1-253的核酸序列的多核苷酸杂交的多核苷酸编码的蛋白质,(iii)至少一种(i)或(ii)中所述至少一种蛋白质的免疫原性部分;或(iv)至少一种(i)或(ii)中所述至少一种蛋白质或
(iii)中所述免疫原性片段的生物学等价物,或
(b)至少一种在严格条件下与(a)中所述任何多核苷酸杂交的多核苷酸。
158.如权利要求157所述的组合物,其中,所述至少一种多核苷酸包含任何奇数编号的SEQ ID NOS:1-253的核酸序列。
159.如权利要求157所述的组合物,其中,所述组合物包含载体。
160.如权利要求157所述的组合物,其中,所述严格条件是高度严格Southern杂交条件。
161.如权利要求157所述的组合物,其中,所述组合物还包含编码其它肽、多肽或蛋白质的核酸序列。
162.一种组合物,其特征在于,所述组合物包含:
(a)至少一种多核苷酸,所述多核苷酸编码至少一种奈瑟氏球菌属的第一菌株的抗原,所述抗原使受试者对奈瑟氏球菌属的第二菌株的感染具有免疫原性;或
(b)至少一种在严格条件下与至少一种(a)中所述多核苷酸杂交的多核苷酸。
163.如权利要求162所述的组合物,其中,所述至少一种分离的多核苷酸含有任何奇数编号的SEQ ID NOS:1-253的核酸序列。
164.如权利要求162所述的组合物,还包含P4前导序列(SEQ ID NO:322)。
165.如权利要求162所述的组合物,其中,所述组合物包含载体。
166.如权利要求162所述的组合物,其中,所述严格条件是高度严格Southern杂交条件。
167.如权利要求162所述的组合物,其中,所述组合物还包含编码其它肽、多肽或蛋白质的核酸序列。
168.一种组合物,其特征在于,所述组合物包含:
载体,所述载体包含:
(a)至少一种含有任何SEQ ID NOS:254-259、260-278或279-299的氨基酸序列的蛋白质;或
(b)至少一种(a)中所述至少一种蛋白质的免疫原性部分;或
(c)至少一种(a)中所述至少一种蛋白质或(b)中所述免疫原性片段的生物学等价物。
169.如权利要求168所述的组合物,其中,所述载体是质粒。
170.如权利要求168所述的组合物,其中,所述载体是噬菌体。
171.如权利要求168所述的组合物,其中,所述载体是细菌噬菌体。
172.如权利要求168所述的组合物,其中,所述载体是温和噬菌体。
173.一种组合物,其特征在于,所述组合物包含:
载体,所述载体含有至少一种编码包含氨基酸序列SEQ ID NO:300的蛋白质的多核苷酸;
其中,x是任何氨基酸;
其中,所述氨基酸位置5-9的区域是任何0-5个氨基酸;
其中,所述氨基酸位置67-69的区域是任何0-3个氨基酸;和
其中,氨基酸位置156是任何0-1个氨基酸。
174.如权利要求173所述的组合物,其中,所述载体是质粒。
175.如权利要求173所述的组合物,其中,所述载体是噬菌体。
176.一种组合物,其特征在于,所述组合物包含:
载体,所述载体包含:
(a)至少一种编码偶数编号的SEQ ID NOS:2-252的至少一种多肽的多核苷酸;或
(b)至少一种在严格条件下与至少一种(a)中所述多核苷酸杂交的多核苷酸。
177.如权利要求176所述的组合物,其中,所述载体包含任何SEQ ID NOS:1-153的核酸序列。
178.如权利要求176所述的组合物,其中,所述载体是质粒。
178.如权利要求176所述的组合物,其中,所述载体是噬菌体。
179.如权利要求176所述的组合物,其中,所述载体是细菌噬菌体。
180.如权利要求176所述的组合物,其中,所述载体是温和噬菌体。
181.一种组合物,其特征在于,所述组合物包含:
用载体转化/转染的宿主细胞,所述载体包含以下任一:
(a)至少一种由奈瑟氏球菌属的开放阅读框(ORF2086)编码的蛋白质,所述开放阅读框编码交叉反应免疫原性抗原,所述交叉反应免疫原性抗原使受试者具有抵抗脑膜炎奈瑟氏球菌血清组B感染的免疫原性;或
(b)至少一种(a)中所述至少一种蛋白质的免疫原性部分;或
(c)至少一种(a)中所述至少一种蛋白质或(b)中所述免疫原性片段的生物学等价物。
182.一种组合物,其特征在于,所述组合物包含:
用载体转化/转染的宿主细胞,所述载体包含以下任一:
(a)至少一种含有任何SEQ ID NOS:254-259、260-278或279-299的蛋白质;或
(b)至少一种(a)中所述至少一种蛋白质的免疫原性部分;或
(c)至少一种(a)中所述至少一种蛋白质或(b)中所述免疫原性片段的生物学等价物。
183.一种用某一方法制备的组合物,其特征在于,所述方法包括:
在宿主细胞中表达编码以下任一的核酸序列:
(a)至少一种由奈瑟氏球菌属的开放阅读框(ORF2086)编码的蛋白质,所述开放阅读框编码交叉反应免疫原性抗原,所述交叉反应免疫原性抗原使受试者具有抵抗脑膜炎奈瑟氏球菌血清组B感染的免疫原性;或
(b)至少一种(a)中所述至少一种蛋白质的免疫原性部分;或
(c)至少一种(a)中所述至少一种蛋白质或(b)中所述免疫原性片段的生物学等价物。
184.如权利要求183所述的组合物,其中,所述核酸序列是任何奇数编号的SEQID NOS:1-253。
185.如权利要求183所述的组合物,其中,所述核酸序列编码包含中任何偶数编号的SEQID NOS:2-252的蛋白质。
186.如权利要求183所述的组合物,其中,所述核酸序列编码包含任何偶数编号的SEQ ID NOS:2-174中的蛋白质。
187.如权利要求183所述的组合物,其中,用质谱测得所述蛋白质的分子量约为26,000-30,000道尔顿。
188.如权利要求1所述的组合物,其中,用10%-20%SDS聚丙烯酰胺凝胶测得至少一种蛋白质的分子量约为28-35kDa。
189.如权利要求183所述的组合物,其中,所述组合物还包含药学上可接受的缓冲剂、稀释剂、佐剂或载体。
190.如权利要求183所述的组合物,其中,所述组合物还包含载体。
191.如权利要求183所述的组合物,其中,所述组合物还包含佐剂。
192.如权利要求191所述的组合物,其中,所述佐剂是液体。
193.如权利要求183所述的组合物,其中,所述蛋白质是脂质化的蛋白质。
194.用一种方法制备的一种组合物,其特征在于,所述方法包括:
从奈瑟氏球菌属中分离并纯化以下任一:
(a)至少一种由奈瑟氏球菌属的开放阅读框(ORF2086)编码的蛋白质,所述开放阅读框编码交叉反应免疫原性抗原,所述交叉反应免疫原性抗原使受试者具有抵抗脑膜炎奈瑟氏球菌血清组B感染的免疫原性;或
(b)至少一种(a)中所述至少一种蛋白质的免疫原性部分;或
(c)至少一种(a)中所述至少一种蛋白质或(b)中所述免疫原性片段的生物学等价物。
195.如权利要求194所述的组合物,其中,至少一种多核苷酸包含任何奇数编号的SEQ ID NOS:1-253的核酸序列。
196.如权利要求194所述的组合物,其中,所述方法还包括将非天然前导序列引入至少一种分离的多核苷酸。
197.如权利要求196所述的组合物,其中,所述非天然前导序列是P4前导序列(SEQ ID NO:322)。
198.用一种方法制备的一种组合物,其特征在于,所述方法包括:
从奈瑟氏球菌属中分离并纯化以下任一:
(a)至少一种包含SEQ ID NOS:254-259、260-278或279-299中任一的蛋白质;或
(b)至少一种(a)中所述至少一种蛋白质的免疫原性部分;或
(c)至少一种(a)中所述至少一种蛋白质或(b)中所述免疫原性片段的生物学等价物。
199.如权利要求198所述的组合物,其中,用质谱测得所述多肽的分子量约为26,000-30,000道尔顿。
200.如权利要求199所述的组合物,其中,用10%-20%SDS聚丙烯酰胺凝胶测得所述多肽的分子量约为28-35kDa。
201.如权利要求198所述的组合物,其中,所述组合物还包含药学上可接受的缓冲剂、稀释剂、佐剂或载体。
202.如权利要求198所述的组合物,其中,所述组合物还包含载体。
203.如权利要求198所述的组合物,其中,所述组合物还包含佐剂。
204.如权利要求203所述的组合物,其中,所述佐剂包含液体。
205.如权利要求198所述的组合物,其中,所述蛋白质是脂质化的蛋白质。
206.用一种方法制备的一种组合物,其特征在于,所述方法包括:
将至少一种包含氨基酸序列SEQ ID NO:300的分离的蛋白质插入载体;
其中,x是任何氨基酸;
其中,所述氨基酸位置5-9的区域是任何0-5个氨基酸;
其中,所述氨基酸位置67-69的区域是任何0-3个氨基酸;和
其中,氨基酸位置156是任何0-1个氨基酸。
207.如权利要求206所述的组合物,其中,所述载体是质粒。
208.如权利要求206所述的组合物,其中,所述载体是噬菌体。
209.如权利要求206所述的组合物,其中,所述载体是细菌噬菌体。
210.如权利要求206所述的组合物,其中,所述载体是温和噬菌体。
211.如权利要求206所述的组合物,还包含非天然前导序列。
212.如权利要求211所述的组合物,其中,所述非天然前导序列是P4前导序列(SEQ ID NO:322)。
213.用一种方法制备的一种组合物,其特征在于,所述方法包括:
在宿主细胞中表达
(a)至少一种分离的多核苷酸,所述多核苷酸编码至少一种由奈瑟氏球菌属的开放阅读框(ORF2086)编码的蛋白质,或至少一种所述至少一种蛋白质的免疫原性部分或生物学等价物,所述开放阅读框编码交叉反应免疫原性抗原,所述交叉反应免疫原性抗原使受试者具有抵抗脑膜炎奈瑟氏球菌血清组B感染的免疫原性,和
(b)与所述至少一种分离的多核苷酸连接的非天然前导序列。
214.如权利要求213所述的组合物,其中,所述非天然前导序列是P4前导序列(SEQ ID NO:322)。
215.用一种方法制备的一种组合物,其特征在于,所述方法包括:
在宿主细胞中表达编码以下任一的核酸序列:
(a)至少一种由奈瑟氏球菌属的开放阅读框(ORF2086)编码的蛋白质,所述开放阅读框编码交叉反应免疫原性抗原,所述交叉反应免疫原性抗原使受试者具有抵抗脑膜炎奈瑟氏球菌血清组B感染的免疫原性;或
(b)至少一种(a)中所述至少一种蛋白质的免疫原性部分;或
(c)至少一种(a)中所述至少一种蛋白质或(b)中所述免疫原性的生物学等价物;或
在宿主细胞中表达在严格条件下与上述核酸序列杂交的核酸序列。
216.如权利要求215所述的组合物,其中,所述核酸序列是任何奇数编号的SEQID NOS:1-253。
217.如权利要求215所述的组合物,其中,所述核酸序列编码任何偶数编号的SEQ ID NOS:2-252。
218.如权利要求215所述的组合物,其中,用质谱测得所述蛋白质的分子量约为26,000-30,000道尔顿。
219.如权利要求218所述的组合物,其中,用10%-20%SDS聚丙烯酰胺凝胶测得所述蛋白质的分子量约为28-35kDa。
220.如权利要求215所述的组合物,其中,所述组合物还包含药学上可接受的缓冲剂、稀释剂、佐剂或载体。
221.如权利要求215所述的组合物,其中,所述组合物还包含载体。
222.如权利要求215所述的组合物,其中,所述组合物还包含佐剂。
223.如权利要求222所述的组合物,其中,所述佐剂包含液体。
224.如权利要求215所述的组合物,其中,所述严格条件是高度严格Southern杂交条件。
225.用一种方法制备的一种组合物,其特征在于,所述方法包括:
从奈瑟氏球菌属中分离并纯化以下任一:
(a)至少一种多核苷酸,所述多核苷酸编码至少一种包含任何偶数编号的SEQ IDNOS:2-252的氨基酸序列的多肽;或
(b)至少一种在严格条件下与至少一种(a)中所述多核苷酸杂交的多核苷酸。
226.如权利要求225所述的组合物,其中,所述至少一种多核苷酸包含任何奇数编号的SEQ ID NOS:1-253的核酸序列。
227.如权利要求225所述的组合物,其中,所述方法还包括将非天然前导序列引入至少一种多核苷酸。
228.如权利要求227所述的组合物,其中,所述非天然前导序列是P4前导序列(SEQ ID NO:322)。
229.用一种方法制备的一种组合物,其特征在于,所述方法包括:
从奈瑟氏球菌属中分离并纯化以下任一:
(a)至少一种包含任何偶数编号的SEQ ID NOS:2-252的氨基酸序列的蛋白质;
(b)至少一种由在严格条件下与含有任何奇数编号的SEQ ID NOS:1-253的核酸序列的多核苷酸杂交的多核苷酸编码的蛋白质;
(c)至少一种(a)或(b)中所述至少一种蛋白质的免疫原性部分;或
(d)至少一种(a)或(b)中所述至少一种蛋白质或(c)中所述免疫原性片段的生物学等价物。
230.如权利要求229所述的组合物,其中,用质谱测得所述蛋白质的分子量约为26,000-30,000道尔顿。
231.如权利要求230所述的组合物,其中,用10%-20%SDS聚丙烯酰胺凝胶测得所述蛋白质的分子量约为28-35kDa。
232.如权利要求229所述的组合物,其中,所述组合物还包含药学上可接受的缓冲剂、稀释剂、佐剂或载体。
233.如权利要求229所述的组合物,其中,所述组合物还包含载体。
234.如权利要求229所述的组合物,其中,所述组合物还包含佐剂。
235.如权利要求234所述的组合物,其中,所述佐剂包含液体。
236.如权利要求229所述的组合物,其中,所述严格条件是高度严格Southern杂交条件。
237.用一种方法制造的一种组合物,其特征在于,所述方法包括:
将以下任一插入载体:
(a)至少一种分离的多核苷酸,所述多核苷酸编码至少一种含有任何偶数编号的SEQ ID NOS:2-252的多肽;或
(b)至少一种在严格条件下与至少一种(a)中所述多核苷酸杂交的分离的多核苷酸。
238.如权利要求237所述的组合物,其中,所述载体是质粒。
239.如权利要求237所述的组合物,其中,所述载体是噬菌体。
240.如权利要求237所述的组合物,其中,所述载体是细菌噬菌体。
241.如权利要求237所述的组合物,其中,所述载体是温和噬菌体。
242.如权利要求237所述的组合物,还包含非天然前导序列。
243.如权利要求24所述的组合物2,其中,所述非天然前导序列是P4前导序列(SEQ ID NO:322)。
244.用一种方法制造的一种组合物,其特征在于,所述方法包括:
在宿主细胞中表达至少一种多核苷酸,所述多核苷酸
(a)编码至少一种由奈瑟氏球菌属的开放阅读框(ORF2086)编码的蛋白质,或至少一种所述至少一种蛋白质的免疫原性部分或生物学等价物,所述开放阅读框编码交叉反应免疫原性抗原,所述交叉反应免疫原性抗原使受试者具有抵抗脑膜炎奈瑟氏球菌血清组B感染的免疫原性;或
(b)在严格条件下与(a)中所述任何多核苷酸杂交。
245.如权利要求244所述的组合物,还包含与所述至少一种多核苷酸连接的非天然前导序列。
246.如权利要求245所述的组合物,其中,所述非天然前导序列是P4前导序列(SEQ ID NO:322)。
247.一种组合物,其特征在于,所述组合物包含:
至少一种免疫原性非菌株特异性脑膜炎奈瑟氏球菌抗原,所述抗原是非病原的且基本上没有任何感染性杂质。
248.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:2-6至少有约70%氨基酸序列同一性的氨基酸序列。
249.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:8-12至少有约70%氨基酸序列同一性的氨基酸序列。
250.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:14-18至少有约70%氨基酸序列同一性的氨基酸序列。
251.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:20-24至少有约70%氨基酸序列同一性的氨基酸序列。
252.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:26-30至少有约70%氨基酸序列同一性的氨基酸序列。
253.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:32-36至少有约70%氨基酸序列同一性的氨基酸序列。
254.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:38-42至少有约70%氨基酸序列同一性的氨基酸序列。
255.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:44-48至少有约70%氨基酸序列同一性的氨基酸序列。
256.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:50-54至少有约70%氨基酸序列同一性的氨基酸序列。
257.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:56-60至少有约70%氨基酸序列同一性的氨基酸序列。
258.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:62-66至少有约70%氨基酸序列同一性的氨基酸序列。
259.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:68-72至少有约70%氨基酸序列同一性的氨基酸序列。
260.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:74-78至少有约70%氨基酸序列同一性的氨基酸序列。
261.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:80-84至少有约70%氨基酸序列同一性的氨基酸序列。
262.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:86-90至少有约70%氨基酸序列同一性的氨基酸序列。
263.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:92-96至少有约70%氨基酸序列同一性的氨基酸序列。
264.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:98-102至少有约70%氨基酸序列同一性的氨基酸序列。
265.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:104-108至少有约70%氨基酸序列同一性的氨基酸序列。
266.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:110-114至少有约70%氨基酸序列同一性的氨基酸序列。
267.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:116-120至少有约70%氨基酸序列同一性的氨基酸序列。
268.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:122-126至少有约70%氨基酸序列同一性的氨基酸序列。
269.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:128-132至少有约70%氨基酸序列同一性的氨基酸序列。
270.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:134-138至少有约70%氨基酸序列同一性的氨基酸序列。
271.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:140-144至少有约70%氨基酸序列同一性的氨基酸序列。
272.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:146-150至少有约70%氨基酸序列同一性的氨基酸序列。
273.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:152-156至少有约70%氨基酸序列同一性的氨基酸序列。
274.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:158-162至少有约70%氨基酸序列同一性的氨基酸序列。
275.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:164-168至少有约70%氨基酸序列同一性的氨基酸序列。
276.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:170-174至少有约70%氨基酸序列同一性的氨基酸序列。
277.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:176-180至少有约70%氨基酸序列同一性的氨基酸序列。
278.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:182-186至少有约70%氨基酸序列同一性的氨基酸序列。
279.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:188-192至少有约70%氨基酸序列同一性的氨基酸序列。
280.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:194-198至少有约70%氨基酸序列同一性的氨基酸序列。
281.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:200-204至少有约70%氨基酸序列同一性的氨基酸序列。
282.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:206-210至少有约70%氨基酸序列同一性的氨基酸序列。
283.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:212-216至少有约70%氨基酸序列同一性的氨基酸序列。
284.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:218-222至少有约70%氨基酸序列同一性的氨基酸序列。
285.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:224-228至少有约70%氨基酸序列同一性的氨基酸序列。
286.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:230-234至少有约70%氨基酸序列同一性的氨基酸序列。
287.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:236-240至少有约70%氨基酸序列同一性的氨基酸序列。
288.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:242-246至少有约70%氨基酸序列同一性的氨基酸序列。
289.如权利要求247所述的抗原,其中,所述抗原包含与任何偶数编号的SEQ IDNOS:248-252至少有约70%氨基酸序列同一性的氨基酸序列。
290.如权利要求1-289中任一项所述的组合物在制备哺乳动物中诱导免疫应答的药物中的应用。
291.如权利要求290所述的应用,其中,所述组合物是肠胃外给药的。
292.如权利要求290所述的应用,其中,所述组合物是粘膜给药的。
293.如权利要求1-289中任一项所述的组合物在制备使哺乳动物有效抵抗细菌性脑膜炎的药物中的应用。
294.如权利要求293所述的组合物的应用,其中,所述组合物是肠胃外给药的。
295.如权利要求293所述的组合物的应用,其中,所述组合物是粘膜给药的。
296.如权利要求293所述的组合物的应用,其中,所述组合物是皮下注射或肌内注射给药的。
297.一种制备组合物的方法,其特征在于,所述方法包括:
在宿主细胞中表达编码以下任一的核酸序列:
(a)至少一种由奈瑟氏球菌属的开放阅读框(ORF2086)编码的蛋白质,所述开放阅读框编码交叉反应免疫原性抗原,所述交叉反应免疫原性抗原使受试者具有抵抗脑膜炎奈瑟氏球菌血清组B感染的免疫原性;或
(b)至少一种(a)中所述至少一种蛋白质的免疫原性部分;或
(c)至少一种(a)中所述至少一种蛋白质或(b)中所述免疫原性片段的生物学等价物。
298.如权利要求297所述的方法,其中,所述核酸序列是体内表达的。
299.如权利要求297所述的方法,其中,所述核酸序列是体外表达的。
300.如权利要求297所述的方法,还包含连接P4前导序列(SEQ ID NO:322)。
301.如权利要求297所述的方法,其中,至少一种蛋白质包含任何SEQ IDNOS:254-299。
302.一种制备组合物的方法,其特征在于,所述方法包括:
从脑膜炎奈瑟氏球菌(N.meningitidis)分离并纯化至少一种多核苷酸,所述多核苷酸
(a)编码至少一种由奈瑟氏球菌属的开放阅读框(ORF2086)编码的蛋白质,或至少一种所述至少一种蛋白质的免疫原性部分或生物学等价物,所述开放阅读框编码交叉反应免疫原性抗原,所述交叉反应免疫原性抗原使受试者具有抵抗脑膜炎奈瑟氏球菌血清组B感染的免疫原性;
或(b)在严格条件下与(a)中所述任何多核苷酸杂交。
303.如权利要求302所述的方法,其中,所述严格条件是高度严格Southern杂交条件。
304.一种制备组合物的方法,其特征在于,所述方法包括:
从奈瑟氏球菌属中分离并纯化这里所述的任何蛋白质、免疫原性蛋白或生物学等价物。
305.一种制备抗体组合物的方法,其特征在于,所述方法包括:
将含有这里所述的任何蛋白质、免疫原性蛋白或生物学等价物的组合物引入动物后从动物回收抗体。
306.一种在哺乳动物中诱导免疫应答的方法,其特征在于,所述方法包括:
给予哺乳动物有效量的一种或多种权利要求1-289所述的组合物。
307.如权利要求306所述的方法,其中,所述组合物是肠胃外给药的。
308.如权利要求306所述的方法,其中,所述组合物是粘膜给药的。
309.一种在哺乳动物中预防或治疗细菌性脑膜炎的方法,其特征在于,所述方法包括:
给予哺乳动物有效量的一种或多种权利要求1-289所述的组合物。
310.如权利要求309所述的方法,其中,所述组合物是肠胃外给药的。
311.如权利要求309所述的方法,其中,所述组合物是粘膜给药的。
312.如权利要求309所述的方法,其中,所述组合物是皮下注射或肌内注射给药的。
313.一种在哺乳动物中预防或治疗细菌性脑膜炎的方法,其特征在于,所述方法包括:
给予哺乳动物有效量的含有抗体的抗体组合物,所述抗体免疫特异性结合含有任何偶数编号的SEQ ID NOS:2-252的氨基酸序列或任何SEQ ID NOS:254-299的氨基酸序列的蛋白质、免疫原性部分或生物学等价物。
313.如权利要求312所述的方法,其中,所述抗体组合物是肠胃外给药的。
314.如权利要求312所述的方法,其中,所述抗体组合物是粘膜给药的。
315.如权利要求312所述的方法,其中,所述抗体组合物是皮下注射或肌内注射给药的。
316.一种制备组合物的方法,其特征在于,所述方法包括:
在宿主细胞中表达编码以下任一的核酸序列:
(a)至少一种包含任何偶数编号的SEQ ID NOS:2-252的氨基酸序列或任何SEQID NOS:254-299的氨基酸序列的蛋白质;
(b)至少一种由在严格条件下与含有任何奇数编号的SEQ ID NOS:1-253的核酸序列的多核苷酸杂交的多核苷酸编码的蛋白质;
(c)至少一种(a)或(b)中所述至少一种蛋白质的免疫原性部分;或
(d)至少一种(a)或(b)中所述至少一种蛋白质或(c)中所述免疫原性片段的生物学等价物。
317.如权利要求316所述的方法,其中,所述核酸序列是体内表达的。
318.如权利要求316所述的方法,其中,所述核酸序列是体外表达的。
319.如权利要求316所述的方法,其中,所述载体是质粒。
320.如权利要求316所述的方法,其中,所述载体是噬菌体。
321.如权利要求316所述的方法,还包含将非天然前导序列与所述至少一种分离的多核苷酸连接。
322.如权利要求316所述的方法,其中,所述非天然前导序列是P4前导序列(SEQ ID NO:267)。
323.一种制备组合物的方法,其特征在于,所述方法包括:
从奈瑟氏球菌属分离并纯化至少一种含有氨基酸序列SEQ ID NO:300的分离的蛋白质;
其中,x是任何氨基酸;
其中,所述氨基酸位置5-9的区域是任何0-5个氨基酸;
其中,所述氨基酸位置67-69的区域是任何0-3个氨基酸;和
其中,氨基酸位置156是任何0-1个氨基酸。
324.如权利要求323所述的方法,还包含将非天然前导序列引入至少一种分离的多核苷酸。
325.如权利要求323所述的方法,其中,所述非天然前导序列是P4前导序列(SEQ ID NO:322)。
326.一种制备组合物的方法,其特征在于,所述方法包括:
从奈瑟氏球菌属中分离并纯化以下任一:
(a)至少一种包含任何偶数编号的SEQ ID NOS:2-252的氨基酸序列或任何SEQID NOS:254-259、260-278或279-299的氨基酸序列的蛋白质;或
(b)至少一种由在严格条件下与包含任何奇数编号的SEQ ID NOS:1-253的多核苷酸杂交的多核苷酸编码的蛋白质。
327.如权利要求326所述的方法,其中,所述严格条件是高度严格Southern杂交条件。
328.一种制备抗体组合物的方法,其特征在于,所述方法包括:
将组合物引入动物后从动物回收抗体,所述组合物含有:
(a)至少一种包含中任何偶数编号的SEQ ID NOS:2-252的氨基酸序列或任何SEQID NOS:254-259、260-278或279-299的氨基酸序列的蛋白质;或
(b)至少一种由在严格条件下与包含任何奇数编号的SEQ ID NOS:1-253的多核苷酸杂交的多核苷酸编码的蛋白质。
329.如权利要求328所述的方法,其中,所述严格条件是高度严格Southern杂交条件。
330.一种转化/转染或感染细胞系的方法,其特征在于,所述细胞系包含:
表达一种核酸序列的重组细胞,所述核酸序列
(a)编码至少一种包含SEQ ID NOS:254-259、260-278或279-299的氨基酸序列的分离的蛋白质,或
(b)在严格条件下与(a)中所述任何多核苷酸杂交。
331.一种转化/转染或感染细胞系的方法,其特征在于,所述细胞系包含:
表达一种核酸序列的重组细胞,所述核酸序列
(a)编码至少一种由奈瑟氏球菌属的开放阅读框(ORF2086)编码的蛋白质,或至少一种所述至少一种蛋白质的免疫原性部分或生物学等价物,所述开放阅读框编码交叉反应免疫原性抗原,所述交叉反应免疫原性抗原使受试者具有抵抗脑膜炎奈瑟氏球菌血清组B感染的免疫原性,或
(b)在严格条件下与(a)中所述任何多核苷酸杂交;或
表达一种核酸序列的重组细胞,所述核酸序列编码:
(c)至少一种由(a)或(b)中任一编码的多肽;或
(d)至少一种包含中任何偶数编号的SEQ ID NOS:2-252的氨基酸序列的多肽。
332.如权利要求331所述的转化/转染或感染细胞系,其中,所述多肽是单克隆抗体。
333.如权利要求331所述的转化/转染或感染细胞系,其中,所述重组细胞是杂交瘤。
334.如权利要求331所述的转化/转染或感染细胞系,其中,所述重组细胞是三体杂交瘤(trioma)。
335.一种转化/转染或感染细胞系,其特征在于,所述细胞系包含:
表达一种核酸序列的重组细胞,所述核酸序列
(a)至少一种编码含有任何偶数编号的SEQ ID NOS:2-252的蛋白质的多核苷酸;
(b)至少一种包含任何奇数编号的SEQ ID NOS:1-253的核酸序列的多核苷酸;
(c)至少一种在严格条件下(a)或(b)中任一杂交的多核苷酸;或
表达一种核酸序列的重组细胞,所述核酸序列编码:
(d)至少一种编码(a)、(b)或(c)中任一的多肽;或
(e)至少一种包含任何偶数编号的SEQ ID NOS:2-252的氨基酸序列的多肽。
336.如权利要求335所述的转化/转染或感染细胞系,其中,所述多肽是单克隆抗体。
337.如权利要求335所述的转化/转染或感染细胞系,其中,所述重组细胞是杂交瘤。
338.如权利要求335所述的转化/转染或感染细胞系,其中,所述重组细胞是三体杂交瘤。
339.一种鉴定免疫原性蛋白质的方法,其特征在于,所述方法包括:
检测测试样品中抗ORF2086抗血清的杀菌活性。
340.一种鉴定免疫原性蛋白质的方法,其特征在于,所述方法包括:
检测测试样品中的多核苷酸抗ORF2086核酸探针的多核苷酸。
341.一种大致如上所述的组合物。
342.一种大致如上所述的应用。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210209882.3A CN102836426B (zh) | 2001-10-11 | 2002-10-11 | 预防和治疗脑膜炎球菌性疾病的新型免疫原性组合物 |
CN201511028093.XA CN105617372A (zh) | 2001-10-11 | 2002-10-11 | 预防和治疗脑膜炎球菌性疾病的新型免疫原性组合物 |
CN201210211368.3A CN102755631B (zh) | 2001-10-11 | 2002-10-11 | 预防和治疗脑膜炎球菌性疾病的新型免疫原性组合物 |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32810101P | 2001-10-11 | 2001-10-11 | |
US60/328,101 | 2001-10-11 | ||
US40693402P | 2002-08-30 | 2002-08-30 | |
US60/406,934 | 2002-08-30 | ||
PCT/US2002/032369 WO2003063766A2 (en) | 2001-10-11 | 2002-10-11 | Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210211368.3A Division CN102755631B (zh) | 2001-10-11 | 2002-10-11 | 预防和治疗脑膜炎球菌性疾病的新型免疫原性组合物 |
CN201210209882.3A Division CN102836426B (zh) | 2001-10-11 | 2002-10-11 | 预防和治疗脑膜炎球菌性疾病的新型免疫原性组合物 |
CN201511028093.XA Division CN105617372A (zh) | 2001-10-11 | 2002-10-11 | 预防和治疗脑膜炎球菌性疾病的新型免疫原性组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1578785A true CN1578785A (zh) | 2005-02-09 |
CN1578785B CN1578785B (zh) | 2013-03-13 |
Family
ID=27668840
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201511028093.XA Pending CN105617372A (zh) | 2001-10-11 | 2002-10-11 | 预防和治疗脑膜炎球菌性疾病的新型免疫原性组合物 |
CN028233301A Expired - Lifetime CN1578785B (zh) | 2001-10-11 | 2002-10-11 | 预防和治疗脑膜炎球菌性疾病的新型免疫原性组合物 |
CN201210209882.3A Expired - Lifetime CN102836426B (zh) | 2001-10-11 | 2002-10-11 | 预防和治疗脑膜炎球菌性疾病的新型免疫原性组合物 |
CN201210211368.3A Expired - Lifetime CN102755631B (zh) | 2001-10-11 | 2002-10-11 | 预防和治疗脑膜炎球菌性疾病的新型免疫原性组合物 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201511028093.XA Pending CN105617372A (zh) | 2001-10-11 | 2002-10-11 | 预防和治疗脑膜炎球菌性疾病的新型免疫原性组合物 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210209882.3A Expired - Lifetime CN102836426B (zh) | 2001-10-11 | 2002-10-11 | 预防和治疗脑膜炎球菌性疾病的新型免疫原性组合物 |
CN201210211368.3A Expired - Lifetime CN102755631B (zh) | 2001-10-11 | 2002-10-11 | 预防和治疗脑膜炎球菌性疾病的新型免疫原性组合物 |
Country Status (19)
Country | Link |
---|---|
US (13) | US8101194B2 (zh) |
EP (14) | EP2371836B1 (zh) |
JP (6) | JP2005515771A (zh) |
KR (4) | KR101215664B1 (zh) |
CN (4) | CN105617372A (zh) |
AU (3) | AU2009213040C1 (zh) |
BE (3) | BE2017C055I2 (zh) |
BR (1) | BRPI0212999B8 (zh) |
CA (5) | CA2918207C (zh) |
DK (10) | DK2341063T3 (zh) |
ES (14) | ES2549765T3 (zh) |
FR (4) | FR15C0056I2 (zh) |
HK (2) | HK1178429A1 (zh) |
IL (5) | IL161052A0 (zh) |
LU (4) | LU92786I2 (zh) |
MX (3) | MX339524B (zh) |
NL (3) | NL300897I2 (zh) |
PT (10) | PT2371836T (zh) |
WO (1) | WO2003063766A2 (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104602704A (zh) * | 2012-06-14 | 2015-05-06 | 诺华股份有限公司 | 针对血清组x脑膜炎球菌的疫苗 |
CN105879021A (zh) * | 2006-04-26 | 2016-08-24 | 惠氏公司 | 使免疫原性组合物稳定且抑制其沉淀的新颖调配物 |
CN106434720A (zh) * | 2016-08-03 | 2017-02-22 | 中国医学科学院医学生物学研究所 | 提高脑膜炎奈瑟菌fHBP蛋白表达的方法 |
CN107056901A (zh) * | 2012-03-09 | 2017-08-18 | 辉瑞公司 | 脑膜炎双球菌组合物及其方法 |
CN110845585A (zh) * | 2010-03-30 | 2020-02-28 | 奥克兰儿童医院及研究中心 | 改性的h因子结合蛋白(fhbp)及其使用方法 |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001031019A2 (en) | 1999-10-29 | 2001-05-03 | Chiron Spa | Neisserial antigenic peptides |
JP5102414B2 (ja) | 1998-05-01 | 2012-12-19 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | 髄膜炎菌抗原および組成物 |
DK2270173T3 (en) | 1999-05-19 | 2016-03-07 | Glaxosmithkline Biolog Sa | Neisserial combination compositions |
CN1416352B (zh) | 2000-01-17 | 2011-05-25 | 启龙股份公司 | 含有脑膜炎奈瑟球菌b血清群外膜蛋白质的外膜囊(omv)疫苗 |
MXPA02008314A (es) | 2000-02-28 | 2002-12-09 | Chiron Spa | Expresion heterologa de proteinas de neisseria. |
GB0118249D0 (en) | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
GB0121591D0 (en) | 2001-09-06 | 2001-10-24 | Chiron Spa | Hybrid and tandem expression of neisserial proteins |
MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
CA2501812C (en) | 2002-10-11 | 2012-07-10 | Mariagrazia Pizza | Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages |
GB0227346D0 (en) * | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
ES2411080T3 (es) | 2003-01-30 | 2013-07-04 | Novartis Ag | Vacunas inyectables contra múltiples serogrupos de meningococos |
MXPA05011110A (es) * | 2003-04-16 | 2006-01-24 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de un padecimiento originado por meningococos. |
RU2378010C2 (ru) | 2003-10-02 | 2010-01-10 | Новартис Вэксинес Энд Дайэгностикс С.Р.Л. | Жидкие вакцины для множественных серогрупп менингококков |
GB0408977D0 (en) | 2004-04-22 | 2004-05-26 | Chiron Srl | Immunising against meningococcal serogroup Y using proteins |
GB0419408D0 (en) * | 2004-09-01 | 2004-10-06 | Chiron Srl | 741 chimeric polypeptides |
US7709001B2 (en) | 2005-04-08 | 2010-05-04 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
EP2425855A1 (en) | 2005-04-08 | 2012-03-07 | Wyeth LLC | Multivalent pneumococcal polysaccharide-protein conjugate composition |
PT2351578T (pt) | 2005-06-27 | 2017-04-07 | Glaxosmithkline Biologicals Sa | Processo para o fabrico de vacinas |
AU2013201318B2 (en) * | 2005-11-25 | 2015-11-19 | Glaxosmithkline Biologicals Sa | Chimeric, hybrid and tandem polypeptides of meningococcal NMB 1870 |
GB0524066D0 (en) * | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
AU2016204760A1 (en) * | 2006-04-26 | 2016-07-28 | Wyeth Llc | Novel formulations which stabilize and inhibit precipitation of immunogenic compositions |
AU2014268186C1 (en) * | 2006-04-26 | 2017-12-07 | Wyeth Llc | Novel formulations which stabilize and inhibit precipitation of immunogenic compositions |
DK2061897T3 (da) | 2006-07-27 | 2020-06-02 | Wyeth Llc | Fed-batch-fermenteringsproces med høj celledensitet til fremstilling af rekombinant protein |
AR064642A1 (es) | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
GB0700562D0 (en) | 2007-01-11 | 2007-02-21 | Novartis Vaccines & Diagnostic | Modified Saccharides |
EP2245048B1 (en) * | 2008-02-21 | 2014-12-31 | Novartis AG | Meningococcal fhbp polypeptides |
CN102300585A (zh) | 2008-12-17 | 2011-12-28 | 诺华有限公司 | 包含血红蛋白受体的脑膜炎球菌疫苗 |
WO2010109324A1 (en) | 2009-03-24 | 2010-09-30 | Novartis Ag | Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates |
WO2010109323A1 (en) | 2009-03-24 | 2010-09-30 | Novartis Ag | Adjuvanting meningococcal factor h binding protein |
ES2596653T3 (es) | 2009-06-16 | 2017-01-11 | Glaxosmithkline Biologicals Sa | Ensayos bactericidas de opsonización y dependientes de anticuerpo mediado por el complemento de alto rendimiento |
AU2010288240B2 (en) | 2009-08-27 | 2014-03-27 | Novartis Ag | Hybrid polypeptides including meningococcal fHBP sequences |
CA2772103A1 (en) | 2009-08-27 | 2011-03-03 | Novartis Ag | Adjuvant comprising aluminium, oligonucleotide and polycation |
WO2011039631A2 (en) | 2009-09-30 | 2011-04-07 | Novartis Ag | Expression of meningococcal fhbp polypeptides |
AU2010310985B2 (en) | 2009-10-27 | 2014-11-06 | Glaxosmithkline Biologicals S.A. | Modified meningococcal fHBP polypeptides |
PL2575870T3 (pl) | 2010-06-04 | 2017-05-31 | Wyeth Llc | Preparaty szczepionek |
EP2585106A1 (en) * | 2010-06-25 | 2013-05-01 | Novartis AG | Combinations of meningococcal factor h binding proteins |
SI3246044T2 (sl) * | 2010-08-23 | 2024-06-28 | Wyeth Llc | Stabilne formulacije antigenov neisseria meningitidis RLP2086 |
CA2810971C (en) | 2010-09-10 | 2020-11-03 | Novartis Ag | Developments in meningococcal outer membrane vesicles |
ES2585328T5 (es) | 2010-09-10 | 2022-12-14 | Wyeth Llc | Variantes no lipidadas de antígenos ORF2086 de Neisseria meningitidis |
GB201015132D0 (en) * | 2010-09-10 | 2010-10-27 | Univ Bristol | Vaccine composition |
US20140112950A1 (en) | 2011-03-02 | 2014-04-24 | Manmohan Singh | Combination vaccines with lower doses of antigen and/or adjuvant |
EP2707009A1 (en) | 2011-05-12 | 2014-03-19 | Novartis AG | Antipyretics to enhance tolerability of vesicle-based vaccines |
JP2015505309A (ja) * | 2011-12-29 | 2015-02-19 | ノバルティス アーゲー | 髄膜炎菌h因子結合タンパク質のアジュバントされた組み合わせ |
ES2654613T3 (es) | 2012-02-02 | 2018-02-14 | Glaxosmithkline Biologicals Sa | Promotores para una expresión aumentada de proteínas en meningococos |
EP2823312B1 (en) | 2012-03-08 | 2019-08-07 | GlaxoSmithKline Biologicals SA | In vitro potency assay for protein-based meningococcal vaccines |
JP2015509963A (ja) | 2012-03-08 | 2015-04-02 | ノバルティス アーゲー | Tlr4アゴニストを含む混合ワクチン |
SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
CN104736563A (zh) | 2012-07-27 | 2015-06-24 | 国家健康与医学研究院 | Cd147作为受体用于脑膜炎球菌至血管内皮的菌毛介导的粘附 |
JP6324961B2 (ja) | 2012-09-06 | 2018-05-16 | ノバルティス アーゲー | 血清群b髄膜炎菌とd/t/pとの組み合わせワクチン |
JP6446377B2 (ja) | 2013-03-08 | 2018-12-26 | ファイザー・インク | 免疫原性融合ポリペプチド |
CN105431167A (zh) | 2013-08-02 | 2016-03-23 | 奥克兰儿童医院及研究中心 | 非天然发生因子h结合蛋白(fhbp)及其使用方法 |
EP3041502A2 (en) * | 2013-09-08 | 2016-07-13 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
CA2940447C (en) | 2014-02-28 | 2023-07-11 | Glaxosmithkline Biologicals Sa | Modified meningococcal fhbp polypeptides |
EP4074726A3 (en) | 2014-07-23 | 2022-11-23 | Children's Hospital & Research Center at Oakland | Factor h binding protein variants and methods of use thereof |
WO2016081314A1 (en) | 2014-11-17 | 2016-05-26 | Alexion Pharmaceuticals, Inc. | Risk evaluation and management strategy involving patient follow-ups relating to a complement inhibitor |
RU2723045C2 (ru) | 2015-02-19 | 2020-06-08 | Пфайзер Инк. | Композиции neisseria meningitidis и способы их получения |
EP3263695A1 (en) | 2016-06-29 | 2018-01-03 | GlaxoSmithKline Biologicals SA | Immunogenic compositions |
US12109259B2 (en) | 2016-09-02 | 2024-10-08 | Glaxosmithkline Biologicals Sa | Vaccines for Neisseria gonorrhoeae |
SI3506935T1 (sl) | 2016-09-02 | 2024-06-28 | Sanofi Pasteur, Inc. | Cepivo proti neisseriji meningitidis |
US10738338B2 (en) | 2016-10-18 | 2020-08-11 | The Research Foundation for the State University | Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate |
IL267733B2 (en) | 2017-01-31 | 2023-10-01 | Pfizer | NEISSERIA MENINGITIDIS preparations and methods therefor |
WO2019065555A1 (ja) | 2017-09-28 | 2019-04-04 | 富士フイルム株式会社 | 撮像装置、情報取得方法及び情報取得プログラム |
CN111316161B (zh) * | 2017-09-28 | 2021-11-23 | 富士胶片株式会社 | 摄像装置、信息获取方法及信息获取程序 |
TWI687696B (zh) * | 2019-06-26 | 2020-03-11 | 國立中興大學 | 回饋型隱藏式馬可夫模型辨識器的建立方法與基於此辨識器的辨識系統的建立方法 |
CN114681601A (zh) * | 2020-12-31 | 2022-07-01 | 基础治疗有限公司 | 脑膜炎奈瑟氏球菌疫苗及其应用 |
TW202245836A (zh) | 2021-02-19 | 2022-12-01 | 美商賽諾菲巴斯德公司 | 重組b型腦膜炎球菌疫苗 |
GB202115077D0 (en) | 2021-10-21 | 2021-12-08 | Glaxosmithkline Biologicals Sa | Assay |
WO2023138914A1 (en) | 2022-01-24 | 2023-07-27 | Koninklijke Philips N.V. | Pulse wave velocity determination using co-registration between intravascular data and extraluminal image, and associated systems, devices, and methods |
GB202208089D0 (en) | 2022-06-01 | 2022-07-13 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
GB202208093D0 (en) | 2022-06-01 | 2022-07-13 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
TW202423477A (zh) | 2022-08-03 | 2024-06-16 | 美商賽諾菲巴斯德公司 | 針對腦膜炎奈瑟氏菌b的含佐劑免疫原性組成物 |
Family Cites Families (248)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT280356B (de) | 1968-03-06 | 1970-04-10 | Telefonbau & Normalzeit Gmbh | Schaltungsanordnung zur Steuerung des zur Zwischenspeicherung des Zeitwertes eines Signales verwendeten Kondensators eines Demodulators einer Zeitmultiplexanlage |
US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
CH660375A5 (it) | 1983-02-08 | 1987-04-15 | Sclavo Spa | Procedimento per la produzione di proteine correlate alla tossina difterica. |
CA1247080A (en) | 1983-03-08 | 1988-12-20 | Commonwealth Serum Laboratories Commission | Antigenically active amino acid sequences |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4650764A (en) | 1983-04-12 | 1987-03-17 | Wisconsin Alumni Research Foundation | Helper cell |
US4668829A (en) * | 1984-07-18 | 1987-05-26 | University Patents, Inc. | Ferroelectric smectic liquid crystals |
JPS6147500A (ja) | 1984-08-15 | 1986-03-07 | Res Dev Corp Of Japan | キメラモノクロ−ナル抗体及びその製造法 |
EP0173494A3 (en) | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric receptors by dna splicing and expression |
GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
GB8424757D0 (en) | 1984-10-01 | 1984-11-07 | Pasteur Institut | Retroviral vector |
SE8405493D0 (sv) | 1984-11-01 | 1984-11-01 | Bror Morein | Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel |
FR2573436B1 (fr) | 1984-11-20 | 1989-02-17 | Pasteur Institut | Adn recombinant comportant une sequence nucleotidique codant pour un polypeptide determine sous le controle d'un promoteur d'adenovirus, vecteurs contenant cet adn recombinant, cellules eucaryotes transformees par cet adn recombinant, produits d'excretion de ces cellules transformees et leurs applications, notamment a la constitution de vaccins |
JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
US4666829A (en) | 1985-05-15 | 1987-05-19 | University Of California | Polypeptide marker for Alzheimer's disease and its use for diagnosis |
WO1987001130A1 (en) | 1985-08-15 | 1987-02-26 | Stauffer Chemical Company | Tryptophan producing microorganism |
US5078996A (en) | 1985-08-16 | 1992-01-07 | Immunex Corporation | Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor |
US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
AU606320B2 (en) | 1985-11-01 | 1991-02-07 | International Genetic Engineering, Inc. | Modular assembly of antibody genes, antibodies prepared thereby and use |
US4861719A (en) | 1986-04-25 | 1989-08-29 | Fred Hutchinson Cancer Research Center | DNA constructs for retrovirus packaging cell lines |
US5514581A (en) * | 1986-11-04 | 1996-05-07 | Protein Polymer Technologies, Inc. | Functional recombinantly prepared synthetic protein polymer |
US4980289A (en) | 1987-04-27 | 1990-12-25 | Wisconsin Alumni Research Foundation | Promoter deficient retroviral vector |
US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
RU2023448C1 (ru) | 1987-07-30 | 1994-11-30 | Сентро Насьональ Де Биопрепарадос | Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в |
JPH01144977A (ja) | 1987-11-30 | 1989-06-07 | Agency Of Ind Science & Technol | 新規組換えプラスミドpTPGIF2 |
WO1989007150A1 (en) | 1988-02-05 | 1989-08-10 | The Trustees Of Columbia University In The City Of | Retroviral packaging cell lines and processes of using same |
US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
CA1339354C (en) | 1988-09-01 | 1997-08-26 | The Whitehead Institute For Biomedical Research | Recombinant retroviruses with amphotropic and ecotropic host ranges |
US7118757B1 (en) * | 1988-12-19 | 2006-10-10 | Wyeth Holdings Corporation | Meningococcal class 1 outer-membrane protein vaccine |
US5124263A (en) | 1989-01-12 | 1992-06-23 | Wisconsin Alumni Research Foundation | Recombination resistant retroviral helper cell and products produced thereby |
KR100188323B1 (ko) | 1989-03-09 | 1999-06-01 | 이곤 이이 버어그 | 비타입성 헤모필루스 인플렌자에 대한 백신 |
US5354844A (en) | 1989-03-16 | 1994-10-11 | Boehringer Ingelheim International Gmbh | Protein-polycation conjugates |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
HU212924B (en) | 1989-05-25 | 1996-12-30 | Chiron Corp | Adjuvant formulation comprising a submicron oil droplet emulsion |
US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
US5585362A (en) | 1989-08-22 | 1996-12-17 | The Regents Of The University Of Michigan | Adenovirus vectors for gene therapy |
CA2039921A1 (en) | 1990-04-16 | 1991-10-17 | Xandra O. Breakefield | Transfer and expression of gene sequences into central nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication |
US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
WO1991018088A1 (en) | 1990-05-23 | 1991-11-28 | The United States Of America, Represented By The Secretary, United States Department Of Commerce | Adeno-associated virus (aav)-based eucaryotic vectors |
EP0467714A1 (en) | 1990-07-19 | 1992-01-22 | Merck & Co. Inc. | The class II protein of the outer membrane of neisseria meningitidis |
JPH0453645U (zh) * | 1990-09-12 | 1992-05-07 | ||
ES2150416T3 (es) | 1990-09-25 | 2000-12-01 | Cantab Pharma Res | Vacuna virica defectiva producida por una linea celular complementada en trans. |
US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
IL101715A (en) | 1991-05-02 | 2005-06-19 | Amgen Inc | Recombinant dna-derived cholera toxin subunit analogs |
AU681572B2 (en) | 1991-10-21 | 1997-09-04 | Med Immune, Inc. | Bacterial expression vectors containing DNA encoding secretion signals of lipoproteins |
US5252479A (en) | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
IT1253009B (it) | 1991-12-31 | 1995-07-10 | Sclavo Ricerca S R L | Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini |
WO1993015115A1 (en) * | 1992-01-24 | 1993-08-05 | Cornell Research Foundation, Inc. | E. coli dna polymerase iii holoenzyme and subunits |
WO1994012649A2 (en) | 1992-12-03 | 1994-06-09 | Genzyme Corporation | Gene therapy for cystic fibrosis |
ES2231770T3 (es) | 1993-03-05 | 2005-05-16 | Wyeth Holdings Corporation | Nuevos plasmidos para la produccion de proteina crm y toxina difterica. |
JPH08507784A (ja) | 1993-03-19 | 1996-08-20 | キャンタブ ファーマシューティカルズ リサーチ リミティド | ウイルス・ワクチン |
DK0624376T3 (da) | 1993-05-13 | 2000-07-24 | American Cyanamid Co | Fremstilling og anvendelse af LOS-udtømte ydre membranproteiner af gram-negative cocci |
FR2705361B1 (fr) | 1993-05-18 | 1995-08-04 | Centre Nat Rech Scient | Vecteurs viraux et utilisation en thérapie génique. |
FR2705686B1 (fr) | 1993-05-28 | 1995-08-18 | Transgene Sa | Nouveaux adénovirus défectifs et lignées de complémentation correspondantes. |
RU2219241C2 (ru) | 1993-07-13 | 2003-12-20 | Рон-Пуленк Роре С.А. | Дефектный рекомбинантный аденовирусный вектор (варианты) |
US5439808A (en) * | 1993-07-23 | 1995-08-08 | North American Vaccine, Inc. | Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis |
AU7477394A (en) | 1993-07-30 | 1995-03-27 | University Of Medicine And Dentistry Of New Jersey | Efficient gene transfer into primary lymphocytes |
FR2708622B1 (fr) | 1993-08-02 | 1997-04-18 | Raymond Hamers | Vecteur recombinant contenant une séquence d'un gène de lipoprotéine de structure pour l'expression de séquences de nucléotides. |
US5550213A (en) * | 1993-12-27 | 1996-08-27 | Rutgers, The State University Of New Jersey | Inhibitors of urokinase plasminogen activator |
FR2714830B1 (fr) | 1994-01-10 | 1996-03-22 | Rhone Poulenc Rorer Sa | Composition contenant des acides nucléiques, préparation et utilisations. |
FR2715847B1 (fr) | 1994-02-08 | 1996-04-12 | Rhone Poulenc Rorer Sa | Composition contenant des acides nucléiques, préparation et utilisations. |
FI98045C (fi) | 1994-02-21 | 1997-04-10 | Arto Remes | Laite inkontinenssihoitoa varten |
FR2716459B1 (fr) | 1994-02-22 | 1996-05-10 | Univ Paris Curie | Système hôte-vecteur utilisable en thérapie génique. |
AU2194895A (en) | 1994-03-25 | 1995-10-17 | Uab Research Foundation, The | Composition and methods for creating syngeneic recombinant virus-producing cells |
US5739118A (en) | 1994-04-01 | 1998-04-14 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
WO1995028494A1 (en) | 1994-04-15 | 1995-10-26 | Targeted Genetics Corporation | Gene delivery fusion proteins |
US5571515A (en) | 1994-04-18 | 1996-11-05 | The Wistar Institute Of Anatomy & Biology | Compositions and methods for use of IL-12 as an adjuvant |
WO1995029662A2 (en) * | 1994-04-20 | 1995-11-09 | U.S. Department Of The Army | Vaccine against gram-negative bacterial infections |
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US5565204A (en) | 1994-08-24 | 1996-10-15 | American Cyanamid Company | Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections |
US5837533A (en) | 1994-09-28 | 1998-11-17 | American Home Products Corporation | Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent |
GB9422096D0 (en) | 1994-11-02 | 1994-12-21 | Biocine Spa | Combined meningitis vaccine |
FR2727679B1 (fr) | 1994-12-05 | 1997-01-03 | Rhone Poulenc Rorer Sa | Nouveaux agents de transfection et leurs applications pharmaceutiques |
BE1008978A5 (fr) | 1994-12-27 | 1996-10-01 | Solvay | Adjuvants pour vaccins. |
IL116816A (en) | 1995-01-20 | 2003-05-29 | Rhone Poulenc Rorer Sa | Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof |
FR2730637B1 (fr) | 1995-02-17 | 1997-03-28 | Rhone Poulenc Rorer Sa | Composition pharmaceutique contenant des acides nucleiques, et ses utilisations |
IL117483A (en) | 1995-03-17 | 2008-03-20 | Bernard Brodeur | MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K. |
AU6043396A (en) | 1995-06-05 | 1996-12-24 | University Of Alabama At Birmingham Research Foundation, The | Composition and methods for creating syngeneic recombinant v irus-producing cells |
EP1741718A3 (en) * | 1995-06-07 | 2007-03-28 | Sanofi Pasteur Inc. | Expression of lipoproteins |
FR2741358B1 (fr) | 1995-11-17 | 1998-01-02 | Centre Nat Rech Scient | Production de vecteurs retroviraux par l'intermediaire de vecteurs viraux a base de virus a adn |
CU22559A1 (es) * | 1996-01-17 | 1999-05-03 | Ct Ingenieria Genetica Biotech | Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión |
US6355255B1 (en) | 1998-12-07 | 2002-03-12 | Regents Of The University Of Minnesota | Streptococcal C5a peptidase vaccine |
US5846547A (en) | 1996-01-22 | 1998-12-08 | Regents Of The University Of Minnesota | Streptococcal C5a peptidase vaccine |
WO1998008874A1 (en) | 1996-08-27 | 1998-03-05 | Chiron Corporation | Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions |
DE69708318T3 (de) | 1996-08-27 | 2006-11-16 | Novartis Vaccines and Diagnostics, Inc., Emeryville | Neisseria meningitidis serogruppe b glykokonjugate und verfahren zu deren verwendung |
WO1998017805A2 (en) | 1996-10-24 | 1998-04-30 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, c/o Centers for Disease Control and Prevention, Technology Transfer Office | Invasion associated genes from neisseria meningitidis serogroup b |
GB9622159D0 (en) | 1996-10-24 | 1996-12-18 | Solvay Sociutu Anonyme | Polyanionic polymers as adjuvants for mucosal immunization |
GB9622660D0 (en) | 1996-10-31 | 1997-01-08 | Biocine Spa | Immunogenic detoxified mutant toxin |
US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
DE19723095C2 (de) | 1997-06-02 | 2001-08-23 | Siemens Ag | Bildrekonstruktionsverfahren für einen Computertomographen |
CZ299473B6 (cs) | 1997-06-30 | 2008-08-06 | Rhone-Poulenc Rorer S. A. | Nukleová kyselina a elektrické pole jako sdruženýprodukt pro prenos nukleové kyseliny do bunek prícne pruhovaného svalstva |
JP4664450B2 (ja) | 1997-06-30 | 2011-04-06 | アンステイテユ・ギユスタブ・ルシー | 多細胞化真核生物細胞に核酸を導入する改良法およびその組合せ |
BR9810500A (pt) | 1997-06-30 | 2000-09-05 | Rhone Poulenc Rorer Sa | Sistema e aparelho para a transferência de ácido nucléico in vivo para o interior de células de organismos eucarióticos pluricelulares |
KR20010021953A (ko) * | 1997-07-17 | 2001-03-15 | 추후제출 | B군 수막염균 포린 및 에이치.인플루엔자 다당류를포함하는 면역원성 접합체 |
JPH1144977A (ja) | 1997-07-25 | 1999-02-16 | Copyer Co Ltd | 画像形成装置 |
AU9120898A (en) | 1997-08-27 | 1999-03-16 | Chiron Corporation | Molecular mimetics of meningococcal b epitopes |
CA2301662A1 (en) * | 1997-08-29 | 1999-03-04 | The Dow Chemical Company | Homogeneous filled polymer composite |
BR9813930A (pt) | 1997-11-06 | 2006-12-19 | Chiron Spa | antìgeno neisserial |
TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
WO1999036544A2 (en) | 1998-01-14 | 1999-07-22 | Chiron S.P.A. | Neisseria meningitidis antigens |
DK1053329T3 (da) * | 1998-02-03 | 2010-01-25 | Ct Disease Contr & Prevention | Rekombinant lipideret PsaA-protein, fremgangsmåder til fremstilling og anvendelse |
GB9806456D0 (en) | 1998-03-25 | 1998-05-27 | Smithkline Beecham Biolog | Vaccine composition |
GB9808734D0 (en) | 1998-04-23 | 1998-06-24 | Smithkline Beecham Biolog | Novel compounds |
GB9808932D0 (en) | 1998-04-27 | 1998-06-24 | Chiron Spa | Polyepitope carrier protein |
WO2001031019A2 (en) | 1999-10-29 | 2001-05-03 | Chiron Spa | Neisserial antigenic peptides |
JP5102414B2 (ja) * | 1998-05-01 | 2012-12-19 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | 髄膜炎菌抗原および組成物 |
US8007815B1 (en) | 1998-05-29 | 2011-08-30 | Novartis Ag | Combination meningitidis B/C vaccines |
AU1199900A (en) * | 1998-09-30 | 2000-04-17 | Walter Reed Army Institute Of Research | Use of purified invaplex from gram negative bacteria as a vaccine |
MXPA01003228A (es) | 1998-09-30 | 2003-06-24 | American Cyanamid Co | Holotoxina de colera mutante como un coadyuvante. |
EP1144998A3 (en) | 1998-10-09 | 2002-08-07 | Chiron Corporation | Neisseria genomic sequences and methods of their use |
US6660843B1 (en) * | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
US6281337B1 (en) | 1998-11-12 | 2001-08-28 | Schering Corporation | Methods for conversion of protein isoforms |
CA2359486A1 (en) | 1999-01-15 | 2000-07-20 | Smithkline Beecham Biologicals S.A. | Neisseria meningitidis polypeptide basb052 |
AU2292800A (en) | 1999-01-22 | 2000-08-07 | Smithkline Beecham Biologicals (Sa) | Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides andprotective antibodies |
GB9902084D0 (en) * | 1999-01-29 | 1999-03-24 | Smithkline Beecham Biolog | Novel compounds |
SI1150712T1 (sl) | 1999-02-05 | 2009-02-28 | Merck & Co Inc | Pripravek cepiva proti humanem papiloma virusu |
ATE279943T1 (de) | 1999-02-26 | 2004-11-15 | Chiron Srl | Verbesserung der bakterizidaktivität von neisseria antigenen mit cg enthaltende oligonukleotiden |
US6245568B1 (en) | 1999-03-26 | 2001-06-12 | Merck & Co., Inc. | Human papilloma virus vaccine with disassembled and reassembled virus-like particles |
US7115730B1 (en) | 1999-04-27 | 2006-10-03 | Chiron Srl | Immunogenic detoxified mutant E. coli LT-A-toxin |
BR0010361A (pt) | 1999-04-30 | 2003-06-10 | Chiron Corp | Seq ências genÈmicas de neisseria e uso destas |
CN100392082C (zh) | 1999-04-30 | 2008-06-04 | 启龙股份公司 | 保守的奈瑟球菌抗原 |
GB9911683D0 (en) | 1999-05-19 | 1999-07-21 | Chiron Spa | Antigenic peptides |
DK2270173T3 (en) * | 1999-05-19 | 2016-03-07 | Glaxosmithkline Biolog Sa | Neisserial combination compositions |
GB9916529D0 (en) | 1999-07-14 | 1999-09-15 | Chiron Spa | Antigenic peptides |
GB9918319D0 (en) * | 1999-08-03 | 1999-10-06 | Smithkline Beecham Biolog | Vaccine composition |
US7384640B1 (en) | 1999-09-30 | 2008-06-10 | Wyeth Holdings Corporation | Mutant cholera holotoxin as an adjuvant |
WO2001038350A2 (en) | 1999-11-29 | 2001-05-31 | Chiron Spa | 85kDa NEISSERIAL ANTIGEN |
GB9928196D0 (en) * | 1999-11-29 | 2000-01-26 | Chiron Spa | Combinations of B, C and other antigens |
WO2001041800A2 (en) | 1999-12-02 | 2001-06-14 | Chiron Corporation | Compositions and methods for stabilizing biological molecules upon lyophilization |
CN1416352B (zh) * | 2000-01-17 | 2011-05-25 | 启龙股份公司 | 含有脑膜炎奈瑟球菌b血清群外膜蛋白质的外膜囊(omv)疫苗 |
MXPA02008314A (es) * | 2000-02-28 | 2002-12-09 | Chiron Spa | Expresion heterologa de proteinas de neisseria. |
CN1309418C (zh) | 2000-06-08 | 2007-04-11 | 英特塞尔生物医药研究发展股份公司 | 免疫刺激性寡脱氧核苷酸 |
AT410635B (de) | 2000-10-18 | 2003-06-25 | Cistem Biotechnologies Gmbh | Vakzin-zusammensetzung |
RO122761B1 (ro) | 2001-01-23 | 2010-01-29 | Aventis Pasteur | Vaccin multivalent antimeningococic conţinând polizaharid-proteină |
GB0103424D0 (en) | 2001-02-12 | 2001-03-28 | Chiron Spa | Gonococcus proteins |
CA2441327A1 (en) | 2001-03-30 | 2002-10-10 | Geneprot, Inc. | Human arginine-rich protein-related compositions |
US6942802B2 (en) | 2001-04-13 | 2005-09-13 | Wyeth Holdings Corporation | Removal of bacterial endotoxin in a protein solution by immobilized metal affinity chromatography |
CN1306956C (zh) | 2001-04-17 | 2007-03-28 | 希龙公司 | 诱导功能活性抗体的脑膜炎球菌b抗原表位的分子模拟物 |
KR20080078717A (ko) | 2001-06-07 | 2008-08-27 | 와이어쓰 홀딩스 코포레이션 | 보조제로서 콜레라 홀로톡신의 돌연변이체 형태 |
EP1404368B1 (en) | 2001-06-07 | 2009-12-09 | Wyeth Holdings Corporation | Mutant forms of cholera holotoxin as an adjuvant |
GB0115176D0 (en) | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
CA2452720C (en) | 2001-07-26 | 2012-04-17 | Chiron S.R.L. | Vaccines comprising aluminium adjuvants and histidine |
GB0121591D0 (en) | 2001-09-06 | 2001-10-24 | Chiron Spa | Hybrid and tandem expression of neisserial proteins |
US20070020622A1 (en) | 2001-09-14 | 2007-01-25 | Invitrogen Corporation | DNA Polymerases and mutants thereof |
MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
GB0129007D0 (en) | 2001-12-04 | 2002-01-23 | Chiron Spa | Adjuvanted antigenic meningococcal compositions |
PT1490409E (pt) | 2002-03-26 | 2009-04-03 | Novartis Vaccines & Diagnostic | Sacáridos modificados possuindo uma estabilidade melhorada em água |
US20060147466A1 (en) | 2002-05-14 | 2006-07-06 | Chiron Srl | Mucosal combination vaccines for bacterial meningitis |
GB0302218D0 (en) | 2003-01-30 | 2003-03-05 | Chiron Sri | Vaccine formulation & Mucosal delivery |
MXPA04011249A (es) | 2002-05-14 | 2005-06-06 | Chiron Srl | Vacunas mucosales con adyuvante de quitosano y antigenos meningococicos. |
GB0220198D0 (en) | 2002-08-30 | 2002-10-09 | Chiron Spa | Modified saccharides,conjugates thereof and their manufacture |
US7785608B2 (en) * | 2002-08-30 | 2010-08-31 | Wyeth Holdings Corporation | Immunogenic compositions for the prevention and treatment of meningococcal disease |
GB0220194D0 (en) | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
CA2501812C (en) | 2002-10-11 | 2012-07-10 | Mariagrazia Pizza | Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages |
ATE466875T1 (de) | 2002-11-15 | 2010-05-15 | Novartis Vaccines & Diagnostic | Unerwartete oberflächenproteine in neisseria meningitidis |
GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
CA2512917A1 (en) * | 2003-01-15 | 2004-08-05 | Wyeth Holdings Corporation | Methods for increasing neisseria protein expression |
ES2411080T3 (es) | 2003-01-30 | 2013-07-04 | Novartis Ag | Vacunas inyectables contra múltiples serogrupos de meningococos |
EP1603950A2 (en) | 2003-03-17 | 2005-12-14 | Wyeth Holdings Corporation | Mutant cholera holotoxin as an adjuvant and an antigen carrier protein |
MXPA05011110A (es) | 2003-04-16 | 2006-01-24 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de un padecimiento originado por meningococos. |
ES2596553T3 (es) | 2003-06-02 | 2017-01-10 | Glaxosmithkline Biologicals Sa | Composiciones inmunogénicas a base de micropartículas que comprenden toxoide adsorbido y un antígeno que contiene un polisacárido |
CA2530434A1 (en) | 2003-06-23 | 2005-01-06 | Aventis Pasteur, Inc. | Immunization method against neisseria meningitidis serogroups a and c |
GB0316560D0 (en) | 2003-07-15 | 2003-08-20 | Chiron Srl | Vesicle filtration |
RU2378010C2 (ru) | 2003-10-02 | 2010-01-10 | Новартис Вэксинес Энд Дайэгностикс С.Р.Л. | Жидкие вакцины для множественных серогрупп менингококков |
GB0323103D0 (en) | 2003-10-02 | 2003-11-05 | Chiron Srl | De-acetylated saccharides |
WO2005065708A2 (en) | 2003-12-30 | 2005-07-21 | Wyeth | Formulations of hydrophobic proteins in an immunogenic composition having improved tolerability |
GB0406013D0 (en) | 2004-03-17 | 2004-04-21 | Chiron Srl | Analysis of saccharide vaccines without interference |
GB0408977D0 (en) | 2004-04-22 | 2004-05-26 | Chiron Srl | Immunising against meningococcal serogroup Y using proteins |
GB0408978D0 (en) | 2004-04-22 | 2004-05-26 | Chiron Srl | Meningococcal fermentation for preparing conjugate vaccines |
GB0409745D0 (en) | 2004-04-30 | 2004-06-09 | Chiron Srl | Compositions including unconjugated carrier proteins |
GB0500787D0 (en) | 2005-01-14 | 2005-02-23 | Chiron Srl | Integration of meningococcal conjugate vaccination |
BRPI0510315A (pt) | 2004-04-30 | 2007-10-16 | Chiron Srl | integração de vacinação com conjugado meningocócico |
GB0410220D0 (en) | 2004-05-07 | 2004-06-09 | Kirkham Lea Ann | Mutant pneumolysin proteins |
GB0411387D0 (en) | 2004-05-21 | 2004-06-23 | Chiron Srl | Analysis of saccharide length |
GB0413868D0 (en) | 2004-06-21 | 2004-07-21 | Chiron Srl | Dimensional anlaysis of saccharide conjugates |
DE602005025647D1 (de) | 2004-07-23 | 2011-02-10 | Novartis Vaccines & Diagnostic | Polypeptide für die oligomerisierung von antigenen |
GB0419408D0 (en) | 2004-09-01 | 2004-10-06 | Chiron Srl | 741 chimeric polypeptides |
GB0419846D0 (en) | 2004-09-07 | 2004-10-13 | Chiron Srl | Vaccine adjuvants for saccharides |
GB0424092D0 (en) | 2004-10-29 | 2004-12-01 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
GB0428394D0 (en) | 2004-12-24 | 2005-02-02 | Chiron Srl | Saccharide conjugate vaccines |
HUE033196T2 (en) | 2005-01-27 | 2017-11-28 | Children's Hospital & Res Center At Oakland | GNA1870-based vesicle vaccines for broad-spectrum protection against diseases caused by Neisseria meningitidis |
WO2006096701A2 (en) | 2005-03-07 | 2006-09-14 | Id Biomedical Corporation Of Quebec C.O.B. As Glaxosmithkline Biologicals North America | Pharmaceutical liposomal compositions |
EP1885734B1 (en) | 2005-05-06 | 2015-01-14 | Novartis AG | Immunogens for meningitidis-a vaccines |
PT2351578T (pt) | 2005-06-27 | 2017-04-07 | Glaxosmithkline Biologicals Sa | Processo para o fabrico de vacinas |
EP2308505A3 (en) | 2005-09-01 | 2011-11-30 | Novartis Vaccines and Diagnostics GmbH | Multiple vaccines including serogroup C meningococcus |
CA2621578C (en) | 2005-09-05 | 2014-07-22 | Glaxosmithkline Biologicals S.A. | Serum bactericidal assay for n. meningitidis specific antisera |
GB0524066D0 (en) | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
EP1940462A2 (en) | 2005-12-23 | 2008-07-09 | GlaxoSmithKline Biologicals S.A. | Conjugate vaccines |
SI2004225T1 (sl) | 2006-03-22 | 2012-08-31 | Novartis Ag | Reĺ˝imi za imunizacijo z meningokoknimi konjugati |
WO2007127668A2 (en) | 2006-04-26 | 2007-11-08 | Wyeth | Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations |
TW200806315A (en) | 2006-04-26 | 2008-02-01 | Wyeth Corp | Novel formulations which stabilize and inhibit precipitation of immunogenic compositions |
JP5275983B2 (ja) | 2006-06-12 | 2013-08-28 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
GB0612854D0 (en) | 2006-06-28 | 2006-08-09 | Novartis Ag | Saccharide analysis |
CN101479293A (zh) | 2006-06-29 | 2009-07-08 | 诺华有限公司 | 脑膜炎奈瑟球菌多肽 |
DK2061897T3 (da) | 2006-07-27 | 2020-06-02 | Wyeth Llc | Fed-batch-fermenteringsproces med høj celledensitet til fremstilling af rekombinant protein |
AR064642A1 (es) * | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
GB0700562D0 (en) | 2007-01-11 | 2007-02-21 | Novartis Vaccines & Diagnostic | Modified Saccharides |
US20100203137A1 (en) | 2007-06-04 | 2010-08-12 | Mario Contorni | Formulation of meningitis vaccines |
GB0713880D0 (en) | 2007-07-17 | 2007-08-29 | Novartis Ag | Conjugate purification |
GB0714963D0 (en) | 2007-08-01 | 2007-09-12 | Novartis Ag | Compositions comprising antigens |
CA2695467A1 (en) * | 2007-08-02 | 2009-03-26 | Children's Hospital & Research Center At Oakland | Fhbp- and lpxl1-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
CA2702871A1 (en) | 2007-10-19 | 2009-04-23 | Novartis Ag | Meningococcal vaccine formulations |
EP2245048B1 (en) | 2008-02-21 | 2014-12-31 | Novartis AG | Meningococcal fhbp polypeptides |
MX2010008799A (es) | 2008-03-05 | 2010-09-07 | Sanofi Pasteur | Proceso para estabilizar una composicion de vacuna que contiene adyuvante. |
EP2265640B1 (en) * | 2008-03-10 | 2015-11-04 | Children's Hospital & Research Center at Oakland | Chimeric factor h binding proteins (fhbp) containing a heterologous b domain and methods of use |
WO2009143168A2 (en) | 2008-05-19 | 2009-11-26 | Novartis Ag | Vaccine assays |
AU2009262893B2 (en) | 2008-05-30 | 2015-05-21 | The U.S.A., as represented by The Secretary of the Army, on behalf of Walter Reed Army Institute Of Research | Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof |
US8476032B2 (en) | 2008-08-27 | 2013-07-02 | Children's Hospital & Research Center Oakland | Complement factor H-based assays for serum bactericidal activity against Neisseria meningitidis |
US8470340B2 (en) | 2008-09-03 | 2013-06-25 | Children's Hospital & Research Center Oakland | Peptides presenting an epitope of a domain of factor H binding protein and methods of use |
IT1394288B1 (it) | 2008-09-12 | 2012-06-06 | Novartis Vaccines & Diagnostic | Immunogeni di proteine che legano il fattore h. |
CA2738243C (en) | 2008-10-29 | 2020-09-29 | Wyeth Llc | Formulations of single domain antigen binding molecules |
GB0822634D0 (en) | 2008-12-11 | 2009-01-21 | Novartis Ag | Meningitis vaccines |
JP5410084B2 (ja) * | 2008-12-15 | 2014-02-05 | 川上産業株式会社 | 梱包箱及び箱状芯材 |
CN102300585A (zh) | 2008-12-17 | 2011-12-28 | 诺华有限公司 | 包含血红蛋白受体的脑膜炎球菌疫苗 |
WO2010109323A1 (en) * | 2009-03-24 | 2010-09-30 | Novartis Ag | Adjuvanting meningococcal factor h binding protein |
WO2010109324A1 (en) | 2009-03-24 | 2010-09-30 | Novartis Ag | Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates |
MX2011011512A (es) | 2009-04-30 | 2012-02-13 | Novartis Vaccines & Diagnostic | Proteinas de union de factor h quimericas (fhbp) y metodos de uso. |
US9365885B2 (en) | 2009-06-16 | 2016-06-14 | Puiying Annie Mak | High-throughput complement-mediated antibody-dependent and opsonic bactericidal assays |
AU2010288240B2 (en) | 2009-08-27 | 2014-03-27 | Novartis Ag | Hybrid polypeptides including meningococcal fHBP sequences |
IT1395574B1 (it) | 2009-09-14 | 2012-10-16 | Guala Dispensing Spa | Dispositivo di erogazione |
WO2011039631A2 (en) | 2009-09-30 | 2011-04-07 | Novartis Ag | Expression of meningococcal fhbp polypeptides |
GB0917647D0 (en) | 2009-10-08 | 2009-11-25 | Glaxosmithkline Biolog Sa | Expression system |
JP3158225U (ja) * | 2009-10-22 | 2010-03-25 | 王 文燦 | 折畳める物置袋 |
AU2010310985B2 (en) | 2009-10-27 | 2014-11-06 | Glaxosmithkline Biologicals S.A. | Modified meningococcal fHBP polypeptides |
EP2519265B1 (en) | 2009-12-30 | 2018-11-14 | GlaxoSmithKline Biologicals SA | Polysaccharide immunogens conjugated to e. coli carrier proteins |
GB201003922D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Conjugation process |
JP2013521770A (ja) | 2010-03-10 | 2013-06-13 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン組成物 |
BR112012022896A2 (pt) | 2010-03-18 | 2018-03-27 | Novartis Ag | vacinas adjuvantes para meningococos do sorogrupo b |
CN102834410B (zh) | 2010-03-30 | 2016-10-05 | 奥克兰儿童医院及研究中心 | 改性的h因子结合蛋白(fhbp)及其使用方法 |
EP2585106A1 (en) | 2010-06-25 | 2013-05-01 | Novartis AG | Combinations of meningococcal factor h binding proteins |
SI3246044T2 (sl) | 2010-08-23 | 2024-06-28 | Wyeth Llc | Stabilne formulacije antigenov neisseria meningitidis RLP2086 |
ES2744471T3 (es) | 2010-09-04 | 2020-02-25 | Glaxosmithkline Biologicals Sa | Ensayos de anticuerpos bactericidas para evaluar la inmunogenia y la potencia de vacunas de sacárido capsular meningocócico |
ES2585328T5 (es) | 2010-09-10 | 2022-12-14 | Wyeth Llc | Variantes no lipidadas de antígenos ORF2086 de Neisseria meningitidis |
CA2810971C (en) | 2010-09-10 | 2020-11-03 | Novartis Ag | Developments in meningococcal outer membrane vesicles |
GB201015132D0 (en) | 2010-09-10 | 2010-10-27 | Univ Bristol | Vaccine composition |
US20120070457A1 (en) | 2010-09-10 | 2012-03-22 | J. Craig Venter Institute, Inc. | Polypeptides from neisseria meningitidis |
GB201101665D0 (en) | 2011-01-31 | 2011-03-16 | Novartis Ag | Immunogenic compositions |
US20140112950A1 (en) | 2011-03-02 | 2014-04-24 | Manmohan Singh | Combination vaccines with lower doses of antigen and/or adjuvant |
WO2012134975A1 (en) | 2011-03-28 | 2012-10-04 | St. Jude Children's Research Hospital | Methods and compositions employing immunogenic fusion proteins |
RU2665841C2 (ru) | 2012-03-09 | 2018-09-04 | Пфайзер Инк. | Композиции neisseria meningitidis и способы их применения |
SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
JP6446377B2 (ja) | 2013-03-08 | 2018-12-26 | ファイザー・インク | 免疫原性融合ポリペプチド |
US9965924B2 (en) | 2013-07-15 | 2018-05-08 | Ahmnon D. Moskowitz | Methods, systems, and apparatus for playing multi-zone 21 |
EP3041502A2 (en) | 2013-09-08 | 2016-07-13 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
RU2723045C2 (ru) | 2015-02-19 | 2020-06-08 | Пфайзер Инк. | Композиции neisseria meningitidis и способы их получения |
IL267733B2 (en) | 2017-01-31 | 2023-10-01 | Pfizer | NEISSERIA MENINGITIDIS preparations and methods therefor |
-
2001
- 2001-10-11 MX MX2012002655A patent/MX339524B/es unknown
-
2002
- 2002-10-11 ES ES10182345.8T patent/ES2549765T3/es not_active Expired - Lifetime
- 2002-10-11 DK DK10182345.8T patent/DK2341063T3/en active
- 2002-10-11 ES ES10182469.6T patent/ES2625876T3/es not_active Expired - Lifetime
- 2002-10-11 PT PT101824878T patent/PT2371836T/pt unknown
- 2002-10-11 EP EP10182487.8A patent/EP2371836B1/en not_active Expired - Lifetime
- 2002-10-11 ES ES10182611.3T patent/ES2562811T3/es not_active Expired - Lifetime
- 2002-10-11 EP EP10182544.6A patent/EP2371837B1/en not_active Expired - Lifetime
- 2002-10-11 CN CN201511028093.XA patent/CN105617372A/zh active Pending
- 2002-10-11 MX MXPA04003356A patent/MXPA04003356A/es active IP Right Grant
- 2002-10-11 EP EP10182324.3A patent/EP2351767B1/en not_active Expired - Lifetime
- 2002-10-11 DK DK10182437.3T patent/DK2348035T3/en active
- 2002-10-11 ES ES10182544.6T patent/ES2603532T3/es not_active Expired - Lifetime
- 2002-10-11 EP EP10182364.9A patent/EP2348034B1/en not_active Expired - Lifetime
- 2002-10-11 PT PT101822989T patent/PT2332961T/pt unknown
- 2002-10-11 EP EP10182469.6A patent/EP2341062B1/en not_active Expired - Lifetime
- 2002-10-11 EP EP10182345.8A patent/EP2341063B1/en not_active Expired - Lifetime
- 2002-10-11 PT PT101824696T patent/PT2341062T/pt unknown
- 2002-10-11 ES ES17156888T patent/ES2781213T3/es not_active Expired - Lifetime
- 2002-10-11 KR KR1020117022199A patent/KR101215664B1/ko active IP Right Grant
- 2002-10-11 US US10/492,427 patent/US8101194B2/en active Active
- 2002-10-11 DK DK10182611.3T patent/DK2371838T3/en active
- 2002-10-11 ES ES10182437.3T patent/ES2532639T3/es not_active Expired - Lifetime
- 2002-10-11 IL IL16105202A patent/IL161052A0/xx active IP Right Grant
- 2002-10-11 PT PT101825909T patent/PT2348036E/pt unknown
- 2002-10-11 CA CA2918207A patent/CA2918207C/en not_active Expired - Lifetime
- 2002-10-11 DK DK10182469.6T patent/DK2341062T3/en active
- 2002-10-11 ES ES10182399.5T patent/ES2603531T3/es not_active Expired - Lifetime
- 2002-10-11 JP JP2003563462A patent/JP2005515771A/ja active Pending
- 2002-10-11 DK DK10182298.9T patent/DK2332961T3/en active
- 2002-10-11 KR KR1020107022714A patent/KR20100121699A/ko not_active Application Discontinuation
- 2002-10-11 ES ES10182590.9T patent/ES2561430T3/es not_active Expired - Lifetime
- 2002-10-11 PT PT101823243T patent/PT2351767E/pt unknown
- 2002-10-11 CA CA2939781A patent/CA2939781C/en not_active Expired - Lifetime
- 2002-10-11 ES ES02804818.9T patent/ES2568895T3/es not_active Expired - Lifetime
- 2002-10-11 EP EP20100182437 patent/EP2348035B1/en not_active Expired - Lifetime
- 2002-10-11 ES ES10182364.9T patent/ES2609039T3/es not_active Expired - Lifetime
- 2002-10-11 PT PT101830206T patent/PT2343308E/pt unknown
- 2002-10-11 ES ES10182324.3T patent/ES2549764T3/es not_active Expired - Lifetime
- 2002-10-11 ES ES10183020.6T patent/ES2532640T3/es not_active Expired - Lifetime
- 2002-10-11 PT PT101824373T patent/PT2348035E/pt unknown
- 2002-10-11 PT PT171568884T patent/PT3199539T/pt unknown
- 2002-10-11 EP EP10182298.9A patent/EP2332961B1/en not_active Expired - Lifetime
- 2002-10-11 CN CN028233301A patent/CN1578785B/zh not_active Expired - Lifetime
- 2002-10-11 PT PT101826113T patent/PT2371838E/pt unknown
- 2002-10-11 BR BRPI0212999A patent/BRPI0212999B8/pt not_active IP Right Cessation
- 2002-10-11 PT PT101823458T patent/PT2341063E/pt unknown
- 2002-10-11 KR KR1020107002131A patent/KR101099916B1/ko active IP Right Grant
- 2002-10-11 WO PCT/US2002/032369 patent/WO2003063766A2/en active Application Filing
- 2002-10-11 CA CA2849427A patent/CA2849427C/en not_active Expired - Lifetime
- 2002-10-11 EP EP02804818.9A patent/EP1442047B1/en not_active Expired - Lifetime
- 2002-10-11 DK DK17156888.4T patent/DK3199539T3/da active
- 2002-10-11 CA CA2463476A patent/CA2463476C/en not_active Expired - Lifetime
- 2002-10-11 DK DK10183020.6T patent/DK2343308T3/en active
- 2002-10-11 EP EP10182399.5A patent/EP2366707B1/en not_active Expired - Lifetime
- 2002-10-11 DK DK10182487.8T patent/DK2371836T3/en active
- 2002-10-11 EP EP20100183020 patent/EP2343308B1/en not_active Expired - Lifetime
- 2002-10-11 CA CA2894296A patent/CA2894296C/en not_active Expired - Lifetime
- 2002-10-11 EP EP17156888.4A patent/EP3199539B1/en not_active Expired - Lifetime
- 2002-10-11 CN CN201210209882.3A patent/CN102836426B/zh not_active Expired - Lifetime
- 2002-10-11 EP EP10182590.9A patent/EP2348036B1/en not_active Expired - Lifetime
- 2002-10-11 KR KR1020047005313A patent/KR101068318B1/ko active IP Right Review Request
- 2002-10-11 EP EP10182611.3A patent/EP2371838B1/en not_active Expired - Lifetime
- 2002-10-11 DK DK10182590.9T patent/DK2348036T3/en active
- 2002-10-11 CN CN201210211368.3A patent/CN102755631B/zh not_active Expired - Lifetime
- 2002-10-11 DK DK10182324.3T patent/DK2351767T3/en active
- 2002-10-11 ES ES10182298.9T patent/ES2593360T3/es not_active Expired - Lifetime
- 2002-10-11 ES ES10182487.8T patent/ES2615206T3/es not_active Expired - Lifetime
-
2004
- 2004-03-24 IL IL161052A patent/IL161052A/en active Protection Beyond IP Right Term
-
2009
- 2009-03-20 US US12/408,286 patent/US9107873B2/en not_active Expired - Lifetime
- 2009-03-20 US US12/408,076 patent/US20120034261A1/en not_active Abandoned
- 2009-09-10 AU AU2009213040A patent/AU2009213040C1/en active Active
-
2010
- 2010-01-18 JP JP2010007996A patent/JP5404441B2/ja not_active Expired - Lifetime
-
2011
- 2011-12-21 US US13/333,123 patent/US8563006B2/en not_active Expired - Lifetime
-
2012
- 2012-04-25 US US13/455,268 patent/US9132182B2/en not_active Expired - Lifetime
- 2012-04-25 US US13/455,326 patent/US9623101B2/en not_active Expired - Lifetime
- 2012-04-25 US US13/455,518 patent/US20120308595A1/en not_active Abandoned
- 2012-05-18 AU AU2012202916A patent/AU2012202916C1/en active Active
- 2012-10-11 MX MX2015018022A patent/MX349481B/es unknown
-
2013
- 2013-04-30 HK HK13105277.8A patent/HK1178429A1/zh not_active IP Right Cessation
- 2013-05-21 HK HK13106021.5A patent/HK1178800A1/zh not_active IP Right Cessation
- 2013-06-05 US US13/910,187 patent/US8563007B1/en not_active Expired - Lifetime
- 2013-07-31 JP JP2013158937A patent/JP5923070B2/ja not_active Expired - Lifetime
-
2014
- 2014-07-08 IL IL233545A patent/IL233545A/en active IP Right Grant
-
2015
- 2015-03-05 US US14/639,543 patent/US9168293B2/en not_active Expired - Lifetime
- 2015-05-18 JP JP2015100931A patent/JP5976880B2/ja not_active Expired - Lifetime
- 2015-07-29 LU LU92786C patent/LU92786I2/xx unknown
- 2015-08-06 US US14/820,452 patent/US9757444B2/en not_active Expired - Lifetime
- 2015-08-10 FR FR15C0056C patent/FR15C0056I2/fr active Active
-
2016
- 2016-03-02 JP JP2016040311A patent/JP5997400B2/ja not_active Expired - Lifetime
- 2016-05-31 IL IL245956A patent/IL245956B/en active IP Right Grant
- 2016-05-31 IL IL245955A patent/IL245955B/en active IP Right Grant
- 2016-07-21 JP JP2016143674A patent/JP2017025061A/ja not_active Withdrawn
-
2017
- 2017-02-27 US US15/443,618 patent/US10300122B2/en not_active Expired - Lifetime
- 2017-10-11 NL NL300897C patent/NL300897I2/nl unknown
- 2017-10-11 LU LU00040C patent/LUC00040I2/en unknown
- 2017-10-11 NL NL300899C patent/NL300899I2/nl unknown
- 2017-10-11 LU LU00041C patent/LUC00041I2/en unknown
- 2017-10-11 LU LU00042C patent/LUC00042I2/en unknown
- 2017-10-11 NL NL300896C patent/NL300896I2/nl unknown
- 2017-11-10 FR FR17C1043C patent/FR17C1043I2/fr active Active
- 2017-11-10 FR FR17C1042C patent/FR17C1042I2/fr active Active
- 2017-11-10 FR FR17C1044C patent/FR17C1044I2/fr active Active
- 2017-11-23 BE BE2017C055C patent/BE2017C055I2/fr unknown
- 2017-11-23 BE BE2017C056C patent/BE2017C056I2/fr unknown
- 2017-11-23 BE BE2017C057C patent/BE2017C057I2/fr unknown
-
2018
- 2018-05-22 AU AU2018203627A patent/AU2018203627A1/en not_active Withdrawn
-
2019
- 2019-02-07 US US16/270,067 patent/US20190151431A1/en not_active Abandoned
-
2020
- 2020-01-07 US US16/736,619 patent/US11116829B2/en not_active Expired - Lifetime
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105879021A (zh) * | 2006-04-26 | 2016-08-24 | 惠氏公司 | 使免疫原性组合物稳定且抑制其沉淀的新颖调配物 |
CN110845585A (zh) * | 2010-03-30 | 2020-02-28 | 奥克兰儿童医院及研究中心 | 改性的h因子结合蛋白(fhbp)及其使用方法 |
CN107056901A (zh) * | 2012-03-09 | 2017-08-18 | 辉瑞公司 | 脑膜炎双球菌组合物及其方法 |
CN107056901B (zh) * | 2012-03-09 | 2021-05-07 | 辉瑞公司 | 脑膜炎双球菌组合物及其方法 |
CN104602704A (zh) * | 2012-06-14 | 2015-05-06 | 诺华股份有限公司 | 针对血清组x脑膜炎球菌的疫苗 |
US10376573B2 (en) | 2012-06-14 | 2019-08-13 | Glaxosmithkline Biologicals Sa | Vaccines for serogroup X meningococcus |
CN106434720A (zh) * | 2016-08-03 | 2017-02-22 | 中国医学科学院医学生物学研究所 | 提高脑膜炎奈瑟菌fHBP蛋白表达的方法 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1578785A (zh) | 预防和治疗脑膜炎球菌性疾病的新型免疫原性组合物 | |
CN1867354A (zh) | 预防和治疗脑膜炎球菌疾病的新颖免疫原性组合物 | |
CN101631858A (zh) | 用于预防和治疗脑膜炎球菌疾病的新颖免疫原性组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20130313 |